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Abstract
Exercise is fundamental to a return to normal living after a Spinal Cord Injury (SCI) but is
complicated by a rapid decline in function and fitness immediately following the injury. In
addition to muscle paralysis, Orthostatic Hypotension (OH), a decline in cardiopulmonary
and vascular fitness, extensive muscle atrophy and bone demineralization each contribute to
an inability to carry out effective forms of exercise. Suitable rehabilitation technologies are
central to overcoming these complications and to facilitate recovery. The aim of the work
presented in this thesis was to identify technologies which may be used for exercise during SCI
rehabilitation, with a focus on early-stage SCI patients at the beginning of the rehabilitation
process. Two such technologies were identified and investigated: Robotic Assisted Tilt Table
Therapy (RATTT) and Whole Body Vibration (WBV). The suitability of these technologies
was evaluated by measuring the acute physiological responses of SCI patients during intensive
use of these systems.
Robotic Assisted Tilt Table Therapy is primarily used to treat OH in stroke and SCI patients.
However, the potential therapeutic effect of RATTT as an exercise modality has so far
not been investigated. An investigation into the physiological responses of early-stage SCI
patients during intensive RATTT stepping was therefore carried out. The intention was to
determine whether RATTT may potentially be used for the combined purpose of increasing
orthostatic tolerance, improving cardiopulmonary fitness and improving vascular health.
RATTT is particularly suited to early-stage rehabilitation because orthostatic tolerance is
not a prerequisite for its use. Three motor-complete and three motor-incomplete early-
stage SCI patients were recruited from the Queen Elizabeth National Spinal Injuries Unit
(QENSIU) in Glasgow to participate in this cross-sectional study. The cardiopulmonary and
vascular responses to different RATTT stepping conditions, including the combination of
RATTT stepping with Functional Electrical Stimulation (FES), were investigated. Increases
in oxygen uptake, respiratory exchange ratio, minute ventilation and heart rate were found
for both motor-incomplete and motor-complete SCI participants. The responses were largest
for the motor-incomplete volunteers with Metabolic Equivalent (MET) values between 1.5 -
3.1. These results confirmed that RATTT can be used as an exercise modality during early-
stage SCI rehabilitation.
Whole Body Vibration was initially developed and commercialised for application during
exercise in a general population with no neurological deficit, and while the physiological
mechanisms which underly the response to WBV are still relatively poorly understood,
current research suggests that WBV may lead to increases in muscle strength, power,
bone mineral density and flexibility. It is hypothesised that the neuromuscular response
to WBV is achieved through reflex activity, though the specific neural pathway is broadly
debated. Nonetheless, an increase in neuromuscular activity duringWBV has been confirmed,
suggesting that it may potentially be used to increase muscle mass, strength and power, and
therefore counteract muscle atrophy and bone demineralization in SCI. However, little is
known about the neuromuscular response of SCI patients to WBV, and it is not clear how
to best administer WBV to this patient group or which vibration parameters should be
applied. A WBV platform was therefore integrated with a partial Body Weight Support
(pBWS) system in order to investigate the application of WBV during SCI rehabilitation.
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The feasibility of this approach was determined in the first instance in experiments with
participants from a general population with no neurological deficit, followed by an evaluation
with a SCI population. The aim was to determine if the stimulus from WBV applied in
conjunction with pBWS was sufficient to elicit an increased neuromuscular response, and if
so, to characterise the magnitudes and trends of the responses.
Ten participants with no neurological deficit were recruited to investigate the feasibility
of WBV-pBWS and to establish a normative data set with which to compare the results
from 14 SCI participants recruited from QENSIU. The main factors under investigation were
vibration frequency, vibration amplitude, level of pBWS, muscle group and classification of
SCI. It was shown that WBV did elicit an increase in neuromuscular activity and that the
magnitude of the response could be moderated by vibration frequency, vibration amplitude
and level of pBWS. Average changes relative to baseline measurements were up to 71% for
the neurologically intact participants, and between 44% to 66% for the SCI participants
depending on classification of injury. Neuromuscular activity was characteristic for each
muscle group and the characteristic was principally moderated by the proximity of the muscle
to the WBV platform and peak platform acceleration. Despite the relatively large change
in neuromuscular activity when compared to baseline, the absolute changes in activity were
relatively small and likely to be of insufficient magnitude to result in muscle hypertrophy.
Results from this study indicated that WBV was of sufficient intensity to elicit a response
from the α-motoneuron but of insufficient intensity to increase muscle strength. Based on
this, the potential use of WBV as a non-pharmacological treatment of spasm was identified
by stimulating part of the neural pathway upon which spasm acts and therefore provide
a mechanism to moderate the threshold for spasm, without the risk of increasing muscle
strength and therefore potential for injury during a spastic episode.
In summary, this thesis presents RATTT and WBV-pBWS as two modalities suitable for
use in early-stage SCI rehabilitation. While RATTT can elicit substantial cardiopulmonary
responses in this patient group, the evaluation of WBV showed limited effects on muscle
activation, but suggested potential application in the treatment of spasticity.
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vThesis Outline
• Chapter 1: This chapter introduces the physiological background of the spinal cord
and Spinal Cord Injury (SCI). The normal function of the central nervous system
is disrupted after a SCI and the prevalence, etiology, and consequences of a SCI
are therefore described. Some of the chronic complications that arise secondary to
a SCI are outlined, emphasising the importance of developing exercise technologies
and protocols, which facilitate SCI rehabilitation. Two such technologies which
were researched in detail for this thesis are Robotic Assisted Tilt Table Therapy
(RATTT) and Whole Body Vibration (WBV) with partial Body Weight Support
(pBWS). The underlying principals of the measurement systems used to assess
the physiological responses of neurologically-intact and spinal cord injury volunteers
to these rehabilitation technologies, which included metabolic rate (pulmonary gas
exchange) and neuromuscular activity (EMG activity), are described.
• Chapter 2: RATTT was investigated to determine its potential application for exercise
during SCI rehabilitation. The study was carried out with a cross-sectional sample
taken from an early-stage (<1 year) SCI population with no lower motor neuron
damage. The potential therapeutic effect of RATTT was determined by assessing the
cardiopulmonary and vascular responses during different stepping conditions for motor-
incomplete SCI and motor-complete SCI participants. The results were compared to
exercise loads in the general population by calculating the metabolic equivalent (MET).
• Chapter 3: This chapter presents a review of the literature on WBV. The review
initially focuses on the acute responses of those from the general population with no
neurological deficit and those with a SCI to WBV. Following this, the main theories
describing howWBV elicits an increased neuromuscular response are described. Studies
investing the chronic changes in muscle after a period of WBV training are presented,
with a focus on changes in muscle strength and muscle power.
• Chapter 4: The experimental methods and protocols used for the WBV studies
outlined in Chapters 5 & 6 are presented, with focus on the experimental setup of
WBV-pBWS system and the resultant data analysis techniques.
• Chapter 5: This chapter presents the first stage of the WBV-pBWS investigation
which was carried out with a sample from the general population with no neurological
deficit. A general population was used in the first instance to establish a normative
baseline with which to compare the response of those with a SCI, and to establish
a suitable protocol for application in SCI. The acute neuromuscular response of the
lower limb to different WBV conditions and levels of pBWS were investigated using
Electromyography (EMG) measurements.
• Chapter 6: This chapter presents the second stage of the WBV-pBWS investigation
which was carried out with a cross-sectional sample taken from a SCI population.
The experimental protocol was informed by the findings from the first stage, with
variations applied to take account of the unique challenges presented by those with a
SCI. The acute neuromuscular response of the lower limb muscles to different WBV
conditions were again investigated using EMG. A case study is included in this chapter
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which investigates the measured electromyographic response from a SCI participant
with flaccid paralysis in order to validate some of the oﬄine filtering techniques used
throughout this thesis.
• Chapter 7: This chapter summarises the conclusions of the thesis and outlines
future work. Observations from both WBV-pBWS studies indicated an increased
neuromuscular response to WBV. The relatively small changes found in SCI may
preclude the use of the technology for increasing the mass or strength of paralysed
muscle, however other equally important uses of the technology for SCI rehabilitation
are discussed which include the treatment of spasm. Suggestions are made for future
improvements to the system design.
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Contributions
1. This thesis presents the first research study which investigated the potential therapeutic
benefit of Robotic Assisted Tilt Table Therapy (RATTT) for cardiopulmonary exercise
in a Spinal Cord Injury (SCI) population. A novel feedback system was developed and
used to encourage greater voluntary participation in the stepping exercise.
2. The RATTT study was the first to directly compare the vascular and cardiopulmonary
responses of both motor-complete and motor-incomplete SCI participants during
non Functional Electrical Stimulation (FES) supported, and FES-supported, RATTT
stepping.
3. A new system was developed which allowed the application of Whole Body Vibration
(WBV) to a SCI population by combining it with a partial Body Weight Support
(pBWS) system. WBV was applied in a standing position rather than on a tilt-table,
standing frame or from a chair as was done previously. This novel system allowed
the examination of the neuromuscular response of both neurologically-intact and SCI
volunteers using similar experimental protocols.
4. This research was the first to investigate and describe the acute, steady-state
neuromuscular response of a general population with no neurological deficit to a broad
range of vibration conditions at reduced load. Changes in loading during previous
applications of WBV were achieved only by increasing the supported weight carried by
the participants.
5. This research assessed the feasibility of applying WBV to a SCI population and
quantified the acute, steady-state neuromuscular response. The investigation was the
first to quantitatively determine and compare the acute neuromuscular responses of
early-stage (<1 year) motor-complete and motor-incomplete SCI populations to a broad
range of vibration conditions in a standing position.
6. Vibration artefact was detected in the Electromyogram (EMG) recorded during WBV.
An appropriate filtering technique was established through statistical analysis and
validated by testing on EMG recorded from a SCI participant with flaccid paralysis.
7. Precision acceleration measurements were used to accurately determine the specific
WBV platform position throughout each test. A novel analysis approach was used
which combined acceleration and EMG measurements to qualitatively describe the
neuromuscular responses of the entire sampled population during a single cycle of the
WBV platform. These findings support the hypothesis that the neuromuscular response
to WBV is moderated by peak acceleration.
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1Chapter 1
Introduction
This thesis presents two studies that have investigated exercise technologies and their poten-
tial application in Spinal Cord Injury (SCI) rehabilitation. Methods for the measurement and
interpretation of these physiological changes are outlined. The effect of damage to the spinal
cord is described, outlining how SCI is classified and describing some of the primary and
secondary complications that arise. The reader is referred to the appendix for a description
of the basic anatomy, structure, and function of the spinal cord and nervous system, along
with a description of how communication within the nervous system occurs, and how this
allows movement to occur via motor action from muscle fibers and their sensory response.
1.1 Physiological Measurements of Muscle
Exercise is carried out by increasing volitional movement at an increased rate or load,
therefore increasing the stress placed on the cardiopulmonary and respiratory systems. To
predict the efficacy of a particular form of exercise it is necessary to measure and record
the magnitude of muscle cell activity during exercise. Two suitable techniques that may be
employed are: (i) EMG, which directly measures neuromuscular activity, and (ii) pulmonary
gas exchange analysis which can be used to infer cell metabolism. Each of these techniques
are used in the studies described in this thesis. The studies investigate the potential benefit
of new rehabilitation techniques for exercise in SCI patient populations.
1.1.1 Electromyography
Electromyography is the recording of the Motor Unit Action Potential (MUAP) generated by
a muscle by placing electrodes in the immediate vicinity of the muscle fiber. MUAP are small,
and are normally in the µV scale. An electromyogram is produced by EMG and is described
as a graphical representation of neuromuscular activity. To record an EMG using modern
recording equipment, it is necessary to amplify the MUAP in order to detect it. The most
common type of amplifier is the differential amplifier. Differential amplification requires the
placement of two detection electrodes in parallel with the muscle fiber. A reference electrode
is placed at an electrically inactive region of the body, away from the muscle fiber (Figure
1.1). Common background signals are detected by the reference electrode and subtracted
from detection electrodes. The amplifier also subtracts the signals recorded from the two
detection electrodes from each other. This allows for the detection of the localised potential
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difference between the two electrodes.
Figure 1.1: Schematic of a single motor unit action potential detected by electromyography.
An action potential propagating along the sarcolemma of the muscle fibre is first detected by
Electrode1. The potential difference reaches a maximum as it passes the first electrode, zero
when it is equidistant to both electrodes and a minimum as it passes the second electrode.
For this reason the action potential creates a bipolar output when it is detected in this way.
A single motor unit action potential can be detected using fine-wire EMG. A needled electrode
inserted into the belly of the muscle can be used to detect a MUAP as it propagates along
the sarcolemma of the muscle fibre. Fine-wire electromyography is particularly suited to
studying the physiology and pathology of individual motor units. Alternatively, the activity
of a several motor units (Compound Motor Action Potential (CMAP)), can be recorded using
surface EMG electrodes. During surface EMG, the detection electrodes are affixed to the skin
over the belly of the muscle rather than inserted into the muscle. Surface EMG is better suited
for investigating more general aspects of neuromuscular activity, such as activation timing
during dynamic contractions, temporal activity, or fatigue. The output will be a summation
of the individual MUAP’s due to the spatial distribution of the muscle fibres with respect to
the detection electrodes as described in Figure 1.2 below.
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Figure 1.2: Schematic outlining the superposition of several action potentials propagating
along different muscle fibres within a single motor unit. The action potential detected by the
detection electrodes placed over the surface of the muscle record a potential difference that
represents the summation of the individual action potentials for each muscle fibre.
1.1.2 Pulmonary Gas Exchange Analysis
Adenosine Triphosphate (ATP) production can be anaerobic or aerobic. At the onset of
exercise, phosphocreatine may be used to produce ATP in the absence of oxygen. However,
there is a limited store of phosphocreatine in the muscle and alternative production methods
are required which include glycolysis and oxidative phosphorylation. ATP and pyruvic acid
are produced during glycolysis. In the absence of oxygen, pyruvic acid is converted into lactic
acid. Oxygen is also required to convert lactic acid back into pyruvic acid during rest and
recovery. During oxidative phosphorylation, oxygen and pyruvic acid are ultimately converted
into energy which is used to produce ATP, carbon dioxide, and water. The supply of oxygen
and the disposal of carbon dioxide is therefore central to sustained muscular activity, and are
linked to respiration as described in Figure 1.3.
Figure 1.3: Schematic describing the coupling of respiration at the pulmonary and cellular
level (adapted from Wasserman et al. [1]). Oxygen consumed, and carbon dioxide produced
at the cellular level are transported by the blood via gas exchange at the lungs to the mouth.
Therefore, recording minute ventilation of oxygen (V˙ O2) and carbon dioxide (V˙ CO2) at the
mouth may be used to infer the muscle metabolism at the cellular level.
Inspired oxygen (V˙ O2) and expired carbon dioxide (V˙ CO2) are transported via the
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circulatory system to and from the mitochondria. These parameters can therefore be
measured at the mouth to infer that which is occurring at the cellular level within the muscle.
1.2 Spinal Cord Injury
A Spinal Cord Injury (SCI) causes damage to the spinal cord resulting in extensive disruption
of the central nervous system leading to significant, global health complications. The damage
to white and grey matter severely disrupts the passing of motor and sensation signals to and
from the brain. The primary consequence of SCI is therefore paralysis of the muscles below
the level of lesion. In some cases the degree of paralysis is minor and significant functionality
may be regained with appropriate health care, management, and physical rehabilitation. In
other cases, the degree of paralysis is severe, and the patient will require a lifetime of extensive
care and management.
SCI is most commonly the result of a trauma caused by a road traffic incident, fall, or
penetrating injury [2]. Depending on the level and severity of the SCI mobility, breathing,
sexual function, bowel function and bladder function can be compromised. Autonomic
disruption may affect the regulation of heart rate, blood pressure, breathing and body
temperature. High cervical injuries result in compromised motor function of the upper limb,
torso and lower limb, and ventilator dependance due to paralysis of the breathing muscles is
common. Low cervical to mid thoracic injuries result in some preserved upper limb and torso
strength but disrupted autonomic function. Low thoracic and high lumber injuries result in
slightly compromised upper body strength but autonomic function is normal. Low lumbar
and sacral injuries result in normal upper body strength but in some cases areflexia of the
lower limb, bowel and bladder occurs.
These severe complications are likely the reason that tetraplegia was initially described as “an
ailment not to be treated” 1 when first diagnosed by an Eqyptian physician around 2500BC.
More recently during World War 1, 10% of patients survived the first year of cord injury,
reducing to 1% after 20 years of injury. However, today with appropriate health care and
management life expectancy is almost normal.
It is now common for the immediate period after cord injury to be sedentary. Most patients
will be surgically stabilised and immobilised after a traumatic SCI. Immobilisation is
necessary to allow skeletal deformities to repair and therefore minimises the risk of further
neurological damage from an unstable fracture. There is a series of chronic complications
which arise subsequently and are secondary to the cord injury. Such complications include
muscle atrophy, bone demineralisation, spasticity, pressure sores, orthostatic hypotension,
and autonomic dysreflexia. Paralysis and immobilisation significantly contribute to the
onset of these secondary health complications. The inability to partake in effective physical
exercise delays rehabilitation and minimises the chance of regaining functionality. The risk
of pneumonia, septicemia, pulmonary emboli, obesity and death from cardiovascular attack
therefore increases.
1A. Swain, ABC of spinal cord injury, BMJ Publishing Group, 4th ed., 2002.
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Re-mobilisation and exercise is primarily delayed due to immobilisation which facilitates the
onset of orthostatic intolerance. Compromised vasomotor control and orthostatic intolerance
result in an inability to participate in intensive exercise. Specialised rehabilitation is therefore
required to achieve orthostatic tolerance, therefore delaying participation in exercise activities
further. Once orthostatic tolerance is achieved, disuse induced muscle atrophy leads to an
inability to participate in prolonged periods of exercise due to muscle fatigue. The inability
to exercise contributes to an additional decline in cardiopulmonary fitness, an increase in the
prevalence of obesity, and an increase in the risk of cardiovascular attack.
Muscle atrophy is linked to the decline in cardiopulmonary health. The inability to utilise
to the large, oxidative muscles of the body reduces the demand normally placed on the
cardiopulmonary and vascular systems, therefore resulting in the decline in their function. To
break this cycle there is now a focus on the utilisation of technology to facilitate rehabilitation
and exercise in the early-stages of SCI, before the onset of secondary health complications.
1.2.1 Overview, Prevalence & Etiology
99 patients were diagnosed with a SCI in Scotland in 2011/12. This was reported to be
consistent with the previous 5 years, where the year on year average of new injuries is 104
per year [3], or approximately one injury per 50,000 population. There is a reasonably
even distribution in the type of injury, where it was reported in the latest Queen Elizabeth
National Spinal Injuries Unit for Scotland Annual Report that, of the new SCI cases reported
in 2011/12, 29 were classed as complete tetraplegia, 31 were complete paraplegia, and 39 were
incomplete tetraplegia or paraplegia. Across all age groups, more males than females suffer a
neurological cord injury. In general there is a reasonably even spread in the number of injuries
across all age groups, with a slight peak in the 20 - 29yrs, and 70 - 79yrs age groups [3]. There
has traditionally been a larger number of injuries in the younger age groups [4]. However,
the increase in the number of injuries now being found in those in the older age groups has
been attributed to an increase in the number degenerative spinal fractures, whose incidence
increase with age [3].
In Scotland, the highest cause of all injuries is falls (55%), followed by road traffic incidents
(23%), with the remainder being made up by sporting injuries, assault, penetrative injuries,
self harm, and disease [3]. In a recent report by the National Spinal Cord Injury Statistical
Centre, which holds a database of patients with SCI in the USA, the main causes of injury
are a reverse of those reported for Scotland. 40% of injuries were a result of road traffic
incidents, and 30% a result of falls in 2005 [5].
Mortality is at its highest within the first year of injury, with life expectancy generally
increasing thereafter. With appropriate medical treatment, management, and lifelong care,
life expectancy is now approaching normal levels. As a result, the leading cause of death
in SCI is now pneumonia and septicemia [5, 6], in addition to some of the leading causes of
death in the general, non-SCI, population such as cardiovascular disease [7].
The typical length of stay in acute care and rehabilitation post-injury typically depends on
severity of cord injury. The average length of stay for those with complete tetraplegia is 170
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days (Range: 4 - 434 days), complete paraplegia is 119 days (Range: 16 - 293 days), and
incomplete tetraplegia or paraplegia is 31 days (Range: 1 - 218 days) [3]. This is considerably
different to the length of stay reported for those in the USA, where the average length of stay
is 11 days [5]. The large difference in the reported length of stay is attributed to the different
philosophies of treatment and rehabilitation practiced in the different countries.
In Scotland, it is reported that the majority of patients do not require re-admission when
discharged. Where re-admission is required, it has largely been due to skin problems
manifested in the form of decubitus ulcers. The main health problems that SCI patients
report, but which do not require re-hospitalisation include: pain and/or spasm (57%), halo
fixation (33%), and urology problems (5%), with the remainder made up by skin problems,
sexual dysfunction, and fertility issues.
SCI, while uncommon, considerably affects an individuals health, social life and work status.
The complexity and severity of this type of injury requires specialised and lifelong after
care. The following sections provide a brief overview of how SCI is classified and the type of
complications that arise secondary to a cord injury.
1.2.2 Classification
The American Spinal Injury Association (ASIA) ‘standard neurological classification of spinal
cord injury’ is a commonly used technique to determine the extent of neurological deficit that
has occurred as a result of a SCI. Pin prick & soft touch sensation, muscle power, reflexes
and cranial nerve function are tested. Sensation at the dermatomes identified in Figure 1.4
are classed as 0 (absent), 1 (partial), 2 (normal) or Not Testable (NT) [8]. The power of
key muscle groups, which include the: elbow flexors and extensors, wrist extensors, finger
flexors and small finger abductors, hip flexors, knee extensors, ankle dorsiflexors, long toe
extensors and ankle plantar flexors tested are also tested. Muscle strength is graded as 0
(total paralysis), 1 (visible contraction), 2 (gravity eliminated full range of motion), 3 (full
range of motion against gravity), 4 (full range of motion against some resistance), 5 (normal,
full range of motion against full resistance) or NT [8]. These dermatomes and myotomes
have been chosen because they are most easily accessed in a supine position. Sacral segments
are tested by digitally checking mucocutaneous and deep anal sensation and voluntary anal
contraction [9]. Based on these tests, the neurological level of lesion is defined as the most
caudal segment of the spinal cord at which sensory and motor function is normal. In some
cases, the neurological level of injury can be quite different to the level at which the largest
degree of vertebral damage has occurred, in the case of vertebral damage due to trauma.
If there is no motor or sensory function below the neurological level of lesion, the injury is
described as being ‘complete’. If some sensory or motor function is preserved below the level
of lesion, the injury injury is described as ‘incomplete’. In some cases, it is possible for an
injury to be motor complete but sensory incomplete (Table 1.1). Depending on the degree
of preserved function, or lack there of, the 5-point ASIA Impairment Scale (AIS) is used to
classify the injury [8]. Paralysis that affect all four limbs is described as tetraplegia, and
paralysis that affects the lower limbs only is described as paraplegia [10].
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Figure 1.4: Standard neurological classification of spinal cord injury [8].
Table 1.1: ASIA Impairment Scale. (Adapted from from May et. al. [8])
Score Description
A Complete. No sensory or motor function preserved in the sacral segments
S4 - S5.
B Incomplete. Sensory but no motor function preserved below neurological
level of lesion, including the sacral segments S4 - S5.
C Incomplete. Sensory and motor function preserved below the
neurological level of lesion. More than half of the key muscles below
the level of have a muscle score < 3.
D Incomplete. Sensory and motor function preserved below the
neurological level of lesion. More than half of the key muscles below
the level of lesion have a muscle score ≥ 3.
E Normal. Sensory and motor function is normal.
1.2.3 Spinal Syndromes
In addition to ASIA classification, the damage caused by a SCI can generally be described
by one of a number of different syndromes, depending on the level and degree of damage
done to the ascending sensory and motor tracts. An anterior cord syndrome generally
results in preserved proprioception but reduced motor function and sensitivity to pain and
temperature (Figure 1.5(a)) [8]. A central cord syndrome generally results in a weakened
upper limb compared to the lower limb and sacral sparing (Figure 1.5(b)) [8]. A posterior cord
syndrome generally results in good power, and pain and temperature sensation but diminished
proprioception (Figure 1.5(c)) [8]. Brown-Sequard syndrome arises when damage occurs to
a hemisphere of the spinal cord and generally results in ipsilateral proprioception and motor
loss, and diminished contralateral pain and temperature sensitivity (Figure 1.5(d)) [8]. These
syndromes are all described as upper motor neuron lesions.
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Conus medullaris and cauda equina syndromes result in damage to the lumbar and sacral
spinal roots resulting in a loss of bowel, bladder and lower limb reflexes [9]. These syndromes
are described as lower motor neuron lesions as they results in areflexia. In some cases, if the
damage to the conus medullaris is sufficiently caudal, the damage resembles an upper motor
neuron lesion.
The neurological deficit and compromised functional ability of this patient population leads
to a number of neurological, skeletal and muscular changes that require careful management
and rehabilitation to minimise the number, and delay the onset, of subsequent chronic health
complications.
(a) Anterior cord syndrome (b) Central cord syndrome
(c) Posterior cord syndrome (d) Brown-Sequard syndrome
Figure 1.5: Upper motor neuron syndromes (Adapted from Swain et. at. [9]).
1.2.4 Chronic Complications
In addition to neurological impairment culminating in paralysis and compromising the normal
functioning of the autonomic and somatic nervous systems, people living with SCI suffer
progressive secondary health complications to the cardiopulmonary and musculoskeletal
systems. While not comprehensive, this section provides a brief overview of some of the
most common chronic health complications encountered by those with SCI.
Muscle atrophy: Disuse muscle atrophy is rapid and extensive, and occurs soon after
injury. A transformation in the composition of the muscle is generally observed, where there
is propensity towards an increased number of fast-twitch, Type II, highly fatiguable muscle
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fibers in the muscle composition [11]. An increased proportion, or a shift in muscle fiber
behavior, toward the Type II phenotype, generally results in a muscle with decreased fatigue
resistance. Decreased fatigue resistance limits the ability to participate in prolonged periods
of physical activity or exercise. This can therefore directly impact upon the magnitude of the
response to rehabilitation activities such as Functional Electrical Stimulation (FES)-assisted
leg cycle ergometry, Whole Body Vibration (WBV) training or robotics-assisted tilt-table or
treadmill exercise. The reduction in muscle mass results in an increased susceptibility to skin
complications and pressure sores due to a reduction in protection of the skin and subcutaneous
tissue from pressure from the underlying skeleton. In addition, it has been suggested that
the bone demineralisation is accelerated due to a reduced load from the muscle acting on the
skeleton [12]. The sudden influx of calcium and protein to the body due to demineralisation
and muscle atrophy can lead also to kidney problems in the early stages of cord injury [11].
Osteoporosis: Significant bone loss is reported in the first two years of SCI [13, 14].
The ‘mechanostat’ theory describes how the absence of normal bone loading from regular
physiological activity leads to a rapid reduction in Bone Mineral Density (BMD) and bone
strength [15], and therefore an increased risk of fracture. In some instances fractures can
occur from a relatively minor trauma. Bone demineralisation causes a rapid influx of calcium
which can later lead to hypercalciuria, ureteral stones or bladder stones [11,16].
In severe cases, the intensive use of weakened bones during exercise may be avoided to
minimise the risk of fracture. The treatment using a cast is generally avoided due to an
increased risk of developing pressure sores (see below). Internal fixation is generally preferred,
but carries the risks of surgery and infection [17]. It has been hypothesised that muscle
activity plays a central role in the maintenance of skeletal BMD [12].
Pressure sores: A pressure sore, alternatively described as a bed sore or decubitus ulcer,
occurs as a result of prolonged, unrelieved pressure or shear force, leading the formation
of an ulcer and eventually and open wound. Pressure sores can lead to rehospitalisation,
and are the primary cause for the re-admission of SCI patients in Scotland [3]. Surgical
intervention and lengthy recovery periods are generally required. Pressure sores generally
arise during extended periods of bed rest or wheelchair use, and are typically found over
a bony prominence such as the ischial tuberosity, greater trochanter or sacrum. Increased
pressure from underlying skeletal structures results in an insufficient supply of oxygen to the
surrounding skin, subcutaneous fat and muscle, causing it to break down and become necrotic.
If left untreated, sores can lead to infection and death. Pressure sores are particularly
common in SCI, where compromised sensation, lack of mobility and muscle atrophy leads to
an increased liklihood of their development [9, 10].
Orthostatic hypotension: Orthostatic Hypotension (OH), otherwise described as postural
hypotension, is caused by the peripheral pooling of blood due to gravity. Vasodilation
occurs during verticalisation, promoting circulatory collapse by compromising cardiac output
and venous return. Symptoms typically include lightheadedness, dizziness, blurred vision,
weakness, fatigue, cognitive impairment, nausea, heart palpitations (irregular heart beat),
headache and syncope [18]. OH affects approximately 74% of early-stage SCI patients
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during mobilisation, and prevents almost one third of these patients from participating in
rehabilitation activities [19]. SCI patients are particularly susceptible to OH due to poor or
absent vasomotor control arising which result from compromised autonomic function, and
an ineffective ‘skeletal muscle pump’ due to muscle paralysis. OH is normally treated using
tilt-table therapy, compressions stockings or an abdominal binder [9].
Spasticity: A commonly used definition of spasticity is ‘a motor disorder characterised by
velocity dependant increase in tonic stretch reflexes with exaggerated tendon jerks, resulting
from hyperexcitability of the stretch reflex, as one component of the upper motoneuron
syndrome’ [20]. A spasm is an involuntary contraction of skeletal muscle and generally
describes any condition of increased muscle tone [10], and occurs exclusively in those with
Upper Motor Neuron (UMN) lesions. As such, the terms UMN lesion and spastic paralysis
are used interchangeably.
Spasticity can be aggravated by irritative lesions, anal fissures, in-growing toe nails, pressure
sores, fractures and urinary tract infections. Severe spasticity can hamper mobilisation,
and strong spasms of the hip flexors can throw a patient from a wheelchair or fracture
the femoral head [9]. A spastic imbalance of antagonistic muscles may result in hypertonia
and contracture. Another form of spasm is clonus, or a clonic spasm, which is a rhythmic
oscillation of a joint caused by a repetitive spasm in a particular muscle [10].
Autonomic dysreflexia: A noxious stimulus applied below the level of lesion can stimulate
sympathetic outflow and elicit a vasoconstrictor reflex, hypertension and bradycardia
(reduced heart rate). Peripheral vasodilation should normally occur to counteract these
symptoms, but does not during autonomic dysreflexia because parasympathetic function
is compromised in some cases of SCI. Appropriate corrective stimuli cannot pass distally
through the injured spinal cord [21]. Autonomic dysreflexia is characterised by headache,
sweating, and flushing of the skin. Without treatment it can lead to intracranial hemorrhage
and death [9]. It typically arises due to a distended bladder but can also be caused by a
pressure sore or FES. Those with a SCI at T6 or above are at the highest risk of suffering
from autonomic dysreflexia.
1.2.5 Early Stage Spinal Cord Injury
A cycle of decline in general health subsequent to SCI is common and a sample pathway of this
decline is shown in Figure 1.6. Immobilisation causes an initial decline in cardiopulmonary
and vascular fitness due to inactivity. OH, caused principally by the SCI but contributed to
by the lack activity also, delays participation in rehabilitation activities. Neuromuscular
degeneration, particularly that of the neuromuscular junction and supporting structures
causes a decline in muscle mass and function (muscle atrophy), minimising the ability to
carry out intensive forms of exercise. The inability to exploit the cardiovascular demand of
exercise, particularly the large demand exerted during the intense use of highly oxidative
leg muscles, compounds the decline in cardiopulmonary fitness and an increases the risk of
coronary heart disease and cardiovascular complications.
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Figure 1.6: Summary of health cycle during early-stage SCI.
Two key elements were highlighted in this pathway. The first was the chronicity of
injury: paralysis and inactivity result in muscle atrophy and reduces orthostatic tolerance,
inactivity causes a decline in cardiopulmonary and vascular health, orthostatic hypotension
delays participation in rehabilitation activities and contributes to muscle atrophy further.
Degeneration of the neuromuscular junction and supporting structures accompanied by a
general shift in the properties of the muscle fiber towards the Type II phenotype results in
decreased fatigue resistance and an inability to carry out prolonged and intensive periods of
exercise thus contributing to a further decline in cardiopulmonary and vascular health. A
subcomponent of this pathway is the inability to use paralysed muscle. In the event that
muscle is paralysed or cannot be utilised to its full effect, as is commonly the case in SCI,
then the options available for carrying out exercise are limited. Furthermore, what exercise
is carried out using paralysed muscle it typically of minimal benefit. In addition, it has been
hypothesised that the reduced load exerted by paralysed muscles on skeletal structures leads
to osteoporosis, and muscle atrophy increases the risk of pressure sores.
There is potentially a large benefit for any new exercise, rehabilitation protocol, or technology
that can break this cycle of decline at the earliest possible time point after injury, before the
rapid onset of declining health and fitness. The benefit would significantly increase the quality
of life of the patient, accelerate their rehabilitation and reduce their cost of care.
1.3 Early Stage Rehabilitation
The principal focus of this research was to identify rehabilitation technologies that could be
implemented during early stage SCI, and to assess their feasibility, with the specific goal
of using the leg muscles to either: counteract neuromuscular degeneration, or attenuate
the decline in cardiopulmonary or vascular health. Each of these factors were identified
as key contributors to the cycle of decline which occurs during the early stages of injury
(Figure 1.6). Two new rehabilitation technologies were identified for this purpose: Robotics-
Assisted Tilt-Table Therapy (RATTT) and WBV. RATTT was investigated to determine its
potential application for attenuating cardiopulmonary decline, and WBV was identified as a
potential technology for counteracting neuromuscular degeneration. The specific aims of the
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investigations into these technologies is discussed in greater detail below.
1.3.1 Tilt-Table
RATTT has primarily been used to counteract orthostatic hypotension in stroke, SCI and
Multiple Sclerosis (MS) patients by activating the skeletal muscle pump using robotic orthoses
attached to the legs. The requirement for orthostatic stability is therefore precluded and a
patient may begin rehabilitation at an earlier time point. It was hypothesised that in addition
to the therapeutic benefit of counteracting OH, that it may be used for exercise at the same
time. Volitional effort during robotic assisted stepping on a treadmill and FES assisted
cycling have been shown to result in increases in cardiopulmonary fitness in SCI populations.
In each instance however, orthostatic stability was a requirement before starting these types
of exercise. It was concluded that RATTT could potentially be used for the same purpose
but with the added benefit of being employed at an earlier time point.
1.3.2 Vibration
Vibration has been used for various forms of therapy in the past, from slowly oscillating
beds used to impart cardiopulmonary and vascular benefits on the elderly [22], hand held
devices used to apply vibration directly to the muscle belly or tendon and therefore elicit
a contraction, to passively driven, mechanical vibration systems which were designed to
maintain bone mass during weightlessness in space flight [23]. A modern motorised version of
this system, called WBV, is now available and is offered as a low impact, low cost alternative
to conventional strength training and fitness programmes in neurologically intact-populations.
A participant stands on a vibration platform during WBV and the vibration is transmitted
to the skeleton via the feet. The vibration is therefore indirectly imparted upon the
neuromuscular system via the skeleton causing a muscle contraction. The response of
paralysed muscle to WBV is poorly understood and has not been properly quantified. In
the event that WBV does elicit a contraction in paralysed muscle then it may potentially
be of therapeutic benefit, as there a few other alternatives for muscle training (e.g. FES).
WBV may be used to encourage muscle utilization during the early stages of SCI and allow
the maintenance of muscle mass until such a time that intensive rehabilitation activities can
begin. It was therefore hypothesised that a vibration induced contraction in paralysed muscle
may be used to counteract neuromuscular decline and reduce the severity of spasm during
early-stage SCI.
1.3.3 Aims & Objectives
The scope of this thesis was to focus on rehabilitation technologies that may be employed
during early-stage SCI rehabilitation. The aim was to investigate the feasibility of these
technologies and determine if they could potentially be used to disrupt the rapid cycle of
decline that occurs soon after injury, specifically by attenuating the loss in cardiopulmonary
and vascular fitness and muscle atrophy. The objectives were as follows:
• Determine the feasibility of RATTT as a form of exercise during early-stage SCI by
measuring the acute vascular, pulmonary and ventilatory responses of an early-stage
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SCI patient population during RATTT training. Assess if the training could be of
sufficient intensity to potentially attenuate the decline in fitness.
• Develop a rehabilitation system that allows those with an early-stage SCI to stand on
a WBV platform. Measure and quantify the magnitude of the acute neuromuscular
response of a neurologically intact and SCI population to WBV in order to determine
the feasibility of the system for early-stage SCI rehabilitation. Assess if the response
was of sufficient magnitude to attenuate or counteract muscle atrophy.
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Chapter 2
Robotic Assisted Tilt Table
Therapy
SCI compromises motor function and sensation below the level of injury, resulting in paralysis
and inactivity leading to reduced cardiopulmonary fitness and an increased risk of coronary
heart disease and cardiovascular attack. These risks may be minimized through regular
physical activity beginning at the earliest possible time point after injury, before extensive
neuromuscular degeneration has occurred. RATTT may be used during this period for early-
stage rehabilitation before orthostatic stability has been achieved. This chapter describes
a cross-sectional, pilot study investigating the physical exertion associated with RATTT in
SCI by measuring the acute responses of early-stage (<1yr) Motor Complete Spinal Cord
Injury (CSCI) and Motor Incomplete Spinal Cord Injury (ISCI) patients to passive, active
and FES-assisted robotic stepping. Active participation resulted in an increased response
from the ISCI participants but the addition of FES did not consistently induce additional
benefit. Extensive muscle atrophy was found to have occurred in those patients with CSCI,
despite being recruited during the early stages of rehabilitation, and the effectiveness of the
FES was therefore minimal. It was concluded that active participation in RATTT may be
used to improve cardiopulmonary fitness in ISCI patients if implemented as part of a regular
training programme. This research was published in the Journal of Rehabilitation Research
and Development in 2013 [24].
2.1 Introduction
Physical inactivity is associated with obesity, diabetes and hypertension, and is a significant
risk for the development of coronary heart disease and cardiovascular attack [7]. People
with SCI suffer neurological impairment, which can result in severe disability and progressive
secondary health complications to the cardiopulmonary and musculoskeletal systems. Their
life expectancy is less than that of the general population [25], and they are at a higher
risk of rehospitalisation and premature death due to cardiovascular disease and diabetes
mellitus [26–30]. Rehospitalisation results in a considerable burden on the health-care system,
emotional trauma and reduced quality of life [29, 31]. They lead sedentary lifestyles as a
consequence of their injury, and their functional capabilities are less than those of their
counterparts in the general population.
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The risk of development of the health complications outlined above may be reduced through
planned exercise and activity in the normal population [32]. The American College of Sports
Medicine (ACSM) now recommend that the specific aim of cardiovascular training in the SCI
population should be the same as that in the general population with no neurological deficit,
and it should be to improve aerobic fitness [33]. Recommendations from the ACSM for aerobic
exercise are consistent with the World Health Organisation (WHO), who advise that exercise
activities should be between 3 - 6 Metabolic Equivalent (MET) carried out for 75 - 150min
per week, depending on exercise intensity [34]. However, a joint report from the ACSM
and Heart Association reduced the advised training intensity to between 50 - 85% maximum
Oxygen Uptake (VO) for an elderly population due to the reduction in physical ability and
the increased risk of harm from strenuous exercise, associated with ageing population [35].
The guidelines for the elderly are more appropriate during the early-stage SCI where physical
disability and de-conditioning significantly compromise the ability to undertake and perform
strenuous physical exercise.
Exercise capacity and functional ability in SCI is related to the neurological level and severity
of cord injury [7, 36]. Muscle paralysis causes rapid and extensive muscle atrophy, which
reduces daily energy requirements and leads to a decline in aerobic fitness. The inability to
use highly oxidative muscles, such as those in the lower limb, reduces the ability to achieve a
high metabolic demand during exercise. In addition, individuals with SCI have been found
to have a diminished response to exercise when compared to the normal population, due
to compromised autonomic function and poor or absent motor control. Hypokinesis [37],
hypotension, reduced cardiac output [38], blunted blood pressure [39], and slow oxygen uptake
kinetics [40] also occur during exercise.
Arm crank ergometry is the most commonly found and readily accessible form of exercise
available to those with a SCI. Peak power outputs between 10 - 100W can be achieved during
arm crank ergometry, depending on the neurological level and severity of injury [7]. The low
metabolic demand of the relatively small muscle mass of upper limb, and the increased risk
of shoulder pain [41] limits its effectiveness and use. Peak oxygen uptake levels achieved by
healthy, neurologically intact test subjects during arm crank ergometry has been found to be
70% of that achieved during maximal treadmill testing [7]. However, unloaded static-FES
training of the lower limb in a chronic SCI patient population has been shown to increase
peak VO and heart rate [42]. These improvements were also shown to be consistent with
a reduction in spasticity as determined using the Spinal Cord Assessment Tool for Spastic
Reflexes (SCATS) measurement [43]. Other assistive technologies, that facilitate exercise
using the lower limb, include robotics-assisted treadmill exercise and FES-assisted leg-cycle
ergometry. Active participation during robotics-assisted treadmill exercise has been found to
elicit an increased cardiovascular response from SCI subjects [44], and FES-assisted leg-cycle
ergometry has been shown to improve cardiovascular fitness and exercise tolerance [40,45,46].
Peak power outputs in untrained people with SCI have been found to be between 10 -
13W during FES-assisted leg-cycle ergometry [47–49], and 12 - 48W during robotics-assisted
treadmill exercise [44]. These technologies are typically employed in the chronic period of SCI,
at a time point after which the individual has been accustomed to sitting and/or standing,
and orthostatic tolerance has been achieved.
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Tilt-table therapy is commonly used to treat orthostatic hypotension. During tilt-table
therapy, an individual will be gradually accustomed to head-up-tilt by incrementally
increasing tilt angle over a period of time. It has been found that tilt-table therapy can
be enhanced by the application of FES to the knee extensors and plantar flexors. The
improved orthostatic tolerance found was attributed to increased peripheral resistance caused
by the muscle contractions elicited by FES [50]. Similar benefits have been found for
healthy adults [51] and tetraplegics [52] using RATTT. RATTT integrates a standard
tilt-table with robotic orthoses, that passively move the lower limbs in a manner that
approaches normal, physiological hip kinematics. This passive movement has been shown
to be effective in maintaining cardiovascular stability during head-up-tilt [51]. In addition, a
study investigating RATTT augmented by FES concluded that the combination of these
therapies was more effective in improving orthostatic tolerance than either intervention
individually [53,54].
In addition to improving orthostatic tolerance, RATTT may also be an effective exercise tool.
Initiating the rehabilitation process at the earliest possible time point may minimise losses
in aerobic fitness that arise due to inactivity in the early-stages of SCI. It was hypothesised
that by employing RATTT in this way, the dual purpose of increasing orthostatic tolerance
and attenuating the decline in aerobic fitness may be achieved.
2.2 Aims & Objectives
The metabolic demand exerted during passive, active and FES-assisted stepping during
RATTT has not yet been investigated in the SCI patient population. The aim of this study
was two-fold: to investigate the physical exertion of RATTT, by describing the ventilatory
and cardiopulmonary response to passive, active and FES-assisted RATTT; and to investigate
the difference in response of ISCI and CSCI patients. This was done by addressing by the
following technical and physiological objectives.
2.2.1 Technical Objectives
The technical objectives were:
1. Develop a visual feedback system to encourage greater volitional participation during
robotic assisted stepping.
2.2.2 Physiological Objectives
The physiological objectives were:
1. Quantify the ventilatory and vascular responses of ISCI and CSCI participants during
different types of RATTT exercises.
2. Determine the difference responses between ISCI and CSCI participants.
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2.3 Experimental Methods
2.3.1 Subjects
Neurologically and orthopedically stable, non-acute (> 1month) SCI patients were recruited
from the Queen Elizabeth National Spinal Injuries Unit for Scotland: three CSCI and three
ISCI. The main inclusion criteria were patients with paraplegia or tetraplegia due to a spinal
cord lesion with no lower motor neuron damage. The study was approved by the NHS South
Glasgow and Clyde Local Research Ethics Committee (ref: 08/S0710/66). Each subject
provided informed consent prior to participation.
Table 2.1: Subject characteristics. AIS: American spinal injuries association impairment
scale; CSCI: Motor complete SCI; ISCI: Motor incomplete SCI; SCI: Spinal Cord Injury; SD:
Standard deviation; M: Male.
Subject Lesion Level Gender Age Weight Time post-injury AIS
[yrs] [kg] [wks]
1 CSCI T4 M 22 70 16 A
2 CSCI T8 M 18 76 18 A
3 CSCI C3 M 25 60 21 B
Mean (SD) - - - 22 (4) 69 (8) 18 (3) -
4 ISCI T9 M 53 86 46 C
5 ISCI T2 M 44 98 40 D
6 ISCI C4 M 54 81 9 C
Mean (SD) - - - 50 (6) 88 (9) 32 (20) -
2.3.2 Robotics-assisted tilt-table
The RATTT device (Erigo, Hocoma AG, Switzerland), shown in Figure 2.1, utilises a tilt-
table with integrated linearly driven, lower limb robotic orthoses. The table can be tilted
from 0 - 80◦ from horizontal. In addition, the table was actuated at the hip and allowed hip
extension up to 20◦. The robotic orthoses were attached to the thighs and impose a stepping
profile on the lower limbs. An upper body harness secured the participant to the table and
provided support around the chest and abdomen. The feet were secured to foot plates which
had an integrated spring system. Each spring provided a resistance up to 450N at maximum
extension, and stepping rates ranged from 4 to 40 steps/minute/leg. The power required to
extend both integrated springs fully was 15W (Equation 2.1) at the highest stepping rate.
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Figure 2.1: Tilt-table with integrated robotics-assisted stepping device shown in a sagittal
and parasagittal view.
W =
F.x.s˙
2
(2.1)
Where W = work; F = spring force; x = spring extension; and s˙ = stepping rate. Maximum
spring extension was 0.05m.
2.3.3 FES
FES is a method by which an electrical impulse is applied to a peripheral nerve bundle.
Among several applications, FES may be used for therapeutic effects, such as the relief of
pain or reduction of spasm [43]; in the study of neural pathways and reflexes [55], such as
the H-reflex; or to produce function or movement, such as FES-Leg Cycle Ergometry [45].
In the context of this thesis, the application of FES to produce function in the form of limb
movement is used. In this context, FES was described by Rushton as generating “movements
or functions which mimic normal voluntary movements, and so to restore the functions which
those movements serve” [56]. FES was used in this study to restore the function of stepping
in the paralysed limb during RATTT.
FES was applied during stepping using a bi-phasic, current controlled electrical stimulation
device (Motionstim, Krauth+Timmermann, Germany). Stimulation was delivered by
transcutaneous neuromuscular electrical stimulation electrodes (PALS Platinum, Axelgaard,
Denmark) placed over the quadriceps (5 × 10cm oval), hamstring (5 × 10cm oval) and calf
(5 × 6.4cm oval) muscle groups. Stimulation frequency and pulse width were fixed at 20Hz
and 300µs respectively. Stimulation current was adjustable for each individual muscle group.
Stimulation timing was automatically synchronised with the RATTT device during stepping:
the hamstring and calf muscle groups were stimulated during knee flexion and the quadriceps
muscle group was stimulated during knee extension.
Robotic Assisted Tilt Table Therapy 19
2.3.4 Feedback System
Hip position was measured from an integrated position sensor on the RATTT device and fed
back to the patient to encourage greater participation during stepping. The hip position signal
was acquired in real-time at 10Hz using a 12bit USB analog-to-digital converter (NI USB-
6008, National Instruments Corporation, Texas, USA). Data acquisition was synchronised
and displayed using LabVIEW 8.6 (National Instruments Corporation, Texas, USA). An
example of the basic graphic displayed in real-time to the participant is shown in Figure 2.2.
Figure 2.2: Screen shot of RATTT real time position display
The graphic showed hip position normalised to maximum hip flexion and displayed
throughout each step. The extremes of hip movement were shown as black bands and
pre-determined limits were set within these extremes for each participant. The participant
was instructed to achieve and exceed the pre-determined limits, where possible, in order to
encourage greater participation in the stepping exercise. The real time position display would
change in colour from red to green if the limits were exceeded. The limits were manually
adjusted throughout a testing session if the participant consistently exceeded or missed the
limits.
2.3.5 Measurement equipment
Pulmonary gas exchange and ventilatory measurements were performed using a breath-by-
breath analysis system (MetaMax 3B, Cortex Biophysic GmbH, Germany) and recorded on
a laptop PC. Prior to use, the system was calibrated by performing a volume analysis, using
a 3 litre volumetric syringe, and gas calibration was carried out using ambient air and a
certified precision-analysed gas mixture. Heart rate was measured and recorded using a short
range telemetry heart rate monitor (Polar S410, Polar Electro Oy, Finland). Blood pressure
measurements were performed using an automatic blood pressure monitoring device (M7,
Omron Healthcare Europe B.V., The Netherlands).
2.3.6 Testing protocol
There were three experimental sessions per participant. During the first session, the
participant was familiarised with the RATTT device and all measurement equipment. Testing
was carried out in the two subsequent experimental sessions. The participant was asked not
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to perform any strenuous exercise, or consume alcohol, in the 24 hours prior to testing, or to
ingest any caffeine in the 4 hours, or food in in the 2 hours, prior to a testing session. No
two experimental sessions were carried out on consecutive days. The participant wore similar
clothing and was in good health for each session.
The participant was fitted with the heart rate monitor and secured to the RATTT device
using the upper body harness at the beginning of each experimental session. Transcutaneous
neuromuscular electrical stimulation electrodes were then placed over the quadriceps,
hamstring and calf muscle groups while in a supine position. Stimulation was then applied
and the current was increased (28 - 100mA) for each individual muscle group to the point
where a palpable muscle contraction was detected. The participants legs were then secured
to the linearly driven orthoses and foot plates. A cuff was then placed above the elbow of
the left arm to allow blood pressure measurement from the brachial artery. The participant
finally donned the mask for the breath-by-breath analysis system.
Each testing session consisted of five discrete phases of 5 minutes duration. Table 2.2 describes
each discrete test and the order in which it was carried out.
Table 2.2: RATTT testing protocol. ISCI = Motor incomplete spinal cord injury. CSCI:
Motor complete spinal cord injury.
Phase Participant Discrete Test
1 CSCI & ISCI Supine posture and with no stepping.
2 CSCI & ISCI Titled to an angle of 70◦ from horizontal.
3 CSCI & ISCI Robotic orthoses activated.
4a ISCI Volitional participation during stepping based on visual feedback.
4b CSCI & ISCI FES applied to augment to participation in the stepping cycle.
The participants worked against the spring resistance system during knee extension, and
the ISCI participants continued to volitionally participate in the stepping cycle during to
the application of FES in Phase 4b. Pulmonary gas exchange, ventilatory and heart rate
measurements were continuously recorded throughout the course of a testing session.
Discrete blood pressure measurements were taken in the final 30s of each phase. Stepping
rate was set and fixed at a value between 20 - 40 steps/minute. At these rates, the estimated
power required to extend the integrated spring system was between 3.75 - 7.5W. Hip extension
was fixed at 0◦ throughout the experimental session.
2.3.7 Outcome Measures
The technical outcome measures directly associated with these methods were:
1. Hip Position - hip position was measured in real time from the RATTT device and used
to provide real-time feedback to the participant.
The physiological outcome measures were:
1. Oxygen Uptake - measured directly from each participant and normalised to body
weight.
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2. Respiratory Exchange Ratio - calculated from oxygen uptake and carbon dioxide
output.
3. Heart Rate - measured directly from the participant and normalised to the target heart
rate.
4. Mean Arterial Blood Pressure - calculated from the discrete blood pressure measure-
ments taken at the end of each discrete test.
2.4 Analysis Methods
Data processing was performed using the Matlab Signal Processing Toolbox (Matlab R2010a,
The Mathworks Inc., USA). Pulmonary, ventilatory and heart rate data were smoothed using
a 10th order, moving average filter. A 10th order moving average filter was implemented to
minimise the high frequency, natural fluctuation in oxygen uptake, breathing rate and heart
rate observed on a breath-by-breath basis and thus allow for the underlying changes in these
parameters to be observed as each phase of testing progressed. The maximum value in the
final 90s of each phase was then found. Each outcome measure was averaged, for each subject
respectively, between the first and second testing sessions.
2.4.1 Equations
Heart rate was normalised to each participants own target heart rate using equation (2.2) [1,7]:
HRN =
HR
220− age (2.2)
Where, HRN : Normalised heart rate. HR: Recorded heart rate.
Mean arterial blood pressure was calculated using equation (2.3) [57]:
MAP =
Psys − Pdia
3
+ Pdia (2.3)
Where, Psys: Systolic blood pressure. Pdia: Diastolic blood pressure.
2.4.2 Statistical Analysis
Statistical analysis was performed using the Matlab Statistics Toolbox (Matlab R2010a,
The Mathworks Inc., USA). Data normality was assessed using quantile-quantile plots and
Levene’s test was used to test for equal variance. A repeated measures Analysis of Variance
(ANOVA), and post-hoc multiple comparisons procedure with Bonferroni correction, was
used to investigate the response, of the ISCI and CSCI subjects respectively, to each phase
of the testing protocol. Paired t-tests were used to investigate the difference in response of
the ISCI and CSCI subjects for a given phase of testing. Pearson’s correlation coefficient was
used to investigate the test-retest reliability of the obtained outcome measures [58]. Cohen’s
d, based on an average standard deviation, was used to estimate effect size.
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2.5 Results
All participants completed each of the experimental sessions. Head-up-tilt was tolerated well
and no instances of hypotension or autonomic dysreflexia occurred. The oxygen uptake,
respiratory exchange ratio, minute ventilation and heart rate response of each of the tested
subjects are shown in Figure 2.3.
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Figure 2.3: Plot of individual results. Ph1: Supine posture with no stepping; Ph2: Titled
to an angle of 70◦ from horizontal; Ph3: Robotic orthoses activated; Ph4a: Volitional
participation during stepping based on visual feedback (ISCI only); Ph4b: FES applied to
augment to participation in the stepping cycle; ISCI: Incomplete spinal cord injury; CSCI:
Complete spinal cord injury.
For the ISCI subjects, it was found that oxygen uptake, respiratory exchange ratio, minute
ventilation and heart rate were unchanged throughout the first three phases (Phase 1 - 3)
of the testing protocol (see Table 2.3). Volitional participation (Phase 4a) in the stepping
cycle and the addition of FES (Phase 4b), led to an increase in oxygen uptake, respiratory
exchange ratio, minute ventilation and heart rate, and these increases were found to be
significant. No statistically significant change in mean arterial blood pressure was found
throughout the testing protocol. For the CSCI subjects, a small and statistically significant
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increase in minute ventilation was identified, but no change in the other outcome measures
was found. The results of the statistical analysis are summarised in Table 2.3.
Pearson’s correlation coefficient indicates a high degree of test-retest reliability for both the
ISCI and CSCI subjects. Correlation coefficients were found to be between 0.64 - 0.95,
and were significant at p<0.05, implying that there is a large or very large between test
relationship for each of the outcome measures.
In comparing the ISCI and CSCI subjects, it was found that there was no significant difference
between either groups oxygen uptake, respiratory exchange ratio, minute ventilation or heart
rate response throughout the first three phases (Phase 1 - 3) of testing. During Phase 4b,
it was found that the oxygen uptake, minute ventilation and heart rate of the ISCI subjects
were significantly larger than those of the CSCI subjects in the same phase. The significantly
larger responses found for the ISCI subjects is attributed to the large effect, as computed
using Cohen’s d, of volitional participation during this phase. Cohen’s d was calculated to
be 1.32 (VO), 1.49 (Minute Ventilation (MinVen)) and 2.22 (Heart Rate (HR)) respectively.
However, despite the overall group averages for the ISCI subjects being significantly larger
than those for the CSCI subjects, a review of the the individual changes on a case by case
basis indicates that the increases in the ISCI group were principally attributable to subject
S4. This is most likely due to the fact that subject S4 was less affected by the severity of cord
injury (T9) compared to the other ISCI participants (T2 & C4). This is discussed in greater
detail in the following section. Mean arterial blood pressure was found to be significantly
larger across all phases for ISCI subjects when compared to the CSCI subjects.
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Table 2.3: The mean oxygen uptake, RER, minute ventilation, heart rate and mean arterial blood pressure, for the incomplete and complete
spinal cord injured subjects respectively, are presented for each phase of the experimental protocol. SD: Standard deviation. ISCI: Motor
incomplete spinal cord injury. CSCI: Motor complete spinal cord injury. F: Repeated measures ANOVA F-statistic. DF: Degrees of freedom.
p: Significance of F-statistic.
Parameter Injury Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 RM
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) F(DF), p
Oxygen Uptake ISCI 4.90 (0.57) 4.95 (0.72) 5.02 (0.32) 6.97 (0.85) 8.53 (1.79) F(4)=6.88,p=0.01
[ml/kg/min] CSCI 5.96 (1.35) 5.20 (0.57) 5.34 (0.28) - 6.58 (1.06) F(3)=1.48,p=0.31
RER ISCI 0.88 (0.05) 0.86 (0.11) 0.88 (0.10) 0.94 (0.08) 1.02 (0.14) F(4)=3.93,p=0.05
CSCI 0.89 (0.06) 0.94 (0.13) 0.93 (0.14) - 0.93 (0.09) F(3)=0.84,p=0.52
Minute Ventilation ISCI 10.82 (0.64) 11.10 (0.67) 12.45 (2.33) 17.54 (3.01) 23.12 (9.65) F(4)=4.41,p=0.04
[l/min] CSCI 9.57 (0.45) 10.31 (1.28) 10.93 (0.91) - 12.86 (1.43) F(3)=6.62,p=0.02
Heart Rate ISCI 44 (5) 48 (4) 49 (6) 61 (11) 63 (9) F(4)=11.63,p<0.01
[%max] CSCI 33 (7) 43 (13) 42 (9) - 42 (9) F(3)=3.96,p=0.07
Arterial Pressure ISCI 104.17 (18.82) 108.17 (20.73) 118.17 (23.53) 110.67 (25.55) 114.83 (16.69) F(4)=1.05,p=0.44
[mmHg] CSCI 86.78 (2.47) 85.67 (10.98) 84.78 (13.45) - 87.39 (13.34) F(3)=0.08,p=0.97
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2.6 Discussion
This cross-sectional, pilot study investigates the feasibility of RATTT as a potential exercise
therapy. It is hypothesised that this technique may be employed during the very early stages
of rehabilitation to facilitate cardiopulmonary exercise. It may be of most benefit during the
acute stage of injury, before orthostatic tolerance is achieved and more traditional exercise
techniques have commenced. The participants in this study were within their first year of
injury and were recruited because they were orthopedically and neurologically stable. These
subjects would be considered to be early-stage rather than acute patients.
In agreement with previous studies [53, 54], head-up-tilt was well tolerated during RATTT
with no instances of pre-syncope or syncope occurring. Some patients, particularly those with
inhibited motor function and compromised vasomotor control, would be considered to be at a
high risk of orthostatic instability. When considered as a group, no significant changes in mean
arterial blood pressure were found during any phase of the testing protocol for the incomplete
or complete SCI subjects. The mean arterial blood pressure of the ISCI group was found to
be significantly higher than that of the CSCI group. This is most likely a consequence of the
higher average age of the incomplete SCI (50 years) compared to the complete SCI (22 years)
group, where systolic and diastolic blood pressure are generally expected to increase with
age [59]. Alternatively, those with an incomplete injury may be exhibiting increased venous
return in comparison to their complete counterparts, due to the presence of an effective
skeletal muscle pump, particularly during active movement of the lower limb. Increased
venous return would result in higher mean arterial blood pressure as recorded at the brachial
artery. Some short-duration spikes in mean arterial blood pressure may have occurred during
the transition from one testing condition to another but the likelihood of such changes being
detected is low because blood pressure was recorded only at discrete time intervals, which
were at the end of each phase. Such spikes were found in the continuously recorded heart
rate of two subjects (Subjects 1 & 2) at the beginning of head-up-tilt (Phase 2) and at the
initiation of robotic assisted stepping (Phase 3). These sharp increases however, soon dropped
and stabilised at the reported values.
When considered together, the responses of the ISCI and CSCI groups are generally
comparable throughout the first three phases (Phase 1 - 3) of the testing. Small increases in
minute ventilation, oxygen uptake and heart rate were found during head-up-tilt (Phase 2)
and head-up-tilt with passive robotics assisted stepping (Phase 3). However, these increases
were not found to be significant and no significant difference between the ISCI and CSCI
groups were elicited.
Due to the nature of their paralysis, the CSCI subjects were unable to volitionally contribute
to the robotics assisted stepping cycle (Phase 4a). Active participation during this phase by
the ISCI subjects did elicit an increase in oxygen uptake, minute ventilation and heart rate
and the increase in heart rate was found to be significant.
FES was used to augment the ISCI subjects’ volitional contribution during the final phase of
the testing protocol (Phase 4b). The CSCI participants progressed directly to this phase upon
completing Phase 3. For the CSCI subjects, the increased cardiopulmonary and ventilatory
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responses found due to FES were small, but significant in the case of minute ventilation.
These increases however are unlikely to be of sufficient magnitude to lead to improved fitness
if implemented in a training programme. Larger increases in these parameters were found
for the ISCI subjects, and in most cases the increases were found to be significant. These
results indicate that FES potentiates the cardiopulmonary and ventilatory response of ISCI
subjects during RATTT. An inspection of the ISCI group averages reveals that volitional
participation during FES-assisted RATTT results in the largest increases in cardiopulmonary
and ventilatory response. Considering each subject individually though, analysis indicates
that the continued increases found are attributable to Subject 4 only. The responses from
Subject 5 & 6 remain consistent throughout the last 2 phases of testing (Phase 4a & 4b).
It is established that functional ability and response to exercise are related to neurological
level and severity of cord injury [7]. Those with a lower level injury are expected to have more
functional muscle available with which physical activity can be performed. Investigations
comparing individuals with incomplete tetraplegia, high-paraplegia and low-paraplegia report
that physical capacity for exercise decreases with increasing levels of cord injury [36].
Decreased capacity for exercise is manifested as a lower achievable peak oxygen uptake and
lower peak heart rate. In this study, it is thus expected that those with a lower level injury
will perform better.
In keeping with this assumption, it was found that the subject with low-paraplegia (Subject 4)
performed considerably better than those subjects with higher level injuries. A review of the
of the individual VO and minute ventilation parameters for subject S4 shows a rapid increase
in each parameter with prolonged volitional participation. By extension, subject S5 would be
considered to be less affected by the severity of cord injury (ASIA D & T6) than subject S6
(ASIA C & C4), but the VO and minute ventilation values were broadly comparable for each.
Surprisingly, the peak heart rate recorded for subject S5 was considerably higher than either
S4 or S5, and this heart rate was inconsistent with oxygen consumed. This is in contrast
to S4 in particular, for whom all physiological parameters indicate was performing work at
a much higher intensity. One possibility is that subject S6, who was 9 weeks post-injury
was less affected by physical de-conditioning than subject S5, who was 40 weeks post-injury.
Furthermore, subject S5 was considerably heavier (98kg) than subject S6 (81kg) and despite
having a lower level and severity of injury, was likely to have been in poorer physical condition
at the time of injury. The cord injury likely compounded issues associated with physical
conditioning and thus negated any potential benefits in exercise performance associated with
a lower level injury. It should be noted that such observations are not limited to SCI and those
who are in poorer physical condition are unlikely to be able to perform sustained physical
activity. Furthermore, those starting at a lower physical baseline generally associate a larger
perceived rate of exertion with a lower level of exercise intensity when compared to those
that are in better health. [35].
By contrast, the results from the CSCI subjects and intra-group comparisons thereof, are
consistent with the level and severity of cord injury. Subjects S1 and S2 each had a comparable
level and severity of injury, and each exhibited a larger response to the FES-assisted RATTT
stepping exercise than subject S3. Somewhat surprisingly, subject S1 exhibited a moderately
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larger response than subject S2, despite having a higher level cord-injury. The differing
responses from each of these subjects principally occurred upon the application of FES. A
review of available information on physical conditioning indicates that each was within the
same age group and were approximately the same weight, and each was therefore likely to
have been affected by physical de-conditioning to the same degree. However, it was noted
that subject S1 suffered to a greater degree from spasm than subject S2. The extent of
neuromuscular decline was therefore less and the physical exertion associated with subject
S1 was therefore likely to be larger upon the application of FES, as was seen in this study.
Oxygen uptake and respiratory exchange ratio are key indicators of the stress being exerted
on the cardiopulmonary system during exercise. The test-retest reliability of these parameters
was found to be high, and as such they provide a reliable indication of the degree of physical
exertion experienced during RATTT. Oxygen uptake is commonly expressed as as a MET
where 1 MET is equivalent to a normalised oxygen uptake value of 3.5 ml/kg/min, which is
the approximate resting metabolic rate of a typical 70kg, 40 year old male [1]. For the ISCI
subjects, normalised oxygen uptake was recorded as between 5.3 - 11.0 ml/kg/min during
Phase 4 of the testing protocol, which equates to 1.5 - 3.1 MET. This is defined by the WHO
to be of low to moderate intensity physical activity. Moderate-intensity physical activity is
defined as being between 3 - 6 MET’s and high-intensity physical activity is at 6 MET’s
and above [34]. The peak oxygen uptake values found in this study are considerably lower
than the maximum achievable values in age matched persons from the general population,
which are expected to be in the range of 34 - 44 ml/kg/min [60]. However, such levels of
oxygen uptake are difficult to achieve in SCI persons due to an inability to effectively recruit
all available muscle. A more appropriate comparison is peak oxygen uptake in chronic ISCI
persons during wheelchair and leg cycle ergometry, where values of 11.14 - 21.6 ml/kg/min
are typical [48, 61]. In summary, the levels of oxygen uptake elicited in the ISCI subjects
during volitional participation in RATTT approach the peak values expected of this patient
population. In addition, respiratory exchange ratio did not usually exceed 1, indicating that
the intensity of the physical activity is aerobic in nature and is likely to be sustainable.
These data suggest that volitional participation in RATTT may be used for low to moderate
intensity physical activity, and if instituted regularly it is likely that this form of activity may
be used to maintain cardiopulmonary fitness.
For the CSCI subjects, normalised oxygen uptake was found to be between 5.0 - 7.5
ml/kg/min during FES-assisted RATTT, which equates to a MET of 1.4 - 2.1. In comparison,
maximum oxygen uptake in age matched individuals from the general population are expected
to be between 43 - 52 ml/kg/min [60]. However, as with the ISCI subjects, these levels of
oxygen uptake are unlikely to be attainable in those with SCI. The peak oxygen uptake
values recorded in this study are similar to those reported for chronic, untrained CSCI
individuals during FES-assisted leg cycle ergometry, where typical values were found to
be 7.3 ± 2 ml/kg/min [45]. These comparisons are considered to be most valid because
FES-assisted leg cycle ergometry, like RATTT utilises the lower limb only with little or no
contribution from the upper limb. It is unlikely that FES assisted RATTT will result in
improved cardiopulmonary fitness as it would be necessary to maintain this level of intensity
of physical activity for a duration in excess of 150mins per week. Nonetheless, this type of
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exercise may be sufficient to attenuate the loss in cardiopulmonary fitness during the acute
stages of SCI.
When comparing the complete and incomplete SCI subjects during FES assisted RATTT
(Phase 4b), it was found that oxygen uptake, minute ventilation and heart rate were
significantly larger for the ISCI subjects. The computed effect size for each of these
parameters was found to be large, indicating that the type of injury, and by extension the
ability to volitionally contribute to the stepping cycle, largely accounts for the difference
in response found. These data suggest that volitional participation is key in eliciting an
increased cardiopulmonary and ventilatory response in SCI participants during RATTT.
This study assessed a small sample of SCI subjects. The average age, weight and time since
injury of the CSCI group (22years, 67kg, 18weeks) was considerably different to that of the
ISCI group (50years, 88kg, 32weeks). Extensive muscle atrophy was found to have occurred
for the CSCI subjects at the time of recruitment, and it is established that persons with
SCI can exhibit a slow response to exercise [40], and may have a blunted heart rate [27].
Fatigue resistance to exercise is compromised due to oxidative, Type I muscle fibers taking
on the properties of the glycolytic, Type II muscle fibers [62]. These considerations affect
the capacity of the aerobic systems to undertake and respond to physical activity. This is
reflected by the fact that peak oxygen uptake levels recorded in this investigation are much
lower than those potentially achievable in the general population, but are comparable to
similarly untrained SCI persons during other forms of exercise.
2.7 Conclusions
A limitation of this study was the inability to perform a real-time measurement of the work
being performed by the subject during RATTT. An estimate of the total power required
to work against the integrated spring system of the RATTT was given, but it is not known
what proportion of this work done was performed by the individual and the robotic orthoses
respectively. Nonetheless, it was clear from changes in oxygen uptake, minute ventilation
and heart rate that some degree of work was being performed as these parameters reflect
an increased metabolic demand from the muscles as the prescribed exercise was carried out.
Given this small and complex case mix, clear trends were shown. It was identified that
volitional effort resulted in an increased cardiopulmonary and ventilatory response during
RATTT, and these increases were sustained or marginally improved upon with the addition of
FES. In this study, changes in minute ventilation, oxygen uptake, heart rate, and respiratory
exchange ratio were each found to be significant for the incomplete SCI subjects. This
evidence is sufficient to warrant further investigation with a larger sample population of SCI
subjects with tighter control of age and time since injury to determine the dose response
to a period of training. It was concluded that a period of RATTT training with volitional
contribution could potentially improve cardiopulmonary and ventilatory fitness in those with
an ISCI, and FES-assisted RATTT may be sufficient to attenuate losses in fitness in those
individuals with CSCI.
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Chapter 3
WBV Literature Review
Investigation into the therapeutic benefit of vibration therapy dates back to the 1930s. Slowly
oscillating beds were initially shown to impart a cardiopulmonary and vascular benefits on
elderly, immobilised patients [22]. The series of investigations which followed confirmed this
and recovery post-bed rest was shown to be faster on an oscillating bed when compared to
a non-oscillating bed [63]. Investigation into the neuromuscular effect of vibration began
in the 1960s when hand held devices were used to apply vibration directly to the muscle
belly or tendon. Electromyography and microneurography studies studies ultimately led to
the characterisation of the Tonic Vibration Reflex (TVR) [64]. Interest into the therapeutic
benefits of vibration therapy for the musculoskeletal system, particularly to that of the lower
limb, has developed more recently and research into the field has risen steadily since the
mid-1990s.
The first conventional form of vibration therapy was a passively driven, mechanical vibration
system developed for the Euro-Mir 95 mission. The mechanical impact from the vibration
system is analogous to the transient loading experienced at heel strike during walking. This
mechanical stimulus was effective in maintaining bone mass during weightlessness in space
flight [23]. Since Euro-Mir 95, interest has grown considerably in commercially available,
motorised alternatives to this system. Vibration therapy is now commonly applied indirectly
through the feet via an actuated vibration platform that supports the person, rather than via
an oscillating bed, hand held device, or passively driven machine. Vibration therapy applied
in this way is called Whole Body Vibration (WBV).
In addition to the broad array of other scientific investigations, a series of bed-rest studies were
carried out between 2003 - 2007 investigating WBV. Bed-rest is now used as an ‘earth-based’
model of the physical de-conditioning that is associated with prolonged weightlessness during
space flight. The potential application of WBV to counteract this decline was investigated in
the bed-rest studies [65–71]. More recently, WBV training was incorporated into the Mars
500 mission, which was a collaboration between the European Space Agency and the Russian
Institute of Biomedical Problems. The Mars 500 mission simulated 520 days of isolation
which is the time expected to travel from Earth to Mars and back. The effect of WBV on
cardiovascular and pulmonary function, muscle function, muscle force, muscle power, bone
mass, and bone strength were investigated.
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The growing interest in WBV is clear. It is offered as a low impact, low cost (time and
economically) alternative to conventional strength training and fitness programmes. It is
thus becoming attractive as an exercise modality not only for space flight, but for those
in the general population, athletes, the elderly, and those with a neurological deficit such
as: Spinal Cord Injury (SCI), stroke, and multiple sclerosis. This review presents the main
theories which describe the neural mechanism by which WBV causes muscles to contract and
then focuses the on four of the key areas of WBV research, including investigations into: (i)
the neuromuscular response to WBV as measured using EMG, (ii) the effect of WBV on the
EMG recording itself, (iii) the physiological response to a recent bout of WBV and (iv) the
physiological response to a prolonged period of WBV training.
3.1 Introduction
3.1.1 Vibration
Vibration is a periodic mechanical disturbance, that can be described by its amplitude (A)
and frequency (f). In most applications, the shape of the mechanical disturbance is sinusoidal
(Figure 3.1), and its peak acceleration (apeak) can be calculated by Equation 3.1.
apeak = ω
2A (3.1)
Where angular frequency ω=2pif .
Figure 3.1: Shape of vibration displacement.
3.1.2 Vibration Device
Vibration can be applied directly to the muscle or tendon, or indirectly via a vibrating
platform. Indirect vibration is more commonly known as WBV, and can be applied in
a number of ways: Vertically-Vibrating (VV)-, Side-Alternating (SA)- or Rotating-WBV
platforms. The VV- and SA-WBV platforms are most common, and are similar because
the main component of displacement is in the vertical direction (Figure 3.2). During VV-
WBV, displacement is exclusively in the z-direction, whereas during SA-WBV, the platform
oscillates about its central axis, thereby resulting in a small component of displacement in
the y-direction and the majority of displacement in the z-direction. During Rotating-WBV,
the platform is displaced about its centre point, with the main components of displacement
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in the x- and y-directions. There is little evidence in the literature describing Rotating-WBV
or advocating its use, and it is therefore not described any further in this thesis.
Figure 3.2: Schematic comparing different whole body vibration platforms.
Vibration is transferred through the feet to the skeleton and tendons eliciting a neuromuscular
response from the vibrated muscles [72–76]. It has been shown that the vibration is dampened
as it is transmitted throughout the body [72,77], and it has been hypothesised that this is a
consequence of increased neuromuscular activity [78,79], in addition to the natural flexibility
of the musculoskeletal structures. The mechanism by which WBV elicits a neuromuscular
response is unclear, though two main theories are generally supported: the TVR, and the
Muscle Tuning Theory. Regardless of the specific mechanism, it is likely that the stretch
receptor plays a central role in the response. This is discussed in greater detail in Section
3.2.
The latencies of the monosynaptic reflexes of the lower limb mediated via the stretch receptor,
previously described in Chapter 1, have thus been used as a benchmark to inform the range
of frequencies most commonly employed by the commercially available WBV systems [71].
For example, the latencies of the Achilles and patellar tendon reflexes are 35.2 and 21.0ms
respectively [80]. Similarly, the average H-reflex latency of the calf muscle group is 30.3ms
[81]. Thus a full contraction-relaxation cycle mediated by the stretch receptor will occur
up to maximum excitation frequency of 28Hz for the calf muscle group, and 48Hz for the
quadriceps muscle group. These frequencies therefore represent the physiological limit of
the stretch reflex. Training at or above these frequencies may lead to an improvement in
muscle strength and power [71]. Training below these frequencies may preferentially target
slow twitch (Type I) muscle fibers frequencies, be less likely to result in muscle fatigue, and
promote improvements in muscle function [69]. The frequencies and amplitudes of vibration
most commonly used are therefore 5 - 50Hz, and 0 - 5mm respectively. The focus of this
literature review is on those studies describing the acute and chronic neuromuscular and
physiological adaptations associated with WBV.
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3.1.3 Vibration Transmission
A basic mathematical model was developed by Yue and Mester [82] describing the internal
loads and the effects of internal masses during the transmission of vibration to the human
body during WBV. Limitations of the model are: (i) that it is for an input vibration along
one dimension only, and (ii) it is for a fixed limb position. Furthermore, the authors concluded
that a lumped mass-spring system cannot be expected to accurately model the complexities
of the human body in-vivo. However, the principal finding of the model is that as the input
frequency from the vibrator and the resonant frequency of the limb move away from each
other, the elastic properties of the limb begin to dominate, as dictated by the magnitude
of neuromuscular contraction, and the vibration is thus largely limited to these structures.
They further describe a flow of energy between the muscle/tendon units and WBV platform,
with some dissipation of energy and thus damping due to inefficiencies in the body [82]. The
model thus suggests that resonance of the lower limb, and therefore risk of damage, may be
avoided by altering the resonant frequency of the lower limb during WBV. Further in-vivo
work principally carried out by Wakeling et al. [79, 83] has gone some way to describing
the natural frequency of the lower limb. They have thus postulated the Muscle Tuning
Theory, which is a mechanism to alter the natural frequency of a limb during vibration,
by changing muscle stiffness through altered neuromuscular activity and therefore protect
against resonance. The Muscle Tuning Theory is described in greater detail in Section 3.2.2.
Vibration is a known occupation hazard and a greater understanding of lower limb natural
frequencies is thus required to understand the potential for harmful effect from WBV. Some
reported work has been carried out to this end [78,79,83,84]. The damped natural frequency
of the Triceps Surae, Tibialis Anterior and Quadriceps were systematically quantified for a
range of joint angles and levels of neuromuscular contraction. Average values were 16, 25
and 10Hz for each muscle respectively at a 0◦ joint angle, or 14, 26 and 10Hz at a 40◦ [83].
Each of these values easily fall within the input frequency range of typical commercial WBV
platforms. However, during an isometric contraction these values increase to a value normally
outside the WBV platform input range. Depending on the magnitude of the neuromuscular
contraction, natural frequency values between 32 - 26Hz for the Triceps Surae, 31 - 49Hz for
the Tibialis Anterior, and 26 - 31Hz for the Quadriceps were found [83]. It would thus be
naturally expected that increased tone or an instance of clonic spasm in an SCI participant
would result in similar increments in muscle natural frequency.
Further work has thus been carried out to advise on the risks and benefits of WBV training
and the dose that should be applied [85, 86]. A summary of the guidelines includes: (i)
vibration to the head should be minimised by standing with a flexed knee; (ii) some resonance
can occur below 20Hz, therefore exposure to frequencies below this value should be kept to a
minimum; (iii) vibration amplitudes between 1 - 2mm should be applied as a starting point
and only increased for training purposes, (iv) bouts of vibration should not exceed 60s; and
(v) those with coronary heart disease or hypertension should be excluded [86].
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3.2 Neural Mechanism
It is evident that WBV elicits an increase in neuromuscular activity from the Electromyogram
(EMG) studies reviewed in later sections. Some have hypothesised that the increased muscle
activity is related to postural control mechanisms, or descending vestibulospinal commands,
that are responding to the mechanical disturbances caused by the vibrating platform [75,87].
However, the Tonic Vibration Reflex TVR, and the muscle tuning theory are more generally
accepted, each of which are described in greater detail in Sections 3.2.1 and 3.2.2 respectively.
Regardless of the mediating mechanism, it is likely that the muscle spindle plays a central
role in the detection and response to WBV. A novel experiment by Ritzmann et al. [88]
showed that a standard blood pressure cuff placed around the soleus suppressed the short
latency stretch reflex and the neuromuscular response to WBV. It was concluded that this
suppression was most likely attributable to a decrease in muscle spindle sensitivity, rather
than changes to the Ia afferent nerve, α-motoneuron or muscle fibre [89].
Vibration induced modification of motor unit excitability is discussed in Section 3.3.3. The
excitability of a motor unit is most easily investigated in two ways: electrical stimulation
of the common nerve or tendon percussion. These types of investigation provide an insight
into the mechanism of muscle activation during WBV. The results presented in Section
3.5.1 indicate that pre-synaptic changes to the α-motoneuron are responsible for the acute
improvements in muscle performance commonly found immediately after a bout of WBV.
The magnitude of the neuromuscular response to WBV is typically larger if the vibration
is superimposed on a voluntary contraction or if the muscle is being stretched, suggesting
that the response is moderated by muscle spindle sensitivity [75, 85, 90]. Spindle sensitivity
is normally increased through increased fusimotor drive during voluntary contraction, or by
muscle lengthening. Therefore, the potentiation of motor unit excitability post-WBV may
also be a result of increased γ-motoneuron activity caused by the repetitive shortening and
lengthening of the muscle during WBV.
3.2.1 Tonic Vibration Reflex
The application of high frequency, low amplitude vibration to skeletal muscle has been
extensively investigated since the 1960s and is reasonably well understood. Vibration applied
to a muscle results in an increase in α-motoneuron activity and a tonic contraction, thus
called the tonic vibration reflex. It is most readily elicited by direct application of vibration
to the muscle belly or tendon [91–98], though it has been shown that indirect application
can also be used [91]. Vibration frequencies between 20 - 220Hz, and amplitudes between
0.5 - 3.3mm [94] are commonly used, though amplitudes up to 25mm have tentatively been
reported [95]. A larger TVR is generally found with higher frequencies of vibration [94].
Primary endings (Type Ia) of the stretch receptor are particularly sensitive to vibration,
whose excitation initiates a volley of Type Ia afferents [91–94, 97, 99]. Secondary spindle
endings (Type II) and the Golgi Tendon Organ (Type Ib) are also excited by vibration,
though to a much smaller extent (cf. Chapter 1) [91–93, 99]. Cutaneous receptors in the
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skin are stimulated by vibration also, but have no motor output as a consequence, and are
thought to play a role in the detection of vibration only [64].
Microneurography studies, which are in good general agreement, have found that muscle
receptor afferents can be ‘driven’ by the frequency of vibration. Primary spindle endings
exhibit better entrainment than secondary endings or the Golgi tendon organ [91, 93, 97].
Furthermore, different receptors were found to have a finite frequency to which they can be
driven. Type Ia afferents have been driven to between 120 - 220Hz, compared to 40 - 50Hz for
Type II and Ib afferents [64,91,93]. The preferential recruitment of primary spindle endings
over the secondary endings and Golgi tendon organ has been shown at lower amplitudes of
vibration [92]. In addition, the force with which the vibrator is applied strongly influences the
TVR [93]. Vibration amplitude and application force must therefore be carefully considered
when comparing the results of studies that used a hand-held vibration device. In summary,
Type Ia afferents most likely mediate the TVR due to the larger sensitivity and better
entrainment of the primary spindle endings to vibration.
Primary spindle endings fire once per vibration cycle in a relaxed muscle. There is a 1:1
relationship between the frequency of vibration and the firing frequency of the primary spindle
ending up to the spindle frequency limit [91, 93]. The spindle is driven at a subharmonic of
the frequency of vibration with a relationship of 2:1 when the spindle frequency limit is
exceeded. The primary ending can fire multiple times during a single vibration cycle during
muscle lengthening, so long as the spindle firing limit has not been exceeded [91].
The TVR is small in comparison to the maximum voluntary capacity of the muscle. It is
characterised by its relatively slow onset and cessation, and gradual increase in magnitude
to plateau within 20 - 60s of initiation [95]. This is fundamentally different to the ‘dead-
beat’ ending of the myotatic or H-reflex, each of which exhibit a characteristic onset latency.
The TVR is readily elicited in muscle that is relaxed, with better compliance during
increased muscle stretch or if it is preceded by a tonic contraction [91, 94]. Good motor
unit synchronisation up to a frequency of vibration of 100Hz has been shown [100] though
an asynchronous motor unit firing frequency has been found also [95]. Finally, the TVR can
be potentiated (for example by the Jendrassik manoeuvre) and voluntarily depressed [96]. In
summary the factors which influence the TVR include [64]:
1. The location of vibration application [91].
2. The excitability of the central nervous system [96,98].
3. The initial length of the homonymous muscle [94].
4. The vibration parameters (frequency and amplitude).
These characteristics indicate that the TVR is mediated via a polysynaptic pathway which
uses some of the peripheral neural components involved in monosynaptic reflexes. The fact
that the TVR can be voluntarily suppressed or potentiated indicates input from higher spinal
segments [94].
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Central nervous system influences has been shown by a number of studies. The TVR has
been suppressed by barbiturates, which selectively inhibit interneuron activity, but with no
effect on the myotatic or H-reflex. This therefore implies interneuron involvement during the
TVR [95, 96]. The TVR was found to be suppressed in human subjects with an ipsilateral
cerebellar deficit when compared to the normal contralateral limb, therefore suggesting a
cerebellar influence also [96]. It is noted however that cerebellar influence has not been
shown in cats [64]. Posture has also been shown to alter the reflex response, suggesting
a vestibulospinal effect [94]. Furthermore, the TVR has been shown to be considerably
depressed in individuals with chronic SCI and those in spinal shock [98].
Vibration of the agonist inhibits α-motoneuron activity of the antagonist (reciprocal
inhibition). Simultaneous vibration of the agonist and antagonist suppresses the TVR in
both [64]. The myotatic reflex and H-reflex have both been shown to be depressed during
vibration [95,96,98,101], which is unusual because the TVR, myotatic reflex and H-reflex are
all thought to have some common neural pathways. This phenomenon has thus come to be
described as the ‘vibration paradox’ [102], for which several causes have been proposed.
Spindle occlusion, the so called ‘busy line’ effect, was initially suggested as the cause of the
vibration paradox [91]. It was proposed that the spindle output was inhibited and unable to
respond to a tendon percussion or electrical impulse, having been so recently stimulated by
vibration, particularly if it was firing at its maximum frequency. This theory has been refuted
by others who suggests that such occlusion would be insufficient to fully suppress the myotatic
or H-reflex [64]. Assuming that the same motoneuron pool is used for each of these reflexes,
it was shown that vibration does not affect the post-synaptic pathway, and hypothesised that
pre-synaptic inhibition due to repetitive stimulation to the Ia afferent is the dominant factor
in suppressing the monosynaptic reflexes during vibration [99]. Pre-synaptic inhibition may
be due to altered muscle spindle sensitivity [97], however despite this the authors concluded
that central nervous adaptations are more likely to be the principal mediating factor.
Pre-synaptic inhibition alone does not explain how a tonic contraction can be maintained by
vibration, yet inhibit reflexes that use the same neural networks. Desmedt and Godaux [102]
proposed that the TVR recruits individual motor units according to the Henneman size
principle and that pre-synaptic inhibition acts in reverse order on the same motor units.
This would thus limit the total number of motor units that could potentially be recruited by
the monosynaptic reflex. In addition, this may explain the typically small magnitude of the
TVR.
In contrast, the myotatic reflex is potentiated after vibration, whereas the H-reflex continues
to be depressed [96, 97, 101, 103]. Post-tetanic potentiation of the myotatic reflex may be
occurring after vibration, whereby Ia afferents are being selectively recruited by the tendon
percussion [103]. On the other hand, electrical stimulation of the mixed nerve to elicit a
H-reflex will preferentially recruit Ib over Ia afferents, which will result in an inhibited motor
response. The authors proposed that this is because the firing threshold of the primary
spindle endings increased due to the repetitive stimulation of the vibration. Meanwhile, the
resting membrane potential of the Golgi tendon organ remained unchanged, due to its relative
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insensitivity to vibration. The Ib afferents were thus preferentially recruited by the electrical
stimulus applied after a period of vibration [103].
There are a number of similarities between the neuromuscular response to the direct
application of vibration and the neuromuscular response to WBV. Each has an asynchronous
motor response, and each similarly moderates the short latency reflexes (cf. Section 3.3.3).
However, the frequencies and amplitudes of vibration are considerably different. In addition,
the transmission of vibration throughout the body during WBV is poorly understood. It
is not known if the vibrations that are ultimately detected by the muscle during WBV are
comparable to those detected during the direct application of vibration. An alternative
theory has therefore been proposed. The muscle tuning theory is described in the following
section [104,105].
3.2.2 Muscle Tuning Theory
The muscle tuning theory was first proposed as a mechanism which moderates neuromuscular
activity during walking with the function of dampening the transmission of vibration to the
body elicited at heel strike during walking and running [106]. Heel strike has a frequency
and amplitude component, and is thus analogous to the mechanical displacement experienced
during WBV. The frequency component of heel strike falls in the range of 10 - 20Hz and
it was shown that the soft tissue of the lower limb could potentially resonate within this
frequency range [83]. The natural frequency of a given muscle was found to be between 8
- 33Hz depending on joint angle. Furthermore, the natural frequency increased to between
19 - 59Hz when the homonymous muscle was under contraction. The ‘muscle tuning’ theory
was thus proposed as a method of moderating the natural frequency of muscle, dampening
the transmission of vibration, and minimising the risk of resonance and damage to the
musculoskeletal structures [78].
A ‘feed-forward’ mechanism was proposed in a later study, whereby a muscle contraction was
initiated before heel strike. This is advantageous for two reasons: the musculoskeletal system
is sufficiently stiff and able to support the body during stance, and sufficient time has passed
to generate adequate tension in the muscle to alter its natural frequency [79]. More recently,
it has been suggested that the muscle tuning response is mediated via the fast twitch muscle
fibres, which can more rapidly act to change muscle tension [84]. This theory is supported
by others who found the largest neuromuscular response of the rectus femoris occurred at a
vibration frequency of 23Hz on a WBV platform [107]. This same frequency was shown to
be the resonant frequency of the muscle.
Notwithstanding the lack of agreement with regards to the specific neural mechanism by which
WBV elicits an increased neuromuscular response from muscle, and the relative infancy of
the muscle tuning theory compared to the TVR, a period of WBV does elicit a number of
acute (Section 3.5) and chronic (Section 3.6) physiological changes. These changes have been
investigated for neurologically intact and neurologically disabled populations.
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3.3 Acute Neuromuscular Response
Investigation into the acute neuromuscular response to WBV has predominantly been carried
out within the last ten years. These studies have focussed on the lower limb and the back,
where the neuromuscular response of the tibialis anterior, gastrocnemius, soleus, rectus
femoris, vasti, biceps femoris, gluteus, and spinae erector muscles have been investigated.
Methodological differences in protocol, data recording and off-line analysis makes between-
study comparisons difficult. In terms of protocol, differences include: (i) the type of vibration
platform used (SA-WBV, VV-WBV), (ii) exercise type (static, dynamic), and (iii) test
population (general, athletic, elderly, neurologically-compromised).
In terms of data recording and off-analysis, differences include: (i) the type of EMG
electrode used (active, passive), (ii) data normalisation with respect to a maximum voluntary
contraction, and (iii) off-line processing of the EMG (cf. Section 3.4). Consideration of these
differences in protocol is particularly important when interpreting EMG recorded during
WBV. It is now generally accepted that these EMG contain movement artefact, and if
neglected will lead to an overestimation of the magnitude of neuromuscular activity during
WBV. Abercromby et al. [75] were the first to advocate the targeted removal of artefact,
thereby calling into question the interpretation of the results from previous EMG studies.
Notwithstanding these differences however some general conclusions can be drawn.
WBV typically elicits an increased neuromuscular response. Larger increases are generally
found in those muscles that are located closer to the vibrating platform [72,75,108], muscles
that are under contraction [109], or muscles that are stretched [110]. For example, the
increased activity induced in the gastrocnemius is normally larger than that induced in the
gluteus [75]. Furthermore, a unilateral static squat will elicit a larger neuromuscular response
than a bilateral squat during WBV [90]. Neuromuscular activity normally increases with an
increase in vibration amplitude [72, 73], or frequency [72], with maximal responses reported
to occur between 23 - 45Hz [76,107,109].
This section begins by describing the acute neuromuscular response of those in the general
population to a short bout of WBV. Those studies with a protocol requiring the support of
additional load during WBV are described separately to those who applied WBV in a more
conventional manner. The response of those with a SCI are discussed next. Studies that
investigated the effect of WBV on the short latency reflex are described at the end.
3.3.1 General Population
Vibration Only
Fatigue has been implicated by SA- and VV-WBV [111, 112], whereby a decrease in the
mean power frequency of the EMG was found as the bout of WBV progressed. It is noted
however that the possible presence of movement artefact or motor-unit entrainment were
unaccounted for in this analysis, each of which could have occurred and potentially result in
a decrease in mean power frequency, and would therefore not necessarily be an indication of
fatigue. In a similar study, the maximal neuromuscular response of the vastus lateralis during
unloaded, static squats occurred at the 30Hz and 5mm vibration on a VV-WBV device [76].
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The neuromuscular response of the quadriceps and calf muscle groups were measured during
unloaded, unilateral- and bilateral- static squats while vibration was applied by a similar
platform in a later study by Roelants et al. [90]. A similar frequency (f = 35Hz), but smaller
amplitude (A = 2.5mm) of vibration was applied. A contraction up to 83% Maximum
Voluntary Contraction (MVC) was found during WBV when in a deep- or unilateral-squat,
each of which were found to result in a considerably larger response than a bilateral shallow
squat. Marin [73] found that the magnitude of the neuromuscular response of the quadriceps
and calf muscle groups increased with vibration amplitude, whilst performing static, unloaded
squats on a VV-WBV platform. Footwear did not affect the neuromuscular response of the
quadriceps, but augmented the response of the calf. Passive EMG electrodes were used in each
of these studies. The presence of vibration induced artefact in the EMG was not accounted
for in the respective analyses and an overestimation of the neuromuscular response to WBV
is likely (cf. Section 3.4).
Abercromby et al. [75] found a larger neuromuscular response from the vastus lateralis, biceps
femoris and gastrocnemius during SA- versus VV-WBV, at a frequency and amplitude of
30Hz and 4mm respectively. They found that static squats elicited a larger response from
the vastus lateralis and gastrocnemius than dynamic squats, supporting other findings that a
voluntary contraction augments the neuromuscular response to WBV. They suggested that
the human body responds to WBV via a postural control mechanism, and hypothesised that
the difference in response between the two devices is related to the fact that the principal
component of vibration during VV-WBV is in the z-direction only, whereas it is in the y-
and z-directions during SA-WBV (cf. Figure 3.2). Surprisingly, they found that a shallow
squat elicited a larger response than a deeper one. This is in contrast to findings from others
who found no difference or a slightly larger neuromuscular response with increasing knee
flexion [90,110].
A positive, linear relationship between the neuromuscular activity of the shank muscles and
the frequency of SA-WBV was identified by Pollock et al. [72]. A small increase, that was
quick to plateau was found for the rectus femoris and biceps femoris. The activity of the
gluteus was found to increase with vibration, but no difference in response was identified for
different vibration frequencies. This data is supported by acceleration measurements which
showed a reduction in the transmission of vibration with increasing proximity to the WBV
platform. It was concluded that both frequency and amplitude of vibration moderate the
neuromuscular response, and that the lower limb considerably dampens the transmission of
vibration to the upper body.
Vibration with Additional Load
An exhaustive bout of SA-WBV, during which the participants performed dynamic squats
while carrying an additional load (40% body-weight) for 4 minutes, was found to decrease the
mean frequency (Equation 3.2) as recorded from the vastus lateralis during a post-vibration
maximum voluntary contraction [113].
MNF =
∑fN
i−1 fiPi∑fN
i=1 Pi
(3.2)
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Where MNF = Mean frequency; N = Number of Frequencies; fN = Maximum Frequency;
f = Frequency; P = Power; i = ith line in power spectrum analysis.
This suggests that resistive vibration exercise has a fatiguing effect on muscle. More recently,
Hazell et al. [109] found that an additional load of 30% body-weight during VV-WBV
increased the acute neuromuscular response by 2.5 - 3.5%. Marin et al. [114] found that
increasing frequency during unloaded, static squats on a VV-WBV platform was equivalent
to increasing the load carried during static squats without WBV. They concluded that
platform acceleration moderates the neuromuscular response to WBV, and that a platform
acceleration of 1.2 - 10g is equivalent to an increased load of 20 - 70kg during a static squat.
3.3.2 Spinal Cord Injured Population
Relatively few studies to date have investigated the acute neuromuscular response of SCI
patients to WBV. Herrero et al. [115] found that SA-WBV implemented with a tilt-table
elicited an increased response from the vastus lateralis and vastus medialis of motor-complete
SCI (CSCI) patients (AIS A), but no difference between the frequencies was found. Chang
et al. [87] found no change in the neuromuscular activity of chronic CSCI patients (AIS A)
to VV-WBV while seated. They suggested that descending input from the vestibular system
may be moderating the neuromuscular response to WBV, and that the lack of excitation of
this system in a seated position accounts for the absence of any response.
3.3.3 Short Latency Reflex
The short latency reflex (cf. Chapter 1) is a monosynaptic reflex that is most readily elicited
via a tendon percussion (myotatic reflex) or electrical stimulation of a spinal root (H-reflex).
It is measured as an EMG and is charactersied by its onset latency and magnitude. In
the lower limb, the myotatic reflex is most readily elicited in the hamstring via an anterior-
posterior tibial translation, in the quadriceps via tendon percussion of the patellar tendon,
or in the calf muscle groups via tendon percussion of the Achilles tendon. The H-reflex can
be most readily elicited in the calf muscle group by electrically stimulating the tibial nerve
via a transcutaneous electrical stimulation electrode placed at the popliteal fossa. The short
latency reflex provides an indication of the excitability of the motoneuronal pool supplying
the homonymous muscle group. It has thus been used as an outcome measure from numerous
studies investigating the acute neuromuscular response to the direct and indirect application
of vibration. This section describes the effect of an acute bout WBV on the short latency
reflex.
Significant decreases in the H-reflex, Hmax and the Hmax/Mmax ratio, have been reported
in the soleus of able-bodied and SCI subjects post-WBV [116–119]. Armstrong et al. [120]
monitored the rate of recovery of the H-reflex in able-bodied subjects, and found it to be
completely suppressed in the first minute post-WBV. Thereafter, they classified recovery
into four groups: (i) the first group exhibited full recovery of the H-reflex back to baseline
within 3mins post-vibration; (ii) the second group recovered within 7mins; (iii) the third
group within 15mins; (iv) and the fourth group showed no recovery within 30mins post-
WBV. Beekhuizen et al. [116] initially showed that standing on a SA-WBV platform for 5
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minutes significantly reduced the H-reflex amplitude by 25%. Kipp et al. [118] later showed
that the rate of recovery of the amplitude of the H-reflex was was between 1 - 2min, though
a VV-WBV platform was used in this later study. This was corroborated by a further study
carried out by Sayenko et al. [117], however the difference in the rates of recovery from the
two different studies likely stems from the fact that the initial study applied vibration at 25Hz
and 2 - 4mm for 5 minutes, compared to 35Hz and 1mm for 1min. Furthermore, Sayenko et
al. [117] recorded the rate of recovery by measuring the H-reflex every 6s. Recommendations
are that no more than one H-reflex be elicited for every 10s period [55]. By contrast Kipp
et al. [118] measured the H-reflex every 15s thus lending greater confidence in their findings.
Chang et al. [119] demonstrated an 83% suppression of the H-reflex which lasted in excess of
2mins. In this study, the vibration was applied from a seated position, rather than standing
as was the case in each of the other studies. Furthermore, the H-reflex was measured both
during and after the application of vibration. There was a high likelihood of sensor movement
during vibration, and thus a comparison of H-reflex depression between vibration and when
it has stopped is not valid because it cannot be guaranteed that the measurements were
taken from the same motor-units. In addition to the methodological differences highlighted
here, Armstrong et al. [120] suggest that differences in muscle fiber composition due to age,
gender, training specificity and conditioning status may each contribute to the variable rates
of recovery observed in these studies.
Conversely, no change in α-motoneuron excitability was found in a similar study by McBride
et al. [121]. However, an increase in the maximum force generating capacity of the triceps
surae was identified after an acute bout of WBV. Rittweger et al. [122] found that the stretch
reflex was potentiated post-WBV, but Hopkins et al. [123] did not. In a well controlled
experiment they found no change in electromechanical delay or the latency of the stretch
reflex either [123].
The H-reflex was inhibited in SCI subjects and completely suppressed in able-bodied subjects
during a bout of WBV [117]. Notwithstanding the methodological flaws (cf. Section 3.4),
that failed to take into account the possibility that the detection electrodes may have moved
during vibration, thus perhaps attributing to the reduced H-reflex, the acute changes in the
reflex amplitude during WBV do bear a resemblance to those changes that occur during the
TVR.
This confounding body of evidence has led some to suggest that reduced post-WBV muscle
performance is due to pre-synaptic inhibition of the primary ending of the muscle spindle
[120], or neurotransmitter depletion [117]. Others suggest that this is not the case and
post-tetanic potentiation, a build up of calcium at the axon terminal of the presynaptic
neuron [121], or altered proprioception leading to enhanced postural control [123] is occurring.
Reduced short latency reflex excitability does seem to contradict the post-WBV potentiation
of muscle performance. Kipp et al. [118] have proposed that there is a reduction in
homosynaptic depression post-WBV, which is a rate-dependant response that moderates
the excitability of the Ia afferent-α-motoneuron synapse.
WBV Literature Review 41
3.4 Vibration Artefact
Vibration artefact is manifested as a series of sharp ‘spikes’ in the power of the EMG when it
is viewed in the frequency domain. These spikes in power occur at the frequency of vibration
and to a lesser extent at its harmonics and are induced in the EMG by movement during
vibration. Failure to take account of vibration artefact could result in an overestimation of
neuromuscular activity and impact upon the interpretation of any EMG results taken during
WBV, such as those studies described in Section 3.3. This section presents the research which
has investigated this form of vibration artefact.
The presence of movement artefact in an EMG recorded during WBV is indicated by an
atypical Power Spectral Density (PSD) plot or amplitude spectral density plot. Figure
3.3 outlines two sample EMG presented in the frequency domain. The first was recorded
prior to WBV, and the second was recorded during WBV (f = 20Hz). Clear increases
in the power of the EMGs recorded during WBV can be seen across all frequencies,
with distinct spikes in signal power at harmonics of the frequency of vibration. In some
instances, these harmonic frequencies have been found to increase the power of the EMG
by 300% [72]. Abercromby et al. [75] were the first to suggest that these distinct spikes
in signal power were vibration induced movement artefacts and advocated their removal.
All EMG studies prior to this did not address the possible presence of movement artefact
[73, 76, 88, 90, 111, 117, 124], and most investigators are now in general agreement that they
should be removed [72, 107–110, 114, 115, 125]. Sharp, stop-band filters are most commonly
used with a stop-band width of 1.5 - 3Hz [75, 107, 126]. Typically the first three harmonics
of vibration are removed [107, 108, 126], though in some cases up to fifteen have been
removed [75, 114, 115]. Others have implemented dual-pass butterworth filters [109], or
spectral smoothing [125].
The magnitude of the artefact induced in an EMG recorded from the quadriceps during
VV-WBV was quantified by Fratini et al. [107, 126]. An EMG electrode was placed on
the comparatively electrically inert patella in addition to EMG recordings from the vastus
medialis, vastus lateralis and rectus femoris. Acceleration was also measured from the skin
over the rectus femoris. Frequency analysis identified that the frequency of vibration, as
recorded from the rectus femoris, corresponded exactly with the artefact signal in the EMG.
The signal-to-noise ratio was estimated by comparing the signal as recorded from the patella,
to that recorded from the muscle. Artefacts were found to constitute up to 30% of the signal
power, and their magnitude typically increased with frequency.
Theses spikes in the EMG have been described to as stretch reflexes rather than motion
artefact by Ritzmann et al. [88]. It was hypothesised that ‘phase-locking’ was occurring.
During phase-locking the muscle activity is synchronised with the frequency of the vibrating,
resulting in an increase in signal power specifically at the frequency of vibration. Indeed this
view is supported by evidence from the tendon vibration studies by Martin and Park [100] who
showed good motor-unit entrainment up to 100Hz during the direct application of vibration
to the tendons of the hand flexor muscles.
It was thus proposed that the experiments by Fratini at al. [107, 126] were flawed because
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Figure 3.3: Example of power spectral density plots for electromyogram data that was
recorded without WBV (No Vibration), and during WBV (Vibration). The power spectral
density plots are derived from raw data acquired during the study presented in Chapter 5.
This raw data was recorded at the 20Hz vibration condition. PSD: Power spectral density.
an EMG recorded from the patella would likely detect cross-talk from the adjacent muscle
groups [88]. Furthermore Ritzmann et al. [88] identified a neuromuscular response during
WBV which had a latency that was in good agreement with that of the stretch reflex.
They therefore concluded that filtering an EMG to remove ‘artefact’ was incorrect because
it would inadvertently eliminate that neuromuscular activity which was phase-locked with
the vibration. An alternative experimental setup using ‘dummy’ EMG electrodes was
used instead. The dummy electrodes were electrically connected using a fixed resistor
and then isolated from the skin. These electrodes were placed in close proximity to the
recording-electrodes and were thus expected to receive the same dose of vibration as genuine
EMG electrodes. It was hypothesised that the dummy electrodes would not detect the
neuromuscular activity of the underlying muscle and would acquire movement artefacts
only. This setup however, would detect only those voltage potentials generated through
the movement of the EMG cable, and would neglect other potential sources, which include:
(i) the relative movement of the bi-polar electrodes with respect to each other, (ii) the relative
movement of the electrodes with respect to the skin, (iii) the relative movement of the skin
with respect to the muscle, and (iv) spatial impedance differences of the underlying tissue.
It is concluded from the evidence presented above that the frequency of vibration and its
harmonics should be filtered to avoid an overestimation of the magnitude of the EMG.
Furthermore, it is conceded that this approach is conservative and will result in an
underestimation of the signal amplitude due to the removal of those frequency components
that coincidentally occur at the frequency of vibration and its superior harmonics.
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3.5 Acute Physiological Response
In addition to changes in the acute neuromuscular response during WBV, and some reported
adaptation of the myotatic and H-reflexes, a number of other acute physiological changes
in muscle performance have been investigated in the general population. These changes are
described in this section. The available literature on similar adaptations in those with a SCI
is particularly limited. A summary of the reported literature for this population is described
below, in addition to describing the acute response of those with other forms of neurological
deficit.
3.5.1 General Population
The acute effect of WBV on muscle performance remains equivocal. Changes in muscle power,
force, and torque have been described, in addition to changes in jump height, grip strength,
balance, flexibility, and stability. These studies have been carried out across a range of WBV
platforms (VV-WBV, SA-WBV), exercise positions (static-squat, dynamic-squat), and loads.
Typically frequencies between 20 - 40Hz, and amplitudes between 1 - 5mm have been applied.
Average force, power and velocity during an isometric squat and dynamic leg press have
been found to remain the same or increase after an acute bout of WBV [127,128]. Cardinale
and Lim [129] found no change in counter-movement jump height after an acute bout of
VV-WBV at 20Hz, and a decrease in the same parameter after vibration at 40Hz. Cormie et
al. [128] found an increase in counter-movement jump height after an acute bout of VV-WBV
at 30Hz. A later study by Bazett-Jones et al. [130] could only show such increases in female
participants, with no improvements found for the male participants. An exhaustive bout
of SA-WBV with an additional load of 40% body-weight led to a decrease in squat jump
height [113]. However, others have shown no change [112, 129], or an increase [111, 129] in
squat jump height if the vibration exercise is performed without an additional load. Cochrane
and Stannard [131] argue that squat jumps and counter-movement jumps are not normal
during every day movement, and suggest that an arm counter-movement jump is a more
representative test. They found that an acute bout of SA-WBV resulted in an increase
in arm counter-movement jump height. Furthermore, they found that bicycling or a non-
vibration condition resulted in a decrease in arm counter-movement jump height.
A follow up study that compared exhaustive SA-WBV with an additional load to a sham
condition [122]. Similar exercises were performed during the sham condition but no vibration
was applied. A similar decrement in squat jump height was found for both the vibration
and sham conditions, but potentiation of the stretch reflex was found in those subjects that
received the vibration treatment only. This finding was corroborated by others who identified
a similar degree of potentiation of the short latency reflex of the hamstring after an acute bout
of VV-WBV [132]. The metabolic demand of exhaustive SA-WBV was found to be moderate,
where peak oxygen uptake values of 50% maximum oxygen uptake and an average heart rate
of 130 min−1 were reported [113]. These values were smaller than those achieved during leg
cycle ergometry. EMG analysis indicated that neuromuscular fatigue was occurring. Knee
extension torque typically remained the same [112], or decreased [133] after an acute bout of
WBV, particularly if the vibration session was performed with additional load [113,122].
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Other findings showed that an acute bout of SA-WBV increased leg muscle stiffness and
knee stability [132, 134]. However, others did not identify the same results for ankle
stability [135]. Improvements in hamstring flexibility, stability and balance have also been
shown [76,111,112,129,132].
Notwithstanding the wide and varied range of these studies and results, some tentative
observations are made. Some aspects of muscle performance are potentiated after an acute
bout of WBV: (i) most studies have found an increase in explosive muscle power as identified
by an increase in jump height and squat power, (ii) the force producing capacity of the muscle
normally decreases, and (iii) the stretch reflex is normally potentiated. The low metabolic
demand and heart rate experienced during WBV exercise, has led to the conclusion that the
fatigue manifested during WBV is neural in origin rather than muscular, and that WBV
results in some potentiation of neural pathways. Furthermore, there exists a balance between
neural potentiation and overall fatigue.
3.5.2 Neurologically Compromised Population
Studies describing the effect of an acute bout of WBV in those with a neurological deficit
is limited. A summary of the literature summarised in this section is provided in Table 3.1.
An acute bout of WBV has been shown to increase isometric and eccentric muscle torque in
acute stroke patients [136]. The authors attributed the improvements to an increase in the
rate of torque development, leading to a faster recruitment of the large motor units, and the
relaxation of the antagonistic muscle, suggesting an acute reduction in tone [136]. Mean and
peak blood flow were also found to increase by 11.3 - 23.0%, and 22.0 - 36.0% respectively,
with increasing angles of tilt when WBV was applied on a tilt-table [115]. These increases in
blood flow and neuromuscular activity were also associated with changes in gene expressions
that are associated with neural plasticity [119]. The transmission of vibration to the head on a
tilt table was 24 - 59% in able bodied controls, and 17 - 42% in those with an SCI [137]. It was
also shown that the proportion of body weight carried by the lower limb when in this setup
was 22 - 46%. A later study by Bernhardt et al. [138] showed that by using a standing frame,
rather than a tilt-table, the weight carried by the lower limb increased to 76 - 85%. Each of
these studies concluded that this evidence is sufficient to warrant further investigation of the
musculoskeletal benefits of WBV training, either with the aid of a tilt-table or a standing
frame [137,138].
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Table 3.1: Acute changes associated with whole body vibration in populations with a neurological deficit. Deficit duration: Time since stroke
or spinal cord injury; VV: Vertically vibrating; SA: Side alternating; WBV: Whole body vibration; f: Frequency; A: Amplitude; a: aRMS ; ♂:
Male; ♀: Female; Age: Mean age of test population; ISO: Isometric; ECC: Eccentric; CTRL: Control; EMG: Electromyography; SCI: Spinal
cord injury; Dose: Total duration of application of vibration; †: Statistically significant; ‡: Numerically estimated.
Author Vibration param. Intervention Test Population Test Results
Tihanyi et al. [136] VV-WBV Seated. Static Stroke ♂♀ a) ISO & ECC stregnth ISO: WBV (36.6%†); CTRL (8.4%). Rate of torque development:
Dose: 6mins squats and Age: 58.2yrs b) EMG WBV (19%†); CTRL (10.9%). ECC: WBV (22.2%†); CTRL (5.3%).
f: 20Hz standing Deficit duration: 3.9wks EMG: 44.9%†increase in vastus lateralis and no change in
A: 2.5mm 8 X WBV biceps femoris during ISO contractions. 33.2%†in vastus
a: 2.8g‡ 8 X CTRL lateralis, and 22.5%†decrease in biceps femoris during
ECC contraction. 13.1%†increase in median frequency.
Herrero et al. [115] SA-WBV Static squat SCI ♂♀ a) Blood flow Peak blood volume increased 11.3 - 23.0%†. NS difference
Dose: 3mins on tilt table Age: 36.1yrs betweent the difference frequencies tested. Mean blood
f: 10 - 30Hz Deficit duration: 8.6yrs flow incresed 22.0 - 36.0%†. Flow at 30Hz was found to be
A: 2.5mm 8 X SCI significantly larger than flow at 10Hz. Overall, blood flow
a: 0.7 - 6.4g‡ increased with frequency.
Asselin et al. [137] VV-WBV Standing on SCI ♂ a) Vibration Increased transmission of 24 - 59% in CTRL group, with tilt
Dose: 4.5mins tilt table Age: 40yrs transmission angle and platform acceleration. 17 - 42% transmission in SCI,
f: 34Hz Deficit duration: 15yrs with NS difference in transmission when comparing each
A: 0.05 - 0.09mm‡ 7 X SCI group. 22 - 46% body weight bourne throug lower limb
a: 0.19 - 0.31g 10 X CTRL (No neurological between 15 - 45 degrees of tilt.
deficit)
Bernhardt et al. [138] VV-WBV Standing with SCI ♂♀ a) Ground rection Ground reaction force of 76 - 85% in motor complete spinal
Dose: 5mins assistance of Age: 40yrs force cord injured participants during WBV in a standing frame.
f: 34Hz standing frame Deficit duration: 11yrs
A: 0.06mm‡ 11 X SCI
a: 0.3g
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3.6 Chronic Physiological Adaptations
This section reviews the chronic physiological adaptations of muscle that have been associated
with the period of extended WBV training. The section begins by reviewing the response of
the general population, and concludes by reviewing the response of sample populations with
a number of differing types of neurological deficit.
3.6.1 General Population
The application of WBV as a training modality has been described for a broad range of
populations with no neurological deficit. Typical test subjects include: (i) non-athletic,
young men and women (< 35years) [124,139–149]; (ii) moderately-trained and sprint-trained,
young men and women (< 35years) [150, 151]; (iii) non-athletic, elderly women (> 65years)
[152–157]; and (iv) athletic and non-athletic, elderly men (>65years) [158,159].
Muscle strength and power are the main outcome measures typically used to describe the
effect of WBV training, and are most commonly quantified by: (i) isometric knee flexion and
extension flexion torque [67, 124, 139, 140, 146, 147, 151, 153, 157, 158, 160]; (ii) isokinetic knee
flexion and extension torque [140, 143, 145, 146, 148, 151, 153, 160]; (iii) maximum voluntary
contraction [69,141,144,149,161]; (iv) maximum electrically elicited force generating capacity
[141, 145]; (v) repetition maximum [144, 148, 150, 155]; (vi) counter movement jump height
[124, 139–142, 144, 145, 147–153, 157]; (vii) squat jump height [142, 145, 149]; and (viii)
multiple vertical jumps [149]. Other outcome measures include: (i) sprint speed/shuttle
run [124, 139, 142, 149, 151]; (ii) body fat/body mass index/fat free mass [143, 146, 148, 160];
(iii) muscle cross sectional area [67, 155, 157, 161]; (iv) fiber phenotype [69, 147]; (v)
balance/postural sway [124,139,154,159]; (vi) agility [142]; (vii) grip strength [124,139]; (viii)
bone mineral density [124,152]; (ix) timed up-and-go [155]; (x) maximal cycling power [147];
and (xi) respiratory parameters [147].
The frequencies and amplitudes of vibration typically used are between 25 - 50Hz and 1
- 5mm respectively. Some studies have investigated frequencies below 8Hz [149, 158], and
amplitudes as low 0.1mm [152], and in some instances, these parameters are used as sham
vibration conditions. Note that the same exercises are carried out during a ‘sham vibration’
condition but without WBV, or WBV at very low intensities. Platform accelerations during
sham vibration are therefore between 0 - 0.05g [158], however the majority of studies describe
platform accelerations between 1.7 - 18g. Training programmes are typically carried out over
2 - 32 weeks, though some have been carried in excess of 52 weeks [157, 159, 160]. Training
is normally carried out 3 - 5 times per week, though a small number of studies have carried
out training in excess of 10 times per week [67, 69]. The total dose of vibration therapy per
training session is typically reported to be between 2 - 30 minutes, with the optimum dose
suggested to be approximately 15 minutes [162]. As endurance and tolerance builds over the
course of the training programme, overload is typically achieved by increasing the frequency
or amplitude of vibration, or by increasing the total dose of vibration during a session.
The majority of studies describe training programmes during which the participants perform
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a series of standing exercises, jumping exercises, static or dynamic squatting exercises, heel-
lifts, repetition maximum, or a combination of these exercises, in a standing position on a
WBV platform. These exercises can be carried out with, or without additional load. Other
studies have investigated the potential of WBV training to counteract musculoskeletal decline
during prolonged bed-rest [67, 69, 161], and the application of WBV training from a seated
position [144].
Some studies, particularly those first published, used a control group that did not perform
any training for comparison with those who did [67,124,139,147,148,152,154,155]. This led to
criticism of some of the early work as it is difficult to determine the efficacy of WBV training,
or to ascertain to what extent any positive effect reported is attributable to WBV and to
the training intervention alone [163]. More recent investigations have used sham-vibration
groups as controls, whereby the same intervention is carried out but in the absence of vibration
[140–142, 144, 146, 148, 150, 160, 161]. Others have compared a WBV training programme to
conventional fitness or strength training programmes [140,143,151,153,159]. A small number
of studies have compared the training effect of different frequencies of vibration [145,149,158].
The original research articles reviewed in this section are summarised in Table 3.2 - 3.4. These
tables outline the vibration parameters, training parameters, test population, control groups,
outcome measures, and significant results. The results are discussed in greater in the next
section.
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Table 3.2: Chronic changes associated with whole body vibration in general populations with no neurological deficit
Author Vibration param. Training param. Intervention Test Population Test Results
Torvinen et al. [139] VV-WBV 16 weeks Multiple static Non-athletic ♂♀ a) CMJ CMJ: WBV (10%†). ISO knee extension strength: WBV (3.7%†).
f: 25 - 40Hz 3 - 5 sessions/week and dynamic Age: 29yrs b) ISO knee strength NS changes found for all other tests.
A: 1mm 4 mins/session exercises 26 X No intervention c) Grip strength
a: 1.7 - 4.5g 26 X WBV d) Shuttle run
e) Postural sway
Russo et al. [152] SA-WBV 24 weeks Static and Non-athletic ♀ a) CMJ Power: WBV (4.7%); No Intervention (-0.4%). Muscle force:
f: 28Hz 2 sessions/week dynamic squats Age: 61yrs b) BMD WBV (0.1%); No intervention (2.6%). Force velocity: WBV (4.9);
A: 0.1mm‡ 6 mins/session 15 X No intervention No intervention (-1.5%). Significant differecnce in velocity
a: 0.3g 14 X WBV and power between groups. NS differences in BMD.
Delecluse et al. [140] VV - WBV 12 weeks Static and Non-athletic ♀ a) ISO knee strength ISO knee extension strength: WBV (13.6%†); RES (14.4%†).
f: 35 - 40Hz 3 sessions/week dynamic squats Age: 22yrs b) CMJ DYN knee extension strength: WBV (9%†); RES (7%†).
A: 1.2 - 2.5mm 3 - 20 mins/session 20 X WBV NS difference in strength post-WBV or RES. CMJ: WBV (7.6%†).
a: 2.2 - 5g 21 X Sham-WBV Sham-WBV and no intervention showed no training benefit.
20 X RES training*
13 X No intervention
Torvinen et al. [124] VV-WBV 32 weeks Static and Non-athletic ♂♀ a) CMJ CMJ: WBV (7.8%†). No change in BMD, biochemical markers
f: 25 - 45Hz 3 - 5 sessions/week dynamic squats Age: 29yrs b) BMD ISO knee extension strenght, grip strength, shuttle run, or
A: 1mm 4 mins/session 27 X WBV c) ISO knee strength postural sway.
a: 1.7 - 5.7g 26 X No intervention c) Grip strength
d) Shuttle run
e) Postural sway
deRuiter et al. [141] SA-WBV 11 weeks Static squats Non-athletic ♂ a) CMJ No significant increase in bi-lateral knee extension strength,
f: 30Hz 3 sessions/week Age: 20yrs b) MFGC MFGC, or CMJ found in either group. Larger tendancy for rate of
A: 4mm 5 - 8 mins/session 10 X WBV c) MVC force rise identified in WBV group.
a: 10g‡ 10 X Intervention only
Roelants et al. [153] VV-WBV 24 weeks Static and Non-athletic ♀ a) CMJ ISO knee extension strength: WBV (12%†); RES (16%†).
f: 35 - 40Hz 3 sessions/week dynamic squats Age: 65yrs b) ISO and DYN knee DYN knee extension strength: WBV (12%†); RES (12%†).
A: 1.25 - 2.5g 3 - 30 mins / session 24 X WBV strength CMJ: WBV (12% †); RES (16%†). NS difference between
a: 2.2 - 5.09g 20 X RES training* groups and no intervention had no training effect.
25 X No intervention
Cochrane et al. [142] SA-WBV 2 weeks Static squats Non-athletic ♂♀ a) CMJ JH: WBV (4.3%). CMJ: WBV (3.9%). NS difference between groups
f: 26Hz 4 - 5 sessions/week Age: 24yrs b) SJ and decrease found in intervention only group. No change
A: 5.5mm 10 mins/session 12 X WBV c) Agility in agaility or sprint speed in either group.
a: 10g‡ 12 X Intervention only d) Sprint
Roelants et al. [143] VV-WBV 24 weeks Static and Non-athletic ♀ a) DYN knee strength DYN knee extension strength: WBV (5.9 - 24.4%†); RES
f: 35 - 45Hz 3 sessions/week dynamic squats Age: 21yrs b) FFM (10.2 - 16.5%†). NS difference between groups. FFM:
A: 1.25 - 2.5mm 3 - 20 mins/session 13 X WBV WBV (2.2%†). No change in body weight or fat in any group.
a: 2.2 - 5g 15 X RES training*
12 X No intervention
Ronnestad [150] VV-WBV 5 weeks 90 - 100% RM Moderately-trainined ♂ a) CMJ RM: WBV (32.4%†); RM (24.2%†). NS difference between
f: 40Hz 2 - 3 sessions/week Age: 31yrs b) RM groups. CMJ: WBV (9.1%†) RM (4.2%).
A: NR NR 8 X WBV
a: NR 8 X RM only
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Table 3.3: Chronic changes associated with whole body vibration in general population with no neurological deficit (continued)
Author Vibration param. Training param. Intervention Test Population Test Results
Delecluse et al. [151] VV-WBV 5 weeks Multiple static Sprint-trained ♂♀ a) ISO and DYN knee No change in ISO or DYN knee flexion or extension strength,
f: 35 - 40Hz 3 sessions/week and dynamic Age: 21yrs strength knee extension velocity, sprint velocity, or CMJ.
A: 1.7 - 2.5mm 9 - 18 mins/session exercises 10 X WBV b) CMJ
a: 2.2 - 5g‡ 10 X Conventional training* c) Sprint
Mulder et al. [67] SA-WBV 8 weeks Static squat Non-athletic ♂ a) ISO knee strength Quadriceps CSA: WBV (-3.5%†); No Intervention (-14.1%†).
f: NR 12 sessions/week with added Age: 33yrs b) Muscle CSA Difference between these groups significant. Quadriceps
A: NR > 1 min/session resistance 10 X WBV maximum torque: WBV (0%); No intervention (-16.8%†). No
a: NR (BRS) 10 X No intervention change in maximum voluntary activation levels.
Blottner et al. [69] SA-WBV 8 weeks Static squat Non-athletic ♂ A) Fiber phenotype ISO triceps surae force producetion: WBV (-9.2%†); No
f: 19 - 25Hz 11 sessions/week with resistance Age: 33yrs b) MVC intervention (-32.9%). Difference between these groups
A: 2.5 - 5.0mm 6 mins/session (BRS) 10 X WBV significant. Myofiber type largely preserved in WBV group with
a: 2.5 - 8g‡ 10 X No intervention soleus muscle showing a shift towards Type I fiber type.
Cheung et al. [154] SA-WBV 12 weeks Standing Non-athletic ♀ a) Balance Improved balance in WBV group only.
f: 20Hz 3 sessions/week Age: 72yrs
A: NR 3 mins/session 45 X WBV
a: NR 24 X No intervention
Bogaerts et al. [157] VV-WBV 52 weeks Static and Non-athletic ♂♀ a) Muscle CSA ISO knee extension strength: WBV (9.8%†); FIT (13.1%†).
f: 35 - 40Hz 3 sessions/week dynamic squats Age: 68yrs b) CMJ CMJ: WBV (10.9%†); FIT (9.8%†). Muscle mass: WBV
A: 1.25 - 2.5mm 2 - 15 mins/session 31 X WBV c) ISO knee strength (3.4%†); FIT (3.8%†). NS difference between WBV and FIT
a: 4.4 - 11.4g‡ 30 X FIT training* groups. No intervention showed no training effect.
36 X No intervention
Bogaerts et al. [159] VV-WBV 52 weeks Static and Non-athletic ♂ a) Balance WBV and FIT associated with a reduction in the number of
f: 35 - 40Hz 3 sessions/week dynamic squats Age: 68yrs falls and a NS but positive improvement in balance
A: 1.25 - 5.0mm 2 - 15 mins/session 31 X WBV
a: 4.4 - 11.4g‡ 30 X Fitness programme*
36 X No intervention
Mulder et al. [161] SA-WBV 8 weeks Multiple static Non-athletic ♂ a) MVC Quadriceps CSA: No intervention (-13.5%†); unchanged
f: 16 - 26Hz 3 sessions/week and dynamic Age: 32yrs b) Muscle CSA in other groups. ISO knee extension strength: No
A: 4mm > 3 mins/session exercises with 7 X WBV intervention (-21.3%†); unchanged in other groups.
a: 3 - 7.5g‡ resistance 7 X Intervention only Triceps surae CSA: No intervention (-28.3%†); Intervention
(BRS) 9 X No intervention only (-10.7%†); WBV (-11%†). Triceps surae MVC:
No intervention (-24.9%†); Intervention only (-14.8%†);
WBV (-12.3%†).
Machado et al. [155] VV-WBV 10 weeks Static squats Non-athletic ♀ a) Muscle CSA CSA: WBV (Vastus medialis (8.7%†); Biceps femoris
f: 20 - 40Hz 3 - 5 sessions/week Age: 78yrs b) RM (15.5%†); Vastus lateralis (2.5%)); No intervention (0.3 - 5%).
A: 2 - 4mm 7.5 - 22 mins/session 14 X No intervention c) Time up-go RM: WBV (38%†). Mobility: WBV (-9%). Muscle power: No
3 - 18g‡ 15 X WBV change post-WBV and decrease post-no intervention.
Carson et al. [144] VV-WBV 4 weeks Seated heel- Non-athletic ♂♀ a) RM RM: WBV (16%†); No intervention (16%†). MVC: WBV
f: 30Hz 3 sessions/week lifts with Age 33yrs b) MVC (14.7%†); No intervention (12.5%). CMJ: WBV (0.3%); No
A: 2.5mm 1.5 mins/session resistance 9 X WBV c) CMJH intervention (0.7%†). No significant difference between
a: 6g‡ 9 X Intervention only groups. No change in rate of force development.
Petit et al. [145] VV-WBV 6 weeks Static squats Non-athletic ♂ a) DYN Knee strength DYN knee extension torque: WBV (14g) (13.2 - 16.3%†). SJ:
f: 30 - 50Hz 3 sessions/week Age: 21yrs b) MFGC WBV (14g) (4.8%†). CMJ: WBV (14g) (9.7%†). Significant
A: 1 - 2mm 10 mins/session 12 X WBV (14g) c) SJ difference bwtween WBV groups. No change in MFGC.
a: 2.5 - 14g‡ 10 X WBV (2.5g) d) CMJ
10 X No intervention
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Table 3.4: Chronic changes associated with whole body vibration in general populations with no neurological deficit (continued). VV: Vertically
vibrating; SA: Side alternating; WBV: Whole body vibration; f: Frequency; A: Amplitude; a: aRMS ; ♂: Male; ♀: Female; Age: Mean age
of test population; CMJ: Counter movement jump; SJ: Squat jump: RM: Repetition maximum; ISO: Isometric; DYN: Dynamic; BMD: Bone
mineral density; MVC: Maximum voluntary contraction; MFGC: Electrically elicited maximal force generating capacity; FFM: Fat free mass;
RES: Resistance; BRS: Bed rest study; NS: Not statistically significant; MVJ: Multiple Vertical Jumps; †: Statistically significant; NR: Not
reported; *: See original reference; ‡: Numerically estimated.
Author Vibration param. Training param. Intervention Test Population Test Results
Kern et al. [158] NR-WBV 8 weeks Seated with Athletic ♂ a) Iso knee strength ISO knee extension strength: 21 - 67%†increase found
f: 1 - 15Hz NR sessions/week 1Hz and 15hz Age: 69yrs across both frequencies with no significant differences
A: 1.5mm NR mins/session applied to 7 X WBV between frequencies found.
a: 0.05 - 1g‡ contralateral
leg
Osawa et al. [146] VV-WBV 12 weeks Multiple static Non-athletic ♂♀ a) FFM ISO knee extension: WBV (10.9%); Intervention only (8.5%).
f: 30 - 40Hz 2 sessions/week and dynamic Age: 27yrs b) ISO knee strength ISO knee flexion: WBV (22.0%); Intervention only (24.3%). NS
A: 2mm 25 mins/session‡ exercises 10 X WBV difference between groups. No change in FFM.
a: 2.5 - 4.5g‡ 8 X Intervention only
Item et al. [147] SA-WBV 5 weeks Static squats Non-athletic ♀ a) Respiration Fiber pheontype: WBV (Type I (16.7%†), Type II (13.8%†),
f: 30Hz 3 sessions/week with resistance Age: 24yrs b) ISO knee strength capilliarisation (14%†)). Lean thigh mass: WBV (14%†).
A: NR >12mins/session and vascular 12 X WBV c) Fiber phenotype Maximal cycling power: WBV (8.7%†). Maximal cardiac
a: NR occlusion 9 X No intervention d) Cycling power output: WBV (8.9%†). No change in ISO knee extension
e) CMJH strength, power, CMJ, VO2max. No intervention had no training
effect.
von Stengel et al. [160] VV-WBV 72 weeks Static and Non-athletic ♀ a) Body fat Trunk extension strength: WBV (6.2%†); Intervention only
f: 25 - 35Hz 2 sessions/week dynamic squats Age: 69yrs b) ISO trunk and knee (6.75%†). ISO knee extension strength: WBV (5%†). Trunk
A: 1.7 - 2.0g 6 mins/session and heel-lifts 50 X Light Intervention* strength flexion strength: WBV (16.5%†). Body fat: Light intervention
3 - 7g‡ 51 X Intervention only c) CMJ (-2.8%†); Intervention only (-11.4%†); WBV (-12.1%†).
51 X WBV CMJ: Light intervention (0.4%); Intervention only (0.8%);
WBV (1.7%). NS difference between groups.
Artero et al. [148] VV-WBV 8 weeks Static and Non-athletic ♂♀ a) 3RM Muscle mass: WBV (3.4%†); Intervention only (4.5%†).
f: 20 - 40Hz 2 sessions/week dynamic squats Age: 22yrs b) DYN knee strength 3RM: WBV(43%†); Intervention only (52%†). NS difference
A: 1.25 - 2.5mm 6 - 10 mins /session and jumping 15 X WBV c) CMJ between groups. No change in DYN knee extension strength,
a: 1.41 - 11.3g exercises 15 X Intervention only d) BMI CMJ. Body fat: WBV (-2.1%†).
e) Body fat
Couto et al. [149] VV-WBV 4 weeks RM Non-athletic ♂ a) MVC MVC: WBV (8Hz) (23.2%†); WBV (26Hz) (22.2%); Intervention
f: 8 - 26Hz 3 sessions/week Age: 26yrs b) SJ (12.1%†). SJ: WBV (8Hz) (11.1%); WBV (26Hz) (9.6%). CMJ:
A: 3mm >1 min/session 13 X Intervention only c) CMJ WBV (8Hz) (8.7%†); WBV (26Hz) (7.5%). Significant difference
a: 0.5 - 5.7g‡ 14 X WBV (8Hz) d) MVJ between WBV and intervention only condition. NS difference
14 X WBV (26Hz) e) Sprint between WBV conditions. NS changes in sptint speed of MVJ.
14 X No intervention
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Muscle Strength
As described above, the outcome measures most commonly used to describe muscle strength
include: unilateral or bilateral knee extension torque, unilateral knee flexion torque, trunk
flexion and extension torque, maximum voluntary contraction, maximum electrically elicited
force generating capacity, and repetition maximum. In the review below please refer to Table
3.2 - 3.4 for the specific tests used when the term strength is used. Strength increases of 3.7
- 67.0% were found after a period of WBV training [139,149,155,158]. However, others have
shown no improvement [141, 143–145, 147, 148], or no statistically significant improvement
when compared to a control group that carried out similar training paradigms in the absence
of vibration, or conventional training programmes [140,150,151,153].
An 8 to 16 week period of WBV training in a group of non-athletic, young men and women
resulted in a 5.7 and 6.7% strength improvement for each group respectively. The control
group, that did not perform any form of training, showed improvements of 2.2 and 5.2% for
the same period. Nonetheless, a statistically significant improvement of 3.7% was shown for
the WBV group when compared to the controls after 8 weeks of training [139]. A follow up
study that investigated the effect of 32 weeks of WBV training showed a 9.8% improvement
in strength, compared to a 7.8% improvement in controls that did not perform any exercise.
This resulted in a non statistically significant between group difference of 1.9% [124]. The
authors suggested that the lack of statistical significance at 16 and 32 weeks was due to the
fact that most of the strength improvement occurred within the first 8 weeks of training, with
a plateau thereafter, and that the improvements in muscle strength found for the controls
was due to a learning effect over the course of the study [139]. While it is unclear whether
the improvements were due to WBV or the exercise intervention alone, it was concluded that
the intervention in the absence of vibration was of insufficient intensity to fully account for
the strength improvements and must therefore be a consequence of the vibration therapy.
A similar study carried out for 12 weeks, but with a larger dose of vibration per session found
strength improvements of 10.9 - 22.0% in the WBV group, and 8.5 - 24.3% in the controls that
carried out the same intervention without vibration [146]. In both instances there was a non-
significant difference between the improvements found for the vibration and control groups.
Similarly, Carson et al. [144] found that WBV did not lead to an additional improvement
in plantar flexor strength or one-repetition maximum when compared to participants that
carried out the same intervention without vibration. These results suggest that the addition
WBV to a training paradigm has a negligible effect on lower limb strength.
Delecluse et al. [140] compared a 12 week WBV training programme in a group of non-
athletic, young females with three control groups: (i) a group that did not perform any
exercise; (ii) a sham group that performed the same intervention, but in the absence of
vibration; and (iii) a group that performed a conventional, resistance based strength training
programme. They found that WBV training and the resistance programme each resulted in a
comparable and statistically significant increase in strength of 13.6% and 14.4% respectively.
A similar study found that a 24 week WBV training programme in a group of non-athletic,
elderly females resulted in a 12% strength increase, and a resistance programme resulted in
a 16% strength increase [153]. In each of these studies, the sham vibration condition and
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no intervention condition did not result in any strength improvements, and no statistically
significant difference was found when comparing WBV to the resistance training programmes.
A 5 week WBV training programme resulted in a significant and comparable increase in
the one-repetition maximum of moderately strength-trained men when compared to those
who carried out the same training programme in the absence of vibration [150]. Increases
of 32.4% and 24.2% were found for the WBV and non-vibration programmes respectively.
It was concluded that during one-repetition maximum, complete voluntary activation of the
muscle was being achieved. WBV therefore facilitated the recruitment of additional muscle
fibers. These additional fibers were activated by reflex activity, thus causing a larger increase
in strength in the WBV group. Conversely, Delecluse et al. [151] compared WBV with a
conventional training programme over a 5 week period in young, sprint-trained athletes. No
strength increases were found and it was concluded that this was due to the small potential
for performance improvement in previously trained athletes.
A similar study, but carried out over a much longer 52 week period, with a group of non-
athletic, elderly women resulted in a statistically significant strength increase of 9.8% after
the WBV training intervention [157]. This was comparable to an increase of 13.1% for the
control group who carried out the conventional fitness programme over the same period. Von
Stengel et al. [160] found comparable increments in muscle strength of 6.2%, in a similar
population after 72 weeks of training. However, these results were not significantly different
to the 6.75% strength increase found for the controls who carried out the same intervention
but in the absence of vibration. Kern et al. [158] found that an 8-week period of WBV-
training in athletic, elderly men resulted in a 21 - 67% increase in strength. This slightly
unconventional study applied a different frequency of vibration to the contralateral lower-
limbs. No significant difference was found for the leg trained at 1Hz compared to the other
trained at 15Hz. Couto et al. [149] found that a 4-week WBV programme resulted in a
22.2 - 23.2% increase in strength. No difference was found between training at 8Hz or 26Hz,
however these improvements were significantly larger than the control group who carried out
the same intervention in the absence of vibration.
A meta-analysis carried out by Marin and Rhea [162] concluded that: (i) a period of WBV-
training is more effective in untrained rather than athletic populations; (ii) the training
effect is larger in elderly populations; (iii) strength improvements are larger if dynamic
exercises with additional load are performed with vibration; and (iv) the training effect
increases with frequency, amplitude, or dose of vibration. However, a review by Nordlund
and Thorstensson [164] suggests that such strength improvements are largely attributable to
a general training effect rather than WBV. They concluded that muscle hypertrophy and
strength improvements are unlikely to occur because of the relatively low loads imposed on
the muscle-tendon unit during WBV.
Muscle Power
The countermovement jump and the squat jump are the most common measures used
to assess changes in muscle power during WBV training programmes. Other measures
include isokinetic dynamometry and the rate of change of force production. A period of
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WBV training was associated with a 0.3 - 12% increase in countermovement jump height
[111, 139, 140, 144, 145, 153], and a 4.3 - 11.1% increase in squat jump height [142, 149].
However, as discussed in relation to changes in muscle strength, some studies have found no
change [141,144,147,148,151], or no significant difference in these parameters when compared
to controls who carried out the same intervention or conventional training programmes [142].
24 weeks of WBV training in a population of elderly women resulted in a 4.7% increase in
muscle power, and a 4.9% increase in force velocity as assessed by a countermovement jump
[152]. These increases were significant when compared to controls that did not participate in
any form of regular exercise. However, in this study as with others, it is not clear if theses
improvements in muscle power were due to WBV or the intervention alone [111,139,152].
Several studies have compared the effect of a muscle training intervention carried out with
and without WBV. DeRuiter et al. [141] did not find a significant increase in muscle power
in a population of non-athletic, young men, though they did note that there was an increased
tendency for rate of force production in the WBV group. Similar findings are reported by
Carson et al. [144]. Conversely, Petit et al. [145] found that a high-frequency (50Hz) WBV
training programme resulted in a significantly larger increase in jump height when compared
to a low-frequency (30Hz) training programme. These finding are in part supported by Couto
et al. [149], who found that WBV elicited a 9.6 - 11.1% increase in squat jump height, and a
7.5 - 8.7% increase in countermovement jump height, in a population of young, non-athletic
men. However, no significant difference was identified when comparing those who trained
at the different frequencies of vibration. It is possible that the lack of significant difference
is due to the different range of frequencies tested (6 & 26Hz), compared to those described
above (30 & 50Hz).
Other study designs have compared a WBV training programme with conventional resistance
based training programmes. Delecluse et al. [140] found that WBV was more effective than
the conventional programme in a population of non-athletic young women, where a 7.6%
increase in countermovement jump height was identified. Similar improvements in a non-
athletic elderly populations of 1.7 - 12.0% have been reported, though these improvements
were not significantly different to those who carried out conventional maintenance, resistance,
or fitness training, who similarly showed increases in countermovement jump height of 0.4
- 16.0% [153, 157, 160]. Ronnestad [150] identified a 9.1% increase in countermovement
jump height in a population of moderately strength-trained youn men, though this was not
significantly different to the improvements of 4.2% found for the control group.
A meta-analysis by Marin and Rhea [165] concluded that: (i) overall WBV could be used
to increase muscle power; (ii) WBV training is more effective in older rather than younger
populations; and (iii) the best improvements in power are achieved by training between 35 -
40Hz, increasing amplitude, or applying a dose of vibration of 360 - 720 seconds in duration.
In addition, it has been suggested that the lack of statistical significance of reported findings
may be due to a lack of power of the statistical tests used and the typically small number of
participants recruited for study [141].
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Counteracting Neuromuscular Decline
A series of bed-rest studies have investigated the potential of WBV training as an exercise
modality to counteract muscular decline [67,69,161]. Physiological decline during prolonged
bed-rest is well documented [63], and is now used as a model of disuse during spaceflight
[66,71]. 8 weeks of bed rest in young, healthy, non-athletic adults resulted in a 13.5 - 14.1%
reduction in quadriceps cross sectional area [67, 67], and a 28.3% reduction in the calf cross
sectional area [69]. A corresponding 16.8 - 21.3% reduction in knee extensor torque [67, 67],
and a 24.9 - 32.9% reduction in the isometric force production of the triceps surae was found
in the same population [69, 161]. In addition, a significant increase in the proportion of fast
twitch (Type II) myofibers was found in the soleus muscle [69]. 8 weeks of WBV training
was then shown to counteract some of these trends and therefore be effective in preserving
muscle size and function [67,69]. A smaller reduction in muscle cross sectional area of 3.5%
and 11% was found for the quadriceps and triceps surae respectively. Knee extension torque
was preserved, and a smaller reduction of 9.2% in triceps surae isometric force production
was found. A shift towards the slow-twitch (Type I) myofiber type was found in the soleus
muscles of those subjects trained with WBV. However, in the final study of the series,
Mulder et al. [161] were unable to identify a significant difference in response between those
that trained with WBV, and those who carried out the same exercise paradigm but in the
absence of vibration.
Other parameters
No change in agility, postural sway, sprint speed, or upper limb grip strength has been found
in young, athletic and non-athletic adults [14, 124, 139, 142]. More promising findings have
been identified in elderly populations, where WBV has been associated with improvements
in balance and a reduction in the number of falls [154,159]. As described in Section 3.5.1, the
metabolic demand of WBV was moderate, where oxygen uptake during WBV was 50% of
maximum [113]. In addition to this finding, Item et al. [147] found that WBV training did not
change V O2max, but did lead to an increase in maximal cycling power, muscle capillarisation,
and lean thigh mass. A 2.2% increase in fat-free mass, and a 2.1% reduction in body fat has
been associated with WBV training [143,148], though these findings have not been replicated
by others [146].
3.6.2 Neurologically Compromised Populations
Chronic physiological adaptations after a period of WBV training have been investigated
in populations that suffer from a neurological deficit. These populations include: stroke
[166, 167], multiple sclerosis [168–171], and spinal cord injury [172, 173]. Typical outcome
measures from these studies include: (i) balance [166, 167, 169–171]; (ii) timed up-and-
go [167–171]; (iii) muscle tone/spasticity [167, 168, 173]; (iv) walking [166–172]; and muscle
strength [167–169,171].
These studies have most commonly been carried out in community dwelling populations,
whose disease or injury occurred greater than one year prior to the beginning of the study.
Training programmes have been carried out for 3 - 10 weeks, with training carried out 2 - 5
times per week. The frequencies and amplitudes typically used are 25 - 50Hz, and 1 - 4mm
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respectively. The total dose of vibration per session is typically between 3 - 15 minutes per
session, and overload is achieved by increasing frequency, amplitude, or dose of vibration, or
by decreasing the duration of periods of rest. Participants almost exclusively perform static
or dynamic squats, heel-lifts, or lunges without additional weight.
As with the studies reviewed for the general population, some studies have shown WBV
training has a positive effect, for example on walking in a population suffering from multiple
sclerosis [170]. However, others have been unable to show any improvement [168], or a
significant difference when compared to controls who carried out the same intervention during
a sham vibration condition [171]. The original research articles reviewed in this section are
summarised in Table 3.5, and the results are discussed in greater detail in later sections.
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Table 3.5: Chronic changes associated with whole body vibration in populations with a neurological deficit. Deficit duration: Time since stroke,
spinal cord injury, or onset of multiple sclerosis; VV: Vertically vibrating; SA: Side alternating; WBV: Whole body vibration; f: Frequency; A:
Amplitude; a: aRMS ; ♂: Male; ♀: Female; Age: Mean age of test population; ISO: Isometric; DYN: Dynamic; NS: Not statistically significant;
†: Statistically significant; NR: Not reported; ‡: Numerically estimated.
Author Vibration param. Training param. Intervention Test Population Test Results
Van Nes et al. [166] SA-WBV 6 weeks Static squats Stroke ♂♀ a) Balance Improvement in balance (70%†); mobility (64%†); trunk
f: 30Hz 5 sessions/week Deficit duration: 5wks b) Mobility control (14%†); activities of daily living (49%†); and
A: 1.5mm 3 mins/session Age: 61yrs c) Trunk control motricity index (26%†). NS difference between WBV and
a: 3.8g‡ 27 X WBV d) Motricity index control groups. Larger improvements during intervention
26 X Exercise with music e) Activities of daily period than post-intervention period. Conclude WBV has
living same treatment effect as execise with music.
Schyns et al. [168] VV-WBV 4 weeks NR Multiple sclerosis ♂♀ a) Muscle tone Tendency for increased tone in absence of WBV therapy. NS
f: 40Hz 3 sessions/week Deficit duration: 6.7yrs b) ISO muscle force increase in ISO muscle force production of key hip, knee, and
A: 1mm 5 mins/session Age: 48yrs c) Sensation ankle flexors and extensors. NS improvement in 10m walk
a: 4.6g‡ 12 X Randomised cross-over d) Proprioception test and time up and go. No change in sensation or
trial. e) 10m walk test proprioception. NS difference between groups. Comclude
f) Time up and go tests underpowered to detect between group differences,
Ness et al. [172] VV-WBV 4 weeks Static squats SCI ♂♀ a) Walking Improved walking speed (24%†); cadence (10%†); step
f: 50Hz 3 days/week Deficit duration: >1yr length (18 - 19%†); and limb co-ordination (10 - 13%†).
A: 1 - 2mm 3 mins/session Age: 48yrs
a: 7.1 - 14.2g‡ 17 X WBV
Ness et al. [173] VV-WBV 4 weeks Static squats SCI ♂♀ a) Spasticity Significant reduction of first swing excursion (20%†) as
f: 50Hz 3 days/week Deficit duration: >1yr assesed during a pendulum test. NS change in the number
A: 1 - 2mm 3 mins/session Age: 51yrs of oscillations. NS difference in response between those
a: 7.1 - 14.2g‡ 16 X WBV that use anti-spastic medication, and those that do not.
Broekmans et al. [169] VV-WBV 20 weeks Static and Multiple sclerosis ♂♀ a) ISO & DYN strength ISO and DYN knee flexion and extension strength (-8.9 -
f: 25 - 45Hz 2 - 3 sessions/week dynamic squats Deficit duration: NR b) Speed of movement 6.8%); NS change in speed of movement; Balance (-6.7%);
A: 2.5mm 2.5 - 16.5 mins/session Age: 48yrs c) Balance Time up and go (-4.4%); 2 min walk test (6.8%); and timed
a: 4.4 - 14.4g‡ 11 X WBV d) Timed up and go walk test (-3.5%). NS difference between WBV group and
12 X No intervention e) 2 min walk test no-intervention group.
f) Timed walk test
Mason et al. [170] SA-WBV 8 weeks Static squats Multiple sclerosis ♂♀ a) Quality of life Improved physical functioning (19%†) after 4 weeks; Faster
f: 15 - 25Hz 3 sessions/week Deficit duration: 10.9yrs b) Timed up and go timed up and go (11%†), 10m walk test (13%†), and
A: 1.30 - 3.65mm 5 - 8 mins/session Age: 50yrs c) Functional reach balance (15%†) compared to baseline. NS change in
a: 0.83 - 3.65g‡ 15 X WBV test functional reach.
d) Balance
e) Time 10m walk test
Claerbout et al. [171] VV-WBV 3 weeks Static and Multiple sclerosis ♂♀ a) ISO strength ISO: WBV (34.6 - 56.2%), Damped WBV (19.5 - 34.5%), No
f: 30 - 40Hz 3 - 4 sessions.week dynamic squats, Deficit duration: 11.6yrs b) 3min walk test WBV (2.8 - 16.5%). Changes in ISO strength of quadriceps
A: 0.8mm 7 - 13 mins/session heel-lifts, and Age: 43.5yrs c) Timed up and go and hamstring significant; NS improvements in all other
a: 2.7g @ 40Hz lunges 16 X WBV d) Balance measures: Timed up and go: WBV (9.1%), Damped WBV
14 X Damped WBV (16.2%), No WBV (4.9%); 3min walk test: WBV (38.7%),
17 X No WBV Damped WBV (31.8%), No WBV (15.8%); Balance:
WBV (10%), Damped WBV (12%), No WBV (3.9%).
Brogardh et al. [167] VV-WBV 6 weeks Static squats Stroke ♂♀ a) ISO & DYN strength Timed up and go: WBV (8%†), CTRL (6%†); 6min walk
f: 25Hz 2 sessions/week Deficit duration: 2.9yrs b) Balance test: WBV (5%†), CTRL (6%†); Balance: WBV (4%†);
A: 0.1 & 1.9mm 3 - 12 mins/session Age: 62.7yrs c) Muscle tone Gait speed: WBV (5%†); ISO strength in paeretic limb:
a: 0.2 & 3.4g‡ 16 X WBV (A = 1.9mm) d) Timed up and go CTRL (12%†). NS difference between groups for any
15 X CTRL (A = 0.1mm) e) Gait speed outcome measure.
f) 6min walk test
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Stroke
A 6 week period of WBV training in an acute stroke population resulted in a significant
improvement in balance, mobility, trunk control and activities of daily living [166]. However,
these improvements were not found to be significant when compared to a control group that
carried out same exercises with music, suggesting that WBV does not infer any additional
benefit to exercise alone during the early stages of stroke recovery. In addition, it is unclear to
what extent the improvements observed would have occurred naturally in the ordinary course
of recovery. A similar study carried out with a chronic stroke population identified smaller
improvements, in addition to increases in isometric strength of the paretic limb [167]. In each
study, the small and non-significant differences found when compared to the control groups
were attributed to the low intensity of the vibration therapy, and thus the small demand it
exerted on the neuromuscular system [166,167].
Multiple Sclerosis
An 8 week WBV training programme resulted in a significant improvement in the balance,
walking capabilities, and timed up-and-go of community dwelling individuals with multiple
sclerosis when compared to baseline [170]. However, these results were not replicated when
compared to others who investigated the same parameters but using a study of a randomised
cross-over design [168], or when compared to a different control group [169]. Broekmans
et al. [169] concluded that the poor results found in their study might be a consequence
of overtraining, as the frequency, amplitude and dose of vibration exceeded those of other
studies [168, 170]. On a more positive note though, Schyns et al. [168] report an increased
tendency of muscle tone in those who did not perform WBV training. This is supported by
similar finding in SCI [173]. In a similar and well controlled study by Claerbout et al. [171],
larger improvements in balance, walking capabilities and timed up-and-go were identified, in
addition to significant increases in quadriceps and hamstring isometric strength. The authors
concluded that the poor results presented in previous studies were due to the fact that the
participants were only mildly affected by their neurological impairment, and were already
functioning near the peak of the physical capability, therefore presenting small scope for
additional improvement. In contrast they recruited a population that was severely affected
by disability, and thus had more potential for improvement with training [171].
Spinal Cord Injury
Literature describing the effect of WBV training in SCI is limited. Ness et al. [172, 173]
investigated the effect of WBV training on walking and spasticity in a population of chronic
(>1 year), motor-incomplete SCI individuals. 4 weeks of WBV training improved walking
speed (24%), cadence (10%), step length (18 - 19%), and co-ordination (10 - 13%), when
compared to baseline measures [172]. Subjects used as their own controls in this way was
justified because these parameters were assumed to have reached a plateau within one year
of cord injury. In addition, a decrease in first swing excursion during a pendulum test (20%)
was found, indicating a significant decrease in quadriceps spasticity [173]. Furthermore,
improvements in tone were independent of the prescription of anti-spastic medication, and
no significant difference was identified between those taking such medication, and those not
taking it. Analysis showed that the largest improvements were found for those with the
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highest degree of spasticity at the beginning of the study [173].
3.7 Summary of Literature
WBV as a training modality has been reasonably well described for a wide range of sample
populations with no neurological deficit. Depending on the specific aim of the exercise
programme, the training effect of WBV tends to increase with frequency, amplitude, or dose
of vibration [130, 145, 149, 162, 165]. However, relatively few studies have directly compared
the acute neuromuscular response of different vibration conditions, with a view to validating
their application in a training programme [72, 73, 174]. Furthermore, no such evidence exits
for the SCI population.
It has also been shown that WBV training may be of most benefit to those in the general
population who are un-trained or elderly [162]. The hypothesis is that such populations
possess a greater capacity for improvement because they have not been previously performing
to the peak of their ability. While it can be argued that this hypothesis is not limited solely
to WBV training programmes, larger improvements have been reported for populations more
severely affected by neurological injury or disease [171,173]. It was therefore concluded that
WBV may be particularly suited to those with a severe neurological deficit such as SCI.
However, studies describing the acute response of such populations are limited, particularly
for those with an acute and sub-acute injury.
SA- and VV-WBV are the most commonly investigated systems. Vibration has almost
exclusively been applied by these systems with the participant in an upright or standing
position, and sometimes carrying additional load. This set-up therefore precludes the
participation of those unable to stand or support their own body weight. It is most likely for
this reason that the majority of research studies investigating WBV have been carried out in
the general population, or with those only moderately affected by neurological de-conditioning
or paralysis. More recently, some investigators have applied WBV in other ways with mixed
success. Vibration was successfully shown to attenuate neuromuscular decline, when applied
to subjects in a supine position during a series of bed-rest studies [67, 69, 161]. However, in
these studies the participants were provided with strapping over the shoulders that inferred
additional load, making the exercise more analogous to standing, and the exercise was thus
termed resistive vibration exercise. Others have applied WBV in a seated position [87], or on
a tilt-table [115] in a sample of motor complete SCI subjects. A poor neuromuscular response
was found for both conditions, though an increase in blood flow was identified on the tilt-
table [115]. Likely reasons for the small response on the tilt-table include: the chronicity
of the cord injury [115] and the poor transmission of vibration to the body [137]. Better
transmission of vibration was shown for SCI subjects bearing their full weight in a standing
position with the support of a conventional standing frame [138]. WBV applied in this way
was shown to have a short term influence on the H-reflex, though the general neuromuscular
response during vibration was not reported [117]. The neuromuscular response of the sub-
acute, motor complete and motor incomplete SCI population, during WBV applied in the
conventional upright position has yet to be investigated.
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It remains equivocal as to whether or not movement artefact is present in an EMG recorded
during WBV. Several authors have put forward evidence suggesting the presence of artefact
and advocating its removal [75,107,126], meanwhile others have suggested that the influence
of artefact is minimal and that the additional myoelectric signals manifested in the EMG are
stretch reflexes that are occurring in synchrony with the vibrating platform [88]. It remains
plausible that a stretch reflex may be evident in an EMG recorded during WBV because there
is firm evidence that the stretch receptor plays a central role in the neuromuscular response to
WBV [88]. However, notwithstanding the potential presence of such stretch reflexes, it is not
possible to preclude the presence of movement artefact in the signal either. The investigation
of WBV with a specific subset of the SCI population may improve the understanding of this
issue. Damage to the lower motor neuron results in areflexia, and therefore a total absence
of the stretch reflex. Studying the acute neuromuscular response of this subset provides a
unique opportunity to determine, and if present quantify, the movement artefact present in
an EMG recorded during WBV.
It was thus concluded to investigate the neuromuscular response of both neurologically intact
and SCI participants under the same experimental conditions by integrating a WBV platform
with a partial Body Weight Support (pBWS) system.
3.7.1 Open Research Questions
The application of WBV in a standing position under conditions of reduced load, as permitted
by reducing body weight using a pBWS system has not been investigated in a neurologically-
intact or SCI population. As such is is not known how the reduction of load may affect the
neuromuscular response to WBV.
The open research questions which were identified included: (i) can WBV be applied in
an upright position to those who cannot support their own weight by providing pBWS?
(ii) does WBV elicit a contraction in muscle when body weight is reduced? (iii) What is
the relationship between vibration frequency, vibration amplitude, level of pBWS and the
neuromuscular response? (iv) Are the same trends in neuromuscular response different for
different levels of pBWS? (v) Is there a measurable neuromuscular response from those with
an early-stage SCI to WBV, and if so, is there a relationship between the neuromuscular
response and the vibration parameters? (vi) Is there a difference in response between those
with no neurological deficit and those with SCI? (vii) How much movement artefact is present
in an EMG recorded during WBV?
3.8 Aims & Objectives
The open research questions were addressed by formulating the following aim: measure and
quantify the acute steady-state neuromuscular response of neurologically intact and SCI
populations before, during and after WBV-pBWS.
A steady-state response was defined as a period of neuromuscular activity which did not
fluctuate for a significant amount of time. A non steady-state response was defined as a
neuromuscular response that fluctuated, for example a transient or inconsistent change which
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typically occurred during the transition from a pre-Vibration to Vibration condition. This
aim was achieved by addressing by the following technical and physiological objectives:
3.8.1 Technical Objectives
1. Integrate a WBV platform with a pBWS system.
2. Quantify the transmission of vibration from the WBV platform to the lower limbs, by
quantifying vibration frequency, vibration amplitude and acceleration at key locations
on the vibration platform and legs.
3. Estimate the proportion of vibration artefact in every EMG recorded during WBV.
4. Assess the suitability of passive vs active EMG electrodes for WBV applications.
5. Optimise the off-line filtering process for vibration artefact removal.
6. Optimise the data analysis process for classification of EMG and rejection of outlying
data.
3.8.2 Physiological Objectives
1. Quantify the magnitude of the EMG response of the Tibialis Anterior (TA), Medial
Gastrocnemius (M-GA), Lateral Gastrocnemius (L-GA), Vastus Lateralis (VL), Rectus
Femoris (RF), and Biceps Femoris (BF) to WBV.
2. Describe the changes in EMG activity with respect to vibration frequency, vibration
amplitude and level of pBWS.
3. Investigate the temporal relationship between the EMG and the position of the WBV
platform.
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Chapter 4
WBV Methods
A WBV platform was integrated with a pBWS system. pBWS was used facilitate standing
in a patient population unable to support their own weight, such as SCI. This combined
system is described hereafter as WBV-pBWS and is shown in Figure 4.1. The intention of
the system was to allow those with a SCI to use WBV in a conventional manner.
Such a system has not been investigated previously. The acute neuromuscular response to
WBV at reduced load was therefore not known. The initial investigation into WBV-pBWS
was described with a general population with no neurological deficit. This population was
used in the first instance to establish a normative baseline and to determine a suitable testing
protocol for application in SCI. The system was then tested with a SCI population.
EMG was used to measure neuromuscular activity of key lower limb muscle groups before,
during and after WBV. A range of different vibration frequencies, vibration amplitudes and
levels of pBWS were tested in order to comprehensively describe the neuromuscular response
to WBV. The EMG were analysed in the time and frequency domains with additional off-line
filtering applied to take account of the unique challenges encountered while acquiring EMG
signals during WBV. The findings of this study were used to inform the study carried out
with a SCI population. This chapter outlines the experimental and analysis methods used
for both studies.
4.1 Experimental Methods
This section outlines the experimental methods and outcome measures of this study. Where
appropriate additional details are provided through worked examples and figures.
4.1.1 Equipment
Figure 4.1 outlines a general overview of the equipment used in this study. Vibration
was applied using a SA-WBV device (Galileo Basic, Novotec Medical GmbH, Pforzheim,
Germany), with the participant in a standing position. Body weight unloading was achieved
using a pBWS system and an upper body harness (Loko S70, Woodway USA Inc, Waukesha,
USA). Neuromuscular activity was recorded from a number of key leg muscles using two types
of EMG amplifier: (i) an 8-channel Bagnoli Desktop EMG system (Delsys Inc., Massachusetts,
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USA), and (ii) a NeuroLog System (Digitimer Limited, England, UK). Active EMG recording
electrodes (DE-2.1, Delsys Inc., Massachusetts, USA) were used with the Delsys system, and
passive EMG recording electrodes (Blue Sensor, Ambu A/S, Ballerup, Denmark) were used
with the Neurolog system. Acceleration (ADXL 335, Analog Devices Inc., Massachusetts,
USA) was recorded from key locations on the WBV platform and the participants body.
All data was acquired at 1kHz, using a 16bit analog-to-digital converter (DAQCard-6036E,
National Instruments Corporation, Texas, USA). Data acquisition was synchronised and
processed using Matlab (MatlabR2010a, The Mathworks Inc., Massachusetts, USA), and
stored on a laptop PC (Latitude D630, Dell, Texas, USA).
Figure 4.1: Picture describing experimental setup.
4.1.2 Participants
Neurologically Intact
Ten able-bodied volunteers (Table 4.1) were recruited to participate in this study. Exclusion
criteria included: pregnancy, acute thrombosis, lower limb implants, acute inflammation of
the locomotor system active orthosis or arthropathy, acute tendinopathy in the lower limbs,
acute hernia, acute discopathy, gallstones or stones in the urinary tract collection system,
rheumatoid arthritis, epilepsy, psychotic illness, neurotic disturbances or reduced cooperation.
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Ethical approval (FBLS1014) was given by the Faculty of Biomedical and Life Sciences Ethics
Committee, University of Glasgow. A copy of the research ethics approval letter is shown in
the appendix. All participants gave written and informed consent prior to participation in
this study.
Table 4.1: Summary of recruited able-bodied subjects. F = Female; M = Male.
Subject Age Weight Gender
[yrs] [kg]
S1AB 30 54 F
S2AB 26 70 M
S3AB 40 69 M
S4AB 26 80 M
S5AB 25 76 M
S6AB 26 50 F
S7AB 24 84 M
S8AB 23 89 M
S9AB 26 95 M
S10AB 44 69 F
Mean (SD) 29 (7) 73 (14) -
SCI
Fourteen volunteers with a SCI were recruited from the Queen Elizabeth National Spinal
Injuries Unit, Glasgow (Table 4.2). Similar inclusion and exclusion criteria were used with the
following additions: (i) male or female volunteers with a traumatic SCI, (ii) motor complete
or motor incomplete SCI, and (iii) a spinal fracture deemed stable for re-ambulation or
rehabilitation. Additional exclusion criteria included: (i) the presence of pressure sores in
the foot or trunk area, (ii) patients with a history of severe susceptibility to autonomic
dysreflexia, and (iii) unstable fracture(s). Ethical approval was given by National Health
Service West of Scotland Research Ethics Service (ref: 11/AL/0096). All participants gave
written and informed consent prior to participation in this study. A copy of the research
ethics approval letter is shown in the appendix.
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Table 4.2: Summary of recruited SCI participants. F = Female; M = Male; AIS = ASIA
Impairment Scale; ASIA: American Spinal Injury Association; Cx = Cervical Spinal Segment;
Tx = Thoracic Spinal Segment; Lx = Lumbar Spinal Segment; x = Spinal Vertebral Number;
TSI = Time Since Injury; SD = Standard Deviation; IQR = Interquartile Range.
Subject Age Weight Gender AIS Level TSI
[yrs] [kg] [days]
S11SCI 19 67 M B L3 107
S12SCI 31 67 M A C4 189
S13SCI 60 85 M D T5 52
S14SCI 49 85 M C C7 169
S15SCI 48 77 M C C6 179
S16SCI 57 74 M D C4 52
S17SCI 28 65 M B T7 5087
S18SCI 52 61 F C C5 51
S20SCI 58 80 M D C4 284
S21SCI 51 81 M C L3 41
S22SCI 17 60 M A T10 262
S23SCI 58 65 F C T2 97
S24SCI 56 87 M D C4 172
S25SCI 40 93 M A C4 223
Mean (SD) 45 (15) 75 (11) - - - 498 (1323)
Median (IQR) 50 (24) 76 (19) - - - 171 (151)
The mean and median values are shown in Table 4.2, including the outlying Time Since
Injury (TSI) from Subject S17SCI . If removed, the mean TSI for the grouped data reduced
to 144 days with a standard deviation of 84 days. The results from this participant were
expanded upon as part of case based discussion.
4.1.3 Experimental Setup
Neurologically Intact
Each neurologically intact subject participated in three experimental sessions. The par-
ticipant was familiarised with the WBV device and measurement equipment during the first
session. No data gathered during the familiarisation session was used for the subsequent oﬄine
analysis. Testing was carried out in the two subsequent sessions. The same experimental
protocol was used in each testing session. The session began by preparing the subject for
EMG measurement. Active EMG electrodes were placed on the TA, M-GA, VL, and BF of
the subject’s preferred leg. Passive electrodes were placed on the L-GA and RF of the same
leg. Different muscles from the quadriceps and triceps surae muscle groups were selected for
the active and passive electrodes to facilitate optimum placement of the electrode, rather than
to compromise the quality of the EMG by positioning a second electrode at an inadequate
point on the same muscle. This setup was determined to be appropriate because subsequent
analysis focusses on the relative performance of each electrode with respect to the muscle
group rather than the individual muscles within that group. The muscles were located by
palpation and electrode placement was done according to Table 4.3. The EMG electrodes
were setup in a bipolar configuration and aligned along the direction of the muscle fibers.
The reference electrode was affixed to the lateral malleolus of the same leg. The MVC were
performed in triplicate in the supine position. The supine position was adopted for each MVC
such that the joint over which the muscle of interest acted was allowed to move through its
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full range of motion. Resistance was provided by the experimenter during each MVC. Full
range of movement of the joint was allowed to ensure that the maximum voluntary force
generating capacity of the muscle was captured and not just that for one muscle length. A
rest period of 60 - 120s was allowed between each maximum contraction. The maximum
recorded value over the three MVCs was taken for subsequent analysis. The subject next
donned an upper body harness for the pBWS system.
Table 4.3: Location of electrode placement.
Muscle EMG Electrode Placement
Tibialis Anterior (TA) Lateral of the tibial crest, 6cm distal of the tibial
tuberosity
Medial Gastrocnemius (M-GA) 8cm distal of the medial femoral condyle
Lateral Gastrocnemius (L-GA) On the lateral surface of the calf muscle group, 8cm distal
of the popliteal crease
Vastus Lateralis (VL) On the lateral surface of the quadriceps muscle group,
8cm caudally from the patella
Rectus Femoris (RF) On the midpoint between the most caudal point of the
patella and the anterior superior iliac spine
Biceps Femoris (BF) On the midpoint between the head of the fibula and
ischial tuberosity
Platform acceleration was recorded, by affixing a triaxial accelerometer to the platform surface
at a position located 42mm from the central axis. The method for measuring the position
of the accelerometer is described in a later section. Acceleration was also recorded from
the dorsal surface of the subjects’ foot and from the EMG electrode placed on their VL.
Each accelerometer was affixed to the body using hypoallergenic tape. The placement and
orientation of the accelerometers are shown in Figure 4.2. The anatomical references relating
the individual components of acceleration (x, y & z) to the directions of motion of the
participant are described in Table 4.4.
Table 4.4: Anatomical references for acceleration measurements
Muscle X-axis Y-axis Z-axis
Platform Medial-Lateral Anterior-Posterior Longitudinal
Foot Medial-Lateral Anterior-Posterior Longitudinal
Vastus Lateralis Medial-Lateral Longitudinal Anterior-Posterior
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(a) Vibration platform
(b) Axes relative to lower
limbs
Figure 4.2: Schematic showing the location and positive orientations of the x-, y- and z-axes
of the accelerometers placed on the WBV platform, foot and thigh. The x-, y- and z-axes
were related to anatomical-axes in Table 4.4. d1 = Displacement of accelerometer, along
the medial-lateral axis, that has been affixed to the WBV platform. This displacement is
estimated using Equation (4.1); d2 = Position of foot on WBV platform and represented as
a displacement along the medial-lateral axis. This position is prescribed as dictated by the
experimental protocol.
SCI
Each SCI subject participated in two experimental sessions and the same experimental
protocol was used in each session. The session began by preparing the subject for EMG
measurement. Active1 EMG electrodes were placed on the TA, M-GA, and VL2 of both
1Passive EMG recording electrodes were shown to be excessively susceptible to vibration induced motion
artefact and therefore had a significantly compromised performance relative to active electrodes. They were
not used with the SCI participants for this reason.
2The neuromuscular response of the BF was shown to be small relative to the other muscles during testing
with the neurologically intact population. There was therefore a small likelihood of detecting a significant
change in neuromuscular response from the SCI participants either. The BF was not tested in the SCI
population for this reason.
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legs3. The muscles were located by palpation and the electrodes ware placed according Table
4.3. MVC were performed in triplicate where possible with the ISCI participants only. Each
MVC was carried out in a seated position from the wheelchair. A rest period of 60 - 120s was
allowed between each MVC. The joint over which the muscle of interest acted was allowed
to move through its full range of motion during each MVC. Resistance was provided by the
experimenter in the event that the participant had sufficient volitional strength to counteract
the resistance. The maximum of the three recorded MVC’s was taken for subsequent analysis.
The subject next donned an upper body harness for the pBWS system. Platform acceleration
was recorded, by affixing an accelerometer to the platform surface at a perpendicular
displacement of 58mm from the central axis. Acceleration was also recorded from the dorsal
surface of the subjects left foot and from the electrode placed on the VL. Each accelerometer
was affixed to the body using hypoallergenic tape.
4.1.4 Accelerometer Placement
Figure 4.3 outlines a schematic which describes how the displacement d1 in Figure 4.2(a) was
computed.
Figure 4.3: Schematic describing how acceleration, as recorded from the surface of the
vibration platform may be used to estimate the point at which the accelerometer has been
affixed to the vibration device.
Displacement in the z-direction (dz) was estimated using the equation below, which is an
expansion of Equation 3.1:
dz =
apeak
4pi2f2
Where dz = Displacement in z-direction; apeak = Maximum acceleration measured in the
z-direction using an accelerometer; and f = Frequency of vibration. When using an
accelerometer apeak and f are directly measured.
The location of of the accelerometer (lx) and displacement in the z-direction (dz) are linearly
related if it is assumed that the WBV platform is completely rigid. According to the
manufacturer guidelines, a point on the platform that is located 55mm along the x-axis
3A bilateral imbalance in lower limb muscle strength is common in SCI and it was therefore concluded to
be appropriate to measure the neuromuscular response of both legs.
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equates to a displacement of 1mm in the z-direction (c.f. Figure 4.3). This linear relationship
can be written as:
lx = 55dz
Where lx = Location along the x-axis; and dz = Displacement in the z-direction.
The location along the x-axis can therefore be calculated by:
lx =
55apeak
4pi2f2
(4.1)
Accordingly, at a measured peak acceleration of 4.08m/s2 and frequency of vibration of
11.66Hz, the location (lx) at which the accelerometer was affixed to the surface of the WBV
platform (d1 (c.f. Figure 4.3)) was 42mm.
In addition, the acceleration of any point on the WBV platform may be extrapolated
from a single acceleration measurement made from the platform surface. This extrapolated
acceleration (aE) was calculated by:
aE =
d2
d1
a (4.2)
Where aE = Extrapolated acceleration; a = Recorded Acceleration; d1 = Location of
accelerometer along x-axis (c.f. Figure 4.2);d2 = Location of point of interest along x-axis.
4.1.5 Experimental Testing
Testing was carried out at nine discrete vibration conditions, which included vibration
frequencies of 12, 20 and 27Hz and vibration amplitudes of ±1, 2 and 3mm. Each
combination of these vibration conditions was tested with 0, 50 and 100% pBWS provided
to the neurologically intact participants yielding a total of 27 discrete test conditions per
experimental session. The same vibration conditions were tested with 50% or 100% pBWS
provided to the SCI participants depending on the severity of injury and the degree of the
functional capability, therefore yielding a total of 9 discrete test conditions per experimental
session. The order of testing was randomised. An individual test began with the subject
taking a squat position on the vibration platform with the knees bent to 125◦(i.e. 55◦from
straight leg position). Knee angle was verified using a manual goniometer and the head of
the tibia was used as the reference point for joint articulation. The subject held this position
for 60s and the test was carried out as outlined in Figure 4.4. A minimum rest period of 30s
was allowed between each discrete vibration condition. Recorded data from each individual
test was stored for subsequent off-line analysis.
Figure 4.4: Time-line for each discrete test.
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4.1.6 Outcome Measures
The technical outcome measures directly associated with methods were:
1. Acceleration - measured directly from the vibration platform, foot, and body of the
thigh muscle.
2. Frequency - derived from acceleration.
3. Displacement - derived from acceleration.
4. Proportion of artefact - derived as a fraction of overall EMG power.
5. Discretised acceleration - time series acceleration data discretised to a single cycle of
vibration, averaged and normalised to maximum - Figure 4.5.
31.9 31.95 32 32.05 32.1 32.15 32.2 32.25 32.3 32.35
−0.2
−0.15
−0.1
−0.05
0
0.05
0.1
0.15
0.2
Single Cycle
Time [s]
Ac
ce
le
ra
tio
n 
[g]
Figure 4.5: Acceleration recorded during a single discrete WBV test presented in the time
domain. The troughs of the acceleration signal are used to identify the beginning and end of
a single cycle of WBV.
The physiological outcome measures were:
1. EMG - measured directly from the TA, M-GA, L-GA, VL, RF, and BF - Figure 4.6.
2. EMGN - derived from the measured EMG by calculating the Root Mean Square (RMS)
and normalising to the Maximum Voluntary Contraction (MVC).
3. ∆EMG - the relative change from in EMG activity during Vibration when compared
to baseline.
4. Discretised EMG - time series EMG data discretised to a single cycle of vibration,
averaged and normalised to maximum.
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Figure 4.6: Cutaway schematic showing muscle groups for EMG measurements (adapted from
Gray [175]).
4.2 Analysis Methods
4.2.1 Summary of Analysis Methods
The off-line filtering and analysis techniques used to report the recorded data are summarised
below. Supporting information in the form of figures or worked examples are provided where
appropriate.
• 4.2.2: Accelerometer Analysis: Vibration frequency, average acceleration (RMS)
and vibration amplitude were calculated from the raw acceleration data recorded from
the vibration platform, foot and thigh.
• 4.2.3: EMG Pre-Processing: Off-line digital filtering of each EMG was carried out
according to current standard guidelines [176].
• 4.2.4: Artefact Quantification: The magnitude of vibration artefact in every EMG
was quantified.
• 4.2.5 EMG: Artefact Removal: Additional off-line digital filters were applied to
each EMG to eliminate vibration artefact.
• 4.2.7: EMG Amplitude Estimation: The amplitude of the filtered EMG was
estimated by computing the RMS of the data.
• 4.2.8: EMG Classification: Platform acceleration was used to automatically classify
the different epochs of the testing protocol: pre-Vibration, Vibration, and post-
Vibration. In addition, a custom algorithm was implemented to calculate the Burst-
to-Tonic Ratio (BTR) of each EMG. The BTR was used to estimate variability and
reject outlying data.
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• 4.2.7: EMG Amplitude Analysis: The magnitude of the neuromuscular response
to WBV was estimated by taking the computed RMS of each EMG and averaging over
each epoch of the testing protocol. Data were normalised to baseline and MVC, and
then grouped according to pBWS and platform acceleration.
• 4.2.10: EMG Vibration Cycle Analysis: The temporal relationship between
neuromuscular activity and WBV was investigated by normalising each EMG to a
single cycle of vibration cycle and then averaging over the entire phase of vibration.
4.2.2 Accelerometer Analysis
Acceleration
All raw acceleration data was smoothed using a fourth order, simple moving average filter.
Low frequency drift and the gravity offset were removed by high pass filtering using a fourth
order Butterworth filter with a cut-off frequency of 1Hz implemented oﬄine in a manner such
that there was zero phase lag. The resultant acceleration (a) was found by combining the
individual vectors (ax, ay, and az) of acceleration:
a =
√
a2x + a
2
y + a
2
z (4.3)
Where a is always > 0; ax = Acceleration in x-direction; ay = Acceleration in y-direction; az
= Acceleration in z-direction.
The WBV platform acceleration pattern is sinusoidal. Average acceleration was therefore
calculated by computing the RMS of the peak resultant acceleration:
aRMS =
apeak√
2
(4.4)
Where aRMS = Average acceleration; apeak = Maximum resultant acceleration.
Displacement
Displacement was calculated by integrating the resultant acceleration to obtain velocity, high
pass filtering as described previously with a cut-off frequency of 1Hz and integrating velocity
to obtain displacement.
Frequency
Figure 4.7 shows sample acceleration data in the time and frequency domains. The frequency
of vibration was found by computing the PSD of the acceleration data and identifying the
frequency component with the largest overall power contribution as shown. PSD plots were
calculated using the periodogram function the Matlab R2010a Statistical Signal Processing
toolbox.
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Figure 4.7: Sample acceleration data in the time and frequency domain. The PSD was used
to identify the frequency of vibration. PSD = Power spectral density.
4.2.3 EMG Pre-Processing
A standard for recording and reporting high fidelity EMG data was produced by the
International Society of Electrophysiology and Kinesiology (ISEK) [176]. These guidelines
outline the optimum electrode type, amplification, sampling frequency, filtering and post-
processing procedures that should be used. It is recommended that the EMG should be high-
pass filtered between 10 - 20Hz, and low-pass filtered between 450 - 500Hz, thus removing
low and high frequency noise whilst maintaining the main frequency components of the EMG.
All EMG data was filtered off-line using fourth order butterworth filters in this study. The
filters were implemented off-line in a manner such that there was no phase lag. The Bode
amplitude plots for the filters used are shown in Figure 4.8. The EMG were high-pass filtered
at 30Hz and low-pass filtered at 450Hz. A higher than recommended high-pass filter cut-off
frequency was used because considerable high magnitude low frequency noise was found below
27Hz during testing. These high magnitude frequencies were consistent with the frequencies
of vibration that were being applied during testing. Line interference was removed using a
fourth order, stop-band butterworth filter between 49 - 51Hz.
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Figure 4.8: Bode amplitude plots for the zero-phase, fourth order, Butterworth filters to
process the EMG data off-line.
4.2.4 Artefact Quantification
Artefact Effect
The ISEK guidelines are predicated on appropriate preparation, placement, and attachment
of the EMG recording electrodes. Furthermore, the guidelines assume little or no movement
of the electrode with respect to the muscle fibers from which they are recording. A change
in the shape of the EMG would occur in the event that the recording electrode itself had
moved during testing. The change in the shape of the EMG is described as an artefact. An
example of an EMG artefact caused by movement of the electrode during WBV is shown in
Figure 4.9.
Artefact Example
Figure 4.9 shows a sample of EMG data that was recorded from the M-GA during an acute
bout of WBV. The EMG data is presented in the time and frequency domains. The data in
the left column was not filtered off-line. The data in the right column was filtered according
to the standards outlined in Section 4.2.3.
Clear increases in the power of the EMG were identified at specific frequencies when the data
was viewed in the frequency domain. It was noted that these frequencies were harmonics of
the frequency of vibration, and that filtering according to the standards outlined above did
little to reduces the amplitude of these frequencies in either the time or frequency domain.
It was hypothesised that these harmonic frequencies were the result of vibration induced
movement of the EMG recording electrode during WBV.
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Figure 4.9: Example of raw and filtered EMG data. The data was recorded from the M-GA
during an acute bout of WBV at a frequency of vibration of 20Hz. The EMG are presented
in the time ((a) & (b)) and frequency ((c) & (d)) domain. Vibration induced movement
artefacts are highlighted in the frequency plots. Plots (a) & (b) and plots (c) & (d) have the
same y-scale respectively. Note that applying off-line digital filters according the the ISEK
standard has a negligible effect on the magnitude of the EMG ((a) vs (b)) and reduces low
frequency noise only as seen in (d). PSD = Power Spectral Density; fvib = Frequency of
vibration; fvib.n = Integer multiples of frequency of vibration.
Artefact Power
The relative magnitude of each harmonic (phn) of vibration was calculated as a fraction of
total signal power using Equation (4.5). Total signal power (Pall) was found by computing
and integrating the PSD across all frequencies. Integer multiples (n) of the frequency of
vibration were assumed to be the harmonic frequencies at which artefact occurred (hn). The
total power of each harmonic (Phn) was then calculated by integrating the PSD within a
frequency band of hn±1Hz.
phn =
Phn
Pall
(4.5)
Where phn = Magnitude of each harmonic; Pall = Total signal power; Phn = Total signal
power in specified frequency range.
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For the data shown in Figure 4.9, ph for the first four harmonics was found to be 0.051V
2/Hz
and 0.054V2/Hz for the raw and filtered data respectively. This indicates that 5% of the
total power of the EMG signal was contained within the first four harmonics of vibration,
i.e. within the frequency ranges of 19 - 21, 39 - 41, 59 - 61, and 79 - 81Hz.
The total contribution of all harmonic frequencies (ph) was calculated by integrating the
contribution of each individual harmonic (phn) using Equation (4.6):
ph =
n∑
i=1
phn (4.6)
4.2.5 Vibration Artefact Removal
Artefact was removed from the EMG recorded in this study using a fourth order, zero-
phase, stop-band (hn±1Hz) Butterworth filters. Bode amplitude plots are shown in Figure
4.10, representing the stop-band filter for the first harmonic of each frequency of vibration.
Validation of this filtering technique is described in Section 5.1.2 using artificially generated
EMG data.
5 10 15 20 25 30 35
−80
−70
−60
−50
−40
−30
−20
−10
0
Am
pl
itu
de
 [d
B]
Frequency [Hz]
Bode Amplitude Plot
 
 
12Hz SBF
20Hz SBF
27Hz SBF
Figure 4.10: Bode plots. SBF: Stop Band Filter.
By applying these stop band filters to the data presented in Figure 4.9, ph for the first four
harmonics was reduced to less than 0.001V2/Hz.
4.2.6 SCI Case Study
The presence of vibration induced motion artefacts in EMG recorded during WBV was
confirmed by carrying out a case investigation of Subject S11SCI . Subject S11SCI suffered a
traumatic Lower Motor Neuron (LMN) lesion which principally affected the shank muscles.
The WBV-pBWS experimental test configuration allowed the application of the WBV in
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a more conventional manner. In this particular instance it was therefore known that a
neuromuscular response from the areflexic shank muscles to WBV was impossible, but
was possible from the spastic thigh muscles. A randomly selected raw data set (vibration
frequency = 20Hz, vibration amplitude = 2mm, pBWS = 50%) was reviewed in the time and
frequency domains. PSD plots were reviewed to specifically identify artefact ‘spikes’ in the
EMG recorded from the TA and VL. The targeted stop-band filters described above were
then applied and the data was reviewed in the time and frequency domains again.
4.2.7 EMG Amplitude Estimation
Every acquired EMG was filtered according to the steps outlined above (Sections 4.2.3 &
4.2.5). The amplitude of the EMG was then calculated by fully rectifying the data and
computing the RMS using Equation (4.7):
xRMS (tn) =
√∑n
i=1 x (tn−i)
2
n
(4.7)
In this study, the RMS of the entire EMG was calculated using 0.2s (200 samples at 1kHz
sample rate) moving, x=EMG data; n=Window size [s]; t=time [s].
4.2.8 EMG Classification
The aim of this study was to measure and quantify the steady-state, acute neuromuscular
response before, during and after WBV with pBWS. By definition, the measured response,
and therefore contraction, must be predominantly tonic in nature to be considered valid. A
tonic contraction was confirmed when the neuromuscular response was uniform, maintained
and reproducible for a given set of experimental conditions.
An initial visual qualification of the recorded EMG data was therefore carried out. Random
and inconsistent burst-like increases in neuromuscular activity were identified in some
instances. These instances were attributed to tripping or spasm and did not meet the criteria
set out above. Such instances were readily identified as a burst in activity superimposed on a
tonic muscular contraction, and were quantified by calculating the ratio of burst-like to tonic
activity. This ratio is described as the Burst-to-Tonic Ratio (BTR) hereafter.
A custom algorithm was used to: (I) split the EMG into either quiescent (pre-vibration or
post-vibration) or active (vibration) epochs, (II) calculate the BTR, and (III) reject invalid
data sets with a high BTR value. This algorithm is described using a worked example in the
following subsections.
(I) Epoch Isolation
Vertical platform acceleration (longitudinal axis, Figure 4.2) was used to identify the three
epochs of interest, which were: (i) pre-Vibration (the start of the test to the start of vibration),
(ii) Vibration (the start of vibration to the end of vibration), and (iii) post-Vibration (the
end of vibration to the end of the test). Transient changes between epochs were eliminated
by ignoring the first 2s and last 2s of data from each epoch. The WBV platform was ramping
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up and down from the target vibration frequency during these transient periods and was
therefore not of interest. Three separate and unique EMG were thus output from this step.
(II) Burst-to-Tonic Ratio
The custom algorithm used to compute the BTR is described using artificially generated
sham data (2Hz sinusoid overlaid with uniformly distributed pseudorandom noise). Sham
data is used in this instance to simplify the description of the BTR computation algorithm.
An example of this same process applied to real EMG data is shown using a worked example
at the end of this section. A 0.5s sample of sham data (x) is shown in Figure 4.11(a). This
is typical of a fully rectified EMG. Large spikes in amplitude are seen with no discernible
underlying level of tonic activity. The RMS of this data was calculated using Equation (4.7)
and is shown in Figure 4.11(b). A consistent underlying level of ‘tonic’ activity in addition
to some interspersed burst-like activity is now easily identified. Tonic activity was defined as
the absolute minimum level of activity, and was identified as the minimum (xmin) computed
RMS value shown in Figure 4.11(b).
Figure 4.11: Schematic describing process for computing BTR.
Tonic activity (xtonic) was calculated using Equation (4.8) by integrating the minimum level
of EMG activity with respect to time:
xtonic =
∫ t1
t0
xmin (t) dt (4.8)
Where xmin = Minimum xRMS as identified in Figure 4.11(b).
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Burst activity (xburst) was calculated in a similar manner using Equation (4.9):
xburst =
∫ t1
t0
xRMS − xmin (t) dt (4.9)
Where xRMS was calculated using Equation (4.7).
The BTR was calculated as the ratio between these two values:
BTR =
xburst
xtonic
(4.10)
(III) Outlier Rejection
The magnitude of tonic muscle activity for a given epoch (pre-Vibration, Vibration or post-
Vibration) was defined in this analysis as the minimum EMGRMS value for the entire epoch
in question. A BTR value was then calculated and assigned to each consecutive 0.5s window
of the epoch. The matrix presented in Table 4.5 was used then used to determine if the EMG
data for the epoch was either valid or an outlier.
Table 4.5: EMG outlier rejection matrix. EMG = Electromyogram; BTR = Burst-to-Tonic
Ratio; *Must be one continuous period to meet the definition of steady-state.
Condition BTR Duration Outcome
1 ≤5 Entire EMG Retain entire sample for further analysis
2 ≤5 6s* Retain 6s sample only for further analysis
≥5 Remainder of EMG and reject remainder as outlier
3 ≤5 <6s Reject entire EMG as outlier
≥5 Remainder of EMG
An example of the application of this procedure to real EMG data is described in the following
worked example.
Worked Example
Figure 4.12(a) presents an EMG that was recorded from the medial gastrocnemius during
a discrete WBV test. The EMG was first filtered off-line, fully rectified, and the RMS
calculated using Equation (4.7). The EMG was next discretised in time and split into the
relevant epochs of the test: pre-Vibration (2 - 16s), Vibration (19 - 51s), and post-Vibration
(55 - 66s). These epochs are shown in Figure 4.12(a). The RMS of the EMG for the Vibration
epoch (Figure 4.12(b)) and post-Vibration epoch (Figure 4.12(c)) are shown. The thresholds
for burst and tonic activity for each epoch were identified. The threshold for tonic activity
was identified as 5.34µV for the Vibration epoch and 3.41µV for the post-Vibration epoch.
The BTR was calculated based on these threshold values using Equations (4.8 - 4.10). A
BTR value in excess of 5 was found at approximately 22s of the Vibration EMG as seen in
Figure 4.12(d). This portion of the EMG was therefore rejected. A BTR value of less than
5 was found for the remainder of the EMG. This portion matched ‘Condition 2’ in Table 4.5
and was retained for further analysis.
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Figure 4.12: Example of BTR calculation using real EMG data. The raw EMG data was
acquired from the M-GA during a WBV test at a vibration frequency of 27Hz and vibration
amplitude of 3mm with 50% pBWS provided. Standard oﬄine filtering including vibration
artefact removal was applied. The filtered EMG is shown in plot (a). The recorded vertical
platform acceleration was used to automatically split the EMG into the three different epochs:
pre-Vibration, Vibration and post-Vibration. The beginning and end of each of epoch is
shown in plot (a). The RMS of each epoch of EMG was calculated. The minimum EMGRMS
value for each epoch was identified and taken to be the magnitude of tonic muscle activity
for that epoch. Tonic and burst activity are shown in the plots for the Vibration (b) and
post-Vibration (c) epochs. The BTR was then calculated for each 0.5s window of each epoch.
Each calculated BTR value is shown for the Vibration (d) and post-Vibration (e) epochs.
The threshold for rejecting a portion or an entire EMG was set at a BTR value of 5. This
threshold is shown for the Vibration (d) and post-Vibration (e) epochs. Portions of the EMG
which exceeded this threshold were considered to be outliers.
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4.2.9 EMG Amplitude Analysis
Neurologically Intact
In summary, the pre-processing steps carried out on the EMG data were: off-line filtering,
full signal rectification, computation of the RMS and outlier rejection. The neuromuscular
response was quantified by calculating the mean of the EMGRMS for each test epoch: pre-
Vibration (xprv), Vibration (xv), and post-Vibration (xpov).
Absolute neuromuscular activity (EMGN ) was quantified by normalising to a MVC using
Equation (4.11).
EMGN =
x
EMGMV C
(4.11)
Where EMGMV C = The maximum RMS value found during the MVC. EMGN can be
any value between 0 and 1. Research has shown that there is a linear relationship between
the myoelectric signal, as recorded recorded using EMG, and motor recruitment and force
output [177, 178]. A value of 1 thus implies that the muscle is contracting at its maximum
capacity. In practice is is not possible to get a value of zero, however as EMGN tends towards
0, it implies that the magnitude of the contraction is small.
The relative change in neuromuscular activity (∆EMG) was quantified by referencing xv to
baseline using Equation (4.12). Baseline was defined in this analysis as xprv.
∆EMG =
xv − xprv
xv
(4.12)
∆EMG can be any value between -1 and 1. A ∆EMG value equivalent to 1 implies that the
neuromuscular response during vibration is much larger than the response before vibration.
A value equal to 0 implies that there was no change in neuromuscular activity. A value
equivalent to -1 implies that there was an attenuation of the neuromuscular response during
vibration.
Throughout the presentation of the results, the test conditions - vibration frequency (f)
and vibration amplitude (d) - were related by the theoretical average platform acceleration
(atheor) which was calculated using Equation (4.13). This value was used group, compare
and contrast the results for different experimental conditions.
atheor =
4pi2f2d√
2
(4.13)
Where atheor = theoretical average platform acceleration; f = vibration frequency; d =
vibration amplitude. According to this relationship, frequency and displacement are related
to platform acceleration as described in the table below.
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Table 4.6: Relationship between acceleration, frequency, and amplitude
Frequency Amplitude Acceleration
[Hz] [mm] [g]
0 0 0.00
12 1 0.41
12 2 0.82
20 1 1.14
12 3 1.23
27 1 2.07
20 2 2.28
20 3 3.41
27 2 4.15
27 3 6.22
SCI
The methodology described above was modified slightly for the SCI participants. Normalisa-
tion of the EMG to the maximum voluntary capacity of the muscle is dependent on a reliable
MVC which was not achieved for many of the SCI participants. Therefore, the EMG was
split into the pre-Vibration, Vibration and post-Vibration epochs for the SCI participants
and the The EMGRMS was calculated. The data was then normalised by calculating ∆EMG
which described the relative change in EMG activity to the pre-Vibration epoch. Absolute
EMG activity was taken as the average of the EMGRMS recorded during the Vibration epoch
only.
4.2.10 EMG Vibration Cycle Analysis
The EMG Amplitude Analysis described above is predicated on the RMS calculation and
focussed on the steady-state neuromuscular response to WBV to this point. Steady-state
was determined by assessing the variability of the EMG by calculating the BTR. Data sets
with a large BTR were deemed as variable and not in a ‘steady-state’ and were therefore
excluded as outliers. The data included in the analysis were therefore concluded to be in
a steady-state and in an ideal case the EMG would have been ‘flat’ for the duration of
the Vibration epoch. The magnitudes of the steady-state EMG were then determined by
calculating the RMS of the data.
This analysis methodology implies that the neuromuscular response over a period of 10s,
for example, is equivalent in magnitude to the response over a single vibration cycle
period. However, it is known that an EMG response is not flat in practice but is rather
a combination of multiple CMAP’s which are separated spatially and in time. The EMG is
a visual manifestation of the summation of all CMAP. The RMS calculations used a 0.2s
moving window and is robust when estimating the amplitude of a static or sustained muscle
contractions [179], however in practice some short duration characteristics of the EMG may
be lost, for example an instance of high amplitude neuromuscular activity occurring once per
vibration cycle. Short duration characteristics may be lost because the RMS calculation is
fundamentally an averaging technique which is predicated on the selected window size. Any
change in the EMG which may occur within a duration less than the window size, say 1/12
seconds (0.083 seconds), 1/20 seconds (0.05 seconds) or 1/27 seconds (0.037 seconds), would
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therefore be averaged out. Therefore, fast acting dynamic changes in neuromuscular activity
occurring during a single vibration period would not be detected from an RMS estimation
applied to an EMG.
Such characteristic changes have previously been proposed by Ritzmann et al. [88], whereby
‘phase-locking’ of the EMG during WBV was shown to occur. Ritzmann et al. described how
the neuromuscular response is locked in phase with the vibration frequency during phase-
locking. They identified a peak in the EMG which occurred once during each single cycle
of vibration. The peak was larger in amplitude than the response at all other points in the
vibration cycle. In addition, they found that the occurrence of the peak had the same latency
as a short latency reflex. It was concluded from this study that the neuromuscular response
to WBV was based on the stretch reflex [88].
Therefore, in addition to the EMG Amplitude Analysis described above, the neuromuscular
response to WBV was investigated by carrying out an additional EMG Vibration Cycle
Analysis. The pre-processing steps carried for the Vibration Cycle Analysis were: off-line
filtering, full signal rectification, and outlier rejection. Each EMG was then discretised for
each 360◦ cycle of the vibration platform, re-sampled such that each period contained the
exact same number of data points, and averaged for all cycles. A single 360◦ cycle of vibration
was defined as beginning at the lowest point (trough) of the platform acceleration and ending
when the platform next returned to this point. Vertical platform acceleration (longitudinal
axis, Figure 4.2) was used to identify each vibration cycle in a data set. The corresponding
EMG and acceleration data was then isolated and averaged to represent a single vibration
period. In this way, an EMG recorded during a 1s period of 20Hz vibration yielded a total
of 20 discretised EMG. The average of these discretised EMG was then taken to smooth the
data. It was hypothesised that any unique neuromuscular responses occurring during a single
period, should they exist, would become evident while random changes in activity would be
minimised by averaging. The response over a single 360◦ cycle of vibration could therefore
be detected.
This analysis was therefore principally qualitative because the shape of the normalised EMG
was assessed to determine the relationship between muscle activity and the phase of vibration.
This methodology is described hereafter as a Vibration Cycle Analysis and was carried out
on every EMG that met the inclusion criteria described in Section 4.2.8.
Data Re-sampling
The exact number of discrete data points per 360◦ vibration cycle for a given sampling
frequency (fs) and vibration frequency (fv) is given by Equation (4.14) under ideal
circumstances:
S =
fs
fv
(4.14)
Where S = number of data points; fs = sampling frequency; fv = vibration frequency.
Thus, an EMG sampled at a frequency of 1000Hz should yield 50 data points per vibration
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period at fv=20Hz, or 37 data points per vibration period at fv=27Hz. This is rarely the
case with a discrete recording setup in practice. More or fewer data points per vibration cycle
than the ideal case above is common. It is therefore necessary to standardise the number
of data points in each vibration cycle to allow for the comparison of the results from the
different test conditions. This was done here by re-sampling the data using a 1 dimensional
linear interpolation function in the Matlab Toolbox (MatlabR2010a, The Mathworks Inc.,
Massachusetts, USA), which yielded exactly 100 data points per vibration cycle.
Worked Example
A graphical representation of this process is presented in Figure 4.13. A 0.4s sample of EMG
and vertical platform acceleration data is shown in the left column. Eight full 360◦ vibration
periods (P1 - P8) were identified. The first period (P1) contained approximately 50 discrete
data points which were re-sampled such that the period now contains exactly 100 discrete
data points. This process was repeated for periods 2 - 8 (P2 - P8). The average of all eight
cycles was calculated and the result is shown in the right column.
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Figure 4.13: Outline of EMG vibration cycle analysis. Real, EMG and acceleration data are presented in the left column. The data were
discretised into individual periods (P1 - P8) according to the position of the vibration platform. Each period of data was re-sampled such that
it contained exactly 100 data points. The average over all periods was then found and the results are shown in the right column. According to
this method, general trends in the EMG response to a single vibration cycle may be observed. Note that platform trajectory was normalised to
maximum for presentation in these plots.
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4.2.11 Statistical Analysis
This section provides a general overview of the statistical tests used in this study. Additional
information about the statistical analyses is provided in the relevant results section where
appropriate. An example of such additional information would be the grouping factors used
in an ANOVA. All statistical analysis was carried out using the Matlab Statistics Toolbox
(MatlabR2010a, The Mathworks Inc., Massachusetts, USA).
Normality
The distribution of grouped data were assessed for normality using the Lilliefors test with a
significance detection level of α ≤ 0.05.
T-test
Paired groups of data were analysed by carrying out a one-sample T-test for paired data or
two-sample T-test for independent data. The alternative non-parametric Wilcoxon signed
rank and Wilcoxon rank sum tests were each used respectively if the distribution of the the
paired groups of data were found to be non-Normal. A significant difference was identified
for a p-value of ≤ 0.05.
Analysis of Variance
Repeated measures data were statistically analysed by carrying out an ANOVA. Grouped
data were first assessed for: (i) Normality as described above, and (ii) equal variance (also
described as sphericity) by carrying out a Bartlett multiple-sample test for equal variances.
In each case, a significant difference was defined for a computed p-value ≤ 0.05. A multi-
way ANOVA was then carried out on the grouped data. In the event that the assumption
of sphericity was found to have been violated, a Greenhouse-Geisser correction factor was
applied to the computed ANOVA F-statistic and the corresponding p-vale was adjusted
accordingly.
In the event that an interaction term was found to be non-significant, the ANOVA model
was changed to test for main effects only and the relevant statistics were re-calculated.
Where statistical significance was identified, a post-hoc multiple comparisons procedure with
Bonferroni correction was carried out to identify significantly different pairs of data. The
Bonferroni correction was applied to minimise Type II errors [58]. The alternative non-
parametric Friedman test was also used in place of the ANOVA where appropriate. Statistical
results were tabulated using Table 4.7 as a template:
Table 4.7: Template for tabulating statistical results.
Grouping Factor Statistical Parameter (DF) p GuGl
Factor 1 Parameter 1 (DF) p-value Significantly different pairs
of data in Factor 1
The following information was noted in the table. Each of these parameters were calculated
automatically by the Matlab Statistics Toolbox:
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• Grouping Factor: The grouping factor under investigation. Vibration frequency,
vibration amplitude and type of SCI are examples of different grouping factors which
were investigated in this thesis.
• Statistical Parameter: The statistical parameter associated with the statistical test
being executed. For example, the ‘F’ statistic was calculated for the ANOVA and the
‘X2’ statistic was calculated for the non-parametric Friedman test.
• Degrees of Freedom (DF): Number of degrees of freedom. It was derived from the
number of groups within the grouping factor.
• p: P-value calculated for the statistical test.
• GuGl: When significance was indicated by the statistical test a pairwise multiple
comparisons procedure was carried out on the data contained within the grouping
factor and the results were tabulated in this field. For example, three different
vibration frequencies were investigated: 12, 20 and 27Hz. During the pairwise multiple
comparison procedure the data recorded at 12Hz would be compared with the data at
20 and 27Hz. Similarly the data recorded at 20Hz would be compared with the data
recorded at 27Hz. A † symbol was recorded in this field in the event that all groups
of paired data were found to be significantly different to one another. The field was
left blank in the event that no significant difference was found between any group of
paired data. The pairs which were significantly different were noted in all other cases.
The paired data with a statistically significant difference were noted as an upper group
(Gu) and lower group (Gl) (i.e. 27Hz12Hz was used to indicate that the data recorded
at 27Hz was significantly different to the data recorded at 12Hz).
Grouped data was plotted using the boxplot function in the Matlab Statistics Toolbox
throughout this thesis. The box plots show the median, interquartile range, upper extreme
value and lower extreme value by default for each set of grouped data. An annotated example
is shown in Figure 4.14. Default whisker lengths were used in all cases and were calculated
automatically using the standard equations in the Matlab Statistics Toolbox (Equation (4.15)
and Equation (4.16)).
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Figure 4.14: Sample box plot.
UpperExtremeV alue = q3 + 1.5(q3 − q1) (4.15)
LowerExtremeV alue = q1 + 1.5(q3 − q1) (4.16)
Where q1 = 25
th percentile and q3 = 75
th percentile. The default value of 1.5 corresponds to
approximately ±2.7σ and 99.3% coverage of normally distributed data.
Effect Size
Effect Size (ES) calculations were based on the Cohen’s d statistic, using the pooled standard
deviation for the two populations under investigation:
x1 − x2
σ1,2
(4.17)
Where x1 = Mean of population 1; x2 = Mean of population 2; σ1,2 = Pooled standard
deviation of population 1 and 2.
A computed ES of 0.1, 0.3, and 0.5 were defined as small, medium, and large respectively [58].
Correlation
Pearson’s correlation coefficient was used to assess the pairwise correlation between two or
more groups of data.
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Chapter 5
WBV Neurologically Intact
A pBWS system was integrated with a WBV platform for this study in order to allow those
with a SCI to stand on the vibration platform enabling them to use it in a conventional
manner. pBWS also provided a degree of flexibility not provided for by other systems, by
allowing the level of support to be adjusted depending on the functional capability of the
participant in question. Furthermore, since WBV can be applied in a more conventional
manner, this setup allows for a more direct comparison of new findings from SCI participants
with existing findings reported in literature. This system was tested with a general population
in the first instance in order determine the feasibility of using WBV at reduced loads, and
to establish a normative baseline against which the SCI participants could be compared.
Furthermore, it provided expertise for the development of an experimental protocol for SCI
testing.
Ten participants with no neurological deficit were recruited from the University of Glasgow
to participate in two experimental sessions as described in Section 4.1.2. Each experimental
session was identical and comprised of 27 discrete test conditions. The vibration was well
tolerated and there were no adverse reactions or instances of erythema as described in the
literature. The response to WBV was measured using two different EMG amplifiers. Pre-
amplification of the EMG at the muscle resulted in a superior quality EMG which was less
susceptible to vibration artefact. Despite the improved performance of pre-amplified EMG
electrodes versus passive EMG electrodes, a proportion of vibration artefact remained in the
EMG and an oﬄine EMG signal processing and classification protocol was required. This
protocol was optimized and used for both the general and SCI studies.
5.1 Results
A summary of the results described in this section is presented below for quick reference:
• Section 5.1.1 Accelerometer Analysis: Average acceleration, displacement and
vibration frequency were calculated for the vibration platform, foot, and thigh. These
data indicate the frequency of vibration artefact expected to be present in the EMG
recorded during WBV and the magnitude of damping that may be occurring.
• Section 5.1.2 Artefact Quantification: The total proportion of vibration artefact
WBV Neurologically Intact 89
present in the recorded EMG was quantified. Bespoke off-line filters were used to remove
the artefact from the EMG.
• Section 5.1.3 EMG Classification: The EMG were discretised into pre-Vibration,
Vibration, and post-Vibration epochs and outlying data was rejected based on the BTR.
• Section 5.1.4 General EMG Amplitude Response: The magnitude of the
EMG was quantified by computing and averaging the RMS of each epoch of data.
The averaged values were then grouped according to test number, epoch, vibration
frequency, vibration amplitude, muscle group and level of pBWS.
• Section 5.1.5 Specific EMG Amplitude Response: The averaged EMGRMS data
were grouped according to muscle group, vibration frequency, vibration amplitude and
level of pBWS.
• Section 5.1.6 EMG Vibration Cycle Analysis: The EMG response over a single
cycle of vibration was investigated.
5.1.1 Accelerometer Analysis
The root mean square of acceleration, described hereafter as average acceleration, recorded
from the vibration platform, foot and VL EMG sensor was calculated for the Vibration period
of every test, session and subject using Equation (4.4). The results were grouped according
to the theoretical platform acceleration (atheor, Equation (4.13)) and are presented in the
boxplots shown in Figure 5.1. The vibration frequency and vibration amplitude parameters
related to atheor may be interpreted using Table 4.6.
A review of Figure 5.1 indicated that there was a good correlation between the measured
average acceleration and atheor. The correlation between average acceleration of the foot and
atheor was poorer, indicating that damping has occurred, resulting in a reduced transmission
of vibration to the foot. The average acceleration of the VL EMG sensor was small and
unrelated to the level of pBWS, vibration frequency or vibration amplitude.
The measured vibration frequency was determined by computing the PSD of the raw
acceleration data and identifying the frequency component with the largest overall power
contribution. The frequency of vibration of the vibration platform, foot and VL sensor are
shown in Figure 5.2. The data were grouped according to the vibration frequency set for
the test and the level of pBWS provided. A visual inspection of Figure 5.2 indicated that
there was a strong correlation between the measured frequency and actual frequency for all
test conditions, and that the transmission of vibration frequency was unaffected by vibration
amplitude or level of pBWS.
Displacement of the WBV platform, foot and VL sensor was calculated by double integration
of the recorded acceleration data. The results were grouped according to the vibration
amplitude set for the test and the level of pBWS provided. The results are presented as
boxplots and are shown in Figure 5.3. A visual inspection of the plots indicated that there
was a strong correlation between the measured vibration amplitude and that which was set for
the test. Conversely, displacement amplitude of the foot and VL sensor was poorly correlated
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Figure 5.1: Average acceleration data recorded during WBV (Epoch 2 from Figure 4.4
only) from the platform (top panel), foot (middle panel) and VL (bottom panel). The
data are grouped according to the expected platform acceleration (atheor) as calculated using
Equation (4.13) for the given discrete WBV test conditions, and the level of pBWS provided.
The discrete vibration conditions used are identifiable by cross-referencing the atheor values
presented on the x-axis above with Table 4.6. The average (median) of each set of grouped
data are also shown. Section 4.2.11 provides a detailed explanation of each of the parameters
shown in the boxplot above, including: median, percentiles, interquartile range and whiskers.
with that which was set for the test. Furthermore it was unaffected by the level of pBWS
provided and inversely correlated with vibration frequency.
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Figure 5.2: Frequency data recorded during WBV (Epoch 2 from Figure 4.4 only) from the
platform (top panel), foot (middle panel) and VL (bottom panel). The data are grouped
according to the frequency and amplitude of vibration set for the test, and the level of pBWS
provided. The average (median) of each set of grouped data are also shown.
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Figure 5.3: Estimated displacement data recorded during WBV (Epoch 2 from Figure 4.4
only) from the platform (top panel), foot (middle panel) and VL sensor (bottom panel). The
data are grouped according to the frequency and amplitude of vibration set for the test, and
the level of pBWS provided. The average (median) of each set of grouped data are also
shown.
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Platform acceleration in this application is sinusoidal in nature. Displacement is therefore
180◦ out of phase with acceleration. The high accuracy acceleration measurements were
therefore used to determine the relative movement of the WBV platform, foot and VL sensor
with respect to one another. Figure 5.4 shows this relative movement. Acceleration was
discretised according to each cycle of vibration, averaged across all cycles and then normalised
to maximum thus yielding a movement pattern for each location. These movement patterns
are described as trajectories hereafter. The longitudinal component of acceleration is plotted
only and the anterior-posterior and medial-lateral components are shown in the appendix.
The longitudinal component is the only component shown here because movement during
vibration primarily occurred in this direction. The trajectory of the WBV platform was
symmetrical and unaffected by pBWS, vibration frequency or vibration amplitude.
Foot trajectory is approximately 180◦ out of phase with the platform trajectory along the
anterior-posterior axis, but almost completely in phase in the longitudinal direction. Foot and
VL trajectories similarly demonstrated an inability to maintain synchrony with the vibration
platform when the frequency of vibration was increased. This was particularly evident in the
VL, possibly indicating a mechanical delay in transmission.
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Figure 5.4: Platform ((a), (b) & (c)), foot ((d), (e) & (f)), and VL ((g), (h) & (i)) trajectory
were estimated using longitudinal acceleration data recorded from each of these locations
during vibration. The data from each discrete test were averaged for each cycle of vibration
and normalised to maximum. The y-scale is therefore unitless. The data presented in the
left column ((a), (d) & (g)) were grouped according the frequency of vibration and averaged
for all subjects, tests, displacements and levels of pBWS. The data presented in the middle
column ((b), (e) & (h)) were grouped according to vibration displacement and averaged for
all subjects, tests, frequencies and levels of pBWS. The data presented in the right column
((c), (f) & (i)) were grouped according to the level of pBWS and averaged for all subjects,
tests, frequencies and displacements.
5.1.2 Artefact Quantification
This section presents the results of the investigation into the artefact content of the EMG
recorded for this study. The analysis focussed on quantifying the vibration induced motion
artefact in the EMG. Vibration artefact was only expected to be present in those EMG
recorded during vibration. However, in this analysis the entire EMG was analysed (pre-
Vibration, Vibration & post-Vibration). This was done to establish a normative data set
with which to compare the Vibration EMG and to confirm that the ‘artefact’ frequencies
were a result of vibration only and not due to some other unexpected source. This
analysis is important because artefact in an EMG could potentially lead to an overestimation
of the magnitude of the EMG and therefore an overestimation of the magnitude of the
neuromuscular response being attributed to WBV in subsequent analyses. In addition, the
optimum EMG recording setup was determined by using two different types of EMG recording
electrode and analysing the relative susceptibility of these electrodes to vibration artefact.
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Artefact was analysed by first quantifying the power of each harmonic frequency contained
within the EMG, and then comparing the relative power of each harmonic with respect to
all others. A statistical analysis was then carried out using an ANOVA and Effect Size
calculations.
Artefact Power
Every acquired EMG, from all participants and test conditions, was initially filtered according
to the filtering steps outlined in Section 4.2.3, and split into the representative epoch: pre-
Vibration, Vibration and post-Vibration. The amplitudes of the first 15 harmonics (h1−15)
of vibration were then calculated as a proportion of the total power (phn) using Equation
(4.5). Each value of phn (presented as a percentage value of total EMG power) was grouped
according to harmonic number (n) and electrode type and the full data set was plotted.
Recall that a phn value of 0 indicates that none of the power of the EMG is contained within
this frequency band, and a phn value of 1 indicates that all of the power within the EMG is
contained within this frequency band.
Data acquired using the active and passive EMG electrodes were plotted in Figures 5.5(a)
and 5.5(b) respectively. Group averages (mean) for each harmonic/electrode combination
were also calculated and overlaid the same plots. These group averages were then used to
compare the relative performance of the active and passive electrodes and to establish general
trends in the occurrence of vibration artefact. Note that the EMG amplifiers were configured
with a high-pass filter cut-off frequency of 30Hz, a significant reduction in EMG and artefact
amplitude below this frequency was therefore expected. Attenuation of each of the following
frequencies was thus observed: h1=12Hz & h2=24Hz (fvib=12Hz); h1=20Hz (fvib=20Hz,);
and h1=27Hz (fvib=27Hz).
No Vibration
The average contribution of any single component of vibration artefact (phn) did not exceed
1% during the pre- and post-Vibration epochs, regardless of the type of electrode used or
harmonic number. Furthermore, there was typically no difference in the results from either
epoch. Maximum values of 6 and 14% were found for the active and passive electrodes
respectively.
Vibration - Active Electrodes
The average contribution increased to between 1 and 11% for the active electrodes during
vibration depending on harmonic number. A maximum value 80% was found which occurred
at the second harmonic. It was noted that the second harmonic occurred at 24, 40 or 54Hz
depending on the vibration condition applied. These frequencies were close to or above the
high pass filter cut-off frequency used in this study. There was a downward trend in the
proportion of artefact at all subsequent harmonic frequencies thereafter.
Vibration - Passive Electrodes
The average contribution of vibration artefact to the total power of the EMG was between
1 and 12% for the passive electrodes during vibration depending on harmonic number. A
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Figure 5.5: The power of the first 15 harmonics of vibration ±1Hz are presented as a
percentage of total EMG power (Equation (4.5)), for all subjects, experimental sessions and
test conditions. The data acquired using active (a) and passive (b) electrodes are shown
separately. Note that the y-scale on each plot is logarithmic and each individual dot is a phn
value. The data are grouped according to the harmonic number and the epoch of the test
condition: pre-Vibration, Vibration and post-Vibration. Averages (mean) are overlaid the
grouped data.
maximum values of 90% was found in this instance, which occurred at the third harmonic.
There was again a general downward trend in the proportion of artefact at each subsequent
harmonic frequency.
The differences between phn in the EMG from the Vibration epoch and the pre- and post-
Vibration epochs were negligible from the 7th harmonic onwards, regardless of the type of
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EMG electrode used. This qualitative observation was quantified with a statistical analysis
in a later section. Furthermore, it was concluded that artefact was present in the EMG
recorded during the Vibration epoch only. The total artefact content during the Vibration
epoch was therefore quantified next. This was done by integrating all values of phn (Equation
(4.6)) and again grouping according to harmonic number for the active and passive electrodes
respectively. Group averages (mean) were calculated and overlaid the same plots. The results
for the active and passive electrodes are shown in Figures 5.6(a) and 5.6(b) respectively.
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Figure 5.6: The integrated contribution of each individual harmonic phn is presented as a
percentage of total EMG power (Equation (4.6)), for all subjects and experimental sessions.
Each data point is shown as a dot. The data are for the vibration epoch only and are grouped
according to harmonic number. The results for the active (a) and passive (b) electrodes are
shown separately. Note that the y-scale of each plot is logarithmic. Group averages (mean)
are overlaid the same plots.
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No Vibration
The total power of the EMG contained within the range of the harmonic frequencies was 10
and 15% for the passive and active electrodes respectively (data not shown on plot) during
the pre- and post-Vibration epochs. It was concluded that these values were representative
of the coincidental neuromuscular activity that occurred within these frequency bands rather
than that from an artificial source.
Vibration
Average values of 23% and 42% were found for the active and passive electrodes respectively
during the vibration epoch. Maximal values of 95% were found for certain conditions. These
conditions were dependent on the vibration frequency, vibration amplitude, muscle group,
level of pBWS and type of EMG electrode.
It is clear from these data that vibration artefact causes a significant increase in the power
of the EMG recorded during the vibration epoch. A visual inspection of the data indicates
that the majority of the increase occurs between the 1st and 7th or 8th harmonic, with little
or no observable change thereafter. A statistical analysis was carried out next to validate
this observation.
Statistical Analysis
Statistically significant differences between the groups of data presented in Figure 5.6 were
investigated by carrying out a multi-way ANOVA, where harmonic number and test condition
(pre-Vibration, Vibration, post-Vibration) were used as the independent grouping factors.
The results for the vibration data only are presented in Figure 5.7. A post-hoc multiple
comparisons procedure with Bonferroni correction was used to identify significantly different
pairs. For simplicity, only those groups of data that were significantly different to the 15th
harmonic (h15) are presented in Figure 5.7. The overall ES of these changes was estimated by
computing Cohen’s d statistic for each consecutive pair of grouped data (Equation (4.17)).
Each point presented in Figure 5.7 is the computed ES between hn and hn−1. An ES ≤ 0.1
was defined as the threshold value for a small change.
It was found that h1−10 (harmonics 1 - 10) caused a significant increase in %Ptotal when
using active or passive EMG electrodes. However, while statistically significant, the overall
effect from h5 and h6 onwards was deemed to be small for the active and passive electrodes
respectively. It was therefore concluded that vibration artefact largely occurred within h1−6
only and that it was adequate to remove the up to the 7th harmonic from the EMG. A
summary of the typical contribution of these artefacts on the EMG recorded during WBV is
described in further detail below.
Artefact Summary
Harmonics h1−7 were grouped according to muscle group, vibration frequency, vibration
amplitude and level of pBWS to describe the general susceptibility of an EMG to movement
artefact under specific experimental conditions. The results for the active and passive
electrodes are plotted separately in Figure 5.8. Statistical significance was assessed using
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Figure 5.7: The average integrated contribution of the individual harmonics phn are plotted
with a solid line on the primary y-axis. The values are presented as a percentage of total
EMG power recorded during the vibration epoch for all subjects and experimental sessions.
The results for the active (a) and passive (b) electrodes are shown separately. Note that
these data are the same as those shown in Figure 5.6 and that the y-scale is linear. The
corresponding effect sizes are plotted with the dashed line on the secondary y-axis. Effect
size was estimated using Cohen’s d statistic (Equation (4.17)). The threshold value for a
small effect size of of 0.1 is also shown on the secondary y-axis. Data groups that were
significantly different to h15 using an n-way ANOVA and a post-hoc multiple comparisons
procedure are highlighted (1 - 10 for active electrodes and 1 - 9 for passive electrodes). ES:
Effect size; ANOVA: Analysis of Variance.
a repeated-measures ANOVA, where vibration frequency, vibration amplitude, level of
pBWS, and muscle group were treated as the independent factors (Table 5.1). Significantly
different pairs were identified using a post-hoc multiple comparisons procedure with a
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Bonferroni correction. The EMG recorded using passive electrodes typically contained a
larger proportion of artefact than those recorded using active electrodes under the same
experimental conditions. It was therefore concluded that only active EMG electrodes should
be used during the application of WBV.
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Figure 5.8: General summary of the overall contribution of the first 7 harmonics of vibration
to the total power of the EMG. The contribution of the first seven harmonics of vibration were
integrated for all subjects and experimental conditions (vibration epoch only) and grouped
according to vibration frequency (a), vibration amplitude (b), muscle group (c) and level of
pBWS (d). The results from the active and passive electrodes are shown separately. TA =
Tibialis Anterior; TS = Triceps Surae muscle group (including Medial Gastrocnemius and
Lateral Gastrocnemius); QD = Quadriceps muscle group (including Vastus Lateralis and
Rectus Femoris; BF = Biceps Femoris.
A number of additional trends were observed: (i) there was a significant increase in the
proportion of artefact in the EMG with vibration frequency, though this trend was less
marked for the passive electrodes; (ii) there was a significant increase in the proportion of
artefact in the EMG with vibration amplitude; (iii) the presence of artefact was largest in
those EMG recorded with 50% pBWS, and smallest in those recorded with 100% pBWS;
(iv) there was significantly more artefact in those EMG recorded from muscles which were
in closer proximity to the vibration platform (TA, M-GA & L-GA), when compared to those
more proximal (VL, BF & RF); and (v) there was no difference in the overall proportion of
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artefact in the thigh muscles (VL and BF). The results of the statistical analysis are shown
in Table 5.1. These trends were consistent, regardless of the type EMG electrode used. It was
therefore concluded that h1−7 should be removed from EMG recorded during WBV using
appropriate stop-band filters, analogous to those used to remove line interference.
Table 5.1: Statistical results from an analysis of the combined contribution of the first 7
harmonics of vibration artefact (h1 to h7) in EMG recorded during WBV using active and
passive electrodes.
Active Electrode Passive Electrode
Parameter F (DF) p F (DF) p
Frequency 316.01 (2) ≤ 0.05 163.14 (2) ≤ 0.05
Displacement 9.83 (2) ≤ 0.05 4.09 (2) ≤ 0.05
pBWS 118.23 (2) ≤ 0.05 20.52 (2) ≤ 0.05
Muscle Group 57.47 (3) ≤ 0.05 17.33 (1) ≤ 0.05
Frequency × pBWS 13.07 (4) ≤ 0.05 7.08 (4) ≤ 0.05
Frequency × Muscle Group 8.89 (6) ≤ 0.05 1.38 (2) = 0.25
Displacement × Muscle Group 5.07 (6) ≤ 0.05 0.26 (2) = 0.75
pBWS × Muscle Group 15.73 (6) ≤ 0.05 29.57 (2) ≤ 0.05
Artefact Filter Validation
Randomly generated, band-limited (20 - 450hz), Gaussian white noise (Data) is shown in
Figure 5.9(a). This signal is used in lieu of real EMG data in this example. A 27Hz sinusoidal
signal with an amplitude equal to the average amplitude of the white-noise was generated and
added to the artificial EMG data. Harmonics (2 - 18) of the 27Hz sinusoid with exponentially
decreasing amplitude were then added to the artificial EMG also Figure 5.9(b). This new
signal is representative of an EMG superimposed with noise analogous to a vibration artefact
(Data + Artefact). This artificial data was used to investigate the efficacy of the stop-band
filters used in this study to eliminate vibration artefact from real EMG data. Artificial data
was used in this first instance because the true power of the artificial EMG and the artefact
was known.
The effect of artefact on the original EMG signal was evident when it was viewed in the time
domain, where a significant increases the amplitude of the EMG signal was seen. Furthermore,
the presence of the artefact was confirmed when viewing the data in the frequency domain.
Sharp ‘spikes’ in signal power were observed at the harmonic frequencies. Filtering this data
using the processes described in Sections 4.2.3 & 4.2.5, and specifically targeting the first
seven harmonics only, resulted in a reduction in the amplitude of the signal to pre-artefact
levels and a complete removal of the artefact spikes from the frequency plots.
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Figure 5.9: Artificially generated EMG data is shown in the left column in the time (a) and
frequency domains (d). The same data with added noise is shown in the middle column (b)
& (e). The noisy data was filtered and shown in the right column (c) & (f). The bottom row
(g), (h) & (i) shows the results of a vibration-cycle analysis for each of these data sets (as
described in Section 4.2.10). Data: Band-limited gaussian white noise; Data + Artefact: Data
with added sinusoidal signal; Filtered Data: Filtered Data + Artefact, specifically removing
sinusoidal signals; PSD: Power spectral density; PT : Sum of PSD; iEMG: Interpolated EMG,
that has been normalised to the maximum computed value.
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This result was quantified by integrating the PSD data shown in Figure 5.9(c), (d) and (e).
This provided an indication of the energy contained within the EMG. Integrating the PSD of
the original data (Figure 5.9(a)) between 0 - 500Hz yielded a total signal energy of 12.95V2.
The same procedure applied to the data with artefact (Figure 5.9(b)) yielded a total signal
energy of 28.76V2. Therefore, the artefact increased the energy of the original signal by:
28.76 − 12.95
12.95
× 100
1
= 122.1%
Specifically removing the first seven harmonics from this data using digital stop-band filters
yielded the data shown in (Figure 5.9(c)). Integrating the power of this signal between 0 -
500Hz yielded a total signal energy of 12.26V2. The difference between this and the original
signal was:
12.26 − 12.95
12.95
× 100
1
= −5.3%
It is known that some of the harmonic signals (h8−18) were still present in this data after
filtering. Nonetheless, the energy of the filtered signal was 5.3% smaller than that of the
original signal. This occurred because the filters almost completely removed all frequencies
within their stop-band range. Some of the frequencies which were removed would have been
genuine signal which coincidentally occurred within the same range as the artefact frequencies.
Therefore eliminating these genuine signals has the effect of reducing the amplitude of the
signal to a level smaller than the original.
The final observable effect of artefact on the EMG was seen when the EMG Vibration
Cycle Analysis (Section 4.2.10) was applied to this artificial data. The data in this example
was taken to be representative of EMG data acquired during the 27Hz vibration frequency
condition. Purely Gaussian white noise with an amplitude of 1 is seen in Figure 5.9(g) as
expected. The addition of a sinusoidal signal artefact to this signal is clearly seen to dominate
(Figure 5.9(h)), therefore hiding the underlying trends in the data. Importantly, filtering the
data returned the signal to its original shape (Figure 5.9(i)). This is analysed in further detail
in Section 5.1.6 using real EMG data.
It was concluded from this analysis that a series of Butterworth stop-band filters were
appropriate for the targeted and specific removal of artefact signals from EMG data acquired
during WBV. Furthermore, this analysis highlighted that these stop-band filters will
eliminate genuine EMG activity which occurs coincidentally at the same frequencies as the
artefact signals.
5.1.3 EMG Classification
A total of 6480 unique EMG recordings were acquired using the active electrodes, filtered
oﬄine according to the standard ISEK guidelines, filtered again to remove vibration artefact
and classified according to the methods described in Section 4.2.8. The variability of each
EMG was then estimated by computing the Burst-to-Tonic Ratio (BTR). EMG data was
classified as either an outlier or retained for further analysis using the criteria described
in Table 4.5. The rejection of outlying data was required because in some instances it was
identified that test subjects would lose balance during testing. This in turn induced additional
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neuromuscular activity into the EMG that was unrelated to that caused by the vibration. The
inclusion of this additional neuromuscular activity would result in an erroneous overestimation
of muscle activity being attributed to WBV.
162 (2.5%) EMG were classified as outliers and rejected. The origins of the rejected EMG are
summarised in Table 5.2. The majority of the rejected EMG were recorded from the TA with
an increasing trend in the number of EMG rejected with increasing vibration frequency and
vibration amplitude. This is reflected by a similar trend identified for increasing platform
acceleration where a larger number of the rejected EMG were for higher levels of platform
acceleration (data not shown in table). There was a reasonably even distribution in the
number of EMG rejected across the different levels of pBWS.
Table 5.2: Breakdown of EMG outlier origins. TA = Tibialis Anterior; M-GA = Medial
Gastrocnemius; VL = Vastus Lateralis; BF = Biceps Femoris.
Parameter Composition of Rejected Values
Muscle TA M-GA VL BF
58.8% 15.2% 12.7% 13.3%
Frequency 12Hz 20Hz 27Hz
23.6% 33.9% 42.4%
Displacement 1mm 2mm 3mm
26.7% 33.3% 40.0%
pBWS 0% 50% 100%
47.9% 20.6% 31.5%
Epoch pre-Vib Vib post-Vib
23.6% 28.5% 47.9%
All of these EMG were classified as outliers because the BTR exceeded 5. This was indicative
of a highly variable signal which was not consistent with the neuromuscular responses
normally found under the same experimental conditions. The average BTR of the included
EMG was typically between 0.5 - 1, and a breakdown of these values found are shown in
Figure 5.10 and 5.11. The BTR was larger during vibration than without as expected, and
there were no differences between the results from the first and second tests of the same
experimental conditions.
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Figure 5.10: Summary of BTR results for the EMG included for further analysis. The data
presented are for all subjects and test conditions and are grouped according to epoch (a) and
test number (b).
The BTR increased with both vibration frequency and and vibration amplitude. Further-
more, there was a decreasing trend in BTR values with increasing levels of pBWS. Typical
values for the M-GA and VL were larger than those found for the TA and BF.
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Figure 5.11: Overall summary of BTR results recorded during the vibration epoch only and
included for further analysis. The data presented are for all subjects and testing sessions,
and are grouped according to frequency (a), displacement (b), muscle group (c), and level of
pBWS (d).
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5.1.4 General EMG Amplitude Response
The intention of this initial amplitude analysis was to describe the general underlying trends
of the neuromuscular response to WBV. A specific analysis is shown in the next section
which investigates the neuromuscular response at specific combinations of vibration frequency,
vibration amplitude and level of pBWS. To do this, it was first necessary to establish if WBV
caused any increase in neuromuscular activity. The difference in response to different testing
conditions (vibration frequency, vibration amplitude and level of pBWS) was investigated
next. Finally, it was established if there was a difference in response of the different muscle
groups to WBV.
General Results
Typical normalised EMG (EMGN ) (Equation (4.11)) values are shown in Figure 5.12 and
the results of the statistical analysis of this grouped data is shown in Table 5.3. EMGN was
significantly different for all three epochs of the testing protocol: pre-Vibration, Vibration,
and post-Vibration, but with the largest amount of activity occurring during vibration as
expected. There was no statistically significant difference between the first and second testing
sessions.
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Figure 5.12: Overall summary of EMG results not rejected. Data for all subjects and test
conditions are presented and grouped according to epoch and testing sessions.
Statistical results were based on a multi-way ANOVA for all EMG not rejected by the BTR
threshold. The independent grouping factors were epoch and test condition. A post-hoc
multiple comparisons procedure with Bonferroni correction was used to identify significantly
different pairs when significance was identified by the ANOVA.
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Table 5.3: General summary of statistical results. F: ANOVA F-statistic; DF: Degrees of
Freedom; p: P-value; GuGl: Groups identified to be significantly different in post-hoc analysis;
GuGL: Paired data groups whose difference was statistically significant; Gu represents the
grouped data with the larger value and Gl represents the grouped data with the smaller value;
†: All grouped pairs found to be significantly different at p≤0.05.
EMGN
Parameter F (DF) p GuGl
Epoch 187.2 (2) ≤ 0.01 †
Test 0.749 (1) = 0.387 -
Vibration Results
It was concluded that vibration did cause an increase in neuromuscular activity and that
this increase was statistically significant. This increase was therefore evaluated in relation
to: (i) vibration frequency, (ii) vibration amplitude, (iii) level of pBWS, and (iv) the specific
muscle group. The relative change in activity (∆EMG) (Equation (4.12)) was calculated by
comparing neuromuscular activity recorded during Vibration to baseline. Baseline was taken
to be the pre-Vibration epoch in this instance. These data are shown with the corresponding
values of EMGN in Figure 5.13. The results of the supporting statistical analysis is shown in
Table 5.4.
Statistical results were based on a multi-way ANOVA for all EMG which met the BTR
inclusion criteria and were recorded during the Vibration epoch. The analysed data are for all
subjects and test conditions, and the independent grouping factors were vibration frequency,
vibration amplitude, muscle group, and level of pBWS. A post-hoc multiple comparisons
procedure with a Bonferroni correction was used to identify significantly different pairs when
overall statistical significance was indicated by the ANOVA.
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Figure 5.13: Summary of EMG amplitude response analysis of data acquired during the
Vibration epoch only. The data presented in the left column ((a), (c), (e) & (g)) are ∆EMG
and the data presented in the right column ((b), (d), (f) & (h)) are EMGN . The data are
for all subjects and tests, and are grouped according to: vibration frequency ((a) & (b)),
vibration amplitude ((c) & (d)), muscle group ((e) & (f)), and level of pBWS ((g) & (h)).
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Neuromuscular activity increased with both vibration frequency and vibration amplitude,
and decreased with level of pBWS. Changes in ∆EMG between 15 and 30% were found for
vibration frequency, with corresponding average EMGN values between 2 and 3%. These
changes were statistically significant and a post-hoc analysis showed that vibration at 27Hz
resulted in a significantly larger increase in neuromuscular activity when compared to those
changes that occurred at 12Hz. Similar values were found for vibration displacement and in
each case the changes in EMGN and ∆EMG were significant. Average values of EMGN were
between 1 and 7% depending on the level of pBWS and these changes were significant also.
The corresponding values of ∆ EMG decreased with increasing levels of pBWS and typical
values of ∆EMG were between 10 and 35%. The post-hoc analysis showed that ∆EMG was
significantly larger at 0% pBWS than at 50 or 100% pBWS.
It was observed that EMGN was considerably different for each of the different muscle groups
during vibration, and that these difference were statistically significant. The VL was most
active during Vibration with typical values of approximately 10% MVC occurring. EMGN
of the M-GA was next with typical values of 5% MVC. The activity of the TA and BF were
smallest and were activated to approximately 1 - 2% MVC. The trend in ∆EMG differed to
this however. Comparatively, the largest relative changes to baseline were in the M-GA with
average ∆EMG values of 50%. Changes compared to baseline for the TA, VL and BF were
20, 20, and 15% respectively. ∆EMG for M-GA was significantly larger than those change
which occurred in the other muscle groups.
Table 5.4: General summary of WBV statistical results. ∆ EMG: Change in EMG during
Vibration with respect to pre-Vibration condition; EMGN : EMG during vibration normalised
to a MVC; F: ANOVA F-statistic; DF: Degrees of Freedom; p: P-value; GuGl: Groups
identified to be significantly different in post-hoc analysis; GuGL: Paired data groups whose
difference was statistically significant; Gu represents the grouped data with the larger value
and Gl represents the grouped data with the smaller value; †: All pairs found to be
significantly different at p≤0.05.
∆ EMG EMGN
Parameter F (DF) p GuGl F (DF) p GuGl
Frequency 64.66 (2) ≤ 0.01 † 30.94 (2) ≤ 0.01 2712; 2720
Displacement 64.06 (2) ≤ 0.01 † 30.90 (2) ≤ 0.01 †
Muscle 90.21 (3) ≤ 0.01 M-GATA;
M-GAV L;
M-GABF
401.3 (4) ≤ 0.01 †
pBWS 76.96 (2) ≤ 0.01 † 350.1 (2) ≤ 0.01 †
5.1.5 Specific EMG Amplitude Response
Analysis of the acceleration data indicated that damping of the vibration was occurring as
it was transmitted through the body, and that the transmission of vibration was degraded
further as the level of pBWS was increased. The general EMG analysis confirmed that
WBV elicited an increased neuromuscular response and that vibration frequency, vibration
amplitude and level of pBWS each had a significant effect upon that response. The analysis
also highlighted that the response across the different muscles was not uniform for a given
set of experimental conditions. It was thus confirmed that the initial conditions for each
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muscle group must be different. It was hypothesised that factors such as pBWS (which
influences muscle tension) and the relative proximity of the muscle to the vibration platform
(which influences vibration transmission) may each play a central role in the magnitude of
the neuromuscular response during WBV.
It was confirmed that the proximity of the muscle to the vibration platform affected the
magnitude of the response during WBV. The relationship between the existing contraction
in the muscle and the magnitude of the neuromuscular response thereafter (during the
application of WBV) was assessed by comparing EMGN for the pre-Vibration and Vibration
epochs. The scatter plots in Figure 5.14 show this relationship for each muscle respectively.
A best fit trend line was overlaid the scatter plot to highlight the general trends and Pearson’s
correlation coefficient was used to quantify the relationship. The results of this statistical
analysis are reported in Table 5.5.
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Figure 5.14: Scatter plot of pre-Vibration and Vibration muscle activity with best-fit trend
line. The best-fit line assessed using Pearson’s correlation coefficient and the slope of the
line is shown on each subplot. Note that a slope (m) <1 indicates an attenuation of
neuromuscular activity during the application of WBV. TA: Tibialis Anterior, M-GA: Medial
Gastrocnemius, VL: Vastus Lateralis, BF: Biceps Femoris.
The slope of the each trend line provides an general indication of the increase in muscle
activity expected to occur during WBV. The slopes of the fitted lines were different in each
case and the trends for the TA and M-GA were larger than those for the VL and BF. This
evidence supports the hypothesis that magnitude of neuromuscular response was different for
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each individual muscle group and that the proximity of the muscle to the source of vibration
had a determinant role in the magnitude of the response. It was concluded that the amplitude
response of each individual muscle group be assessed separately based on these two pieces of
evidence.
Table 5.5: Trend-line statistics describing relationship between pre-Vibration and Vibration
muscle activity. Best-fit line assessed using Pearson’s correlation coefficient; R-value:
Pearson’s best fit correlation.
Muscle Slope Intercept R-value P-value
TA 2.1 0.0 0.2 <0.01
M-GA 2.4 0.0 0.4 <0.01
VL 1.2 0.0 0.8 <0.01
BF 1.4 0.0 0.5 <0.01
It was next determined that the initial muscle tension was different for each muscle group
by comparing the magnitudes of neuromuscular activity (EMGN ) during the pre-Vibration
condition. pre-Vibration was considered analogous to a vibration frequency of 0Hz and
vibration amplitude of 0mm and is described otherwise as the 0.0g condition. The magnitude
of neuromuscular activity during the 0.0g condition is plotted for each muscle in Figures 5.15 -
5.18 below. It can clearly be seen that the magnitude of EMGN decreases with each increasing
increment in the level of pBWS at the 0.0g condition. Furthermore, the baseline underlying
level of neuromuscular activity in each muscle group was different.
The amplitude response of each individual muscle to WBV is presented in Figures 5.15-
5.18 where the data is presented in three ways: (i) by describing the absolute measured
values (this data is not used for further discussion in this chapter but is provided for
subsequent comparison with SCI data); (ii) by describing the magnitude of neuromuscular
activity relative to MVC; and (iii) by describing the relative change in neuromuscular activity
when compared to a baseline condition. The presented data are for all EMG that were not
rejected by the criterion set out in Section 4.2.8. The data were grouped according to level
of pBWS and platform acceleration and the 0.0g condition represents baseline data. The
specific vibration frequency and vibration amplitude conditions associated with each data
group may be determined by referencing the acceleration values described on the x-axis to
those outlined in Table 4.6. A multi-way ANOVA was carried out on all EMGN and ∆EMG
data at each level of pBWS. The independent grouping factors were vibration frequency and
vibration amplitude and the results of the statistical analysis are presented in Tables 5.6-5.9.
Tibialis Anterior
WBV caused an increase in TA neuromuscular activity. ∆EMG increased with platform
acceleration with the largest change occurring at 0% pBWS and smallest at 100% pBWS.
∆EMG was typically between 20 - 50% at 0% pBWS, which equated to comparatively small
EMGN of 1 - 2%. ∆EMG at 50 and 100% pBWS were broadly similar, where increases
between 10 - 30% were found. This equated to an EMGN of approximately 1%. The results
of the statistical of these findings are outlined in Table 5.6.
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Table 5.6: Summary of the statistical analysis of TA amplitude response results. A multi-way
ANOVA was used to identify significant changes in EMGN and ∆EMG. The independent
grouping factors were vibration frequency and vibration amplitude. The interaction between
these terms was also investigated. EMGN : EMG normalised to a MVC (Equation (4.12));
∆EMG: Change in activity relative to baseline (Equation (4.12)); TA: Tibialis anterior;
pBWS: Partial body weight support; F: ANOVA F-statistic; ANOVA: Analysis of Variance;
DF: Degrees of freedom; p: P-value; GuGL: Paired data groups whose difference was
statistically significant; Gu represents the grouped data with the larger value and Gl
represents the grouped data with the smaller value.
∆EMG EMGN
pBWS Parameter F (DF) p GuGl F (DF) p GuGl
0% Frequency 14.60 (2) ≤0.01 2712; 2720 0.98 (2) =0.35 -
Displacement 12.01 (2) ≤0.01 31; 32 3.97 (2) =0.08 -
Interaction 0.32 (4) =0.84 - 1.13 (4) =0.34 -
50% Frequency 6.47 (2) ≤0.05 2712; 2720 1.25 (2) =0.29 -
Displacement 13.18 (2) ≤0.01 31; 32 0.52 (2) =0.49 -
Interaction 0.64 (4) =0.63 - 0.94 (4) =0.36 -
100% Frequency 3.75 (2) =0.05 2712 0.08 (2) =0.78 -
Displacement 2.34 (2) =0.14 - 0.70 (2) =0.43 -
Interaction 0.79 (4) =0.52 - 0.96 (4) =0.35 -
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Figure 5.15: Amplitude response of TA to WBV. The neuromuscular response is presented
as EMG (a), EMGN (b) and ∆EMG (c). The presented data are for all subjects and test
conditions. The data were grouped according the platform acceleration (Equation (4.2)) and
level of pBWS. Pre-Vibration data is presented for reference purposes and can be identified
as the 0.0g condition. The specific vibration and amplitude conditions used are identifiable
by cross-referencing the acceleration values presented to those described in Table 4.6.
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Medial Gastrocnemius
Larger increases in ∆EMG were found for the M-GA. These increases were largest at 0%
pBWS and smallest at 100% pBWS. This trend is consistent with that found for the TA.
∆EMG was broadly similar at the 0 and 50% pBWS conditions, where typical values were
between 25 - 70%. This equated to a typical EMGN of 6 - 20% MVC at 0% pBWS, and 3 -
10% MVC at 50% pBWS. ∆EMG was between 5 and 60% which equated to an EMGN of 1
- 7% MVC at 100% pBWS. These increases were statistically significant in many cases and
the results of the statistical analysis are are outlined in Table 5.7.
Table 5.7: Summary of the statistical analysis of M-GA amplitude response results. A
multi-way ANOVA was used to identify significant changes in EMGN and ∆EMG. The
independent factors used are vibration frequency and vibration amplitude. The interaction
between these terms was also investigated. EMGN : EMG normalised to a MVC (Equation
(4.12)); ∆EMG: Change in activity relative to baseline (Equation (4.12)); M-GA: Medial
gastrocnemius; pBWS: Partial body weight support; F: ANOVA F-statistic; ANOVA:
Analysis of Variance; DF: Degrees of freedom; p: P-value; GuGL: Paired data groups
whose difference was statistically significant; Gu represents the grouped data with the larger
value and Gl represents the grouped data with the smaller value; †: All grouped data were
significantly different from one another.
∆EMG EMGN
pBWS Parameter F (DF) p GuGl F (DF) p GuGl
0% Frequency 21.33 (2) ≤0.01 † 16.69 (2) ≤0.01 2712; 2720
Displacement 5.80 (2) ≤0.05 31 14.16 (2) ≤0.01 32; 31
Interaction 0.21 (4) =0.90 - 1.17 (4) =0.34 -
50% Frequency 6.39 (2) ≤0.01 2712; 2720 7.65 (2) ≤0.05 2712; 2720
Displacement 12.48 (2) ≤0.01 31; 21 13.97 (2) ≤0.01 32; 31
Interaction 0.31 (4) =0.87 - 1.03 (4) =0.39 -
100% Frequency 10.08 (2) ≤0.01 2712; 2720 2.86 (2) =0.10 -
Displacement 6.00 (2) ≤0.05 31 6.99 (2) ≤0.05 32; 31
Interaction 0.41 (4) =0.80 - 1.24 (4) =0.31 -
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Figure 5.16: Amplitude response of M-GA to WBV. The neuromuscular response is presented
as EMG (a), EMGN (b) and ∆EMG (c). The presented data are for all subjects and test
conditions. The data were grouped according the platform acceleration (Equation (4.2)) and
level of pBWS. Pre-Vibration data is presented for reference purposes and can be identified
as the 0.0g condition. The specific vibration and amplitude conditions used are identifiable
by cross-referencing the acceleration values presented to those described in Table 4.6.
Vastus Lateralis
EMGN of the VL was considerably different at each level of pBWS where typical values at
0% pBWS were between 18 - 28% MVC. Typical values at 50% pBWS were approximately
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10% MVC and 1% MVC at 100% pBWS. ∆EMG was broadly similar across all levels of
pBWS where typical values were between 5 and 30%. Results of the statistical analysis are
presented in Table 5.8.
Table 5.8: Summary of the statistical analysis of VL amplitude response results. A multi-way
ANOVA was used to identify significant changes in EMGN and ∆EMG. The independent
grouping factors were vibration frequency and vibration amplitude. The interaction between
these terms was also investigated. EMGN : EMG normalised to a MVC (Equation (4.12));
∆EMG: Change in activity relative to baseline (Equation (4.12)); VL: Vastus lateralis; pBWS:
Partial body weight support; F: ANOVA F-statistic; ANOVA: Analysis of Variance; DF:
Degrees of freedom; p: P-value; GuGL: Paired data groups whose difference was statistically
significant; Gu represents the grouped data with the larger value and Gl represents the
grouped data with the smaller value.
∆EMG EMGN
pBWS Parameter F (DF) p GuGl F (DF) p GuGl
0% Frequency 8.82 (2) ≤0.01 2712; 2720 2.75 (2) =0.11 -
Displacement 2.74 (2) =0.09 - 1.18 (2) =0.33 -
Interaction 0.03 (4) =1.00 - 0.09 (4) =0.97 -
50% Frequency 0.23 (2) =0.79 - 0.55 (2) =0.56 -
Displacement 2.64 (2) =0.11 - 1.05 (2) =0.36 -
Interaction 0.46 (4) =0.76 - 0.09 (4) =0.96 -
100% Frequency 0.45 (2) =0.64 - 0.08 (2) =0.86 -
Displacement 0.18 (2) =0.84 - 0.46 (2) =0.63 -
Interaction 0.29 (4) =0.88 - 0.08 (4) =0.98 -
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Figure 5.17: Amplitude response of VL to WBV. The neuromuscular response is presented
as EMG (a), EMGN (b) and ∆EMG (c). The presented data are for all subjects and test
conditions. The data were grouped according the platform acceleration (Equation (4.2)) and
level of pBWS. Pre-Vibration data is presented for reference purposes and can be identified
as the 0.0g condition. The specific vibration and amplitude conditions used are identifiable
by cross-referencing the acceleration values presented to those described in Table 4.6.
Biceps Femoris
The trends in ∆EMG for the BF were broadly similar to those found for the TA and M-GA
where the levels of activity were largest at 0% pBWS and smallest at 100% pBWS. ∆EMG
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was typically between 5 and 70% at 0% pBWS which equated to an EMGN of 3 - 8% MVC.
∆EMG was between 3 - 35% at 50% pBWS and 3 - 8% at 100% pBWS. These increases
equated to an absolute EMGN of 1 - 2% MVC. The results of the statistical analysis are
presented in Table 5.9.
Table 5.9: Summary of the statistical analysis of BF amplitude response results. A multi-way
ANOVA was used to identify significant changes in EMGN and ∆EMG. The independent
grouping factors were vibration frequency and vibration amplitude. The interaction between
these terms was also investigated. EMGN : EMG normalised to a MVC (Equation (4.12));
∆EMG: Change in activity relative to baseline (Equation (4.12)); BF: Biceps femoris; pBWS:
Partial body weight support; F: ANOVA F-statistic; ANOVA: Analysis of Variance; DF:
Degrees of freedom; p: P-value; GuGL: Paired data groups whose difference was statistically
significant; Gu represents the grouped data with the larger value and Gl represents the
grouped data with the smaller value.
∆EMG EMGN
pBWS Parameter F (DF) p GuGl F (DF) p GuGl
0% Frequency 19.14 (2) ≤0.01 2712; 2720 10.51 (2) ≤0.01 2712; 2720
Displacement 14.20 (2) ≤0.01 31; 21 4.88 (2) ≤0.05 31
Interaction 0.13 (4) =0.97 - 0.40 (4) =0.75 -
50% Frequency 3.06 (2) =0.11 - 2.28 (2) =0.15 -
Displacement 2.08 (2) =0.17 - 0.35 (2) =0.61 -
Interaction 0.39 (4) =0.67 - 0.34 (4) =0.75 -
100% Frequency 0.22 (2) =0.77 - 0.36 (2) =0.65 -
Displacement 2.41 (2) =0.12 - 0.28 (2) =0.70 -
Interaction 0.54 (4) =0.66 - 0.09 (4) =0.91 -
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Figure 5.18: Amplitude response of BF to WBV. The neuromuscular response is presented
as EMG (a), EMGN (b) and ∆EMG (c). The presented data are for all subjects and test
conditions. The data were grouped according the platform acceleration (Equation (4.2)) and
level of pBWS (bottom panel). Pre-Vibration data is presented for reference purposes and
can be identified as the 0.0g condition. The specific vibration and amplitude conditions used
are identifiable by cross-referencing the acceleration values presented to those described in
Table 4.6.
In summary this specific analysis supports the findings of the general analysis described in
Section 5.1.4. Vibration frequency, vibration amplitude and pBWS did significantly affect the
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magnitude of the neuromuscular response to WBV. The trends of increase in neuromuscular
response were specific to each muscle group as expected. Both ∆EMG and EMGN were
generally largest at 0% pBWS and smallest at 100% pBWS. Furthermore, each of these
parameters were typically found to increase with platform acceleration.
The TA and BF were the least active with similar values of ∆EMG and correspondingly
showed the smallest EMGN values. Conversely the M-GA and VL were the most active.
EMGN values in excess of 20% MVC were found for each muscle, however the corresponding
∆EMG values were considerably higher in the M-GA than the VL. These results further
support the hypothesis that proximity (of the muscle to the source of vibration) and tension
(the initial magnitude of voluntary muscle activity) each play a central role in determining
the amplitude of the overall neuromuscular response to WBV.
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5.1.6 Vibration Cycle Analysis
The Vibration Cycle Analysis methodology was described in detail in Section 4.2.10 and
was qualified using an example which used artificially generated data that resembled a real
EMG. The same qualification process was repeated in the case study below. Increases in the
amplitude of the EMG which occurred at regular intervals during each vibration cycle were
expected to be visible in the normalised EMG output from the analysis. It was established
previously that vibration artefact also affected the shape of an EMG when viewed in this
way. This effect was minimised with appropriate off-line filtering.
A regular increase in the magnitude of the EMG was found to occur over the course of a single
vibration cycle in the case study described below and it was concluded that this increase was
not related to vibration artefact. This finding is fundamentally different to that found for
the artificial data (Section 5.1.2) for which all periodic changes in the EMG amplitude were
eliminated by off-line filtering.
Case Study
The previous worked example (Section 4.2.10) anticipated the effect of vibration artefact on
the shape of an EMG. The same analysis methodology was carried in this instance with real
EMG data that was recorded during WBV. The results were plotted and are shown in Figure
5.19. The first plot is of an EMG which was recorded during the pre-Vibration epoch, the
second EMG during WBV but with only basic filtering (Section 4.2.3) applied, and the third
EMG is the same as the second but with the harmonic frequencies specifically removed also
(Section 4.2.5).
Peaks at the vibration frequency and harmonics were found when the EMG was viewed in
the frequency domain as expected. This was confirmed by viewing EMG recorded during
WBV with only basic filtering applied. No spikes were present in the pre-Vibration EMG
because vibration artefact can not occur in the absence of vibration, nor were any identified
in the fully filtered Vibration EMG either. This finding eliminates any potential electrical
source for the artefact and corroborates the hypothesis that the artefact was caused by the
WBV. It was also finally found that the amplitude of the EMG recorded during WBV was
reduced when the vibration artefact was removed.
A Vibration Cycle Analysis was carried out next and the results are plotted in Figure 5.19
also. No significant temporal changes were found for the first EMG. A temporal relationship
was indicated in the second EMG, where a distinct shape and discernible peak in the EMG
was identifiable. However, it was not clear if this observed change was the consequence of
vibration artefact or regular and repeated increases in neuromuscular activity occurring at a
particular point of the vibration cycle. A well defined peak in the EMG was present in the
third fully filtered EMG though it was reduced in magnitude when compared to that for the
second. This result indicates that a temporal relationship did indeed exist between the phase
of vibration and the neuromuscular response, whereby a well defined and distinct increases in
neuromuscular activity occurred at a specific time point during each single cycle of vibration.
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Figure 5.19: Results from a Vibration Cycle Analysis carried out using real EMG data
recorded from Subject 4 during Test 1. Vibration was applied at a vibration frequency of
20Hz and a vibration amplitude of 2mm. No pBWS was provided. The data presented in
column (a) are from the EMG recorded during the pre-Vibration epoch. The EMG was
filtered according to the standards outlined in Sections 4.2.3 & 4.2.5. The data presented in
column (b) are from the EMG recorded during the Vibration epoch. The EMG was filtered
according to the standards outlined in Sections 4.2.3 only. The data presented in column (c)
are from the EMG presented in column (b) but with additional filtering applied as described
in Section 4.2.5. The data presented in the first row are the EMG presented in the time
domain. The data presented in the second row are the same EMG presented in the frequency
domain. The data presented in the third row are from the same EMG analysed using the
vibration cycle analysis. ffull: Standard filtering with additional artefact removal according
to the methods described in Sections 4.2.3 & 4.2.5; fbasic: Filtering according to the standards
described in Section 4.2.3; PT : Energy of the EMG when viewed in the frequency domain as
calculated by integrating the PSD; PSD: Power Spectral Density; pvc: Per Vibration Cycle.
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A Vibration Cycle Analysis was therefore carried out for every participant in this study to
determine which parameter specifically elicited such a response. The results are outlined in
the General Analysis below.
General Analysis
A Vibration Cycle Analysis was carried out on every EMG that met the inclusion criteria
described in Section 4.2.8 and the results are summarised in Figure 5.20. The vibration
cycle data from each test were averaged for all subjects, tests, and test epoch: pre-Vibration,
Vibration, post-Vibration. The averaged data were then grouped according to: vibration
frequency, vibration amplitude, muscle, and level of pBWS, and normalised to maximum.
This was done to determine qualitatively which of these factors was most likely to influence
a temporal relationship between neuromuscular activity and a single cycle of vibration.
0 20 40 60 80 100
0.4
0.6
0.8
1
(a)
N
EM
G
pv
c
 
 
12Hz
20Hz
27Hz
0 20 40 60 80 100
0.4
0.6
0.8
1
(b)
 
 
1mm
2mm
3mm
0 0.2 0.4 0.6 0.8 1
0.4
0.6
0.8
1
Platform Position
(c)
N
EM
G
pv
c
 
 
TA
M−GA
VL
BF
0 0.2 0.4 0.6 0.8 1
0.4
0.6
0.8
1
(d)
Platform Position
 
 
0%
50%
100%
Figure 5.20: Summary of Vibration Cycle Analysis results. The presented data were derived
from all of the recorded EMG that met the inclusion criteria outlined in Section 4.2.8. The
results were grouped for all subjects, tests, and test epoch. Pre-, and post-Vibration data
are indicated by dashed lines and highlighted by the grey band, and vibration data are
indicated by solid lines. Depending on the factor being plotted, additional grouping factors
included: vibration frequency (a), vibration amplitude (b), muscle (c), and level of pBWS
(d). Grouped and averaged data were normalised to maximum. The sub-categories of each
grouping factor are defined in the corresponding legends. NEMGpvc: Per vibration cycle of
the EMG normalised to its maximum.
No significant fluctuation or change in neuromuscular activity was observed for those EMG
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recorded during the pre-, and post-Vibration epoch as expected and were therefore excluded
from further analysis. Some fluctuation was found for the EMG grouped according to
vibration amplitude and level of pBWS. However, these changes were relatively small when
compared to those EMG which were grouped and averaged according to the muscle group
and vibration frequency. It was thus hypothesised that: (i) the neuromuscular response was
related to vibration frequency, and (ii) the response was specific to each muscle. These two
grouping factors were therefore analysed in greater detail.
Specific Analysis
The Vibration Cycle Analysis was repeated and restricted to include those EMG which were
recorded during the Vibration epoch only. Furthermore, the analysis included data only from
those subjects whose output EMG from the first and second testing sessions were similar in
shape as determined using Pearson’s correlation coefficient. For example, the shape of the
output EMG recorded from Subject 1 during Test 1 at the 20Hz, 1mm, 0% pBWS test
condition needed to be similar to that recorded from the same subject and conditions during
Test 2.
Pearson’s correlation coefficient (r) was used to determine if the output EMG from each of
the testing sessions were sufficiently ‘similar’. Both output EMG were rejected if: (i) the
correlation between the two EMG was non-significant (p≥0.05), or (ii) very poor or negative
(r≤0.1). In the first version of this analysis an accepted correlation (r) of 0.7 or greater was
set, which would indicate a high between test correlation. However, this limitation was found
to be excessively restrictive with a small quantity of TA and M-GA data retained, and no VL
or BF data retained. A lower accepted r-value of 0.1 was used instead and the analysis was
re-run. The retained data were averaged for all subjects and grouped according to muscle
group and vibration frequency and the results are shown in Figure 5.21.
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Figure 5.21: Results of vibration cycle analysis for EMG recorded during WBV only. The
presented data were derived from the recorded EMG that met the inclusion criteria described
in Section 4.2.8. The results were averaged for all subjects and tests, and grouped according
to vibration frequency and muscle group. Grouped and averaged data were normalised to
the respective maximum values. NEMGpvc: Per vibration cycle of the EMG normalised to
its maximum.
A distinct but broadband increase in the amplitude of the EMG was found. The point
at which this distinct peak occurred was different for each muscle and vibration frequency
respectively and the latencies of the occurrence of the peaks relative to the start of the
vibration cycle are summarised in the table below.
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Table 5.10: Summary of vibration cycle results. Data grouped and averaged for the Vibration
epoch, muscle group, and vibration frequency. Peak values were identified using Figure 5.21
and the results are presented as the point during the vibration cycle at which the peak
occurred. This point is presented as a percentage of completion of the vibration cycle where
0% is the beginning of the vibration cycle, and 100% is the end of the vibration cycle. No data
is presented for the BF because no relationship was identified. FV ib = Vibration frequency;
TA = Tibialis Anterior; M-GA = Medial Gastrocnemius; VL = Vastus Lateralis; BF =
Biceps Femoris.
Muscle FV ib = 12Hz FV ib = 20Hz FV ib = 27Hz
TA 9% 40% 82%
M-GA 9% 48% 77%
VL 7% 28% 60%
The occurrence of each of the peaks were broadly similar for the different participants at a
given vibration frequency, but at a different latency from the beginning of the vibration cycle.
It was hypothesised that a common stimulus may be eliciting this characteristic response and
that the stimulus may be common for the different vibration periods. The latency between
each peak and the preceding platform positions were therefore determined for each muscle
group and vibration period. An example from the M-GA is plotted in Figure 5.22.
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Figure 5.22: Outline of two consecutive vibration cycle EMG responses recorded from the
M-GA. The vibration cycle EMG were analysed for each vibration period, normalised to
maximum (NEMGpvc) and plotted against platform position, where 0 indicates the beginning
of a vibration cycle and 1 indicates the end of the same vibration cycle. The NEMGpvc
recorded at a vibration frequency of 12Hz (83ms) is indicated by a solid line (-), theNEMGpvc
recorded at a vibration frequency of 20Hz (50ms) is indicated by a dashed line (- -), and the
NEMGpvc recorded at a vibration frequency of 27 Hz (37ms) is indicated by a dash-dot (
- .). The relative amplitudes of each NEMGpvc are plotted against the primary y-axis (a).
Vertical platform acceleration was also normalised to maximum and plotted against platform
position. The amplitude of normalised acceleration is plotted against the secondary y-axis
(a). The solid vertical line indicates the transition from one vibration cycle to the next. The
dashed vertical lines indicate the peaks in each NEMGpvc and highlight the relative difference
in their occurrence relative to each other. The latency of each of peak response relative to the
preceding platform positions were determined and are indicated by the straight lines plotted
in (b), where the slope of each line is equivalent to the corresponding vibration period (i.e.
83, 50, & 37ms). Convergence of the lines occurred at approximately 0.54 completion of the
previous vibration cycle, and is equivalent to a latency of 46ms for all vibration frequencies.
M-GA: Medial-Gastrocnemius, NEMGpvc: Normalised EMG Per Vibration Cycle.
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The results from Figure 5.22 indicated that a common stimulus did indeed exist, and that it
was coincident with the preceding peak platform acceleration. TheNEMGpvc and normalised
acceleration data from Figure 5.22 were plotted against time in Figure 5.23, rather than
platform position, to highlight this observation.
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Figure 5.23: The NEMGpvc and normalised acceleration data from Figure 5.22 and recorded
from the M-GA at the 12Hz (83ms) vibration condition (a), 20Hz (50ms) vibration condition
(b) and 27Hz (37ms) vibration condition (c) were plotted against time. The normalised
acceleration data sets were selected in a manner such that each of the initial peak acceleration
points coincided. NEMGpvc was plotted against the primary y-axis and normalised
acceleration was plotted against the secondary y-axis. It was determined previously that
the latency between the common stimulus and the peak in NEMGpvc was 46ms and it
is shown that this delay coincides approximately with peak acceleration. M-GA: Medial-
Gastrocnemius, NEMGpvc: Normalised EMG Per Vibration Cycle.
The process described above was repeated for the VL and TA. The results for all three
muscles are shown in Figure 5.24, and the plots are equivalent to those initially presented in
Figure 5.22(b).
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Figure 5.24: Approximation of maximum neuromuscular response initiation point. The
data were grouped according to vibration frequency and muscle group. The data describe
the latency (y-axis) from a potential stimulus occurring at selected points of the previous
vibration cycle (x-axis) to the maximum neuromuscular response in the current vibration
cycle. 0 is the beginning of the previous cycle and 1 is the end of the previous cycle (or
beginning of the current cycle). The point at which the lines converge are identified by the
intersection line. TA = Tibialis Anterior; M-GA = Medial Gastrocnemius; VL = Vastus
Lateralis.
The intersection point was found to occur at 48 and 46% from the completion of the previous
vibration cycle for the TA and M-GA respectively, and 34% for the VL. This equates to
a 46.55 and 46.13ms latency between the potential stimulus and response for the TA and
M-GA respectively, and 33.27ms for the VL. It is hypothesised that the shorter latency for
the VL is due to mechanical delay in transmission of vibration from the foot to the leg.
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5.2 Discussion
The objectives of this study were categorised as being technical and physiological in nature.
The physiological objectives were: (i) to measure and quantify the magnitude of the acute,
steady-state neuromuscular response of the lower limbs to WBV-pBWS and to determine the
relationship between this response and vibration frequency, vibration amplitude and level
of pBWS and (ii) to investigate the temporal relationship between neuromuscular activity
and the position of the WBV platform. The technical objectives were: (i) to quantify the
transmission of vibration from the WBV platform to the lower limbs, (ii) to estimate the
proportion of vibration artefact in each EMG and then assess the suitability of active and
passive EMG recording electrodes for WBV applications and (iii) to determine the optimum
off-line digital filtering processes for EMG acquired during WBV and then to optimise
the outlier rejection procedure. Theses technical and physiological objectives are discussed
separately in the following sections.
5.2.1 Physiological
The physiological objectives were addressed using the EMG data with supporting data from
the acceleration measurements.
EMG Amplitude Response
Every EMG was initially filtered oﬄine, outliers were removed and then discretised according
to the different test epochs: pre-Vibration, Vibration and post-Vibration. The discretised
EMG were pooled according to epoch and test number (Test 1 or Test 2) and a statistical
analysis was carried out which confirmed that the vibration caused a significant increase in
the amplitude of the EMG and that there was no significant difference between the data
recorded during the first and second testing sessions.
The magnitude of the increase in neuromuscular activity was quantified in two ways: ∆EMG
(relative change in neuromuscular activity from baseline) andEMGN (neuromuscular activity
normalised to maximum (MVC)). Determining each of these parameters was important
because it was previously hypothesised that the magnitude of the response to WBV may
be dependent upon the state of the muscle prior to vibration. The initial condition of each
muscle group was determined by measuring baseline activity prior to vibration and comparing
for the different muscle groups. It was confirmed that neuromuscular activity prior to the
application of vibration was different for each muscle group and was relatively large for the
M-GA and VL when compared to the TA and BF. Therefore, simply comparing absolute
neuromuscular activity between the different muscle groups for a given test condition was
not appropriate because they were not all starting from the same baseline condition. The
magnitude of neuromuscular activity prior to vibration is somewhat irrelevant to the ∆EMG
value because it it the relative change that is being determined, it was therefore deemed to
be useful for assessing common trends in the responses of the different muscles. However,
recording EMGN remained important also as it was used to confirm if any change in activity
were clinically relevant. For example, if baseline activity was small to begin with then any
small increase in neuromuscular activity would result in a large ∆EMG being calculated,
however since the actual increase in activity was small originally then it may not be clinically
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beneficial.
∆EMG and EMGN were pooled for the Vibration epoch only and grouped according to the
four main factors under investigation in this study: vibration frequency, vibration amplitude,
muscle group and level of pBWS. The magnitude of the neuromuscular response was
significantly different for each of these grouping factors. There was a decreasing trend in
the magnitude of neuromuscular activity with increasing levels of pBWS whereby ∆EMG
was typically 9% at 100% pBWS and 35% and 0% pBWS. This supported the hypothesis
that the level of contraction in a muscle prior to vibration affected the magnitude of the
response during vibration.
Increasing vibration frequency and vibration amplitude each resulted in a statistically
significant increase in neuromuscular activity, where typical ∆EMG values were between 14 -
33%. These increases were equivalent to an EMGN of 2 - 3% MVC. It is worth noting that
the average values shown here were calculated for all muscles and all levels of pBWS resulting
in a small overall average being reported. Results presented later show that the changes in
activity were considerably smaller when a high level of pBWS was provided compared to
when a low level of pBWS was provided.
There was a significant difference between the magnitudes of the neuromuscular responses
of the different muscle groups during the Vibration epoch. The largest changes occurred in
the M-GA and VL, where typical ∆EMG values were 49% and 20%. These changes were
equivalent to a contraction of 5% and 10% MVC respectively. The changes in the TA and
BF were smaller: 20% and 15% respectively, equating to approximately 2% MVC.
These results confirmed that WBV did indeed elicit an increase in neuromuscular activity
and indicate that the effect of WBV on the different muscle groups was different. This is not
surprising because the acceleration data indicated that the dose of vibration received by the
thigh muscles was different to that received by the shank muscles. It was also noted that the
total magnitude of muscle activity for each muscle during the 0.0g condition was different also.
For example, at 0% pBWS the magnitudes of the contraction for the TA, M-GA, VL, and BF
respectively were 0.01%, 0.04%, 0.14%, and 0.02% MVC. These results confirmed that an
intermuscular comparison of the Vibration epoch results was not appropriate in this instance.
This was supported by investigating the relationship between pre-tension and the response
to WBV, i.e. by comparing EMGN for the pre-Vibration and Vibration epoch. Figure 5.14
showed this relationship for each muscle group respectively. A best fit trend line was overlaid
the scatter plot to indicate the general relationship between the initial level of muscle activity
and that which occurred during the Vibration epoch. There was a positive and statistically
significant increase in muscle activity for all vibration conditions confirming that there was
an increased neuromuscular response to WBV. However, the type of response for each muscle
was different as indicated by the slope of the trend line. It was noted that the slope for the
shank muscles was an order of magnitude larger than that of that for the thigh muscles.
It was therefore concluded that it would be inappropriate to group the responses of all the
muscles together and that they should be assessed on an individual basis.
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EMGN and ∆EMG were assessed for each individual muscle, grouped according to level
of pBWS and plotted in Figures 5.15 - 5.18. The same general trend was observed for all
muscles and the salient results are summarised in Table 5.11 below. These results supported
those originally described in Figure 5.14 which showed a steeper slope translated into a larger
change in neuromuscular activity relative to baseline.
Table 5.11: Range of typical EMGN and ∆EMG values for each muscle. EMGN and ∆EMG
data were grouped according to level of pBWS and platform acceleration for all participants
and tests. The median of each set of grouped data was found. The maximum and minimum
median values presented are representative of the typical range of values found. pBWS:
partial Body Weight Support; TA: Tibialis Anterior; M-GA: Medial Gastrocnemius; VL:
Vastus Lateralis; BF: Biceps Femoris; EMG: Electromyogram; MVC: Maximum Voluntary
Contraction; EMGN : EMG amplitude normalised to MVC; ∆EMG: Relative change in EMG
between pre-Vibration and Vibration normalised to the Vibration value.
pBWS Muscle EMGN ∆ EMG
[%] [%] [%]
0 TA 1.1 - 2.0 21.8 - 55.5
M-GA 5.9 - 18.9 27.2 - 71.7
VL 17.7 - 26.5 13.4 - 25.0
BF 2.5 - 8.1 7.6 - 68.3
50 TA 0.7 - 1.2 6.9 - 29.7
M-GA 3.6 - 12.6 22.6 - 73.7
VL 9.4 - 10.9 15.5 - 24.4
BF 1.8 - 2.0 3.2 - 35.2
100 TA 0.7 - 0.9 4.5 - 22.7
M-GA 1.5 - 7.5 5.6 - 67.5
VL 1.6 - 1.7 20.3 - 26.5
BF 1.3 - 1.5 3.7 - 8.6
In summary the results showed that: (i) the most active to least active muscles during the
Vibration epoch were VL, M-GA, BF and TA respectively. This order was irrespective level
of pBWS provided; (ii) the largest to smallest change in neuromuscular activity relative to
the pre-Vibration epoch was M-GA, TA, VL and BF and this was consistent with the slope
values presented in Figure 5.14; and (iii) neuromuscular activity decreased with increasing
levels pBWS and ∆EMG decreased accordingly as a consequence.
The main factors under investigation in this study were vibration frequency, vibration
amplitude, muscle group and level of pBWS. The change in neuromuscular response during
the Vibration epoch could not be attributed to any single one of these factors but was
rather a combined response to all of them. However, general trends were observed which
were consistent across all muscle groups. It was confirmed that the initial conditions for
the different muscle groups were different and this had a significant effect upon the type of
response from each muscle.
It was concluded that the difference in response was primarily due to the relative proximity
of the muscle group to the vibration platform. Better vibration transmission resulted in a
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larger relative change in neuromuscular activity when compared to baseline. For example,
the change in activity of the shank muscles was relatively large compared to the change
in response of the thigh muscles, whereby the change in activity of the shank muscles was
2.3:1 compared to 1.3:1 for the thigh muscles. Despite this however, the absolute levels of
neuromuscular activity of the VL muscle group was highest, most likely because the level
of pre-contraction in the VL was largest in order to facilitate standing in a shallow squat
positing. It was therefore concluded that though the relative change in activity was larger
in the M-GA the potential therapeutic benefit of WBV would be larger in the VL. Overall
however, neuromuscular activity during WBV applied in this manner remains small with
little potential for hypertrophy or an increase in muscle performance.
EMG Temporal Response
The amplitude response analysis above was concerned with the steady-state neuromuscular
response to WBV only. The analysis was predicated on a RMS calculation which is
fundamentally an averaging technique. The RMS averages out most of the variability in
the EMG within the range over which the RMS calculation is carried out. In this study the
RMS was calculated over a 0.5s moving window which was considerably larger than a single
vibration period. A qualitative review of the time series EMG data was therefore carried out
and characteristic peaks in the EMG were identified. The peaks were not be considered to
be artefacts because they were removed from the data prior to this review. Such peaks were
characterised previously by Ritzmann et al. [88] as a stretch reflex which was locked in phase
with the period of vibration. The peaks were shown to occur once per vibration cycle and
the latency to the maximum of the peak was the same as that of a short-latency reflex. They
therefore concluded that the neuromuscular response to WBV was based on the stretch reflex.
A similar analysis was carried out using this data set. However, general trends were
investigated here rather than analysing each individual EMG on a case by case basis. This was
done by using the acceleration data to discretise every EMG to a single vibration period. The
average over all periods was then calculated. In this manner genuine and regular increases in
the EMG amplitude which occurred at a specific instance during a vibration period should
be apparent and small, random changes in the EMG amplitude should be minimised. The
outcome of the analysis was a single characteristic ‘EMG pattern’ that was of one vibration
period in duration. This analysis was thus used to assess two alternative hypotheses: (i) was
the increase in neuromuscular activity random during WBV? or (ii) was there a particular
instance during a WBV cycle that elicited a specific increase in neuromuscular activity?
Every EMG that was recorded in this study was analysed in this manner. The EMG patterns
were initially grouped and averaged according to the four main factors under investigation:
vibration frequency, vibration amplitude, level of pBWS and muscle group. No characteristic
pattern was identified for the pre-Vibration or post-Vibration epoch as expected. This
is typical of a CMAP recorded by surface EMG electrodes from a muscle under normal
contraction (e.g. when there is no external stimulus such as a patellar tendon tap or electrical
stimulation of the α-motoneuron). In contrast to this, a specific and discernible increase in
the amplitude of the EMG pattern was found during the vibration epoch. The increase in
amplitude was particulary discernible for the data grouped according to vibration frequency
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and supports those results found by Ritzmann et al. [88].
The peak response of the shank muscles was found to occur approximately 7, 24 and 29ms
after the initiation of the vibration cycle for the 12, 20 and 27Hz vibration conditions
respectively. If it is initially assumed that the occurrence of this peak was the result of an
elicited response, and in the knowledge that latency of a monosynaptic reflex for these muscles
is approximately 30ms [55], it is therefore unlikely that the stimulus occurred within the
present vibration period and was therefore more likely to have occurred within the previous
vibration period. Further analysis confirmed this hypothesis.
The analysis indicated that the neuromuscular response during WBV was not random, but
rather there was a specific instance during which the amplitude of the neuromuscular response
increased rapidly. The cause for this increase is inconclusive, but the data suggests that
there was a point during the WBV cycle that acted as a trigger which subsequently elicited
a maximal neuromuscular response. If it is assumed that this trigger was common for all
test conditions and that it occurred at the same instance irrespective vibration frequency,
vibration amplitude or level of pBWS, then these data show that the latency between the
trigger and maximal response was approximately 46ms for the TA and M-GA respectively,
and 33ms for the VL. This corresponds to approximately 50% completion of the previous
vibration cycle for the shank muscles, which was one of the two points at which maximum
platform acceleration occurred. The estimated trigger for the VL occurred at approximately
68% of the previous vibration cycle, which was also a point of maximum acceleration. Note
that the point of maximum acceleration of the VL lagged that of the platform and foot (Figure
5.4) and maximum acceleration of the VL actually occurred at 30% and 70% completion of a
single vibration cycle. It was thus concluded that were there to be a specific stimulus during
a single WBV cycle that elicits a short-latency reflex type of neuromuscular response, then
peak platform acceleration is likely to be the trigger.
In summary, a relationship between the neuromuscular response to WBV and a single cycle
of vibration was identified in this study. However, in contrast to the findings by Ritzmann
et al. [88], the ‘phase-locking’ of the EMG to the cycle of vibration was not as distinct in
these results. The relationship identified in this study was a peak that consistently appeared
in the EMG in phase with the vibration frequency, however the peak is described as being
more broadband in nature, rather than a distinct peak that could be described as having
a fixed latency analogous to a stretch reflex. It is hypothesised that this is most likely due
to the fact that this analysis pools the response of all ten participants rather than assessing
each EMG on an individual basis. In addition, this analysis assumed common mechanical
delay between the vibration platform and the elicited neuromuscular response. In practice,
the participants were of differing height and body composition, each of which may have
affected the transmission of vibration. Furthermore, in all cases the latency of the response
was larger than that which would be expected for a short latency reflex. It was therefore
concluded that the maximal neuromuscular response was elicited by the preceding instance
of maximum platform acceleration, and the lag between peak acceleration and peak response
corresponded to the time taken for the muscle to respond to the stimulus.
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5.2.2 Technical
The technical objectives were predominantly addressed using the acceleration data.
Vibration Transmission
Acceleration measured during vibration comprises two main characteristic components:
frequency and amplitude. These individual components were derived from the acceleration
signals measured in this study in order to confirm the vibration parameters being delivered
during WBV and to quantify the dose of vibration received by different segments of the body
during WBV.
A larger weighting was initially given to acceleration and frequency data rather than
amplitude when interpreting these results, because of the increased likelihood compounding
any quantization error in the raw acceleration data during integration. The likelihood of this
occurring was minimised by band pass filtering the acceleration data within the frequency
range of interest (10 - 30Hz) therefore eliminating high and low frequency noise components,
however, the complete elimination of these error sources was never guaranteed.
Displacement was recalculated using a frequency based method to confirm the results of the
integration method in an effort to improve confidence in the data. The frequency based
method comprised of identifying the peak acceleration value of each vibration cycle and then
averaging for the full data set. Vibration frequency of the same data set was then identified
by computing the PSD and finding the peak. The only remaining unknown was vibration
amplitude which was then calculated using Equation 3.1 (Chapter 3). The results from the
integration and frequency based processing method were compared and found to be the same
and therefore only one set of the results were presented in this thesis.
In summary, the results showed that vibration frequency was perfectly correlated between all
test conditions at all measurement locations. Acceleration and displacement measurements
taken directly from the WBV platform closely matched the expected values. Acceleration and
displacement of the foot was well correlated but not in exact synchrony with the vibration
platform. Meanwhile, an increase in acceleration and displacement of the VL was indicated
for all test conditions, though it was not well correlated with that of the WBV platform.
The positive correlation between platform and foot displacement and poor correlation
between platform and VL displacement was expected. The feet were in direct contact with the
WBV platform and were therefore expected to closely match platform movement. The feet
were simply moved across the vibration platform to achieve the different vibration amplitudes
required. The corresponding movement of the VL was relatively small by comparison and was
consequently unaffected by foot movement and therefore vibration amplitude. Furthermore,
the VL was indirectly linked to the WBV platform via the feet and lower leg. It was therefore
expected that foot placement would most likely influence foot displacement only. This
observation was corroborated by the platform, foot and VL trajectories which showed that
the foot and platform trajectories are well correlated but lagged by the VL trajectory. Despite
this, vibration frequency was unaffected by damping and was the same at all measurement
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locations for a given test condition.
A 1mm offset between platform and foot displacement was found. For example, a 1mm
displacement of the vibration platform was translated to a 2mm displacement of the foot.
This occurred because it was not possible to completely align the entire foot with the exact
point of 1mm vertical displacement of the WBV platform. In practice the inside of the foot
would have been vibrating at a smaller amplitude than this and the outside of the foot at
a larger amplitude. There was a decreasing trend in the measured displacement of the foot
with increasing vibration frequency also. This is likely due to the kinematics of lower limb
movement during high frequency vibration. As the foot is flexible rather than perfectly rigid,
it cannot match the movement of the platform dynamically at high frequencies.
By comparison the displacement of the VL was between 1 - 2mm regardless of the test
condition. It was therefore concluded that displacement, and therefore acceleration, were
being attenuated as the vibration was being transmitted upwards from the vibration platform.
This was probably due to the uncoupling of the thigh section of the lower limbs and the
vibration platform and the absorption of some of the vibration energy by the lower part of
the leg.
The transmission of vibration to the body from the platform was expected to occur via the feet
and skeleton. Furthermore, it was hypothesised that the propagation of vibration throughout
the body was via the skeleton only. A review of the acceleration data indicated that vibration
was being damped as it was transmitted upwards. This was indicated by a decrease in the
absolute values of acceleration recorded from the platform, foot and thigh respectively. It was
hypothesised that damping was caused by the soft tissues of the body which interconnect the
skeletal segments and provide some shock-absorbing capacity. In particular, the viscoelastic
properties of cartilage acts to absorb the impact energy and therefore minimise the potential
for damage thus preserving the joint [180]. In addition, a mechanical model has described
how elastic properties of the muscles and tendons act to absorb vibration energy and store
it for one half of a vibration cycle, and then transfer the vibration back to the platform for
the second half of the vibration cycle [82]. Thus, minor inefficiencies in tendons will cause
some of the vibration energy to be dissipated as heat, therefore reducing the transmission of
the amplitude of vibration through each subsequent joint. Furthermore, muscles themselves
are thought to play a significant role in the reduction of vibration transmission. Wakeling
et al. [78] initially showed that the lower limb resonates between 10 - 50Hz depending on
joint angle and contraction. They established that this resonant frequency can be modulated
by increasing or decreasing muscle activity and therefore muscle tension. They described
that common walking and running conditions result in a heel strike frequency that easily
falls within this range. In a subsequent study they put forward a theory that for a given
input at or near the limb resonant frequency, fast-twitch, Type II muscle fibers act to change
the tension within a muscle and therefore move the resonant frequency of the limb away
from the input frequency, thus attenuating vibration amplitude and therefore reducing the
likelihood of damage [84]. In this manner the the amplitude of the vibration is damped as it is
transmitted longitudinally through the body. Damping of vibration was therefore expected
and indeed did occur during these experiments. Analysis indicated that damping did not
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affect vibration frequency. It was therefore concluded that the reduction in acceleration as it
was transmitted throughout the legs was a direct result of a reduction in vibration amplitude
only. In all likelihood, this reduction was due to the absorption of vibration energy by the
shank muscles.
Analysis of the vibration amplitude results from each recording location supported this
conclusion. Displacement recorded from the vibration platform was generally well correlated
to that set for the test, with a slight overestimation at 12Hz only. However, displacements
recorded from the foot and thigh were not well correlated. Displacement of the foot increased,
but not in proportion with the displacement set for the test, and displacement of the thigh
increased during vibration but was typically unrelated to that of the WBV platform.
It was not possible to empirically determine the magnitude of damping which occurred at
each lower limb skeletal segment using this data set. Acceleration was recorded using sensors
affixed to the outside of the body in this study. It was therefore not possible to differentiate
between damping that occurred at each skeletal segment, and that which occurred between
a skeletal segment and the local acceleration sensor. This led to the conclusion that this
recording setup may be used infer general trends of damping only but may not be used to
quantify it. The transmission of vibration was generally reduced as proximity to the source
of vibration increased.
Three principal implications of damping were identified, the first being that damping implies
the absorption of the vibration energy at some point lower down in the legs. This absorption
of energy most likely occurred in the muscles which contracted in order to counteract the
vibration. Secondly, any therapeutic effect attributable to vibration may be reduced with
decreasing proximity to the WBV platform. Finally, a reduction in the proportion of vibration
artefact present in EMG recorded at an increased distance from the WBV platform was
expected because movement of the electrode appeared to diminish therefore reducing the
potential for the occurrence of movement artefact.
In summary, it was concluded that the relative dose of vibration received by a muscle from the
WBV platform could be inferred from the acceleration data. The attenuation of acceleration
implies a reduction in vibration amplitude and not vibration frequency. This form of damping
acted to reduce the dose of vibration received by those muscle furthest from the vibration
platform. It was therefore hypothesised that any change in neuromuscular activity during
vibration would be smallest in those muscles that were furthest from the platform and largest
in those muscles that were closest. Finally, these results indicated that vibration artefact
would only be present at the fundamental frequency of vibration and it’s harmonics, therefore
simplifying the process of removing artefact from the EMG.
Vibration Artefact
The frequency of vibration was found to induce some error into the recorded EMG in the
form of artefact. The artefact acted to change the shape of the EMG, resulting in an increase
in its amplitude. It was manifested as a series of ‘spikes’ in the PSD of the EMG which
occurred specifically at the frequency of vibration and multiples of its harmonics. This error
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was determined to be a limiting factor in the type of electrode that could be used to record
EMG during WBV, and it was concluded that only active EMG electrodes were appropriate
for such applications. This was in contrast to others who suggested that these spikes were
non-significant [126] or were manifestations of stretch reflexes rather than artifact [88].
Relatively few studies have quantified the proportion of artefact contained in an EMG
recorded during WBV. Earlier work has primarily been carried out by Fratini et al. [126],
and the significantly larger quantities of artefact identified in this study was determined to
be a consequence of the failure of previous work to consider that EMG electrodes placed
on the patella and then electrically isolated from the skin will only detect artefact due to
vibration of the cable, and not that which occurs due to movement of the electrode itself. The
conclusion of this work was that artefact content was significant, and that the elimination
of it from the EMG was relatively trivial due to its presence at known and specific frequencies.
The typical frequencies of interest in an EMG are between 10 and 500Hz. As a result the
standard ISEK guidelines recommend band pass filtering the EMG within this range. These
guidelines were adhered to in the first iteration of the analysis carried out for this study
but with a high pass filter cut-off frequency of 30Hz rather than 10Hz. The higher cut-off
frequency was selected because the frequencies of vibration applied in this study were between
12 and 27Hz. A large proportion of interference was therefore expected to occur within this
frequency band. Qualitative checks of the EMG were carried out next, whereby a random
selection of the Time Series Data (TSD) sets and frequency plots were checked for abnormal
characteristics. Sharp increases in signal power were found at harmonics of the vibration
frequency in all cases. This phenomenon was identified previously by others who concluded
that the spikes were artefacts which occurred during impact between the legs and vibration
platform [85]. A second iteration of analysis of the EMG was therefore carried out to quantify
the artefact specifically.
The quantity of artefact was measured as a proportion of total EMG power to determine how
best to remove it. It was most likely manifested in the EMG by the relative movement between
the recording electrodes and the underlying muscle. However, relative movement between
the recording electrodes themselves and movement of the EMG cables may have led to the
presence of artefact also. It was concluded that an overestimation of the EMG amplitude
would occur if artefact was not removed first, resulting in a considerable overestimation of
the neuromuscular response being attributed to WBV.
Artefact was detected in every EMG recorded in this study. The total magnitude of vibration
artefact in each EMG was quantified in order to inform the type of EMG electrode that should
be used and to determine how much off-line filtering should be applied. It was ultimately
concluded that artefact should be removed using fourth-order stop-band filters implemented
specifically at the frequency of vibration and its harmonics. The principal limitation of
this approach was that genuine neuromuscular activity which coincidentally occurred at the
frequencies which fell within the stop-band ranges were eliminated from the EMG also. An
underestimation of the neuromuscular response being attributed to WBV was therefore likely.
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Analysis indicated that the minimum quantity of artefact present in an EMG was 7.6%
and 4.2% of the total EMG signal power when recorded using passive and active electrodes
respectively. However in some isolated instances, vibration artefact accounted for 95.8% and
91.4% of the total EMG signal power for the passive and active electrodes respectively. In
general however the mean quantity of artefact was 42.1% of EMG power when recorded using
passive electrodes, and 24.1% when recorded using active electrodes. It was concluded that
passive electrodes were inadequate for WBV applications based on this evidence alone.
Several sources of vibration artefact were identified previously and included movement of the
EMG electrode cable, movement of the bi-polar electrodes with respect to one another and
movement of the recording electrodes with respect to the muscle underneath. Vibration of
the electrode can potentially introduce noise into the acquired signal by creating an unstable
potential differences between the individual cores contained within the cable. This may be
minimised by twisting the individual cores together however it is generally preferable to
carry out pre-amplification of the signal at the recording site prior to transmission along the
cable. This acts to increase the signal-to-noise ratio and makes any noise generated by the
movement of the cable negligible. A small signal-to-noise ratio was most likely the cause of
the additional artefact present in the EMG recorded by the passive electrodes when compared
to those recorded using the active ones. Pre-amplification was carried out at source by the
active electrodes, whereas it was carried out out after transmission along the sensor cable for
the passive electrodes.
The active electrodes had an added benefit whereby the bi-polar sensing elements of the
electrode were enclosed within a robust housing which eliminated the potential for relative
movement between them. By process of elimination it was thus determined that the relative
movement of the active electrode with respect to the muscle belly underneath was the most
probable source of artefact in the EMG. This was in contrast to the passive electrodes
whose bipolar sensing elements were affixed to the skin separately. Relative movement of the
passive bipolar electrodes with respect to one another was possible, in addition to the relative
movement of each electrode with respect to the muscle belly.
The power of the first 15 harmonics of vibration were calculated as a percentage of total
EMG power. High power artefact at the frequency of vibration was not found because a large
proportion of this frequency was removed online by the recording hardware. The second and
third harmonics of the vibration frequency did not fall within the range of the hardware high
pass filters and were not removed. These frequencies thus contributed substantially to the
quantity of artefact in the EMG. There was an exponential decline in quantity of artefact at
the other harmonic frequencies thereafter. A statistical analysis was carried out to determine
quantitatively the effect of each harmonic frequency on the amplitude of the EMG.
A statistically significant increase in the amplitude of the EMG was found at each of the first
10 harmonic frequencies when using active electrodes, but the effect size of each increase was
medium to large (ES≥0.1) for the first 5 harmonics only. The results for the passive electrodes
were broadly similar, where the first 9 harmonic frequencies resulted in a significant increase
in the amplitude of the EMG, and the effect size of each increase was medium to large for
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the first 6 harmonics only. These statistical results are summarised in Table 5.12.
Table 5.12: Summary of relevant statistical results from analysis of harmonics. n = harmonic
number; Ptotal =
∑n
i=1 hi, and is a percentage of total EMG power; Effect Size (ES) is
calculated between hn and hn−1.
Active Passive
Harmonic Ptotal ES Harmonic %Ptotal ES
[n] [%] [n] [%]
6 19.60% 0.065 7 37.56% 0.073
10 22.78% 0.020 9 39.98% 0.037
15 24.11% 0.010 15 42.10% 0.010
In summary, over 80% of the vibration artefact recorded by the active electrodes occurred
within the first 6 harmonics. The artefacts were readily identifiable in the frequency plots
and caused a large and statistically significant increase in the amplitude of the EMG. A
further 13.2% of vibration artefact occurred between the 7th and 10th harmonics, which
was statistically significant but irrelevant in practice because the effect size was small. All
remaining vibration artefact did not significantly affect the amplitude of the EMG and was
non-distinguishable from regular neuromuscular activity in the frequency plots.
Similarly, over 89% of the vibration artefact recorded by the passive electrodes occurred
within the first 7 harmonics. An additional 5.7% occurred between the 8th and 9th harmonics,
and while this additional artefact caused a significant increase in the amplitude of the EMG,
it was not readily differentiated from regular neuromuscular activity in the frequency plots
and the effect size was small. All remaining artefact in the EMG was non-significant.
These results strongly suggest that vibration artefact resulted in an unacceptable increase in
the amplitude of the EMG which would be best removed oﬄine using stop-band filters prior
to further processing. To ensure consistency in all subsequent analyses, it was concluded that
the first 7 harmonics of vibration should be removed. A small but statistically significant
proportion of artefact possibly remained in the EMG but the overall consequence of its
inclusion was deemed to be negligible.
Having determined that the the first 7 harmonics contributed the majority of vibration
artefact to the EMG, and concluded that they should be removed, the investigation shifted
to which of the experimental conditions resulted in the generation of the largest amount of
artefact. The experimental conditions analysed were vibration frequency, vibration amplitude
and muscle group. An increase in artefact content with vibration frequency was found. The
EMG recorded during 12Hz vibration typically comprised 14.2% artefact, compared to 36.1%
for 27Hz vibration condition. Artefact content was broadly similar, at 24.0% on average,
for all vibration amplitude conditions, but was typically higher in the EMG recorded from
the shank muscles versus the thigh muscles. The TA and M-GA EMG comprised 24.5%
and 34.9% artefact respectively, whereas the VL and BF EMG comprised 20.6% and 19.0%
artefact respectively. All of these values were markedly higher for the passive electrodes.
These findings were in good general agreement with the vibration transmission results which
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showed that the vibration dose received at the thigh (VL sensor) was considerably less than
that received at shank (foot sensor). This suggested that the excitation of the upper leg
was smaller than that of the lower leg during vibration. There was less movement and
therefore less artefact content in the EMG recorded from upper leg as a consequence. The
increased quantity of artefact with vibration frequency was most likely due to the fact that
the excitation stimulus, which in this case was acceleration, was proportional to the square
of vibration frequency. By contrast acceleration was linearly related to vibration amplitude.
Thus, a larger increase in artefact content with vibration frequency relative to vibration
amplitude would be expected.
In conclusion, these results confirmed that the EMG recorded during WBV contained an
unavoidable but large proportion of artefact. Failure to remove such artefact would cause
an overestimation of the EMG amplitude. Artefact was limited to specific frequency bands
which nominally occurred at the frequency of vibration and its harmonics, which simplified the
process for artefact removal. It was also confirmed that the performance of passive electrodes
was inferior to that of active electrodes, and that the passive electrodes were inappropriate
for EMG measurements carried out during WBV. Statistical analysis indicated that it was
adequate to remove the first 7 harmonics of the vibration frequency only.
EMG Signal Processing
Vibration artefact was not the only source of error found in the EMG recorded for this study.
Spurious increases in the amplitude of the EMG were identified during qualitative checks
of randomly selected data sets. Such fluctuations could not be reasonably attributed to the
neuromuscular response to WBV and were considered unrelated because the response was not
repeatedly found for the same subject under the same conditions during the repeat test, or at
the other vibration conditions. It is most likely that these random increases in the amplitude
of the EMG occurred as a result of tripping or volitional movement. It was concluded that
EMG which contained this error should be excluded as outliers because they could potentially
bias the results.
The procedure for rejecting outlying data was automated to ensure consistency in application.
In the first instance, the mean (x) and the standard deviation (σ) of the EMG RMS was
calculated, and high and low limits acceptable limits were set at: x ± 3σ. EMG that
contained data outwith these limits were rejected as outliers. However, this techniques was
found to be inadequate. It was excessively sensitive for small magnitude tonic contractions
(small magnitude EMG) and insensitive to large magnitude dynamic contractions (large
magnitude EMG). A large standard deviation was typically found for large magnitude EMG
because there was typically a large amount of underlying tonic activity in addition to burst
like activity. There was therefore a large ‘acceptable’ band calculated which was relatively
insensitive to volitional neuromuscular activity. Conversely, small magnitude EMG which
were predominantly tonic in nature were calculated to have a small standard deviation. Very
minor fluctuations in the EMG amplitude were flagged as outliers and being rejected as a
result. A custom algorithm based on the BTR of the EMG was therefore developed and used
instead.
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Trial and error with qualitative spot checks of the rejected EMG resulted in an acceptable
BTR value of 5. 162 EMG were ultimately rejected as outliers using this method. This
accounted for 2.5% of all recorded EMG, 50% of which were recorded during the post-
Vibration epoch which were not used in the subsequent analysis in any case. The majority
of the rejected EMG were from the shank muscles. There was also an increase in the number
of rejected EMG with increasing vibration frequency, increasing vibration displacement, and
decreasing levels of pBWS.
BTR statistics of the accepted EMG were calculated. There was no statistically significant
difference between tests, and the BTR was higher during the Vibration epoch than during
the pre-Vibration epoch as expected. The BTR was largest in the M-GA and VL, and lowest
in the TA and BF. It increased with vibration frequency and vibration displacement, and
decreased with pBWS. These results suggest that there was an increased tendency away
from a tonic contraction with increased stimulation intensity. It was therefore hypothesised
that the participants found it increasingly difficult to maintain a consistent contraction and
recruited larger muscle fibers to compensate. Larger muscle fibers are typically harder to
moderate and fire with greater amplitude, therefore leading to the higher BTR values found
during higher intensity vibration conditions.
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5.3 Conclusions
An increase in the amplitude of the EMG was confirmed despite the rigorous process of
eliminating artefact and other incidental increases in the amplitude of the EMG which were
unrelated WBV. Clear and consistent increases in the amplitude of the EMG were identified
for all test conditions and muscle groups. The response characteristics of each muscle group
were different and complex, and it was not possible to attribute the increase in neuromuscular
activity to any single test parameter. However, in general the magnitude of the response was
indicated by the dose of acceleration received at each location. This was further supported
by the vibration cycle analysis, whereby the peak neuromuscular response was apparently
elicited by the preceding peak platform acceleration. In general the peak neuromuscular
response was small for all test conditions, whereby the maximal neuromuscular response was
recorded from the VL, and average values did not exceed 27% MVC.
These results confirmed that the neuromuscular response to WBV was being moderated by
platform acceleration. An increase vibration frequency therefore resulted in a comparatively
larger increase in neuromuscular activity than that elicited by vibration amplitude. This is
due to the fact that acceleration is proportional to amplitude and the square of frequency.
However, this relationship was generally limited to those muscles that were in close proximity
to the vibration platform and breaks down for those muscles that are further away. Damping
acted to significantly reduce the dose of vibration received by muscles further from the
vibration platform, as a result an increase in platform acceleration had a limited effect on the
thigh muscles. There was a relatively small increase in neuromuscular activity in the thigh
muscles when compared to the shank muscles.
It is concluded that WBV may be applied with pBWS, but in all cases the magnitudes of
the responses are relatively small when compared to maximum voluntary capacity of the
muscle. The neuromuscular response may be moderated by increasing vibration amplitude
or vibration frequency in any combination that increases acceleration. If a gradual increase
in vibration stimulus is required then frequency should be fixed and displacement should be
increased. If a rapid increase in vibration stimulus is required then both parameters should be
increased together. Maximal responses are achieved when a muscle is under prior contraction,
therefore the level of pBWS provided should be minimised and a standing position should be
taken on the platform such that the muscles for treatment are required to contract. This was
confirmed in this study whereby the standing posture adopted required the VL and M-GA
to contract and each of these muscle groups exhibited the largest neuromuscular response to
WBV.
The primary purpose of the acceleration measurements was to confirm the vibration
parameters being applied and to infer the efficiency of vibration transmission. The principal
limitation of the acceleration recording setup was that the accelerometers were affixed to
the skin, whereas movement of the skeleton rather than movement of the surface of the
skin was primarily of interest. However, affixing the sensors to the skin was the only
practicable solution, particularly because it was to be used again in a clinical environment
later. Notwithstanding this limitation, some reasonable conclusions were derived from the
acceleration data. Measurements taken directly from the platform confirmed that the correct
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vibration conditions were being applied during testing. Damping of the vibration did occur
as it was being transmitted upwards whereby the dose of vibration being received further up
the leg was smaller than that received lower down.
The main challenge of acquiring EMG data during WBV was the introduction of vibration
induced movement artefact into the EMG signals. The results from this study confirmed those
reported by others and showed that artefact was manifested as an increase in the amplitude of
the EMG. Artefact signals were most readily identified as a series of ‘spikes’ in the frequency
plots and a review of these plots in combination with the acceleration data confirmed that
the vibration artefact occurred at specific multiples of the vibration frequency only. It was
concluded that if EMG is to be measured duringWBV then pre-amplified recording electrodes
should be used. Their performance was shown to be significantly better than that of standard
passive electrodes. It was still necessary to remove artefact from the EMG recorded using
active electrode, though it was sufficient to remove the first seven harmonics of the vibration
frequency only. The increases in the power of the EMG at higher harmonic frequencies
thereafter was non-significant and the power of the harmonics at these higher frequencies was
not distinguishable from the neuromuscular activity which coincidentally occurs at the same
frequencies.
The main conclusions from this study to be carried forwards to the SCI investigation are as
follows: (i) passive EMG recording electrodes are not suitable for WBV applications, due
to the susceptibility of this type of sensor to vibration induced movement artefact, (ii) the
increase in the neuromuscular response of the BF during WBV is small in comparison to the
TA, M-GA, and VL under the same test conditions and should therefore not be monitored,
and (iii) a small level of pBWS should be provided in order to maximise any potential
neuromuscular response.
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Chapter 6
WBV SCI
The findings from the initial study carried out with a neurologically intact population
indicated that WBV-pBWS is feasible, and that there was an increase in neuromuscular
activity which was directly associated with WBV. The magnitude of the neuromuscular
response was largest at 0% pBWS and smallest at 100% pBWS. In addition, the
neuromuscular response was larger in those muscles which were in closest proximity to the
source of vibration, and in those muscles which were already under contraction or stretch.
These results are in good agreement with other findings in the published research literature.
It was also identified that: (i) passive EMG recording electrodes were not suitable for WBV
applications, due to the susceptibility of this type of sensor to vibration induced movement
artefact, and (ii) the increase in the neuromuscular response of the BF during WBV was
small in comparison to the TA, M-GA and VL under the same test conditions. It was
therefore concluded that this evidence was sufficient to merit further investigation with an
SCI population, for whom such a system was intended.
Fourteen SCI participants were recruited from the Queen Elizabeth National Spinal Injuries
Unit for Scotland: 5 CSCI and 9 ISCI. 9 discrete WBV conditions were tested with a level
of pBWS which was appropriate to the functional capability of the participant. Acceleration
and EMG measurements were recorded throughout each test and analysed oﬄine. The
acceleration measurements were in good agreement with the normative data gathered from
the neurologically intact participants indicating that the vibration was being successfully
transferred to the SCI subjects.
It was confirmed that WBV-pBWS is feasible with an early-stage SCI population. Increases
in neuromuscular activity were found and the increases were related to the vibration. The
vibration was well tolerated, there were no adverse incidents during testing and all of the
vibration test conditions were successfully applied. Some instances of spasm, particularly
in the CSCI participants, did occur and in these cases it was necessary to stop testing and
wait for the spasm to stop before resuming testing. It was concluded however that though
the relative change in neuromuscular activity from baseline was typically large, the absolute
change in activity was small and unlikely to lead to muscle hypertrophy.
The EMG data contained a higher proportion of artefact than expected from the normative
data, particularly those EMG recorded from the CSCI participants. A specific analysis was
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carried out on one of the CSCI participants with a LMN lesion affecting the shank muscle
groups, which confirmed that artefact was indeed present in the EMG. It was therefore
concluded appropriate to apply rigorous oﬄine filtering to eliminate all artefact from the
EMG.
The ISCI participants consistently showed a larger increase in neuromuscular activity with
increasing WBV intensity when compared to the CSCI participants. This was partly due
to the fact that the ISCI participants carried out the tests with less pBWS than their
CSCI counterparts, which was in agreement with the normative data which showed that
the neuromuscular response at reduced levels of support were larger, and also partly due to
the fact that the ISCI participants suffered muscle atrophy to a lesser degree. The higher
proportion of artefact in the CSCI EMG is therefore explained by the smaller signal-to-noise
ratio for this group.
Clear trends and statistically significant increases in EMG amplitude, which were consistent
with WBV intensity, were found for the shank muscles of the ISCI participants. A small
but non statistically significant increase in VL neuromuscular activity was found also. These
findings are consistent with the normative data gathered previously and those reported in
the literature. In addition, the relative change in neuromuscular activity from baseline was
generally larger for the ISCI participants when compared to the neurologically intact subjects.
There was insufficient data gathered in this study to identify any temporal relationship
between neuromuscular activity and the position of the WBV platform.
Nonetheless, further testing after a period of training is warranted. Results from the
neurologically intact subjects indicate that vibration at reduced levels of pBWS increases
the neuromuscular response, therefore a gradual reduction in support may lead to a training
benefit in SCI. Furthermore, the incidental episodes of spasm which occurred with the CSCI
indicate that WBV is acting on a portion of the pathway which leads to spasm. Training
with WBV may modulate the excitability of this pathway, and since the magnitude of the
response from the CSCI participants with 100% pBWS was small, the training would not
strengthen the muscle, which is mutually beneficial outcomes for the treatment of spasticity.
6.1 Results
A summary of the results presented in this section are described below:
• Section 6.1.1 Accelerometer Analysis: Average acceleration, amplitude and
frequency were calculated for the vibration platform, foot, and thigh. The results for
the SCI participants were broadly similar to those found for the neurologically intact
participants. The full set of results are therefore not presented and instead a summary
of the relevant findings are described.
• Section 6.1.2 Artefact Quantification: The total proportion of vibration artefact
present in the recorded EMG was quantified. Again, the results were similar to those
for the neurologically intact participants and a summary of the findings is presented
instead.
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• Section 6.1.3 Case Study: A randomly selected EMG is selected from a subject with
an upper motor neuron lesion. The standard EMG filtering techniques are applied. The
same data set is then reprocessed specifically removing vibration artefact. The two sets
of processed data are then compared.
• Section 6.1.4 EMG Classification: The EMG were discretised into pre-Vibration,
Vibration, and post-Vibration epochs and outlying data was rejected based on the BTR.
• Section 6.1.5 General EMG Amplitude Response: The magnitude of the
EMG was quantified by computing and averaging the RMS of each epoch of data.
The averaged values were then grouped according to test number, epoch, vibration
frequency, vibration amplitude, muscle group and classification of SCI.
• Section 6.1.7 Specific EMG Amplitude Response: The averaged EMGRMS data
were grouped according to muscle group, vibration frequency, vibration amplitude and
classification of SCI.
• Section 6.1.8 EMG Vibration Cycle Analysis: The EMG response over a single
cycle of vibration was investigated.
6.1.1 Accelerometer Analysis
Average acceleration, vibration frequency and vibration amplitude of the platform, foot and
VL were found for the ISCI and CSCI participants respectively. The same protocol as was
used with the neurologically intact participants was applied and the results were broadly the
same. The plots are therefore not repeated here but have been included in the appendix for
reference.
There was typically only a small difference in response for the ISCI and CSCI participants
at each recording location. The main differences were between the absolute acceleration
values recorded at each location and those which were expected to occur. The recorded
vibration platform accelerations were consistent, as indicated by the median values and
small interquartile ranges, and were almost identical to the expected values. An increase in
average acceleration recorded from the foot was found with increasing platform acceleration.
However, the response was not well correlated with platform acceleration, particularly at
higher vibration amplitudes and frequencies and did not typically exceed 4g. Vibration
frequency measured at each location and that set for the test were identical in almost all
cases. Finally, the differences in measured displacement for the ISCI and CSCI participants
were small. Displacement measured directly from the WBV was typically within 1mm of
that set for the test. Displacement of the foot and thigh increased to between 1 and 4mm,
but the increases were not in proportion to those set for the test.
A review of the time series acceleration data again indicated that the motion was sinusoidal.
Acceleration along the longitudinal axis was again found to be larger than either of the
anterior-posterior or medial-lateral axes. Analysis of the individual components of the foot
and VL acceleration profiles showed that any motion along the medial-lateral or anterior-
posterior axes were predominantly out of phase with the platform along the medial-lateral
axis but almost completely in phase in the longitudinal direction.
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6.1.2 Artefact Quantification
This section presents the results of the analysis of vibration artefact in the EMG recorded
before, during, and after the application of WBV. The analysis is the same as that done
with the neurologically intact participants1. The results for those with a ISCI and CSCI
were analysed separately because it was likely that the total presence of artefact in the EMG
recorded from the participants would be different, due to the differing levels of injury, severity
of injury, and functional capability.
The trends in vibration artefact content were ultimately found to be similar to those found
for the neurologically intact participants. The figures are therefore not repeated here but
are presented in the appendix for reference. The statistical analysis indicated some minor
differences to those found previously and are described in greater detail below.
Individual Vibration Harmonics Components
The contribution of frequency components, which were typically associated with vibration
artefacts, to the total power of the EMG were less than 3.0% throughout the pre-Vibration
and post-Vibration conditions, regardless of the classification of SCI or harmonic number.
Group averages (median) were 1.7% and 2.2% for the ISCI and CSCI participants respectively.
These results are comparable to those from the neurologically intact participants where the
average proportion of artefact was 1%.
The average contribution of vibration artefact to the total power of the ISCI EMG was
between 0.2 and 8.5% during the Vibration epoch depending on harmonic number. Maximum
values up to 79.9% were detected at specific harmonic frequencies. There was a downward
trend in the proportion of artefact in the EMG from the second harmonic onwards, noting that
the first and second harmonic frequencies were normally cut-off by the acquisition hardware
high pass filter. These results were broadly comparable to those found for the participants
with no neurological deficit where corresponding average values were between 1 and 11%
depending on harmonic number.
The average proportion of artefact contained within the EMG from the CSCI participants was
between 0.1 and 12.5% during the Vibration epoch. Maximum values up to 93.2% were found
for specific harmonic numbers. There was a downward trend in the proportion of artefact
from the second harmonic onwards also. There was little discernible difference between the
proportion of artefact content in Vibration or non-Vibration EMG from the seventh harmonic
onwards.
Overall Vibration Harmonics Contribution
The overall average (median) contribution of all harmonic frequencies (h1 - h15) to the power
of the EMG recorded during the pre- and post-Vibration epochs were between 9.1% and 7.9%
1In practice, vibration induced artefact is not present in EMG recorded during pre-Vibration or post-
Vibration. These EMG were treated in a similar manner to those recorded during Vibration in this analysis.
This was done to establish a baseline against which EMG recorded during WBV could be compared.
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for the ISCI and CSCI participants respectively.
Average values of 22.7% were found for the ISCI participants during vibration, and 29.6% for
the CSCI participants. However, up to 94.3% of the power of the EMG was contained within
the harmonic frequency search bands for the ISCI participants under certain test conditions.
The highest values for the CSCI participants was similar at 97.5%. It was noted that these
results were similar to those from the neurologically intact participants where highest values
were 95%.
Statistical Analysis
The overall effect of vibration artefact on the SCI EMG was determined by carrying out
a multi-way ANOVA as was done in Section 5.1.2. Harmonic number (h1 - h15) and test
epoch (pre-Vibration, Vibration and post-Vibration) were used as the independent grouping
factors. The results presented in Figure 6.1 are for the Vibration epoch only because this
was the only instance during which artefact could occur in practice.
The first 8 harmonics resulted in a significant change in %Ptotal, with a non-significant change
thereafter for the ISCI participants, and likewise for the first 5 harmonics for the CSCI
participants. The overall ES of these changes was estimated by computing Cohen’s d for each
consecutive pair of grouped data (Equation (4.17)), where each point presented in Figure 6.1
is the computed ES between hn and hn−1. A small ES (≤ 0.1) was defined as the threshold
value.
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Figure 6.1: The average (median) contribution of the individual harmonics (phn) are plotted
with a solid line on the primary y-axis. The values are presented as a percentage of total
EMG power for all test subjects, test conditions and EMG recorded during vibration for the
ISCI (a) and CSCI (b) participants. The corresponding effect size, as estimated by Cohen’s
d (Equation (4.17)) are also presented as a dashed line on the secondary y-axis along with
the threshold value for a small effect size of of 0.1. Data that were found to be significantly
different to h15 using an n-way ANOVA and a post-hoc multiple comparisons procedure were
identified. ES: Effect size; ANOVA: Analysis of Variance.
This statistical analysis shows that h1−8 resulted in a significant increase in %Ptotal for the
ISCI participants, and h1−5 for the CSCI participants. However, while statistically significant,
the overall effect from h6 onwards was small for both groups. This provides justification for
the removal of h1−6 only. The summary below is for h1 to h7 in order to allow for a direct
comparison with the neurologically intact participants.
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Artefact Summary
The susceptibility of an EMG to movement artefact under specific experimental conditions
was described using the integral of h1 to h7. The integrated data were pooled according to
the four main grouping factors of interest in this study: muscle group, vibration frequency,
vibration amplitude and classification of SCI. The pooled data were plotted according to
these grouping factors in Figure 6.2. Bartlett’s test was used to assess equal variance across
all grouped data sets. As equal variance was not found, the non-parametric equivalent of the
ANOVA (Friedman Test) was used. The results of this statistical analysis are described in
Table 6.1. Significantly different pairs were identified using a post-hoc multiple comparisons
procedure with a Bonferroni correction.
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Figure 6.2: Summary of the overall contribution of the first 7 harmonics of vibration to the
total power of the EMG. The contribution of the first seven harmonics of vibration were
integrated for all subjects and test conditions and grouped according to vibration frequency
(a), vibration amplitude (b), muscle group (c), and classification of SCI (d).
There was a larger proportion of artefact in the EMG recorded from CSCI participants than
ISCI participants across all experimental conditions. Within each SCI group however, the
trends were broadly similar, where: (i) there was an increase in the proportion of vibration
artefact with increasing vibration frequency, and this was statistically significant for the ISCI
participants; (ii) there was an increase in the proportion of vibration artefact with increasing
vibration amplitude, and this was statistically significant for the CSCI participants; and (iii)
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the proportion of vibration artefact was largest in the EMG recorded from the M-GA and
smallest in the TA, this was in contrast to the results found for the neurologically-intact
participants the proportion of artefact in the TA EMG was relatively high. The results of
the statistical analysis are shown in Table 6.1.
Table 6.1: Statistical results from analysis of artefact in EMG recorded during WBV from
ISCI and CSCI participants
ISCI CSCI
Parameter X2 (DF) p X2 (DF) p
Frequency 19.13 (2) ≤ 0.01 3.13 (2) = 0.21
Displacement 5.10 (2) = 0.08 12.51 (2) ≤ 0.01
Muscle Group 5.38 (2) = 0.07 51.53 (2) ≤ 0.01
In summary, over 74% of the vibration artefact recorded from the ISCI participants occurred
within the first 5 harmonics. This vibration artefact was readily identifiable in frequency plots
and resulted in a large and statistically significant increase in the amplitude of the EMG. An
additional 14% of total vibration artefact occurred between the 5th and 8th harmonics. This
additional artefact significantly increased the magnitude of the EMG but the effect size was
small and the characteristic spikes were not easily identifiable in the frequency plots.
Similarly, over 77% of the artefact recorded from the CSCI participants occurred within the
first 4 harmonics. An additional 8% of total vibration artefact occurred between the 4th and
5th harmonics, and while this additional artefact caused a significant increase in the amplitude
of the EMG, it was not readily identifiable in the frequency plots and the effect size was small.
It was thus concluded that artefact content was excessively high within h1−7 and that it should
be removed from the EMG within these frequency bands as was done with the neurologically
intact participants. This conclusion was supported by the results of the following case study.
6.1.3 Case Study
The analysis of Subject S11SCI provides a unique opportunity to investigate the effect of
movement artefact in EMG recorded during WBV. Subject S11SCI was a 19 year old male
who suffered a transection of the spinal cord at the L3 segmental level resulting in a motor
complete SCI. The injury damaged the motor nerves directly and was classified as a lower
motor neuron lesion. It is extremely difficult to elicit a contraction in muscle innervated
below this level of injury and direct electrical stimulation of the muscle cells, rather than the
motoneurone, is required to cause a contraction. Typically, this may also only be achieved
before extensive atrophy of the muscle cell has occurred.
Trauma at the L3 segmental level generally results in damage the tibial and peroneal nerves,
which supply the TA, M-GA and BF muscle groups respectively. The femoral nerve which
supplies the quadriceps muscle group is normally spared, therefore resulting in some retained
functionality of the VL rather than the characteristic LMN damage associated with the the
other muscles. Subject S11SCI was classified as B on the AIS at the time of participation in
this study, and demonstrated areflexia and a complete absence of tone in the muscles below
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the level of injury. Muscle motor scores of 0 (zero) were found for the plantar flexors and
long toe extensors, 4+ for the knee flexors and 5 for the knee extensors. This participant
therefore had a complete absence of motor capability in the shank muscles, but near normal
motor capability in the thigh muscles.
Subject S11SCI participated in the same experimental protocol as every other volunteer.
The EMG recorded from the TA and VL recorded during the 20Hz/2mm test condition were
isolated for specific analysis in this case study, because an increased neuromuscular response
from the VL was expected during vibration, meanwhile no change in TA activity was expected
to occur. It was anticipated that any vibration induced artefact would therefore be easily
identifiable in the TA EMG should it be present.
Figure 6.3 shows the raw EMG recorded from the TA and VL in both the time and frequency
domains. The pre-Vibration and Vibration phases of the test are highlighted in the time
domain plots. A 2µV increase in electrical activity was detected in the TA EMG at the onset
of vibration. A larger increase between 10 and 15µV was detected in the VL EMG. The
increased activity of the TA was found to occur specifically at 20Hz, and its harmonics, in
the frequency domain plots. By comparison, there was a more ‘typical’ broadband increase
in neuromuscular activity of the VL across the entire recorded frequency spectrum.
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Figure 6.3: Raw electromyogram recorded from an areflexic (TA) and neurologically-intact
(VL) muscle during whole body vibration. (a) Electromyogram of TA presented in the time
domain. (b) Electromyogram of VL presented in the time domain. (c) Electromyogram of
TA presented in the frequency domain. (d) Electromyogram of VL presented in the frequency
domain. TA: Tibialis anterior. VL: Vastus lateralis. PSD: Power spectral density.
The first 7 harmonics of vibration (20, 40, 60, 80, 100, 120, and 140Hz) were removed resulting
in a complete reduction in the EMG amplitude to pre-Vibration levels for TA. In contrast,
removing of the same frequencies from VL, resulted in only a small decrease in the EMG
amplitude.
Filtering applied in this manner left two distinct regions of increased activity in the TA EMG.
Thess regions are highlighted in Figure 6.4(a). It was known that the vibration platform was
‘ramping’ up and down from the target vibration frequency during these periods from the
acceleration measurements, which in this instance was 20Hz. The notch filters removed
this frequency and its harmonics only, and did not remove those frequencies which occurred
during ramping stages. The movement artefact which was introduced during these stages
was therefore not removed from the EMG. This was not considered to be important in this
analysis because the neuromuscular activity which occurred during these periods was not of
interest.
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Figure 6.4: Filtered electromyogram recorded from an areflexic (TA) and neurologically-intact
(VL) muscle during whole body vibration. (a) Electromyogram of TA presented in the time
domain. (b) Electromyogram of VL presented in the time domain. (c) Electromyogram of
TA presented in the frequency domain. (d) Electromyogram of VL presented in the frequency
domain. TA: Tibialis anterior. VL: Vastus lateralis. PSD: Power spectral density.
The primary outcome measure used in this thesis to assess the magnitude of the neuromuscu-
lar response to WBV was the EMGRMS . This is the most common parameter used for such
analyses and is recommended by ISEK [176]. The EMGRMS of the data present above was
calculated using a 0.2s moving window and the results were plotted against time in Figure
6.5. The amplitude of the TA EMG was confirmed to be reduced to pre-Vibration levels for
the entire Vibration epoch. The reduction in the VL EMG amplitude as a result of filtering
was small by comparison.
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Figure 6.5: Filtered electromyogram recorded from an areflexic (TA) and neurologically-intact
(VL) muscle during whole body vibration. (a) RMS of TA. (b) RMS of VL. TA: Tibialis
anterior. VL: Vastus lateralis.
It was concluded from this case study that WBV resulted in a broadband excitation of the
muscle, rather than simply inducing a neuromuscular response specifically at the frequency of
vibration. Furthermore, the off-line stop-band filters applied in this analysis were adequate,
and effectively eliminated vibration artefact from the EMG.
6.1.4 EMG Classification
A total of 4,536 unique EMG were recorded from the SCI participants in this study. Of these
recorded EMG, it was those which exhibited a ‘steady-state’ response to WBV which were
of principal interest. The variability of each EMG was therefore estimated by computing the
BTR, which was then used to classify and reject outlying data. This section describes such
outlying data and quantifies those eliminated from further analysis.
Some instances of clonic spasm or contracture occurred during testing. It is plausible that such
spasm was induced by the WBV platform, but this phenomenon is not of principal interest
here because such activity was not classed as steady-state, nor found to occur repeatedly for
a given set of experimental conditions. Such EMG were therefore classified as outliers and
ignored from further analysis.
A total of 680 (15.0%) EMG were classified as outliers and were rejected. These data are
summarised in Table 6.2. There was an even spread in EMG rejected from each of the muscle
groups. An increasing trend in the number of rejected EMG was identified with increasing
vibration frequency and vibration amplitude. There were a larger number of EMG rejected
from the ISCI participants than the CSCI participants, and the majority of EMG were
rejected during the post-Vibration epoch when compared to the pre-Vibration and Vibration
epochs. These trends are consistent with those from the neurologically intact participants,
though the proportion of rejected EMG is higher, most likely a result of the occurrence of
spasm during testing.
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Table 6.2: Breakdown of rejection rates
Parameter Composition of Rejected Values
Muscle TA M-GA VL
35.0% 28.4% 36.6%
Frequency 12Hz 20Hz 27Hz
26.2% 30.0% 43.8%
Displacement 1mm 2mm 3mm
30.7% 27.6% 41.6%
Phase pre-Vib Vib post-Vib
27.2% 29.6% 43.2%
Injury iSCI cSCI -
54.9% 45.1% -
The BTR was largest during the Vibration epoch and typical values for all epochs were
between 0.25 and 1. A breakdown of the common values are shown in Figures 6.6 and 6.7.
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Figure 6.6: Summary of the BTR data for the EMG not rejected. The data presented are
for all subjects and tests and are grouped according to epoch (a) and test number (b).
The BTRs increased with both vibration frequency and vibration amplitude, and were larger
for those with an ISCI. No difference in BTR of the different muscle groups was identified. It
was hypothesised that the larger BTR values found for the ISCI participants was attributable
to the fact that a vibration induced response was occurring, in a similar manner that of
the neurologically-intact participants. By contrast, the small BTR found for the CSCI
participants was attributable to their small neuromuscular response to WBV.
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Figure 6.7: Overall summary of BTR data not rejected during the Vibration epoch. The
presented data are for all subjects and testing sessions, and are grouped according to vibration
frequency (a), vibration amplitude (b), muscle group (c), and classification of SCI (d). CSCI:
motor-complete SCI; ISCI: motor-incomplete SCI; SCI: spinal cord injury.
A total of 3,856 recorded EMG were retained for further analysis.
6.1.5 General EMG Amplitude Response
The intention of this initial analysis was to determine the general underlying trends which
described the neuromuscular response to WBV in SCI. The assessment then quantified the
magnitude of this response according to the four main grouping factors which were being
investigated: (i) vibration frequency, (ii) vibration amplitude, (iii) muscle group and (iv)
classification of SCI.
General Results
Average EMG amplitude results are shown in Figure 6.8. The neuromuscular response was
larger during Vibration when compared to the pre- and post-Vibration epochs, and this
increase was determined to be statistically significant (Table 6.3). Overall, the magnitudes
of the neuromuscular responses were larger during the first testing session when compared to
the second.
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Figure 6.8: Overall summary of EMG results not rejected. Data for all subjects and test
conditions are shown and were grouped according to test epoch (a) and testing session (b).
The statistical results were based on a multi-way ANOVA. The independent grouping factors
were test epoch and test condition. Where significance was identified a post-hoc multiple
comparisons procedure with Bonferroni correction was used to identify significantly different
pairs of grouped data. The results of the statistical analysis are reported in Table 6.3.
Table 6.3: General summary of statistical results. F: ANOVA F-statistic; DF: Degrees of
Freedom; p: P-value; GuGl: Groups identified to be significantly different in post-hoc analysis;
Gu: Upper group; Gl: Lower group; †: All pairs found to be significantly different at p≤0.05.
EMG
Parameter F (DF) p GuGl
Epoch 45.5 (2) ≤ 0.05 Vibpre−V ib; Vibpost−V ib
Test 51.4 (1) ≤ 0.05 †
Vibration Results
Having confirmed that there was a significant increase in neuromuscular activity during the
Vibration epoch, the analysis next investigated how the change in neuromuscular activity
was related to: (i) vibration frequency, (ii) vibration amplitude, (iii) muscle group and
(iv) classification of SCI. The relative changes in activity (∆EMG) (Equation (4.12)) were
calculated by comparing pre-Vibration (baseline) and Vibration EMG2. In addition, the
corresponding absolute values of EMG amplitude were compared. These data are presented
in Figure 6.9 and results of the statistical analysis are shown in Table 6.4.
Statistical results are based on a multi-way ANOVA for the EMG recorded during the
Vibration epoch only. The data were analysed for all subjects and test conditions, and the
independent grouping factors were vibration frequency, vibration amplitude, muscle group
and classification of SCI. A post-hoc multiple comparisons procedure with a Bonferroni
2Note that the pre-Vibration EMG were typically small when compared to those from the ISCI or
neurologically intact participants. ∆EMG was therefore more sensitive to any change in neuromuscular activity
by comparison. The interpretation of ∆EMG results should therefore be carried out in conjunction with the
raw EMG results.
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correction was used in the event that statistical significance was identified. The results of the
statistical analysis are presented in Table 6.4.
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Figure 6.9: Summary of EMG amplitude response for data acquired during the vibration
phase and not rejected as outliers. The data shown are the medians and interquartile ranges,
and are for all subjects and test conditions. Relative changes in activity with respect to
baseline are shown in (a), (c), (e) and (g) and absolute levels of activity are shown in (b),
(d), (f) and (h). The data were grouped according to vibration frequency ((a) and (b)),
vibration amplitude ((c) and (d)), muscle group ((e) and (f)) and classification of SCI ((g)
and (h)). TA: Tibialis Anterior, M-GA: Medial Gastrocnemius, VL: Vastus Lateralis, ISCI:
motor-incomplete SCI, CSCI: motor-complete SCI, SCI: spinal cord injury.
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Neuromuscular activity increased with both vibration frequency and vibration amplitude.
Increases were smaller for the CSCI participants when compared to the ISCI participants.
∆EMG was between 25 and 41% for the different frequency conditions, which equated to a
0.38 to 0.50µV change in neuromuscular activity. These changes were statistically significant,
and a post-hoc analysis showed that vibration at 27Hz elicited a significantly larger increase
in neuromuscular activity than both 12 and 20Hz. Similar increases were found for vibration
amplitude, and the increases were significantly larger at 3mm when compared to a vibration
amplitude of 1 or 2mm. Changes in vibration amplitude resulted in a range of ∆EMG
values between 21 and 43%, which equated to a 0.37 to 0.54µV increase in EMG amplitude.
Vibration caused a larger increase in activity for the ISCI when compared to the CSCI
participants, where the overall ∆EMG was 48% and 15% for each sub-group respectively.
∆EMG was similar for each of the TA and M-GA, and smallest for the VL. In absolute terms,
however, the VL was the most active during vibration. Typical ∆EMG values were between
36 and 44% for the TA and M-GA, and 17% for the VL. These ∆EMG values equated
to a 0.38 - 0.46µV increase in EMG activity. These trends are consistent with those found
for the neurologically-intact participants. The ∆EMG values for the SCI and neurologically
intact participants are directly comparable when grouped according to vibration frequency,
vibration amplitude and muscle group. In all cases the values for the SCI participants are
either the same or marginally larger than those for the neurologically intact participants.
Table 6.4: Summary of statistical analysis results. ∆ EMG: Change in EMG during Vibration
with respect to pre-Vibration condition; EMG: EMG recorded during vibration; F: ANOVA
F-statistic; DF: Degrees of Freedom; p: P-value; GuGl: Groups identified to be significantly
different in post-hoc analysis; Gu: Upper group; Gl: Lower group; †: All pairs found to be
significantly different at p≤0.05.
∆ EMG EMG
Parameter F (DF) p GuGl F (DF) p GuGl
Frequency 16.67 (2) ≤ 0.01 2712; 2012 1.923 (2) = 0.15 -
Displacement 29.58 (2) ≤ 0.01 † 3.18 (2) = 0.04 31
Muscle 45.75 (2) ≤ 0.01 VLM−GA;
VLTA
2.89 (2) = 0.06 -
Injury 218.6 (1) ≤ 0.01 † 63.89 (1) ≤ 0.01 †
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6.1.6 Case Analysis (S17)
The average TSI for the SCI participants overall, excluding Subject S17, was 171 days,
and 164 days for the CSCI participants only. By comparison the TSI of Subject S17 was
5087 days. Subject S17 was a 28 year old male who suffered a traumatic spinal cord injury
at T7, resulting in motor-complete paralysis below the level of lesion with some retained
sensation. Subject S17 was an attendee at the Queen Elizabeth National Spinal Injuries Unit
and undertook regular FES-Leg Cycle Ergometry training sessions. He met the inclusion
criteria for this study and a unique opportunity was presented to compare and contrast the
response of a chronic SCI participant against the responses from early-stage SCI participants.
The average (mean) EMG and ∆EMG responses of the TA, M-GA and VL were calculated
and isolated for each CSCI participant and plotted in Figures 6.10 - 6.12 below. The same
values were calculated for Subject S17 and overlaid the same plots.
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Figure 6.10: TA EMG response of Subject S17 during WBV. The neuromuscular response
is presented as absolute EMG (a) and ∆EMG (b). The presented data are for all CSCI
participants and test conditions. The presented data are average (mean) values for each
participant and grouped according platform acceleration (Equation (4.2)). The specific
vibration frequency and vibration amplitude conditions used are identifiable by cross-
referencing the acceleration values presented on the x-axis to those described in Table 4.6.
TA: Tibialis Anterior; EMG: Absolute EMG activity; ∆EMG: Change in EMG relative to
baseline.
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Figure 6.11: M-GA EMG response of Subject S17 during WBV. The neuromuscular
response is presented as absolute EMG (a) and ∆EMG (b). The presented data are for
all CSCI participants and test conditions. The presented data are average (mean) values
for each participant and grouped according platform acceleration (Equation (4.2)). The
specific vibration frequency and vibration amplitude conditions used are identifiable by cross-
referencing the acceleration values presented on the x-axis to those described in Table 4.6.
M-GA: Medial Gastrocnemius; EMG: Absolute EMG activity; ∆EMG: Change in EMG
relative to baseline.
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Figure 6.12: VL EMG response of Subject S17 during WBV. The neuromuscular response
is presented as absolute EMG (a) and ∆EMG (b). The presented data are for all CSCI
participants and test conditions. The presented data are average (mean) values for each
participant and grouped according platform acceleration (Equation (4.2)). The specific
vibration frequency and vibration amplitude conditions used are identifiable by cross-
referencing the acceleration values presented on the x-axis to those described in Table 4.6.
VL: Vastus Lateralis; EMG: Absolute EMG activity; ∆EMG: Change in EMG relative to
baseline.
There were no notable difference between the group averages of the early-stage SCI
participants and Subject S17. Tabulated results of the data presented in the figures above
are shown in Table 6.5 & 6.6.
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Table 6.5: Comparison of CSCI EMG averages against Subject S17. The tabulated values
are the average (mean) EMG values for the CSCI group. CSCI: Motor Complete Spinal Cord
Injury; TA: Tibialis Anterior; M-GA: Medial Gastrocnemius; VL: Vastus Lateralis.
Platform Acceleration [g]
Muscle Group 0.4g 0.8g 1.1g 1.2g 2.1g 2.3g 3.4g 4.1g 6.2g
TA CSCI 1.23 0.80 0.63 0.46 0.83 0.88 0.62 1.19 0.66
S17 0.99 0.96 1.02 1.17 1.17 0.98 1.79 1.22 1.66
M-GA CSCI 0.35 0.44 0.37 0.70 0.55 0.46 0.70 0.47 0.56
S17 0.59 0.75 0.72 1.04 1.58 0.89 1.59 1.05 0.91
VL CSCI 0.50 0.82 0.55 0.48 0.54 0.66 0.65 0.72 0.46
S17 0.47 0.47 0.47 0.59 0.44 0.45 0.74 0.47 0.55
Table 6.6: Comparison of CSCI ∆EMG averages against Subject S17. The tabulated values
are the average (mean) ∆EMG values for the CSCI group. CSCI: Motor Complete Spinal
Cord Injury; TA: Tibialis Anterior; M-GA: Medial Gastrocnemius; VL: Vastus Lateralis;
∆EMG: Change in EMG amplitude relative to baseline.
Platform Acceleration [g]
Muscle Group 0.4g 0.8g 1.1g 1.2g 2.1g 2.3g 3.4g 4.1g 6.2g
TA CSCI 0.14 0.13 0.13 0.26 0.23 0.21 0.39 0.35 0.43
S17 0.06 0.05 0.08 0.29 0.18 0.04 0.46 0.30 0.43
M-GA CSCI 0.17 0.29 0.22 0.39 0.25 0.28 0.44 0.29 0.41
S17 0.22 0.45 0.35 0.54 0.64 0.48 0.64 0.51 0.57
VL CSCI -0.28 -0.11 0.14 0.14 0.07 0.05 0.26 0.22 -0.11
S17 0.04 0.04 0.03 0.30 0.01 0.00 0.27 0.06 0.13
It was observed that the EMG and ∆EMG values for Subject S17 recorded from the TA and
VL were at or near the CSCI group averages. Similarly, the ∆EMG values for Subject S17
recorded from the M-GA were broadly inline with the CSCI group averages also, and only
the EMG values of the M-GA were found to be consistently larger than the group averages.
Despite being larger however, they were typically of the order of 05 - 1.0µV larger, and such
a difference is relatively small, particularly when compared to the changes recorded for the
ISCI participants. It was thus concluded that the chronicity of injury had little effect upon
the magnitude of the acute neuromuscular response of the lower limb to a bout of WBV.
6.1.7 Specific EMG Amplitude Response
The general analysis above confirmed the assumption that the magnitudes of the neuromus-
cular responses of the ISCI and CSCI participants were significantly different. The differing
responses from the different muscle groups shown above were also expected from the analysis
carried out previously with the neurologically-intact participants. Vibration was shown to
be damped as it was transmitted upwards through the legs and the results from the SCI
participants are consistent with that finding. Considering these results in combination with
the fact that the CSCI participants were unable to elicit a voluntary muscle contraction
during pre-Vibration, whereas the ISCI participants could, it was concluded that the ISCI
and CSCI subgroup should be analysed separately hereafter.
The magnitudes of neuromuscular activity during pre-Vibration and Vibration were compared
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by plotting average Vibration EMGRMS values against average pre-Vibration EMGRMS
values for the different muscle and SCI groups. The results are plotted in Figure 6.13 and
a best fit trend line is overlaid the scatter plots, with the slope of the line reported, to
highlight the general trends. Note that a slope <=1 indicates that neuromuscular activity
was either unchanged or decreased during the Vibration epoch. Table 6.7 summarises the
relevant statistics for the trend lines.
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Figure 6.13: Scatter plot of pre-Vibration and Vibration muscle activity with best-fit trend
line. Best-fit line assessed using Pearson’s correlation coefficient. TA: Tibialis Anterior,
M-GA: Medial Gastrocnemius, and VL: Vastus Lateralis, CSCI: motor-complete SCI, ISCI:
motor-incomplete SCI, SCI: spinal cord injury.
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Table 6.7: Trend-line statistics describing relationship between pre-Vibration and Vibration
muscle activity. Best-fit line assessed using Pearson’s correlation coefficient. R-value:
Pearson’s best fit correlation; P-value: statistical significance.
SCI Group Muscle Slope Intercept R-value P-value
ISCI TA 1.5 0.7 0.6 <0.01
M-GA 2.6 0.2 0.8 <0.01
VL 1.7 0.0 0.7 <0.01
CSCI TA 1.7 -0.1 0.7 <0.01
M-GA 1.0 0.2 0.2 <0.01
VL 0.9 0.2 0.3 <0.01
The slope of the trend line indicates the change in muscle activity expected to occur with
vibration. In all cases there was a positive and statistically-significant increase in muscle
activity for the ISCI participants. In contrast, this trend was only seen in the TA of the
CSCI participants. There were some instances where M-GA and VL activity increased but
in general these increases were small. It was therefore concluded that the type of response
was dependent on the muscle group and classification of SCI. This confirmed that the initial
conditions were different for the muscle groups (e.g. pre-contraction in the muscle) and
affirmed that the SCI groups should be assessed separately.
The amplitude responses of each individual muscle group to WBV are presented in the
following sub-sections. The amplitude of the muscle responses were quantified in two ways:
(i) by describing the overall magnitude of neuromuscular activity by computing the RMS and
calculating the average for the Vibration epoch and (ii) by describing the relative change in
neuromuscular activity to a baseline condition (Equation (4.12)). The data are presented for
all EMG which were not rejected as outliers. The data were grouped according to classification
of injury and platform acceleration (Equation (4.13). The 0.0g (pre-Vibration) condition
is representative of baseline. The specific vibration frequency and vibration amplitude
conditions used may be determined by referencing the acceleration values described on the
x-axis to those defined in Table 4.6.
Supporting statistical analyses are provided in associated tables throughout. A multi-way
ANOVA of all EMGRMS and ∆EMG data was carried out for both SCI groups. The
independent grouping factors were vibration frequency and vibration amplitude.
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Tibialis Anterior
WBV resulted in an increase in TA neuromuscular activity. ∆EMG generally increased with
platform acceleration, and the increases were larger for the ISCI participants. ∆EMG was
typically between 35 and 87% for the ISCI participants, which equated to an EMG increase
between 0.32 and 0.70µV. By comparison, ∆EMG was typically between 6 and 39% for
the CSCI participants, which equated to an EMG increase between 0.20 and 0.43µV. The
statistical significance of these findings are outlined in Table 6.8.
In summary, the relative change in activity at the 3mm condition was significantly larger
than the change at the 1mm and 2mm conditions for both the ISCI and CSCI participants.
In addition, the relative change in activity during 27Hz vibration was significantly larger than
the relative change at the 12Hz condition for both the ISCI and CSCI participants.
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Figure 6.14: Amplitude response of Tibialis Anterior to WBV. The neuromuscular response
is presented as absolute EMG (a) and ∆EMG (b). The presented data are for all
participants and test conditions. The data were grouped according the platform acceleration
(Equation (4.2)) and classification of SCI. Pre-Vibration data are presented for reference
purposes and can be identified as the 0.0g condition. The specific vibration frequency and
vibration amplitude conditions used are identifiable by cross-referencing the acceleration
values presented on the x-axis to those described in Table 4.6.
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Table 6.8: Statistics table of TA results. A multi-way ANOVA was used to identify significant
changes in EMG and ∆ EMG. The independent factors used were vibration frequency
and vibration amplitude. The interaction between these terms was also investigated.
Where statistical significance was identified, a post-hoc multiple comparisons procedure with
Bonferroni correction was used to identify significantly different pairs. EMG: EMG recorded
during WBV; ∆ EMG: Change in activity relative to baseline (Equation (4.12)); TA: Tibialis
anterior; F: ANOVA F-statistic; ANOVA: Analysis of Variance; DF: Degrees of freedom; p:
P-value; GuGl: Pairs identified to be significantly different in post-hoc analysis; Gu: Upper
group; Gl: Lower group.
∆ EMG EMGN
SCI Group Parameter F (DF) p GuGl F (DF) p GuGl
ISCI Frequency 5.91 (2) ≤0.01 2712 0.87 (2) =0.42 -
Displacement 7.52 (2) ≤0.01 31; 32 1.73 (2) =0.18 -
Interaction 0.69 (4) =0.60 - 0.11 (4) =0.98 -
CSCI Frequency 12.70 (2) ≤0.01 2720; 2712 0.20 (2) =0.82 -
Displacement 19.46 (2) ≤0.01 31; 32 0.16 (2) =0.85 -
Interaction 0.94 (4) =0.44 - 0.32 (4) =0.87 -
Table 6.9 compares these results with the relative changes in neuromuscular activity of the
the neurologically-intact participants to baseline. In every case, ∆EMG was larger for the
ISCI (50% pBWS) and CSCI (100% pBWS) participants when compared to the neurologically
intact participants under similar experimental conditions.
Table 6.9: Comparison of the average change in TA neuromuscular activity for the
neurologically-intact (AB) and SCI participants for each platform acceleration and level
of pBWS. The tabulated values are the average (mean) changes in neuromuscular
activity relative to baseline (pre-Vibration epoch) and all tabulated values are presented as
percentages (∆EMG×100). pBWS: partial Body Weight Support; ISCI: Motor Incomplete
Spinal Cord Injury; CSCI: Motor Complete Spinal Cord Injury; TA: Tibialis Anterior.
Platform Acceleration [g]
Group pBWS 0.4g 0.8g 1.1g 1.2g 2.1g 2.3g 3.4g 4.1g 6.2g
AB 0 24.06 24.06 25.91 40.31 41.94 36.89 46.96 48.08 60.96
AB 50 9.49 17.35 12.87 30.20 26.25 21.51 30.17 26.93 36.06
ISCI 50 37.60 34.42 40.61 48.61 45.14 45.36 63.03 58.76 66.30
AB 100 9.73 9.15 9.06 11.35 14.61 14.24 15.15 14.34 25.57
CSCI 100 12.28 12.99 12.99 26.12 23.29 21.19 39.90 34.14 43.69
WBV SCI 171
Medial Gastrocnemius
Similar increases in ∆EMG were found for the M-GA. The increases were larger for the
ISCI participants and ∆EMG was between 32 and 68%, this equated to a 0.39 to 1.39µV
increase in EMG. In comparison, ∆EMG was typically between 12 and 51% for the CSCI
participants, which equated to an EMG increase between 0.36 and 0.42µV. These increases
in neuromuscular activity were statistically significant at the 3mm condition for both the
ISCI and CSCI participants when compared to the 1mm condition. The relative increase
at the 27Hz condition was significantly larger than that for the 12Hz condition for the ISCI
participants. The results of the statistical analysis are summarised in Table 6.10.
0
0.5
1
1.5
2
2.5
3
EM
G
 [µ
V]
(a)
 
 
ISCI
CSCI
0.0g 0.4g 0.8g 1.1g 1.2g 2.1g 2.3g 3.4g 4.1g 6.2g
−0.2
0
0.2
0.4
0.6
0.8
Platform Acceleration [RMS]
∆ 
EM
G
(b)
Figure 6.15: Amplitude response of Medial Gastrocnemius to WBV. The neuromuscular
response is presented as absolute EMG (a) and ∆EMG (b). The presented data are for all
participants and test conditions. The data were grouped according the platform acceleration
(Equation (4.2)) and classification of SCI. Pre-Vibration data are presented for reference
purposes and can be identified as the 0.0g condition. The specific vibration frequency and
vibration amplitude conditions used are identifiable by cross-referencing the acceleration
values presented on the x-axis to those described in Table 4.6.
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Table 6.10: Statistics table of GA results. A multi-way ANOVA was used to identify
significant changes in EMG and ∆ EMG. The independent factors used were vibration
frequency and vibration amplitude. The interaction between these terms was also
investigated. Where statistical significance was identified, a post-hoc multiple comparisons
procedure with Bonferroni correction was used to identify significantly different pairs. EMG:
EMG recorded during WBV; ∆ EMG: Change in activity relative to baseline (Equation
(4.12)); M-GA: Medial gastrocnemius; F: ANOVA F-statistic; ANOVA: Analysis of Variance;
DF: Degrees of freedom; p: P-value; GuGl: Pairs identified to be significantly different in
post-hoc analysis; Gu: Upper group; Gl: Lower group.
∆ EMG EMGN
SCI Group Parameter F (DF) p GuGl F (DF) p GuGl
ISCI Frequency 4.58 (2) ≤0.05 2712 0.61 (2) =0.54 -
Displacement 3.09 (2) ≤0.05 31 1.70 (2) =0.19 -
Interaction 0.42 (4) =0.80 - 0.29 (4) =0.89 -
CSCI Frequency 0.51 (2) =0.60 - 0.09 (2) =0.91 -
Displacement 8.09 (2) ≤0.01 31 2.97 (2) =0.05 -
Interaction 0.30 (4) =0.88 - 0.76 (4) =0.56 -
Table 6.11 compares these results with the relative changes in neuromuscular activity of
the the neurologically-intact participants to baseline. At the lower intensity vibration
levels, typically at platform accelerations of 2.3g or less, the ∆EMG values of the SCI
participants were larger than the responses of the neurologically intact participants under
similar experimental conditions. However this trend reversed as platform acceleration
increased, particularly at platform accelerations greater than 4g. It was hypothesised that
the neurologically intact participants were able to successfully maintain their posture and
position on the vibration platform due to their greater capacity for motor control, therefore
resulting in the high intensity vibration being effectively imparted on them. By contrast,
the decreased functional capacity of the SCI participants, and particularly that of the CSCI
participants, possibly increased the likelihood of their feet moving during the Vibration epoch
and therefore reducing the transmission of vibration.
Table 6.11: Comparison of the average change in M-GA neuromuscular activity for
the neurologically-intact (AB) and SCI participants for each platform acceleration and
level of pBWS. The tabulated values are the average (mean) changes in neuromuscular
activity relative to baseline (pre-Vibration epoch) and all tabulated values are presented
as percentages (∆EMG×100). pBWS: partial Body Weight Support; ISCI: Motor
Incomplete Spinal Cord Injury; CSCI: Motor Complete Spinal Cord Injury; M-GA: Medial
Gastrocnemius.
Platform Acceleration [g]
Group pBWS 0.4g 0.8g 1.1g 1.2g 2.1g 2.3g 3.4g 4.1g 6.2g
AB 0 15.70 32.53 40.45 38.56 55.89 48.11 58.09 70.80 71.44
AB 50 26.70 45.01 26.83 49.45 44.85 44.10 53.08 53.72 70.51
ISCI 50 35.72 40.60 47.13 52.07 52.34 52.21 54.63 52.86 58.30
AB 100 17.16 20.71 21.63 27.30 31.35 23.61 37.27 41.94 55.65
CSCI 100 18.36 31.37 24.15 39.52 28.75 31.77 44.37 31.16 41.78
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Vastus Lateralis
In general, the EMG response of the VL to WBV was similar to that of the M-GA even
though the relative change in activity was smaller. ∆EMG was between 7 and 87% for
the ISCI participants, and this equated to a 0.43 to 1.23µV increase in EMG amplitude.
In comparison, ∆EMG was typically between 5 and 27% for the CSCI participants, which
equated to an EMG amplitude of 0.28 to 0.52µV. There was no instance where the increase
in neuromuscular activity for any of the participants was significant and these results are
summarised in Table 6.12.
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Figure 6.16: Amplitude response of Vastus Lateralis to WBV. The neuromuscular response
is presented as absolute EMG (a) and ∆EMG (b). The presented data are for all
participants and test conditions. The data were grouped according the platform acceleration
(Equation (4.2)) and classification of SCI. Pre-Vibration data are presented for reference
purposes and can be identified as the 0.0g condition. The specific vibration frequency and
vibration amplitude conditions used are identifiable by cross-referencing the acceleration
values presented on the x-axis to those described in Table 4.6.
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Table 6.12: Statistics table of VL results. A multi-way ANOVA was used to identify
significant changes in EMG and ∆ EMG. The independent factors used were vibration
frequency and vibration amplitude. The interaction between these terms was also
investigated. Where statistical significance was identified, a post-hoc multiple comparisons
procedure with Bonferroni correction was used to identify significantly different pairs. EMG:
EMG recorded during WBV; ∆ EMG: Change in activity relative to baseline (Equation
(4.12)); VL: Vastus lateralis; F: ANOVA F-statistic; ANOVA: Analysis of Variance; DF:
Degrees of freedom; p: P-value; GuGl: Pairs identified to be significantly different in post-
hoc analysis; Gu: Upper group; Gl: Lower group.
∆ EMG EMGN
SCI Group Parameter F (DF) p GuGl F (DF) p GuGl
ISCI Frequency 1.36 (2) =0.26 - 1.18 (2) =0.31 -
Displacement 2.60 (2) =0.08 - 1.07 (2) =0.34 -
Interaction 0.67 (4) =0.61 - 0.18 (4) =0.95 -
CSCI Frequency 1.17 (2) =0.31 - 0.30 (2) =0.74 -
Displacement 0.23 (2) =0.79 - 1.13 (2) =0.32 -
Interaction 1.06 (4) =0.38 - 0.36 (4) =0.84 -
Table 6.13 compares these results with the relative change in neuromuscular activity of the the
neurologically-intact participants to baseline. The ∆EMG values from the ISCI participants
were generally larger or comparable to the values from the neurologically intact participants
for all platform acceleration levels. By contrast there were a large number of instances where
the response of the CSCI participants actually decreased during the Vibration epoch. This
is most likely due to the sensitivity of the ∆EMG calculation for the CSCI participants. The
level of activity during the pre-Vibration epoch was always small by comparison to the ISCI
and neurologically intact participants. Any small change in neuromuscular output would
appear magnified when viewing the ∆EMG value and comparing to the other participant
groups. It is therefore necessary to view the absolute EMG magnitudes also (Figure 6.16)
where it can be seen that CSCI activity during the pre-Vibration and Vibration epochs was
always small.
Table 6.13: Comparison of the average change in VL neuromuscular activity for the
neurologically-intact (AB) and SCI participants for each platform acceleration and level
of pBWS. The tabulated values are the average (mean) changes in neuromuscular
activity relative to baseline (pre-Vibration epoch) and all tabulated values are presented as
percentages (∆EMG×100). pBWS: partial Body Weight Support; ISCI: Motor Incomplete
Spinal Cord Injury; CSCI: Motor Complete Spinal Cord Injury; VL: Medial Gastrocnemius.
Platform Acceleration [g]
Group pBWS 0.4g 0.8g 1.1g 1.2g 2.1g 2.3g 3.4g 4.1g 6.2g
AB 0 14.18 17.57 18.11 19.42 25.20 21.78 25.33 28.32 31.95
AB 50 17.01 24.77 18.93 22.44 8.11 21.60 28.41 22.75 27.51
ISCI 50 2.60 7.52 24.30 37.48 29.85 22.35 31.53 21.99 35.66
AB 100 17.95 26.84 19.18 25.84 29.85 23.12 23.19 23.77 28.36
CSCI 100 -37.87 -20.41 14.99 17.37 10.00 4.35 27.02 26.46 -17.16
In summary, analysis of the individual muscles generally reflected those trends identified
in the general analysis (Section 6.1.5). Vibration frequency and vibration amplitude each
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elicited an increase in neuromuscular activity, but the magnitude of the increase was not
consistent across each of the muscle groups. Overall, both ∆EMG and EMG were larger
across all test conditions for the ISCI participants and in general the neuromuscular response
increased with platform acceleration.
The VL and M-GA were the most active muscle groups, each exhibiting similar values of
∆EMG and EMG, and the TA was the least active. ∆EMG is the parameter of most interest
from this analysis. It was not possible to perform intermuscular comparisons of the EMG
amplitude results from the SCI participants, because it was not possible to normalise the
EMG to a MVC. Normalisation to MVC was not done because: (i) it was not possible to
perform an MVC with the CSCI participants and (ii) those MVC recorded from the ISCI
participants were highly variable and therefore an unreliable indication of the maximum
capacity of the muscle. The largest changes in activity were found in those muscles which
were in closest proximity to the vibration platform, and in the event that there was a change
in EMG activity there was a corresponding change in ∆EMG also.
6.1.8 EMG Vibration Cycle Analysis
This analysis has focussed on the steady-state neuromuscular response to WBV up to this
point. An ideal, steady-state EMG would therefore be ‘flat’ during the entire period of
vibration, therefore implying that the neuromuscular response over a period of 6s for example
would be equivalent to the response over a single cycle of vibration. However, a review of
time series EMG data showed that this was not the case. In practice, fluctuations in the
EMG were compensated for by averaging the EMG over a set period by calculating the
RMS. Some characteristics of the EMG were lost by doing this, such as those identified
previously by Ritzmann et al. [88]. The evidence suggested was the occurrence of a peak in
the neurological response which was akin to a short latency reflex and a similar phenomenon
was identified in this study, see Section 5.1.6, for the neurologically intact participants. A
Vibration Cycle Analysis was carried out to determine if the same trends occurred in an SCI
population.
General Analysis
A vibration cycle analysis was carried out on every EMG that met the inclusion criteria
described in Section 4.2.8 and the results are summarised in Figure 6.17. The vibration cycle
data from each test were averaged for all participants, tests, and test epoch: pre-Vibration,
Vibration, post-Vibration. The averaged data are then grouped according to: vibration
frequency, vibration amplitude, muscle group and classification of SCI, and then normalised
to the maximum response. This was done to determine qualitatively which of these factors
was most likely to influence a temporal relationship between neuromuscular activity and a
single cycle of vibration.
WBV SCI 176
0 20 40 60 80 100
0.4
0.6
0.8
1
(a)
N
EM
G
pv
c
 
 
12Hz
20Hz
27Hz
0 20 40 60 80 100
0.4
0.6
0.8
1
(b)
 
 
1mm
2mm
3mm
0 0.2 0.4 0.6 0.8 1
0.4
0.6
0.8
1
Platform Position
(c)
N
EM
G
pv
c
 
 
TA
M−GA
VL
0 0.2 0.4 0.6 0.8 1
0.4
0.6
0.8
1
(d)
Platform Position
 
 
ISCI
CSCI
Figure 6.17: Summary of vibration cycle analysis for all EMG. The results were grouped for
all participants, tests and test epoch. Pre-Vibration and post-Vibration data are indicated by
dashed lines and are enclosed within the light grey banded area. Vibration data are indicated
by solid lines. The grouping factors were: vibration frequency (a), vibration amplitude (b),
muscle group (c), and classification of SCI (d). Grouped and averaged data are normalised
maximum. NEMGpvc: Per vibration cycle of the EMG normalised to its maximum.
No significant fluctuation or change in neuromuscular activity was observed for those EMG
recorded during the pre-Vibration and post-Vibration epoch as expected, and were therefore
excluded from further analysis. Some fluctuation of the EMG grouped according to vibration
amplitude and classification of injury were shown but the changes were erratic, relatively
small by comparison, and difficult to distinguish when compared to those EMG that were
grouped according to the muscle group and vibration frequency. The data grouped according
to muscle group and vibration frequency were erratic and difficult to distinguish also but
were analysed further on the basis that the magnitude of these signals were larger than those
data grouped according to vibration amplitude and injury classification.
Specific Analysis
The analysis was repeated using those EMG which were repeatable between tests and were
recorded during the Vibration epoch only. Pearson’s correlation coefficient was used to
determine if the EMG from each of the testing sessions were sufficiently ‘similar’. Both output
EMG were rejected if: (i) the correlation between the two EMG was non-significant (p≥0.05)
or (ii) very poor or negative (r≤0.1). All retained data were averaged for all participants and
grouped according to muscle group, leg, classification of SCI and vibration frequency. The
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results are shown for the CSCI participants only in Figure 6.18 because none of the EMG
recorded from the ISCI participants met the inclusion criteria outline above.
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Figure 6.18: Results of vibration cycle analysis for EMG from the CSCI participants recorded
during WBV only. The results were averaged for all CSCI participants and tests, and
grouped according to vibration frequency and muscle group. Grouped and averaged data
were normalised to the respective maximum values. The top panels show the results for the
TA recorded from the left (a) and right (b) legs, the middle panels shows the results for the
M-GA from the left (c) and right (d) legs, and the bottom panels show the results for the VL
from the left (e) and right (f) legs. Note that no data is shown for the VL because none of
the EMG met the inclusion criteria outlined for this test. NEMGpvc: Per vibration cycle of
the EMG normalised to its maximum; TA: Tibialis Anterior; M-GA: Medial Gastrocnemius;
VL: Vastus Lateralis.
No temporal relationship between platform position and neuromuscular response was
identified for the ISCI participants. However, while some relationships were identified for
the CSCI participants, the changes were small in magnitude.
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6.2 Discussion
Evidence supporting the application of WBV in SCI rehabilitation is limited, and it has
been applied with limited success using a tilt-table and from a seated position [87,115]. The
results from this study were the first to demonstrate the application of WBV to both ISCI
and CSCI patients in a standing position, with the support of a pBWS system. The feasibility
of this system was confirmed, as positive changes in neuromuscular output were found and
directly attributed to the application of vibration. A range of low to high frequencies and
amplitudes were systematically assessed and directly compared with normative data recorded
from a neurologically intact population. Furthermore, the normative data gathered from
the neurologically intact participants was the first to systematically quantify the effect of
reduced self-supported body weight on the neuromuscular response duringWBV - rather than
increasing load as is typically done. The findings from the tests at 0% pBWS were consistent
with those reported in the literature, and the findings at 50% and 100% pBWS have added
to the understanding of how leg muscles respond to vibration at reduced body loads. A novel
analysis approach then allowed for a detailed investigation of both neurologically intact and
SCI EMG over a single cycle of vibration. New evidence here suggests that peak platform
acceleration is central to eliciting a peak neuromuscular response.
A systematic approach was carried out to quantify the presence of vibration artefact in EMG
recorded duringWBV with statistical analysis supporting the number of harmonic frequencies
which should be removed. The results from this study suggest that a higher proportion of
artefact was present in the EMG than that reported by others in the literature [107, 126],
however methodological differences between the studies exist and were highlighted in greater
detail in the literature review (Section 3.4). Some have removed artefact simply due to the
presence of atypical EMG frequency spectra [72, 107–110, 114, 115, 125], meanwhile others
have contested that vibration artefact is present at all [88]. Despite reports to the contrary,
firm supporting evidence, in the form of a case study, was presented in this thesis which
identified the presence of vibration artefact and highlighted the requirement for its removal.
The overall objectives of this study were the same as those for the general population. To
recap, the technical objectives were: (i) determine the feasibility of WBV-pBWS in a SCI
population, (ii) to quantify the transmission of vibration from the WBV platform to the
lower limbs, and (iii) to estimate the proportion of vibration artefact in each EMG. The
physiological objectives were: (i) to measure and quantify the magnitude of the acute, steady-
state neuromuscular response of the lower limbs to WBV-pBWS and to compare the response
of the SCI population with the response of a general population with no neurological deficit
and (ii) to investigate the temporal relationship between neuromuscular activity and the
position of the WBV platform. Theses technical and physiological objectives are discussed
separately in the following sections.
6.2.1 Physiological
The specific physiological objectives outlined at the beginning of this chapter are addressed
below. These objectives were achieved by analysing the acquired EMG data in a similar
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manner to that done for the neurologically intact population and therefore allowed for a
direct comparison of the results from the different populations. Recall, that the neurologically
intact population were tested with all levels of pBWS whereas the SCI participants were tested
with a level of support appropriate to their functional capability. In this study all of the ISCI
participants were tested with 50% pBWS and the CSCI participants were tested with 100%
pBWS.
∆EMG was comparable across all sampled populations because this outcome measure was
not influenced by the level of functional capability of the participant, though it was sensitive
to small levels of baseline activity, which was the case for the CSCI participants. For a given
set of experimental conditions, the magnitude of change in neuromuscular activity of the ISCI
participants from pre-Vibration to Vibration was equivalent or in excess of that achieved by
the neurologically intact participants. Specific values are discussed in the following section,
but typical changes for the neurologically intact participants were between 6.9 - 29.7% (TA),
22.6 - 73.7% (M-GA) and 15.5 - 24.4% (VL). Equivalent results for the ISCI participants
were between 34.7 - 76% (TA), 31.8 - 67.7% (M-GA) and 7.5 - 50.3% (VL).
These relative changes were normalised to MVC for the neurologically intact participants and
were found to be between 0.7 - 1.2% MVC (TA), 3.6 - 12.6% MVC (M-GA) and 9.4 - 10.9%
MVC (VL), and were considered to be relatively small when compared to the changes at 0%
pBWS. At 0% pBWS, the overall changes in activity were between 1.1 - 2.0 MVC (TA), 5.9 -
18.9 MVC (M-GA) and 17.7 - 26.5 MVC (VL). The findings in this study and those reported
in the literature are in good agreement. The same relationship between the magnitude of
the neuromuscular response with vibration frequency and vibration amplitude was found,
though the overall magnitudes of contraction reported here were smaller [72, 76, 90, 109].
This is likely a consequence of the robust off-line EMG classification procedure used here to
reject outlying data and artefact, in addition to methodological differences which included
supported load, applied vibration frequency/amplitudes and posture. A similar investigation
carried out by Pollock et al. [72] reported equivalent values between 2 - 32% (approx.) MVC
(TA), 5 - 42% MVC (approx.) and (M-GA) and 5 - 18% MVC (approx.) (RF - VL was
not reported on). In general, the smaller EMG amplitudes reported in this study are most
likely accounted for by differing testing methodologies, for example Pollock et al. [72] applied
vibration amplitudes at 2.5 & 5.5mm in a straight leg position, compared to 1, 2, & 3mm
in a flexed knee position in this study. Roelants et al. [90] on the other hand increased
the magnitude of neuromuscular response during vibration by increasing pre-contraction by
prescribing unilateral static squats, while Hazell et al. [109] simply increased the supported
load. Others have suggested that the maximal response of the VL occurs at 30Hz [76], however
these findings could not be corroborated using this data set because the WBV platform used
here was limited to a maximum vibration frequency of 27Hz.
Thus, despite the overall changes being considered as relatively small for the neurologically
intact participants, they would be considered large for a SCI participant. Furthermore, the
magnitudes of the neuromuscular responses found for those with a SCI were larger than
those found elsewhere. Neither Herrero et al. [115] or Chang et al. [87] identified an increased
neuromuscular response from an SCI population. Herrero et al. [115] applied vibration on
WBV SCI 180
a tilt-table, rather than in an upright and standing position, and was thus unlikely to have
applied an adequate ground reaction force to ensure a constant and reliable contact with
the vibration platform. Chang et al. [87] on the other hand applied vibration from a seated
position and concluded that the absence of an increased neuromuscular response was due to
a lack of vestibulospinal activity, suggesting that a postural control mechanism mediates the
acute neuromuscular response. However, data gathered as part of this work did not support
this conclusion, and evidence from this study suggested that platform acceleration mediated
the peak neuromuscular response. This observation was in line with findings from others [88].
It was thus determined that, given the similarities between ∆EMG for both the SCI and
neurologically intact participants, it is therefore plausible that similar increments in actual
muscle contraction would occur for the SCI participants also. The conclusions of a comparison
between ∆EMG values from the neurologically intact participants with 100% pBWS and
CSCI participants are the same. Values in the ranges between 4 - 40% (TA), 5 - 68% (M-GA)
and 5 - 28% (VL) were found for both populations. These values compare favorably with those
reported above but they were typically associated with a muscular contraction <8% MVC
in the M-GA, and <2% MVC in the TA and VL for the neurologically intact participants.
Furthermore, a review of the raw EMG data from the CSCI participants demonstrated the
sensitivity of the ∆EMG calculation to small baseline levels of neuromuscular activity, as in
many cases the EMG amplitude either remained the same during the Vibration epoch, or
decreased to a smaller level than that recorded for the pre-Vibration epoch. It is possible
that the decrease in neuromuscular activity was the result of some neural inhibition, however
it is more likely a consequence of the oﬄine analysis. Filtering of the data to remove artefact
would have a comparatively large effect on CSCI EMG signals which would be relatively
small to begin with.
In any case, the same rationale that applied to the ISCI participants above, applies again for
the CSCI participants here. The CSCI participants in particular have no capacity for any
volitional contraction of muscle, therefore any induced contraction would have a potential
therapeutic benefit, however small the contraction may be.
The trends in the change in neuromuscular activity with vibration frequency and amplitude,
both of which are components of acceleration, are in agreement with those observed elsewhere,
where there was an increase in neuromuscular output with both vibration frequency and
amplitude [72,73,76,109]. However, the analysis carried out for this thesis went further and
analysed the neuromuscular response over a single cycle of vibration. The novel analysis
methodology averaged the EMG to allow the identification of the most likely pattern of
neuromuscular activity over the course of a single vibration cycle. Maxima were observed in
the EMG of the TA, M-GA and VL of the neurologically intact participants and the latency
of the maxima were traced back to peak platform acceleration in the preceding vibration cycle.
Such maxima were identified previously by Ritzmann et al. [88] who concluded that these
maxima were short latency reflexes being elicited by some component of motion of the
vibration platform. The results of the analysis carried out in this study neither confirm
nor refute this conclusion though the latencies identified in this study were longer than those
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reported in the literature, noting that in this study the TA, M-GA and VL were assessed
whereas Ritzmann et al. assessed the TA, RF and soleus. These results therefore imply
that the maxima were induced by reflex activity, probably by peak platform acceleration,
but were not short latency reflexes. Such maxima were not successfully identified for the SCI
participants. Ritzmann et al. showed that the stretch receptor was central to the elicited
neuromuscular response to WBV (Section 3.2). It is possible that the failure to identify the
maxima in the SCI EMG was due to the cord injury itself, whereby the elicited afferents
from the stretch receptor were either being misinterpreted, were of insufficient intensity to
depolarise the α-motoneuron, or the neuromuscular response was simply too small to be
detected reliably. Furthermore, it is known that SCI severely disrupts normal spinal reflexes
and pathways, e.g. stretch receptor activation resulting in clonic spasm.
The physiological objectives specific to this chapter are discussed in greater detail below.
EMG Amplitude Response
The analysis techniques used to quantify the amplitudes of the EMG recorded from the
neurologically intact participants were repeated for the SCI participants3. Analysis confirmed
that WBV resulted in a significant increase in the amplitude of the EMG. Having established
that WBV caused an increase in neuromuscular activity, the magnitude of this increase was
assessed. The amplitude was quantified in two ways: ∆EMG (relative change in EMG from
baseline) and EMG (simply the maximum amplitude of the EMGRMS).
∆EMG and EMG were pooled for the Vibration epoch only and grouped according to the
four main factors under investigation in this study: vibration frequency, vibration amplitude,
muscle group and classification of SCI. The differences in the magnitudes of the responses
were significantly different for each of these grouping factors. The change in neuromuscular
activity was significantly larger for the ISCI participants during the Vibration epoch than it
was for the CSCI participants. ∆EMG was typically 48% for the ISCI participants and 15%
for the CSCI participants. This supported the hypothesis that some degree of muscle activity
or contraction prior to vibration significantly affected the magnitude of the response during
vibration.
Vibration frequency and amplitude each resulted in a significant increase in neuromuscular
activity, where typical positive ∆EMG changes were between 21 - 43%. These increases
were equivalent to an EMG change of 0.37 - 0.54 µV. At the outset, these overall increases in
activity were small, however it is worth noting that these average values include the responses
from both SCI groups, and it is known that the response of the CSCI group were significantly
smaller than the ISCI group.
The largest changes occurred in the shank muscles, where typical ∆EMG were 33% and 45%
in the TA and GA respectively during WBV. The corresponding changes in the VL were
considerably smaller at 16%. However as with the neurologically intact population, though
3Recall that the principal method for normalising EMG was to calculate ∆EMG. This was particularly
relevant for the SCI participants because it was not possible to record a reliable MVC due to a combination
of factors which included classification and severity of injury, and time since injury.
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the relative change in activity was smaller, the absolute level of activity of the VL appeared
to be larger.
This was supported by comparing the level of neuromuscular activity during the pre-Vibration
and Vibration epochs. Figure 6.13 shows this relationship for each muscle and SCI group
respectively. In all cases there was a positive (i.e. slope >1) and statistically significant
change in muscle activity for the ISCI participants. However, these same increases were only
seen in the TA for the CSCI participants. These data confirm that there was an increased
response to WBV, but that the increase was predominantly found for the ISCI participants.
In addition, it was also noted that the type of response for each muscle group was different,
as indicated by the slope of the trend line.
EMG and ∆EMG were assessed for each individual muscle and SCI group and plotted in
Figures 6.14 - 6.16. The same general trends were observed for all muscle groups and the
salient results from these figures are summarised in Table 6.14 below for reference. These
results are supported by those presented in Figure 6.13 where it was shown that there was a
steeper slope for the shank muscles when compared to those increases for the thigh muscles,
and that the ISCI participants generally exhibited a larger response.
Table 6.14: Range of typical EMG and ∆EMG values for each muscle and SCI group. EMG
and ∆EMG data were grouped according to classification of SCI and platform acceleration
for all participants and tests. The largest and smallest group average were then taken to
be representative of the typical ranges of EMG & ∆EMG values. TA: Tibialis Anterior;
M-GA: Medial Gastrocnemius; VL: Vastus Lateralis; EMG: Electromyogram; EMG: EMG
amplitude; ∆EMG: Relative change in EMG between pre-Vibration and Vibration normalised
to the Vibration value; ISCI: Incomplete SCI; CSCI: Complete SCI; SCI: Spinal Cord Injury.
pBWS Muscle EMG ∆EMG
[%] µV [%]
ISCI TA 0.32 – 0.70 34.7 – 76.0
M-GA 0.39 – 1.39 31.8 – 67.7
VL 0.44 – 0.98 7.5 – 50.3
CSCI TA 0.20 – 0.43 6.0 – 39.0
M-GA 0.36 – 0.43 12.3 – 51.1
VL 0.28 – 0.52 5.0 – 27.7
In summary, these results indicate that the M-GA was the most active muscle group during
the Vibration epoch and the TA was the least active, with the VL in between for both SCI
groups. Furthermore, the relative change in activity from the pre-Vibration epoch (baseline)
to the Vibration epoch was largest for the M-GA muscle group and smallest for the TA,
with the VL again in between in terms of ranking. Finally, while the relative change in
neuromuscular activity of the ISCI were typically small they were always associated with an
identifiable increase in underlying EMG activity, whereas some of the increase in activity for
CSCI participants were drawn into speculation, because the absolute changes in EMG were
very small and possibly random.
The main factors under investigation in this study were vibration frequency, amplitude,
WBV SCI 183
muscle group, and classification of SCI. The neuromuscular responses during the Vibration
epoch could not be attributed to any single one of these factors directly, but was rather a
combined response to all of the parameters. However, general trends were observed which
were consistent across the different muscle groups. It was confirmed that the initial conditions
for each of the muscle groups were different (e.g. baseline level of neuromuscular activity prior
to the application of vibration) and this likely had a significant effect on the type of response
from each muscle group. It was concluded that the difference in response was primarily
due to the relative proximity of the muscle to the vibration platform, whereby there was
better transmission of vibration to the shank muscles compared to the thigh muscles. As a
consequence the change in activity of the shank muscles was approximately 2.1:1 compared
to approximately 1.6:1 for the thigh muscles. This was consistent with the absolute changes
in neuromuscular activity. It was also noted that though these findings were in contrast to
those for the neurologically intact population at 0% pBWS, they were consistent with the
findings at 100% pBWS.
In summary, the relative changes in neuromuscular activity compared to baseline were
large, but small in terms of absolute activity. It was thus concluded that the potential for
hypertrophy or an increase in muscle performance using WBV-pBWS with an SCI patient
population was small, however the application of this technique may have other potential
therapeutic benefits such as the treatment of hypertonia, spasm and contracture. In addition,
though the increases in neuromuscular activity were small, they could be used to augment
existing functional capability in an ISCI group and be used to accelerate rehabilitation.
Furthermore, the application of WBV may be used as an adjunct to proven rehabilitation
technologies, such as FES, as it likely acts upon the neuromuscular system in a different
manner and may potentially target different neuromuscular functional units.
EMG Vibration Cycle Analysis
The amplitude response analysis above was concerned with the steady-state neuromuscular
response to WBV only, whereby averaging of the variability the EMG over a pre-determined
epoch was carried out by computing the RMS. It was shown for the neurologically intact
population in Chapter 5 that there may be a relationship between the neuromuscular response
to WBV and a single cycle of vibration. Characteristic maxima in the EMG with a fixed
latency were identified, possibly elicited during a period of peak platform acceleration.
The same analysis was repeated in this study. The EMG patterns were initially grouped
according to the four main factors under investigation, which were: vibration frequency,
vibration amplitude, muscle group, and classification of SCI. The EMG patterns were
averaged according to each grouping factor and no characteristic maxima were identified for
the pre-Vibration or post-Vibration epochs as expected. In contrast, a discernible maxima
was identified for the Vibration epoch, despite not being as well defined as that for the
neurologically intact population. This maxima was particulary discernible for the data
grouped according to classification of SCI. The patterns for the other factors were not as
clear, though a maxima related to vibration frequency was indicated.
A second analysis was carried out whereby the EMG recorded during the Vibration epoch only
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were pooled according to muscle and SCI. For the acquired ‘EMG pattern’ to be classified as
valid it also had to meet the following requirements: (i) the correlation between the ‘EMG
pattern’ from the first and second testing session had to be statistically significant and (ii)
the correlation had to be positive as determine using Pearson’s correlation coefficient. The
criterion for a positive correlation was broad (r≥0.1) by necessity, due to the complexity and
range of complications experienced during experimental testing with SCI participants. For
reference, it is more common for an r-value of 0.7 or larger to be accepted as valid, however
this threshold had to be reduced to 0.1 in this analysis because no single pair of EMG
conformed to a correlation of 0.7 or greater. The r-value of 0.7 was previously determined to
be excessively restrictive during the analysis of the neurologically intact population also.
No ‘EMG Pattern’ from the ISCI participants was retained in this second analysis, though a
pattern was found for the CSCI participants. The TA and GA each exhibited characteristic
maxima (or repeatable attributes) for the CSCI participants, though in the case of the TA
the pattern did not fluctuate, and was akin to the pattern recorded for the pre- or post-
Vibration epochs. The pattern from the GA was broadly similar to the results found for the
neurologically intact population, where a maxima was present at 13% and 50% for the 12Hz
and 20Hz vibration frequency conditions respectively.
It was concluded that though this relationship was shown, it was generally not as clear or
consistent as it was in the neurologically intact population. The complexity of the case mix,
which included additional co-factors such as classification on the AIS, level of injury and
functional capability were likely to have precluded the ability to detect such changes in this
sample.
Additionally, if the assumption that the maxima, which were observed for the neurologically
intact population, were based upon reflex neuromuscular activity, as postulated by Ritzmann
et al. [88] then it is likely that such phenomenon may never be observed for some SCI
patient groups. Extensive disruption on normal central and peripheral neural function can
exist depending on the level and severity of cord injury. Any component of a spinal reflex
being induced by a WBV platform, should it exist, may never be manifested as a muscular
contraction because the reflex signals may never reach the spinal cord, or be incorrectly
interpreted by the spinal cord, or the neuromuscular system may have insufficient functional
capacity to act upon the stimulus.
6.2.2 Technical
The technical objectives for this chapter were the same as those for the analysis of the
neurologically intact participants. The objectives were principally to assess the transmission
of vibration and then to determine the effect of the vibration on the EMG signal. The
findings from the SCI participants and were in good agreement with the neurologically intact
participants and were therefore not reported on extensively, but rather a succinct summary
of the findings were reported instead.
There were no particular difference between the transmission of vibration to the neurologically
intact and SCI participants, other than noting that vibration transmission decreased as pBWS
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increased. This was most likely due to the reduction in ground reaction force, from the
reduced load at the feet, and therefore less rigid contact between the feet and the platform.
The most relevant result was the damping of vibration amplitude at higher frequencies in both
the shank, and particularly the thigh. It is likely that the vibration amplitude was damped
by the soft tissues, particulary the tendons, which acted like a low pass filter resulting in
some absorption of the vibration energy, which was subsequently released as kinetic energy
as the vibration switched direction. As a result, acceleration4 plateaued at approximately 4g
in the shank and remained constant in the VL at approximately 1.5g.
Considering that acceleration was identified as central in determining the neuromuscular
response during the vibration cycle analysis, and combining this with the fact that
acceleration was stable across all combinations of frequency and amplitude applied at the
feet, the constant neuromuscular output of the VL, rather than increasing, across all test
conditions should be expected. By contrast the output of the TA and M-GA typically
increased with platform acceleration as the shank muscles were affected by damping to a
lesser degree.
Vibration
In summary, results show that vibration frequency was well correlated for all test conditions
at all measurement locations. Acceleration and displacement measurements taken directly
from the WBV platform closely match those expected. Acceleration and vibration amplitude
of the foot increased with the vibration platform parameters but were not particularly
well correlated with them. Meanwhile, a very small increase in acceleration and vibration
amplitude of the VL was indicated for for the ISCI participants, and the changes for the CSCI
participants were negligible. The positive correlation between platform and foot vibration
amplitude, and poor correlation between platform and VL vibration was expected and these
same trends were indicated by the results from the neurologically intact participants.
These results are broadly similar to those from the neurologically intact participants where
the same trends were identified. The results for all participants, including those without a
SCI, are as follows:
• Vibration transmission was higher at lower levels of pBWS.
• Vibration was damped as it was transmitted away from the WBV platform and feet.
• Damping occurred in the form of an attenuation of vibration amplitude.
Damping may have occurred within the skeleton or soft tissue, though damping within the
soft tissue was most likely. While indicated by these results, total damping could not be
quantified with this data set, because all measurements were carried out at the skin, whose
relative movement to the tissue underneath was unknown.
4Recall that acceleration is a function of frequency squared, and is linearly related to amplitude. Low pass
filtering will therefore reduce the amplitude of vibration at that frequency and therefore reduce the detected
acceleration overall.
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It was concluded that the relative dose of vibration received by a muscle from the WBV
platform may be inferred from the acceleration data, whose amplitude was attenuated by a
reduction in vibration amplitude. Damping therefore acted to reduce the dose of vibration
received by those muscle furthest from the vibration platform. It was therefore expected that
the relative changes in the EMG due to vibration would be smallest in those muscles that
were furthest from the platform. It was thus hypothesised that the excitation stimulus to the
upper leg was predominantly moderated by vibration frequency because vibration amplitude
had largely been damped. Whereas the vibration stimulus to the lower leg would have
been equally moderated by vibration frequency and vibration amplitude. Finally, vibration
artefacts in the EMG were expected to be present at the fundamental and harmonics of the
vibration frequency, therefore simplifying the process of removing artefact from the EMG.
Artefact
As was found with the neurologically intact participants, artefact was found in every EMG
recorded in this study. It typically comprised 19.4% of the EMG recorded from the ISCI
participants, and 23.5% of the EMG recorded from the CSCI participants. However, during
some particularly intense periods of vibration application, artefact comprised 94.3% and
97.5% of the total EMG power for the ISCI and CSCI participants respectively.
Statistically significant increases in the amplitude of the EMG were found for each of the first
8 harmonic frequencies in the EMG recorded from the ISCI participants. The overall effect
size of these increases were medium-to-large for the first 5 harmonics only. The results for
the EMG recorded from the CSCI participants were comparably better, where only the first
5 harmonic frequencies resulted in significant increases in the amplitude of the EMG, and
the effect size of these increases were medium-to-large for the first 4 harmonics. The most
relevant of these statistical results are presented in Table 6.15, as derived from the results
presented in Figure 6.1.
Table 6.15: Summary of relevant statistical results from analysis of harmonics. n = harmonic
number; Ptotal =
∑n
i=1 hi as a percentage of total EMG power; Effect Size (ES) is calculated
between hn and hn−1; ISCI = Incomplete SCI; CSCI = Motor Complete SCI; SCI = Spinal
Cord Injury.
ISCI CSCI
Harmonic Ptotal ES Harmonic %Ptotal ES
[n] [%] [n] [%]
5 14.34% 0.111 4 18.16% 0.176
8 16.99% 0.029 5 19.86% 0.069
15 19.37% 0.009 15 23.49% 0.005
These results strongly indicate that vibration artefact resulted in an unacceptable addition to
the amplitude of the EMG and should be removed oﬄine using stop-band filters. To maintain
consistency in the analysis of the data in Chapter 5 and considering the results above, it was
concluded that it was adequate to remove the first 7 harmonics of vibration. A small, and in
some cases statistically significant, percentage of artefact would have remained in the EMG,
but the overall effect of the artefact on the results was deemed to be minimal.
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Artefact content increased with vibration frequency and vibration amplitude for both the
CSCI and ISCI participants. The EMG recorded during 12Hz or 1mm vibration typically
comprised 12 - 16% artefact, compared to 16 - 24% artefact for the EMG recorded during
27Hz or 3mm vibration. Artefact content was typically larger in the EMG recorded from the
shank muscles versus the thigh muscles. These results were broadly comparable to those from
the neurologically intact participants. It was also noted that, in all cases, artefact content
was highest for the CSCI participants.
These results confirm that EMG recorded during WBV contained a large and unavoidable
proportion of artefact. Some have hypothesised that ‘artefact’ such as this has been
misinterpreted, and is in fact genuine neuromuscular activity analogous to a short latency
reflex. Furthermore, some supporting evidence of this hypothesis was presented in this work
in the form of the vibration cycle analysis. The results however were inconclusive and it was
determined prudent for this study to remove such artefact in order to avoid the potential
overestimation of the EMG amplitude.
The results of the case study described in Section 6.1.3 strongly supports this standpoint. The
study precluded the possibility of the observed maxima in the EMG as originating from spinal
reflex activity, and confirmed the presence of vibration artefact in the EMG. It showed that
the induced spikes in the EMG could be misinterpreted as genuine neuromuscular activity.
When viewed in the frequency domain, the spikes were confirmed as being present in a flaccid
muscle and therefore could not have originated from spinal reflexes. Furthermore, the spikes
were effectively removed by filtering, thus reducing the amplitude of the EMG recorded
during the Vibration epoch from the flaccid muscle to pre-Vibration levels. Similarly, the
spikes were also found in a neurologically-intact muscle of the same participant, and while
these spikes were reduced by filtering, it resulted in only a minor reduction in EMG amplitude.
Artefact signals were again limited to specific frequency bands which nominally occurred at
the vibration frequency and its harmonics. This simplified the process for artefact removal.
Results from the statistical analysis showed that it was adequate to specifically remove
the first 5 harmonics of the vibration frequency, however, the first 7 harmonic frequencies
were removed in this analysis to maintain consistency with the analysis carried out for the
neurologically intact participants.
EMG Classification
Vibration artefact was not the only source of error found in the EMG recorded for this study.
It was observed during testing that WBV would elicit a series of clonic spasms in some of
the SCI participants, and while this phenomenon is of interest, it was not under investigation
in this study. It was therefore deemed that the corresponding EMG showing this spasmodic
neuromuscular activity be removed from the analysis.
The procedure for rejecting these EMG was automated in order to maintain consistency and
remove the element of ‘human error’. The same custom algorithm, as that used previously,
was used here. The ratio between the burst-like (spasm) to tonic activity was used to
determine whether the EMG contained outlying data. 680 EMG were ultimately rejected
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as outliers. This accounted for 15% of all recorded EMG, 43% of which were recorded during
the post-Vibration epoch which was not considered in the subsequent analysis in any case.
These rejection rates were considerably higher than those rejected from the neurologically
intact participants and the majority of the rejected EMG were from the shank muscles. There
was also an increase in the number of rejected EMG with increasing vibration frequency and
amplitude. These results were broadly comparable to those from the neurologically intact
population. Most of the rejected EMG were from the ISCI participants. This was expected
because those subject with an incomplete injury typically had stronger muscles, therefore
when a spasm did occur it was more likely to be detected by the EMG electrodes and rejected
by the algorithm.
BTR statistics of the accepted EMG were calculated. There was no statistically significant
difference between tests, and the BTR was higher during the Vibration epoch than during
the pre-Vibration epoch, and higher for the ISCI participants, as expected. It increased with
vibration frequency and amplitude, and was approximately the same for the different muscle
groups.
These results confirmed that the application of WBV with pBWS was feasible in a SCI
population. Despite the comparably large number of rejected EMG, over 3,800 discretised
EMG were retained for further analysis. The BTR values corroborated the physiological
findings above which confirmed an increased neuromuscular response during the application
of WBV.
6.3 Conclusions
It was shown that WBV-pBWS was feasible in both neurologically intact and SCI populations.
This was confirmed by the increased neuromuscular response found during the Vibration
epoch. Furthermore, increases in neuromuscular activity were identified with all levels of
pBWS, including 100% pBWS when applied with a neurologically intact population. It
was shown that pBWS may be used to facilitate conventional WBV training (i.e. with
the participant standing on the vibration platform). The same measurements and analysis
techniques were applied during the study of SCI and neurologically intact participants
allowing for the results of each group to be directly compared with one another.
Overall, the neuromuscular responses to WBV were small, irrespective of vibration frequency,
vibration amplitude, muscle group, level of pBWS or classification of SCI. The increases
in neuromuscular activity were typically less than 10% MVC for the neurologically intact
participants and the likelihood of muscle hypertrophy occurring in a SCI population as a
result of WBV training was concluded to be small, particularly because a SCI population
would typically carry the WBV exercises with higher levels of pBWS.
Acceleration measurements indicated that the vibration was damped as it was transmitted
throughout the legs, and that it was damped to the same degree regardless of a SCI or not.
The magnitude of the damping decreased with the proximity of the muscle to the vibration
platform. Vibration transmission was also reduced with increasing levels of pBWS. It was
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thus concluded that the dose of vibration was lowest for the neurologically intact population
at 100% pBWS and CSCI participants.
Damping reduces the total dose of vibration received at a particular location and therefore
directly impacts upon the magnitude of the neuromuscular response. This is evidenced by
the fact that the relative changes in EMG (∆EMG) were consistently larger for the shank
muscles than the thigh muscles. However, despite the relative change in activity recorded,
the absolute magnitude of neuromuscular activity achieved by the muscle during vibration
(EMG & EMGN ) was primarily predicated on the level of contraction in the muscle prior
to the onset of vibration. This is evidenced by the fact that the most active muscles both
before or during vibration were the GA and VL, regardless of neurological injury or not.
However, in all cases the magnitude of the response to WBV was small, despite the fact that
the relative change to baseline was often large.
It is difficult to directly compare the absolute levels of activity for the SCI participants to
those from the neurologically intact population, because the EMG from the SCI participants
were not normalised to a MVC. Despite this limitation, it was concluded that the absolute
level of activity achieved by the SCI participants was small. There are a number of indicators
for this conclusion: (i) the ∆EMG for the SCI participants and those from the neurologically
intact population were similar. Therefore, since it is known that the EMGN values for the
neurologically intact population are small, it can thus be inferred that the values for the SCI
participants are small also; (ii) The EMG values recorded from the SCI participants were
less than 16µV, and while these values may not be used for inter-subject comparisons, they
are generally considered to be small; and (iii) ∆EMG are similar for both test populations,
however the SCI participants are most likely starting from a much lower baseline due to
disuse induced muscle atrophy, a large ∆EMG would still be equivalent to a small absolute
level of muscle activity.
The presence of vibration artefact was initially described during the analysis of the results of
results from the neurologically intact participants (Chapter 5) where it was concluded that
artefact significantly increases the amplitude of the EMG. It was shown that the artefact is
effectively eliminated by using notch-filters specifically at the frequency of vibration and its
harmonics, and that it is sufficient to remove to first 7 harmonics only. Supporting data from
the case study carried out with a SCI participant confirmed that the ‘spikes’ in the power
spectrum of the EMG were more likely to be vibration artefacts rather than a short latency
reflex. The outcome of the case study was twofold: (i) it was known that a neuromuscular
response cannot be elicited in a flaccid muscle, therefore the increase in the amplitude of the
EMG were confirmed to be artefact, and (ii) applying notch-filters to the first 7 harmonics
of vibration effectively reduced the magnitude of the EMG to pre-Vibration levels, and were
therefore effective in eliminating artefact from the EMG.
Clear trends were identified from this small and complex case mix. This cross-sectional
study recruited early-stage SCI participants of differing levels of cord injury, severities of
injury, time since injury, and possible bi-lateral limb imbalances. Further analysis of the data
grouped according to AIS classification and ASIA muscle scores could perhaps elucidate
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further a particular ISCI or CSCI subgroup that may benefit from WBV training to a
greater degree, however insufficient data was collected in this study to carry out such an
analysis. The results for the SCI participants were similar to those results for those from
the neurologically intact population when they were provided with 100% pBWS. Vibration
caused a small but confirmed increase in neuromuscular activity, and the magnitude of the
increase was determined to be elicited by peak platform acceleration. It was concluded
that despite the increases being small, WBV-pBWS should be investigated further as a
rehabilitation technology. In the case of the CSCI participants, any increase in neuromuscular
activity is larger than the maximum voluntary capacity of the muscle and is therefore of
potential benefit. In the case of the ISCI participants, the WBV platform may be used
to augment existing functional capability and could be employed as an adjunct to existing
muscle strengthening or rehabilitation exercises.
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Chapter 7
Conclusions & Future Work
A cycle of decline in cardiovascular and pulmonary health of early-stage SCI patients,
accompanied by muscle atrophy, bone demineralisation and orthostatic intolerance were
highlighted at the beginning of this thesis. The scope of the work set out was to focus
on rehabilitation technologies which may be employed during early-stages SCI rehabilitation
and used to attenuate some of these declines.
Two suitable technologies were identified: RATTT and WBV-pBWS. In the case of
RATTT, the commercial system was sufficiently well developed such that it was adequate to
integrate a cognitive feedback system to encourage volitional participation, and then measure
cardiopulmonary and vascular output during robotic-assisted stepping, and robotic-assisted
stepping with the support of FES. In the case of WBV, the neuromuscular response of a SCI
population to vibration was poorly understood with only limited evidence available in the
literature. Furthermore, an adequate system to test WBV with a neurologically compromised
population did not exist. A WBV platform was therefore integrated with a pBWS system to
facilitate testing in this population.
Having identified two such technologies for application in SCI, the following objectives were
set out: (i) determine the feasibility of RATTT as a form of exercise during early-stage SCI
by measuring the acute vascular, pulmonary and ventilatory responses of an early-stage SCI
patient population during RATTT training and assess if the training could be of sufficient
intensity to potentially attenuate the decline in fitness, and (ii) develop a rehabilitation
system that allows those with an early-stage SCI to stand on a WBV platform, measure and
quantify the magnitude of the acute neuromuscular response of a neurologically intact and
SCI population to WBV in order to determine the feasibility of the system for early-stage
SCI rehabilitation, and then assess if the response was of sufficient magnitude to attenuate
or counteract muscle atrophy.
7.1 Conclusions
In the case of both RATTT and WBV, the initial requirement was to assess the feasibility
of each and determine if they could be applied for SCI rehabilitation. One of the principal
contributions of this thesis was the demonstration of this feasibility. RATTT and WBV
were well tolerated by the neurologically intact and SCI populations, and no severe adverse
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effects were reported. In both cases there was concern of orthostatic instability arising due
to the verticalisation of a patient group unused to being in a standing position. RATTT was
identified as having the smallest risk of this occurring, due to the activation of the skeletal
muscle pump during robotic stepping, and the fact that patients were verticalised to 70◦ from
supine rather than being fully upright. In the case of WBV-pBWS, there was one instance of
pre-syncope during testing, as is possible during any form upright training with SCI patients.
There were no other adverse effects which were reported in the literature, such as erythema.
In addition to the successful trial of these systems with SCI patients, both were shown to have
potential for a positive effect. This was particularly the case for the ISCI participants who
exhibited increased metabolic demand and heart rate during robotic stepping and relatively
large changes in neuromuscular activity during WBV. The corresponding changes from the
CSCI participants were typically not as large, but some increases occurred nonetheless. In the
case of both technologies, it was possible for the ISCI participants to utilise their remaining
function to augment the effect of the rehabilitation technology. In this regard, the feasibility
of both technologies was demonstrated. Not mentioned in either study was the potential
psychological benefit of carrying out rehabilitation in an upright position. This was an
aspect of the technologies that was frequently remarked upon during testing but was not
under particular investigation in this thesis and as such was not discussed any further.
The second aspect of the RATTT investigation was to assess if the training was of sufficient
intensity to attenuate the decline in fitness. The metabolic demand of the ISCI participants
was equated to 1.5 - 3.1 METs, which is considered to be of low to moderate intensity by the
WHO. The metabolic demand of the CSCI participants was equated to 1.4 - 2.1 MET’s, or low
intensity activity. In both cases though, these levels of activity were typical of the maximum
achievable metabolic demand in the absence of any training of the SCI patients. It was thus
determined that RATTT was suitable for SCI rehabilitation. Furthermore, it was noted that
the intended application of this technology was for early-stage SCI rehabilitation only. It was
shown that it can be applied with success, and no adverse effect or instance of OH occurred,
thus resulting in an increased metabolic demand. It is proposed that RATTT is used in this
way until such a time that the patient is comfortable with being in an upright posture and
can then progress to other forms of proven exercises such as walking (if functionality permits)
or cycling, with or without the support of FES.
The second aspect of the WBV-pBWS investigation was to describe the steady-state
neuromuscular response during its application, principally because little or no evidence
existed in the literature to that effect. A limited number of studies investigated the effect of
WBV on changes in isokinetic strength and blood flow in neurologically compromised patient
groups, with little supporting evidence available on which vibration conditions should be
applied [115,136]. The results from Chapters 5 & 6 confirmed that WBV-pBWS may be used
to elicit an increase in neuromuscular activity and it was shown that increasing frequency
or amplitude elicited an increased neuromuscular response. Each of these parameters were
combined into an acceleration value, and the vibration cycle analysis indicated that it was
platform acceleration that ultimately moderated the neuromuscular response. This was the
second principal contribution of this thesis: providing a systematic and detailed description of
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the steady-state neuromuscular response to a range of low, medium and high WBV platform
accelerations.
Confirmation that acceleration moderated neuromuscular output was evidenced further by
the fact that the neuromuscular activity of the shank muscles typically increased with
acceleration regardless of neurological injury or not, meanwhile, acceleration data indicated
that the transmission of vibration to the thigh was low due to the attenuation of vibration
amplitude, resulting in a non-specific increase in VL neuromuscular activity during WBV.
It was thus concluded that in order to achieve training of the shank muscles with WBV, it
would be adequate to increase frequency or amplitude, however a corresponding increase in
output of the thigh muscles should not be expected. Overall, the magnitude of the response
to WBV-pBWS were relatively small, thus precluding the likely effectiveness of WBV-pBWS
for improving muscle strength or power in SCI. However, other potential applications of
WBV for rehabilitation in SCI were identified.
7.2 Future Work
7.2.1 Limitations & Alternative WBV Support Systems
One of the principal challenges in applying WBV-pBWS in SCI was fitting the participant
with the support harness, and achieving an appropriate standing position. This was
particularly difficult with the CSCI participants who in some cases also exhibited hypertonia
of the hip flexors and extensors. In these cases it took considerable time to get the
leg to stretch and settle into the prescribed position. In some cases, it was preferred if
the participant had spent time stretching in a standing frame prior to taking part in an
experimental session. This was typically part of a standard rehabilitation regime in the
spinal unit though it was not a requirement for inclusion in this study.
Secondly, in some cases the feet of the SCI participants would move during testing with high
platform accelerations, particularly with the CSCI participants. While this movement was
not reflected in the acceleration data, it was concluded that the foot was able to move because
there was insufficient ground reaction force, and therefore insufficient friction to hold the foot
in place.
It is therefore proposed that it may also be appropriate to integrate a WBV platform into
a standing frame. Full support would be provided by the frame while maintaining a large
component of body weight being supported by the legs. There would therefore still be a
large ground reaction force. In many cases, a standing frame is more practicable than a body
weight support system, and may therefore be more likely to be used in a clinical environment.
Increased loads could be achieved with this system by increasing frequency or amplitude. A
limitation of the application of vibration in this way however is the inability to control the
load carried by the participant themselves. In a worst case scenario the participant could
simply allow the frame to take all of the body weight. There would consequently not be a
prior level of contraction in the muscle, which is important in modulating the magnitude of
response achieved during vibration. The advantage of the pBWS system in this regard is
that the participant must use some volitional effort where appropriate.
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To overcome this limitation with a standing frame, a force transducer could be built into the
base of the standing frame. Feedback could be provided from the force transducer indicating
how much load was being carried by the standing frame and how much load was being carried
by the participant. The integration of a force transducer would also open up the possibility
of comparing the neuromuscular response to different levels of ground reaction force.
7.2.2 Muscle Performance
The work in this thesis described the acute neuromuscular responses of neurologically intact
and early-stage SCI volunteers to WBV-pBWS. The next logical step is to investigate the
effect of a longer term regular WBV training programme on muscle strength. Despite the
conclusion that the overall increase in neuromuscular activity during the vibration was small,
it was generally larger than that which could be achieved by the SCI participant on their
own. Furthermore, WBV typically resulted in larger gains in untrained populations (Section
3.6) and empirical evidence generated as part of the EMG studies presented in this thesis
provide justification of which vibration parameters should be used and which muscle groups
tested.
It is thus proposed that the effectiveness of a longitudinal WBV training programme be
assessed in a chronic SCI (>1 year since injury) patient population. It is important that
the effectiveness of the training programme be compared against an established exercise
programme, such as recumbent FES cycling, as this has been a major shortfall in assessing
the effectiveness of other WBV training programmes reported in the literature. Ideally the
investigation should be a randomised control trial, with patients randomly allocated to the
WBV or standard group. A chronic SCI patient group should be selected as their functional
capability would have plateaued and therefore any change in muscle performance could be
more reliably attributed to the intervention. The drawback of this approach is that the nerves
and muscle tissue may have degraded to such a point that the training period required would
be extensive and the gains may be minimal, since the level of muscle performance would
likely be very low to begin with.
An increase in training load should be achieved with the ISCI patients by first decreasing
the level of pBWS and then by increasing platform acceleration. The VL and M-GA were
typically found to exhibit the largest neuromuscular response during vibration, and as such a
pre-contraction of the muscle should be encouraged by performing heel lifts and deep squats.
Dynamometry could be used at regular intervals to assess changes in muscle strength.
Increased training load with the CSCI patients may only be achieved by increasing platform
acceleration. Effective transmission of the vibration to the CSCI patients legs is key, due to
the increased tendency of their legs to move during instances of high platform acceleration.
Strapping of the feet to the WBV platform would be one such approach. FES should be used
with dynamometry to assess any changes in muscle strength.
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7.2.3 Contraction Onset Latency
This study characterised the steady-state neuromuscular response to different WBV condi-
tions, and it was assumed that steady-state had been achieved within the 30s time frame
during which vibration was applied. Another potential aspect of the neuromuscular response
to WBV would be to investigate the onset latency of the contraction during WBV. The
question arises: is the neuromuscular response immediate and constant soon after the
application of vibration? Or does the neuromuscular response start slowly and build gradually
as it does with a TVR?
The same experimental methodology as was used in this thesis could be used again. However,
it is proposed that a single vibration condition be used, apply vibration for a longer period
of time, repeat in triplicate, and investigate in a larger test population. During the analysis,
the RMS should be calculated with a relatively small moving window such that the onset of
the contraction is not averaged out if it occurs quite rapidly.
7.2.4 Spasticity
Spasm is a major contributing factor which inhibits the ability to participate in effective
forms of rehabilitation. Results from this study indicate that WBV may provide sufficient
stimulation to modulate the neural pathway which leads to spasm and therefore potentially
act to reduce it, while at the same time not significantly acting to increase muscle strength
or power. The use of WBV to treat spasticity was initially proposed by Ness and Field-
Fote [173]. Clonus and hypertonia, which were both a consequence of hyperexcitability of
the α-motoneuron among other complicating factors, resulted in an increase in muscle tone
or contraction from a very minor stimulus.
WBV may be particularly suited to the treatment of spasticity for two main reasons. Firstly,
it is apparent that WBV increases neuromuscular activity which primarily acts via the α-
motoneuron. It is hypothesised that repeated stimulation of the α-motoneuron by WBV
could ultimately lead to an increase in the de-polarisation threshold of the α-motoneuron
and therefore decrease in its excitability. The excitability of the α-motoneuron could be
assessed by measuring the H-reflex at repeated intervals during a longitudinal course of WBV
treatment. Secondly, the intention of any treatment of spasm would be to ensure that the
treatment itself would not make the spasm worse, for example by increasing muscle strength,
in which case the consequence of the spasm would be considerably more severe. The findings
from this study show that the likelihood of any increase in muscle strength from WBV applied
with pBWS is small.
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The Nervous System
The human nervous system comprises the central and peripheral nervous systems. The central
nervous system consists of the brain and spinal cord, and the peripheral nervous system
consists of cranial and spinal nerves. The functionality of the nervous system is divided into
two subcategories: the autonomic, and somatic nervous systems. The somatic nervous system
allows volitional movement to be achieved through interaction with the peripheral nervous
system. The peripheral nervous system conveys effector signals away from the central nervous
system towards muscles and glands (efferents), and conveys sensory information from sense
organs towards the central nervous system (afferents). Afferents, and efferents, are volleys of
action potentials which are generated and transmitted by nerve cells. As such, the nerve cell
is considered to be one of the most basic functional units within the nervous system.
Spinal Cord
The spinal cord connects the brain to the peripheral nervous system and is made up of white
and grey matter. It extends caudally from the base of the skull to the conus medullaris,
which is located approximately at the L1\L2 vertebral level [181]. The function of the spinal
cord is to transport sensory and motor information to and from the brain. The peripheral
region of the spinal cord contains longitudinally oriented, ascending and descending, sensory
and motor tracts [8]. The myelin sheath(s) that protect the axons of these ascending and
descending tracts are white in colour, and the region is so called white matter. Contained
within the white matter is a butterfly shaped region called grey matter, which is a densely
packed region of neuronal cell bodies. The spinal cord is housed within the bony vertebral
column, which is considered as four separate and distinct regions, known as the cervical,
thoracic, lumbar and the sacral regions. The cervical, thoracic and lumbar regions are made
up of 24 articulating vertebrae and the sacral region is fused.
The spinal cord is involved in many bodily functions from pupil dilation and sweating to
movement, and its functional activity is carried out through the somatic and autonomic
nervous systems. The somatic nervous system innervates skeletal muscle, and is generally
involved in coordinated muscle activities for posture, movement and control. The autonomic
nervous system innervates smooth and cardiac muscles, and glands, and is involved in
involuntary bodily functions. In some cases the somatic and autonomic nervous systems
can and do interact, for example in the maintenance of body temperature. If there is a
drop in body temperature, the somatic nervous system initiates heat generation by eliciting
a contraction in skeletal muscle, while at the same time the autonomic nervous system
minimises heat loss by eliciting vasoconstriction [181].
Autonomic Nervous System
The autonomic, or visceral, nervous system is composed of three subdivisions, which include:
(i) the sympathetic, (ii) parasympathetic, and (iii) eccentric divisions. Sympathetic, or
thoracolumbar, outflow occurs between spinal segments T1 - L2. It is generally involved in
‘fight-or-flight’ responses and innervates the heart and lungs, abdominal viscera, and urinal,
genital and lower digestive systems [181]. Parasympathetic, or craniosacral, outflow occurs
from nerves that take their origin from the cranium and spinal segments S2 - S4. It is
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generally involved in conservation and restoration of resources, and is mainly involved in
urination, defecation, and erection mechanisms [181]. The eccentric division is involved in
the functioning of the gut, and is described as the ‘gut-brain’ as it can operate without central
nervous system control [181].
Sympathetic and parasympathetic outflow both exert control over certain systems such as
the heart, lungs and gastrointestinal tract. Sympathetic function can elicit an increase in
heart rate, dilation of blood vessels and bronchial lumen and stimulation of the sphincter,
whereas the parasympathetic system will decrease heart rate, constrict bronchial lumen and
inhibit the sphincter.
Somatic Nervous System
The somatic nervous system communicates with higher level cortical centers, the peripheral
nervous system, and the autonomic nervous system, via interneurons and spinal roots. The
somatic nervous system is responsible for the control of all volitional motor activity and
innervation is taken from all spinal segmental levels. The motor and sensory signals involved
in voluntary movement are conveyed via spinal roots, and innervation of the roots for a
particular part of the body is generally taken from one segmental level. During volitional
motor tasks, an efferent is sent from the central nervous system, via the peripheral nervous
system to a muscle cell resulting in a contraction. This contraction is detected by sense
organs which send a sensory signal back to the central nervous system, therefore creating a
closed loop system and permitting control over the motor output.
Involuntary motor activity is not part of the somatic nervous system and occurs where a
sensory nerve synapses directly with a motor nerve cell. This therefore results in a short circuit
of the path to the muscle cell, and bypasses the central nervous system. Such involuntary
activity is described as a spinal reflex, whose function is generally to protect. Spinal reflexes
are characterised by their short latency and examples include the withdrawal and myotatic
reflexes.
Spinal Roots
Dorsal and ventral roots, which carry sensory and motor information respectively, combine
to form a spinal root (Figure 1). Sensory afferents are conveyed towards the posterior horn of
the spinal cord from discrete regions of the peripheral nervous system known as dermatomes.
Motor efferents from the anterior horn of the spinal cord are conveyed to a group of muscle
fibers, known as a myotome. It is possible for a root to innervate more than one muscle and
one muscle to be innervated by more than one root [8].
The spinal roots, of which there are 31 pairs, are named based on the vertebral foramina
through which they pass. There are 8 pairs of cervical roots, 12 pairs of thoracic roots, 5
pairs of lumbar roots, 5 pairs of sacral roots and a single coccygeal root [182]. The head,
neck, arms and hands are supplied by the roots that take their innervation from the cervical
spine (C1 - C8). The chest and trunk are supplied by the roots innervated at the thoracic
level (T1 - T12). The legs are innervated at the lumbar level (L1 - L5), and the feet and anus
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Figure 1: Schematic of spinal segment with spinal roots (adapted from Grays [175]).
are innervated at the sacral level (S1 - S5). Since the spinal cord is shorter than the vertebral
spinal column itself, the lumbar and sacral roots are longer and extend caudally within the
spinal cistern known as the cauda equina (horses tail) [181]. A basic schematic is outlined
in Figure 2 identifying the relationship between different regions of the body and the spinal
column.
Figure 2: Schematic of spinal column and cord with corresponding dermatome and myotome
regions (adapted from Noback et. al. [181]).
Volitional movement occurs when an action potential is generated by the somatic nervous
system and propagated along the relevant spinal root to the appropriate neuromuscular
junction, eliciting a MUAP. As the MUAP propagates along the muscle, it elicits a
contraction of the individual muscle fibers within the muscle.
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Muscle Fiber
The extrafusal muscle fiber is one of the most basic functional units that comprises striated
muscle. The basic components that make up a muscle fiber are outlined in Figure 3. The
contraction of a muscle cell is described by the sliding filament theory.
Figure 3: Basic schematic of a muscle fiber describing the main components involved in the
contraction of muscle (adapted from Branstrom et al. [183]). Not shown in this figure are
troponin, tropomyosin, the terminal cisterna, mitochondria, the binding sites on actin for
the myosin heads, or the binding sites on the myosin heads for the adenosine triphosphate
molecule. During a muscle contraction, the actin subunits are drawn together by multiple
cross bridging cycles between actin and the myosin heads therefore causing the muscle to
shorten.
Single Cross Bridge Cycle
During a single cross bridge cycle, a MUAP propagates along the sarcolemma and down
the t-tubules of a muscle fiber, stimulating the release of Ca2+ from the terminal cisternae
(not shown). As the Ca2+ ions enter the intracellular fluid (cytosol), they bind to troponin,
therefore changing the troponin-tropomyosin complex conformity on the actin subunit. This
change in conformation exposes the myosin binding sites on the actin subunit. Energised
myosin heads, found on the myosin chains bind with the exposed binding sites, forming
a cross-bridge. Once bound, the myosin head releases Adenosine Diphosphate (ADP) and
inorganic phosphate, causing the myosin head to flex and pull the actin in. This is called the
power stroke. At the end of the power stroke, an ATP molecule binds to the myosin head,
and is converted into ADP and inorganic phosphate in a process called hydrolysis, therefore
energising the head and causing it to disconnect from the actin subunit. The Ca2+ ions
are pumped back into the terminal cisternae, restoring the troponin-tropomyosin complex
conformation, and covering the myosin binding sites. A sustained contraction of muscle
occurs during multiple cross bridge cycling.
ATP is a key component of the single cross bridge cycle and it is produced by the
mitochondrion. ATP is used during the power stroke and during the pumping of Ca2+ in and
out of the terminal cisternae. A small store of ATP is available within the muscle, however
during periods of sustained activity it is necessary to generate additional ATP. Mitochondria
are therefore commonly described as the ‘cellular power plant’.
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ATP Production
ATP is produced by one, or a combination, of the following processes: (i) hydrolysis of
creatine phosphate, (ii) glycolysis, or (iii) oxidative phosphorylation. Hydrolysis of creatine
phosphate and glycolysis can occur in the absence of oxygen and are therefore described
as anaerobic. Oxidative phosphorylation occurs with oxygen and is therefore described as
aerobic.
During rest and recovery, lactic acid built up in the muscle is converted back into pyruvic
acid, which is converted into CoA which is used to produce ATP, carbon dioxide, and water.
ATP is then used to replenish creatine phosphate stores from creatine.
Fiber Type
Muscle fibers are broadly categorised into three sub-groups based on their physical, electrical,
and axonal properties: (i) slow twitch (Type I), (ii) fast twitch-fatigue resistant (Type IIa),
and (iii) fast twitch (Type IIb). The general properties of these muscle fibers are described
in the Table 1. The fatigue resistance of a muscle fiber is related to the capillarisation, and
number of mitochondria present in the fiber. A fiber is more resistant to fatigue if it is
oxidative, i.e. a plentiful supply oxygen is available, and it can readily produce ATP due
to a large number of mitochondria. In the absence of oxygen and mitochondria, a muscle
fiber will be more reliant on glycolytic, or anaerobic, processes and it will therefore be more
readily fatiguable.
Table 1: Summary of the mechanical, electrical, and axonal properties of the different types
of muscle fiber.
Fiber Type Mechanical Electrical Axon
Type I Slow twitch; small force
production; fatigue resis-
tant; small fiber diameter
Slow nerve conduction ve-
locity
Small; recruited for low
force production
Type IIa Fast twitch; fatigue resis-
tant
Intermediate nerve conduc-
tion velocity
Intermediate; recruited for
moderate force production
Type IIb Fast twitch; high force pro-
duction; fatiguable; large
fiber diameter
High nerve conduction ve-
locity
Large; recruited for high
force production
Muscle activity can be studied by inferring the chemical and electrical processes that are
occurring during a muscle contraction. The MUAP which elicits a cross-bridge cycle resulting
in a muscle contraction can be measured using EMG. The chemical processes within the
mitochondria leading to the generation of ATP which is used as a fuel during a muscle
contraction can be monitored by measuring gas exchange at the mouth. These techniques
are discussed in greater detail in Section 1.1.
Sensory Receptors
While movement is achieved through the contraction muscle fibers, the motor output is
controlled by the central nervous system based on feedback of the movement from sensory
receptors. Two examples of sensory receptors that are found in muscle are muscle spindles and
Golgi tendon organs. These receptors are integral to proprioception and control of movement.
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Furthermore, they are thought to play a role in the neuromuscular response to WBV which
is discussed in greater detail in Chapter 3.
Muscle Spindle
The muscle spindle is a sensory receptor that lies in parallel with the extrafusal muscle fibres
of skeletal muscle. Its function is to detect the change in length of skeletal muscle, and it is
thought to play a central role in the neuromuscular response to WBV. The muscle spindle
in encapsulated with modified muscle fibres called intrafusal fibres. The intrafusal fibres
moderate the sensitivity of the muscle spindle during both static and dynamic contractions
of skeletal muscle. The spindle thus has both sensory and motor innervation.
There are two sensory fibres that innervate the muscle spindle: type Ia and type II fibres.
The type Ia fibre plays a central role in the stretch reflex. Motor innervation is provided
via the γ-motoneuron, which itself is subdivided into γ-dynamic and γ-static motoneurone.
The γ-motoneuron innervates the intrafusal fibres, causing them to contract and increase the
sensitivity of the muscle spindle. The γ-dynamic motoneuron is essential to allow the body to
react to external disturbances while the γ-static motoneuron ensures that the spindle remains
taut when the extrafusal fibres are held at a constant length.
The Ia fibre synapses directly with: the α-motoneuron that supplies the same muscle
(homonymous muscle), the α-motoneuron that innervates synergistic muscles, and interneu-
rone that inhibit antagonistic muscles (heteronymous muscles). Type II fibres can also
synapse directly with the α-motoneurone innervating homonymous muscles.
Golgi Tendon Organ
The golgi tendon organ is found at the tendinous insertion of the muscle and it detects
tension. It is innervated by type Ib sensory fibres that act to inhibit homonymous muscle
activation. Chief among its functions are to prevent damage to the tendon from excessive
forces generated by the muscle and to facilitate contraction of the antagonistic muscle through
reciprocal inhibition.
Spinal Reflexes
The command to elicit a contraction in skeletal muscle, and therefore movement, normally
originates from the central nervous system. Central commands via the somatic nervous
system are normally voluntary. In some instance, commands originating from the peripheral
nervous system can also elicit a contraction in muscle. These are called spinal reflexes, and
they are involuntary, have a short latency, and they bypass the central nervous system. A
simple example is the stretch, or myotatic, reflex.
A stretch reflex of the quadriceps muscle group (knee jerk reflex) can easily be achieved by
tapping the patellar tendon with a tendon hammer. Striking the patellar tendon causes it
to shorten, resulting in a stretch of the quadriceps. This is detected by the muscle spindle,
which sends a volley of action potentials via the 1a fibre, to synapse with the homonymous α-
motoneuron. These action potentials are excitatory and act to depolarise the α-motoneuron
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and cause the muscle to contract, thereby shortening back to its original length. For this
reason the stretch reflex is described as monosynaptic (see Figure 4), i.e. it involves only one
synapse.
Figure 4: Schematic of a stretch reflex (adapted from Noback et al. [181]).
In addition to synapsing with the homonymous α-motoneuron, the 1a fibre also synapses
with with interneurons that inhibit α-motoneuron activity in the antagonistic muscle. In this
example the quadriceps will thus contract and the hamstring will relax, causing the knee to
jerk. This highlights the interaction between motor-, sensory- and interneurons, and the role
they each play in the generation of human movement. It has been widely suggested in the
literature that the stretch reflex plays a central role in the neuromuscular response to WBV
(Chapter 3).
The Jendrassik maneuver may be used to potentiate the stretch reflex. In this maneuver,
the subject is asked to interlock their fingers and pull. Facilitatory action potentials are
thought to descend from higher levels and potentiate the response to stretch. The H-
reflex is analogous to the stretch reflex, however instead of stretching the muscle to elicit
the contractile response, an electrical stimulus applied to the spinal root, thereby directly
depolarising the α-motoneuron, and eliciting a contraction in the homonymous muscle group.
To better understand reflexes, and the interaction between sensory fibers and muscle cells it
is necessary to describe the nerve cell in greater detail.
The Nerve Cell
Efferent nerve cells are described as UMN if located in the central nervous system, or LMN
if located in the peripheral nervous system. Most UMN are found within the white matter
of the spinal cord. The majority of nerve cells found within the grey matter of the spinal
cord are interneurons, which interconnect the ascending and descending spinal tracts, and
the peripheral nervous system.
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The nerve cell itself consists of a cell body (soma), a dendrite and an axon. The axon, which
is protected by an insulating sheath called myelin (Figure 5), can have a number branches
called collaterals. It stems from the axon hillock, and is the point at which an action potential
is generated. An action potential is a small electrical impulses that allows all communication
within the nervous system.
Figure 5: Schematic of nerve cell (adapted from Jaroz [184]).
Action Potential
An action potential is a large change the resting membrane potential of a nerve cell (Figure
6) that results in a change in the permeability of the cell to Na+ and K+ ions. The action
potential is a characteristic of the nerve cell that generated it as it it always of the same
magnitude. The action potential is generated at the axon hillock, where the density of Na+
ions is greatest. The typical membrane potential of a nerve cell at rest is approximately
-70mV, so called the resting membrane potential. If incoming signals from the dendrites
and cell body are sufficient to bring the membrane potential to a threshold of approximately
-55mV, voltage-sensitive Na+ gates open, thereby changing the cells permeability to the Na+
ions. The influx of Na+ down their concentration gradient and into the cell results in a rapid
increase in the membrane potential, and forms a positive feedback loop that opens additional
voltage-sensitive Na+ gates. The membrane potential will continue to rise to a peak value
of approximately +30mV. This process is called depolarisation. If the initial stimulus is not
sufficient to reach threshold, the voltage-sensitive Na+ gates will not open and no action
potential will be generated. It is for this reason that an action potential is described as an
all-or-none event.
Two processes interrupt the positive feedback loop and bring the generation of the action
potential to an end. The open Na+ channels become inactivated by a time-sensitive gate
that closes after a period of time, preventing an influx of additional Na+. Voltage-sensitive
K+ channels also become active. The K+ channels respond slowly to the initial change in the
membrane potential and only become fully active after the peak of the action potential has
occurred. K+ begins to move out of the cell, resulting in a decrease in the membrane potential
back towards its resting value. This process in known as repolarisation. Due to the slow
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response of the K+ channels, there is a delay between reaching the resting membrane potential
and the channels finally closing. This results in the cell membrane becoming hyperpolarised.
Figure 6: Schematic of action potential. A-RF: Absolute refractory period. R-RF: Relative
refractory period
During the absolute refractory period it is not possible to generate another action potential.
It occurs when most of the Na+ channels are inactive during repolarisation. The epoch
immediately after this is known as the relative refractory period. During the relative
refractory period it is possible to generate an action potential but a larger than normal
stimulus is required. This is because some of the Na+ channels remain inactive and some of
the K+ channels are still open. Having generated an action potential at the axon hillock, it
is conducted down the axon to the next synapse.
Synapse
A synapse is a chemical or electrical connection, found at junction between: two nerve cells,
a nerve cell and a gland, or a nerve cell and a muscle fibre. The most common synapse in
the human nervous system is chemical (Figure 7) and is characterised by the presence of
a synaptic cleft, synaptic vesicles, and a delay due to neurotransmitter release. Chemical
synapses are advantageous because they can be excitatory or inhibitory.
Figure 7: Schematic of chemical synapse (adapted from Branstrom et al. [183]).
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Neuron-to-neuron synapses are typically found to be between: the axon terminal of the
presynaptic neuron and the dendrite of the postsynaptic neuron (axodendritic synapse),
the axon terminal of the presynaptic neuron and the soma (cell body) of the postsynaptic
neuron (axosomatic synapse), or two axon terminals (axoaxonic synapse). Axodendritic and
axosomatic synapses are similar because they directly carry input signals to the postsynaptic
neuron. Axoaxonic synapses do not directly carry an input signal to the neuron, instead they
can control the amount of neurotransmitter released by another neuron. Axoaxonic synapses
can thus be excitatory or inhibitory.
An action potential arriving at the axon terminal opens voltage-sensitive Ca2+ channels,
increasing the permeability of the terminal to Ca2+, thereby permitting the flow of Ca2+ into
the axon terminal. The influx of Ca2+ causes the synaptic vesicles to bind the membrane of
the axon terminal and release a fixed amount of neurotransmitter into the synaptic cleft. The
neurotransmitter diffuses through the synaptic cleft and binds to specific receptors on the
postsynaptic cell membrane. This causes a change in the permeability of the cell membrane
to particular ions, allowing them to flow, resulting in a polarisation of the membrane and
a generation of a synaptic potential. If the synaptic potential is of sufficient magnitude,
threshold will be exceeded and an action potential will be generated. Polarisation ends when
the neurotransmitter dissociates from the the binding receptor. The neurotransmitter is then
pumped back into the presynaptic axon terminal or is broken down by support cells and
re-synthesised.
Synaptic Potential
Depending on the type of neurotransmitter released and the type of receptor binding site,
the postsynaptic cell membrane will depolarise or hyperpolarise. Excitatory postsynaptic
potentials are generated when the movement cations such as Na+ and K+ is allowed, resulting
in an increased membrane potential and an enhanced postsynaptic potential. Inhibitory
postsynaptic potentials are generated when the movement of anions such as Cl2− is allowed,
causing the the membrane potential to become more negative and resulting in an inhibited
postsynaptic potential (Figure 8).
Figure 8: Schematic of a depolarising and hyperpolarising synaptic potential
Unlike the action potential, whose amplitude is always of the same magnitude, the synaptic
potential is described as a graded potential. The magnitude of the synaptic potential is
variable. It is dependent on the number of vesicles releasing neurotransmitter, which in turn
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is related to the amount of Ca2+ entering the presynaptic axon terminal. Furthermore, a
single synaptic potential is not of sufficient magnitude to reach threshold and generate an
action potential at the axon hillock of the postsynaptic cell. For this reason the temporal, or
spatial, summation of many incoming excitatory potentials is required.
Temporal summation occurs when several action potentials are delivered along the same axon
but separated in time. The rapid firing of action potentials allows more Ca2+ to enter the
axon terminal, releasing more neurotransmitter, which results in an enhanced post-synaptic
potential. This is called potentiation. A similar effect is found with spatial summation, but
in this case the action potentials are delivered from different axons rather than the one.
Inhibitory postsynaptic potentials can also be summed with excitatory postsynaptic poten-
tials. Inhibitory signals counteract the excitatory action potentials and reduce the membrane
potential to prevent threshold from being reached. The Renshaw cell is an example of an
inhibitory neuron. It takes its innervation from the collateral of an α motoneuron and
contains the neurotransmitter γ-aminobutyric acid (GABA). GABA permits the movement
of Cl2− across the postsynaptic cell membrane, thereby acting to reduce the overall membrane
potential. Alternatively, the synaptic potential can also be reduced by presynaptic inhibition.
This occurs when signalling at an axoaxonic synapse reduces the entry of Ca2+ to the
presynaptic axon terminal.
Motor Unit Action Potential
The neuromuscular junction is the synapse between a nerve, such as the primary motor nerve
(α-motoneuron), and a muscle fiber, and it operates in a similar manner to the neuron-to-
neuron synapse (Figure 9).
Figure 9: Schematic of a neuromuscular junction (adapted from Branstrom et al. [183]).
An action potential arriving at the axon terminal of the α-motoneuron opens voltage sensitive
Ca2+ channels. The influx of Ca2+ into the axon terminal causes the synaptic vesicles to
fuse with the axon terminal membrane. The neurotransmitter, acetylcholine, is liberated into
the synaptic cleft and binds to specific receptors on the motor end plate. The motor end
plate is a folded region of the sarcolemma, which itself is the membrane that surrounds the
muscle cell. The binding of acetylcholine allows the influx of Na+ and eﬄux of K+ across
the motor end plate, causing it to depolarise and generate an action potential. The action
potential travels along the sarcolemma and down into the muscle cell via the t-tubules. Upon
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entering the t-tubules, the action potential causes the terminal cisterna, which are reservoirs
located on either side of the t-tubules to release Ca2+ ions into the surrounding intracellular
fluid, called cytosol. The release of Ca2+ into cytosol generates a MUAP which propagates
along the sarcolemma of the muscle cell causing it to contract, in a process described by the
sliding filament theory. The MUAP ends when the acetylcholine dissociates from the binding
receptor on the motor end plate.
A series of MUAP’s occurring in relatively quick succession will result in a sustained
contraction of the muscle fiber. The summation of several MUAP is described as a CMAP.
Figure 10 below outlines how the summation of several MUAP in space and time result in a
CMAP, which can be measured using EMG.
Figure 10: Example of the summation of several motor unit action potentials to give a
compound motor action potential (adapted from Konrad [185]). The compound motor action
potential here is representative of a typical electromyograph.
The motor nerve and muscle fibre that it supplies are one of the most basic functional units
in the nervous system. Combined they form a motor unit. A contraction in skeletal muscle
is detected by sensory receptors that relay information back to the nervous system regarding
the position, location and orientation of the muscle in space, so called proprioception. The
sensory receptors do this by measuring the length, change in length, and tension of the muscle.
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Electromyography: surface Electromyography (sEMG) was recorded using the 8-channel
Bagnoli Desktop EMG system (Delsys Inc., Massachusetts, USA). An amplification of ×0,
100, 1k, or 10k can be set on each channel. On-line cut-off frequencies are 20±5Hz (high-pass
filter) and 450±50Hz (low-pass filter), and system noise within this bandwidth is<1.2µVRMS .
Single-differential, pre-amplified (×10 gain), surface electrodes (DE-2.1) with a parallel bar
configuration and an inter-electrode distance of 10mm were used. A 50.8mm, circular,
reference electrode (PALS Platinum, Axelgaard, Denmark) was used and placed in a region
of low electrical activity, which was taken to be the lateral malleolus of the same limb. To
ensure a high fidelity electromyograph, the skin of each recording site was prepared by gentle
abrasion, using an abrasive gel (NuPrep, Weaver and Company, USA) and cleansing with an
alcohol swab (UHS, UK). Recording electrodes were affixed to the skin using microporous
hypo-allergenic surgical tape (3M Micropore, St.Paul, USA).
Accelerometry: Acceleration was recorded using tri-axial, ±3g, accelerometers (ADXL 335,
Analog Devices Inc., Massachusetts, USA).
Goniometer: A linear potentiometer (Analog Devices Inc., Massachusetts, USA) was
integrated into a knee brace and used to provide real-time visual feedback of knee angle,
by displaying the voltage output on an oscilloscope.
Vibration: WBV was applied using a side-alternating vibration platform (Galileo Basic,
Novotec Medical GmbH, Pforzheim, Germany). Vibration frequencies in the range of 12 -
27Hz, and vibration amplitudes in the range of ±0 - 3.9mm can be applied. The amplitudes
of vibration used in this study were guided by appropriate placement of the feet on designated
markings on the vibration platform. Peak-to-peak vertical displacements at these markings
are ±1, 2 and 3mm respectively.
Support: pBWS was provided using a body weight unweighing system (Loko S70, Woodway
USA Inc, Waukesha, USA). An upper-body harness, fastened around the abdomen and
strapped to the legs allows no- to full- body weight support.
Data Acquisition: All data was acquired at 1kHz, using a 16bit analog-to-digital
converter (DAQCard-6036E, National Instruments Corporation, Texas, USA). Acquisition
was synchronised using the Matlab Data Acquisition Toolbox, data was stored on a laptop
pc, and signal processing was performed using the Matlab Signal Processing Toolbox, Curve
Fitting Toolbox and Statistics Toolbox (MatlabR2010a, The Mathworks Inc., Massachusetts,
USA).
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Figure 11: Platform trajectory along medial-lateral axis recorded from study with
participants with no neurological deficit
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Figure 12: Platform trajectory along medial-lateral axis recorded from study with
participants with a SCI
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Figure 13: Platform trajectory along anterior-posterior axis recorded from study with
participants with no neurological deficit
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Figure 14: Platform trajectory in along anterior-posterior axis recorded from study with
participants with a SCI
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Figure 15: Research ethics approval letter for study which investigated RATTT during early-
stage SCI rehabilitation, page 1 of 3
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Figure 16: Research ethics approval letter for study which investigated RATTT during early-
stage SCI rehabilitation, page 2 of 3
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Figure 17: Research ethics approval letter for study which investigated RATTT during early-
stage SCI rehabilitation, page 3 of 3
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Figure 18: Research ethics approval letter for study which investigated WBV-pBWS in a
general population, page 1 of 2
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Figure 19: Research ethics approval letter for study which investigated WBV-pBWS in a
general population, page 2 of 2
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Figure 20: Research ethics approval letter for study which investigated WBV-pBWS in a SCI
population, page 1 of 4
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Figure 21: Research ethics approval letter for study which investigated WBV-pBWS in a SCI
population, page 2 of 4
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Figure 22: Research ethics approval letter for study which investigated WBV-pBWS in a SCI
population, page 3 of 4
Appendices 242
Figure 23: Research ethics approval letter for study which investigated WBV-pBWS in a SCI
population, page 4 of 4
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SCI Acceleration Analysis
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Figure 24: Average acceleration data recorded during WBV (Phase 2 from Figure 4.4 only)
from the platform (a), foot (b) and VL (c). The data were grouped according to the expected
platform acceleration (atheor) which was calculated using Equation (4.13). The medians of
the grouped data and the corresponding interquartile ranges are shown. Specific vibration
frequency and vibration amplitude conditions may be identifiable by cross-referencing the
atheor values presented on the x-axis above with Table 4.6.
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Figure 25: Frequency data recorded during WBV (Phase 2 from Figure 4.4 only) from the
platform (a), foot (b) and VL (c). The data were grouped according to the vibration frequency
and vibration amplitude set for the test. The medians and interquartile ranges of each set
of grouped data are shown. Note that vibration frequency was transmitted perfectly to each
of the measurement locations in the majority of cases. The interquartile ranges therefore
coincided with the median values.
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Figure 26: Displacement recorded during WBV (Phase 2 from Figure 4.4 only) from the
platform (a), foot (b) and VL (c). The data were grouped according to vibration frequency
and vibration amplitude. The medians and interquartile ranges of the grouped data are also
shown.
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Figure 27: Platform, foot, and VL trajectories were estimated using longitudinal axis
acceleration data recorded from each of these locations respectively during vibration. The
data from each test was averaged for each cycle of vibration and normalised to the
maximum acceleration value rendering them unitless. The data presented in (a), (d) and
(g) were grouped according the vibration frequency and averaged for all participants, tests,
displacements and classification of SCI. The data presented in (b), (e) and (h) were grouped
according to vibration amplitude and averaged for all participants, tests, frequencies and
classification of SCI. The data presented in (c), (f) and (i) were grouped according to
classification of SCI and averaged for all participants, tests, frequencies and displacements.
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SCI Artefact Analysis
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Figure 28: The power of the first 15 harmonics of vibration ±1Hz are presented as a
percentage of total EMG power (Equation (4.5)), for all SCI participants, sessions and test
conditions. Each individual dot is a single data point. The data were grouped according to
the harmonic number and the test epoch: pre-Vibration, Vibration and post-Vibration. The
medians of each grouped data are also shown.
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Figure 29: The integrated contribution of the individual harmonics phn are presented as
a percentage of total EMG power (Equation (4.6)), for all participants, sessions and test
conditions. Each individual dot is a single data point. The data were grouped according to
the harmonic number and the test epoch: pre-Vibration, Vibration and post-vibration. The
medians of the grouped data are also shown.
